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Abstract 
Tryptophan analogues have been shown to play an important role in the binding and 
anchoring of peptides in lipid membranes. Mono-substituted tryptophan derivatives were 
synthesized to study the importance of the relative contribution of electrostatic, quadrupolar 
and induced dipolar interactions to binding. Binding constants for the adduct formation of 
amino acid derivatives, lipid molecules and water with themselves and each other were 
analysed on a molecular level both experimentally, using N M R host-guest titrations and 
isothermal titration calorimetry (ITC), and computationally via molecular dynamics 
simulations. Free-energy calculations support the data presented and allowed a quantitative 
comparison. 
When free energies of the association of 5-monosubstituted tryptophan analogues 
(Figure 0.1) with DMPC lipid molecules were plotted against a measure of electron density 
of the indole ring (the Hammett parameter), an n-shaped pattern was observed. Binding was 
found to increase for substituted amino acid derivatives with maximal responses for the most 
electron withdrawing (5-nitro) and the most electron donating (5-methoxy) compounds. This 
trend was seen both in the titration-data and in the molecular dynamics simulations. The 
latter allowed the sampling of preferred binding conformations and a determination of the 
importance of hydrogen bonding and cation-n interactions for and in adduct formation. 
Additionally, amino acid analogues were incorporated into a model peptide 
(AcWLWLL) to study the electrostatic effects of the substituent's on the peptide-lipid 
interactions in the biologically important lipid bilayer environment. 
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Figure 0.1: Schematic representation o f the research described in this thesis. T ip* stands for 5-monosubstituted 
tryptophan compounds, with the substituent R being H , F, CI , Br, I , Me, MeO or N 0 2 . 
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Chapter 1: Introduction 
1.1 Overview 
This chapter provides the reader with an introduction to the area of peptide-lipid interactions 
(§1.2), their importance in biological systems (§1.2.2.a), and how they have been 
investigated in the past (§1.2.2.b). It also outlines how the research presented in this thesis 
aims to contribute to the field (§1.2.3). An introduction to and background information about 
the key concepts and models important in peptide-lipid research is described in the following 
sections. Membrane structure and properties and the underlying models that describe them 
are presented (§ 1.3), including information about the structure and properties of single lipid 
molecules, and in particular of the lipid used in this study (DMPC) and a short introduction 
to membrane proteins. Details, specific to the synthesis and literature preparation of 
tryptophan derivatives (Figure 1.1) are discussed in §1.4. Subsequently, the model peptide 
A c W L W L L and its characteristics are presented (§1.5). §1.6 of this chapter provides 
information about computational approaches to simulate peptide lipid interactions. A detailed 
breakdown of factors that are important for peptide lipid interactions and their importance for 
tryptophan derivative-lipid interactions (as viewed in the literature) are given thereafter 
Figure 1.1: Common tryptophan derivatives. Tryptophan derivatives commonly carry substitutions on the 
carboxylic acid and the amine functional groups (R t and R 2 respectively) and can exhibit substitutions (R 3 ) on 
the indole ring, which is highlighted here. The tryptophan derivatives synthesised and studied for this thesis are: 
R 3 = F , CI , Br, I , Me, MeO, or N 0 2 , on the indole 5 or 6 position of the indole ring, with R, = O H and R 2 = 
Fmoc, and R, = NHEt and R 2 = Ac respectively. 
(§1-7). 
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1.2 Introduction to Peptide-Lipid Interactions 
1.2.1 Definition of Peptide-Lipid Interactions 
Peptide-lipids interactions (and protein-lipid interactions respectively) have received much 
attention since proteins have been discovered to play a role in the structure and functioning 
of cell membranes in 1972.' The exact nature and strength o f these interactions varies 
between proteins and lipids of different types but is generally influenced by electrostatic and 
non-polar {e.g. hydrophobic) effects. Each amino acid and lipid type may exhibit a different 
relative combination of these forces and may be influenced differently. For tryptophan 
residues, many favourable non-covalent interactions between the aromatic amino acid and 
lipids are feasible. Besides the amphiphilic character of the indole side chain and intrinsic 
polarity, there is evidence for favourable dipolar interactions between the aromatic amino 
acid side chain and lipids 2, and hydrogen bonding with the headgroups or carbonyl groups of 
the lipids or with water molecules in the headgroup region.3 Some of the possible favourable 
interactions (divided into non-polar and polar forces) are discussed briefly here. More detail 
can be found in §1.7. 
1.2.La Non-polar forces 
Non-polar forces can arise from two effects: 
The hydrophobic effect (§1.7.1.a), which favours exclusion of hydrophobic moieties (e.g. 
phenyl ring of the indole) from aqueous solvent. Tryptophan has the largest surface area of 
any natural amino acid, which w i l l favour such an exclusion. 
The lipophobic effect4 (§1.7.1 .b), describes the solvation of uncharged solutes by the bilayer 
lipids. It is the analogue of the hydrophobic effect. The geometry of tryptophan, being rigidly 
planar, may favour localization due to compatibility with the liquid-crystalline-like order of 
the lipid bilayer, which varies strongly with depth in the hydrocarbon core. 
1.2. Lb Polar Forces 
Polar forces can be subdivided into: 
Hydrogen bonding (§1.7.2.a) between the tryptophan residue and lipids. An example of 
such hydrogen bonding includes the N l proton of indole (Figure 1.1) and the lipid carbonyl 
groups located in the glycerol region o f the lipid bilayer. 
2 
Cation-7i interactions (§1.7.2.b) between the aromatic indole ring and positively charged 
choline groups in phosphatidylcholine lipids. 
Electrostatic interactions (§1.7.2.c) include charge-charge interactions between proteins 
and bilayers and electrostatic interactions between the indole dipole moment and the electric 
field of the bilayer. Some lipids carry charged head groups attracting proteins and peptides 
that carry a charge of opposing sign by coulombic interactions. Additionally, phosphocholine 
bilayers normally have a strong positive electrostatic potential in the hydrocarbon core, 
which rapidly drops o f f in the interfacial region. 5 This strong electrostatic gradient (2 < s 
< 80, where s is the dielectric constant) could trap and hold molecules, such as indole, which 
have a large molecular dipole (D ~1.7, where D is the dipole moment). 
Other nonspecific electrostatic interactions between indole and the lipid and water 
molecules o f the interfacial region. For example, simulations indicate that the interfacial 
region possesses a large dielectric (i.e. 80) 6 but a lower surface tension than bulk water.7 
Molecules with a large surface area might prefer to move into the interfacial region to lower 
the free energy of nonpolar solvation, but they might be too polar to move into the low 
dielectric hydrocarbon core region. They are effectively being trapped in the interfacial 
region. 
1.2.2 The Study of Peptide-Lipid Interactions 
1.2.2.a Motivation 
The study of peptide-lipid interactions is of great scientific value, as it provides a simplified 
model system to aid the understanding o f the complex relationship between proteins, their 
folding, association, and integration with lipid membranes. Water-soluble peptides or 
proteins binding to or inserting into lipid bilayers profoundly alter the properties of the 
bilayer. Examples include the activation of some cytosolic enzymes upon post-translational 
insertion of proteins into membranes.8'9 Other peptides act as antibiotics upon partition into a 
bacterial membrane.1 0 Knowledge of the precise nature of peptide-lipid interactions w i l l help 
to gain insights to molecular mechanisms such as the action o f antibiotic peptides, the 
association of proteins used in cell signalling, and membrane fusion. This in turn w i l l aid the 
development of new drugs (such as anti-inflammatories), drug delivery methodology 
(efficient crossing of the drug through the cell membrane or using carrier molecules/particle 
3 
for crossing), and potentially new cancer therapies (binding of proteins and drug molecules 
alters the properties of the bilayer and might lead to its disruption and subsequent 
apoptosis)." 
1.2.2.b Techniques 
Several groups have used different experimental and computational techniques to elucidate 
peptide-lipid interactions in detail. The experimental studies range from site-directed spin 
labelling 1 2, isothermal titration calorimetry ( ITC) ' 3 , infrared spectroscopy14, fluorescence 
quenching 1 5, x-ray 1 6 and neutron scattering1 7, to nuclear magnetic resonance (NMR) 
techniques, in the solid-state18 and via host-guest titrations 1 9. Other techniques that work well 
on water-soluble proteins (e.g. nuclear magnetic resonance (NMR) and crystallography) are 
more difficult to employ due to the hydrophobic nature of the proteins and their tendency not 
to crystallize well in the absence of lipids. Nevertheless, there are a number of protein 
structures published in the protein databank (PDB) that contain one or more bound lipids of 
varying type. 
There have been numerous approaches to simulate peptide lipid interactions varying 
in detail and size of the analysed system as well as in technique. These include coarse-
grained computational analysis of membrane proteins and peptides2 0, molecular dynamics 
and stochastical approaches (for a recent review see Ref. 21). 
1.2.3 Scope of this Thesis 
This thesis aims to investigate the specific influence of tryptophan residues on peptide-lipid 
interactions. In particular, electrostatic interactions of the indole ring of the aromatic amino 
acid with lipids were analysed. This was achieved by synthesis of a homologous series o f 
tryptophan derivatives with monosubstitutions on the 5 and 6-position of the indole ring, 
altering its electron density to access electron rich compounds (such as derivatives carrying a 
methoxy group) and electron poor compounds (such as derivatives carrying a nitro 
functionality) (see §2.2). The synthesis demonstrates an improved version of the original 
Snyder et al." synthesis, building on the expertise from Yokoyama et al. The tryptophan 
derivatives (A^-acetyl-L-tryptophan ethyl amides) were designed to mimic the non-terminal 
tryptophan residue in proteins. 
4 
N M R host-guest titrations and isothermal titration calorimetry (ITC) were employed 
as experimental tools to determine binding constants of tryptophan-lipid adducts in the non-
competitive solvent chloroform (see §2.3 and §2.4). Additionally, these interactions were 
modelled using molecular dynamics (MD) simulations helping to visualise and study 
interactions on a time-scale inaccessible by experiment and to gain insight into the binding 
conformation of key adducts (see §2.5). Furthermore, computations allowed the calculation 
of free energies of association by using thermodynamic cycles (see §2.6). Tryptophan 
derivatives were also incorporated into a model peptide (AcWLWLL) and its binding to a 
DMPC bilayer analysed (§2.7). 
The obtained data allowed a detailed analysis of the electrostatic influence o f the n-
electron system of the tryptophan derivatives and the importance of hydrogen bonding in 
various complexes (see §Chapter 3). The information gained, also helps to understand the 
underlying principles of tryptophan-lipid interactions. As tryptophan has been shown to play 
an important role in the anchoring, localisation and orientation of proteins in lipid bilayers 
and membranes (§1.4.2), this research has implications for the wider field of peptide-lipid 
binding. 
1.3 Introduction to Membranes 
1.3.1 The Structure of the Membrane 
A l l cells are surrounded by a membrane, which separates cellular contents from the external 
environment and forms special compartments within the cytoplasm (the interior of a cell) that 
separate various cellular processes from the remainder of the cell (e.g. respiratory 
mitochondria). The membrane itself consists of a semi-permeable lipid bilayer, which is a 
complex, dynamic system with unique structural and mechanical properties which are critical 
to membrane organization and function. 2 4 The types of the lipids present in the bilayer and 
their relative ratios affect the partitioning of peptides and proteins into membranes2415 (Figure 
1.2) and hence the proper functioning of membrane receptors, channels and enzymes depends 
on the composition, structure and mechanical properties of the bilayer. 2 5 
5 
Figure 1.2: Model representation of a membrane. Blue circles represent the head group of a lipid to which two 
fatty acyl chains are attached. Red barrels represent trans-membrane proteins, while green barrels depict surface 
proteins. (Figure adapted from Ref. 19) 
The membrane itself is formed by a two molecule thick bilayer o f lipids (between 4 -
8 nm), which are mainly phospho- and sphingolipids (Figure 1.2).26 A schematic picture o f a 
general lipid molecule (Figure 1.4) and a description o f its properties are given in §1.3.4. The 
essential structure o f the bilayer was suggested by Goiter and Grendel (1925) who 
discovered that a cell membrane consisted o f "a layer o f fatty substances that is two 
molecules thick". 2 7 Later, in 1935, Danielli and Davson 2 8 proposed a model for the 
membrane that suggested a lipid bilayer core that is coated with protein on either side. This 
model was subsequently refined to the model that is used today: the fluid-mosaic model 
(§1.3.2), devised by Singer and Nicolson in 1972.1 
The stability and form o f the membrane is mainly determined by the aggregation behaviour 
of the lipid to form a bilayer; length and degree o f saturation o f the lipid acyl chains 
determine the thickness and ordering o f the hydrophobic region o f the membrane. 
1.3.2 The Fluid-Mosaic Model 1 
The fluid-mosaic model explains the structure o f biological membranes including those o f 
animals, plants, and microorganisms. Since its introduction, no modifications of the model 
have been necessary. The fluid-mosaic model assumes that the amphipathic lipid molecules 
form a bilayer with a tail-to-tail arrangement (Figure 1.2). The driving force for this 
association arises from a favourable like-with-like arrangement that keeps the hydrophobic 
fatty acyl chains, the tails o f the lipid molecules, segregated from the surrounding aqueous 
6 
fatty acyl chains, the tails of the lipid molecules, segregated from the surrounding aqueous 
environment. This also allows the polar heads of the lipid molecules (hydrophilic groups 
such as choline) to interact favourably with the water they are exposed to. 
The model states that the lipid molecules as well as the proteins embedded and 
associated with the membrane are mobile and diffuse freely, both retaining their vertical 
orientation within the bilayer during this process. The lipid molecules diffuse about 100 
times faster than an average membrane associated protein (D p r o t e in = 10 pm cm"2, ^phospholipid = 
1000 pm cm"2; where D is the diffusion constant). The lipids in the membrane can exist either 
in a gel-like (solid) state or in a liquid-like (liquid crystalline) state, which gives the lipid 
molecules more mobility. In living cells, the membrane seems to be in a transition between 
the two states, depending on physical conditions and the lipids and proteins that are present 
in the membrane layer. 
The fluid-mosaic model was confirmed experimentally by fusing two cell membranes 
together that each carried distinct, labelled proteins. These proteins were found equally 
29 
distributed over the newly created cell membrane, confirming the diffusion of the proteins. 
Similarly the diffusion of lipid molecules may be demonstrated. 
1.3.3 Properties 
The bilayer itself is constituted of amphipathic lipid molecules which are comprised of a 
polar, hydrophilic head group and non-polar, hydrophobic fatty acid chains. This gives rise to 
a complex environment of hydrophobicity (the bilayer interior), hydrophilicity (aqueous 
environment on either side of the membrane) and a complex water-lipid interface of polar 
lipid head groups and interfacial water molecules (see Figure 1.3, A) . There is a steep 
polarity gradient across the interfacial region from highly non-polar ( f = 2 ) near the 
hydrocarbon core o f the bilayer to highly polar {s = 80) near the aqueous outer sides of the 
membrane, where £ is the dielectric constant.30 The bilayer essentially functions as an 
electrical isolator separating aqueous environments (Figure 1.3, B ) . Only small, hydrophobic 
particles can diffuse through the bilayer. 
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Figure 13: Hydrophobicity profile of a bilayer. A represents the structure of a fluid DOPC bilayer. Its polarity 
profile is shown in B. (Adapted from Ref. 31) 
The lipid-water interfacial region accounts for 50% o f the thermal thickness o f the 
bilayer 3 2 and highly influences and promotes the binding and folding o f proteins and peptides 
and determines their precise orientation in the membrane. 3 3 ' 3 4 
1.3.4 Lipids 
1.3.4.a General Structure and Overview 
A lipid molecule is comprised o f a polar head group, a linkage region and one or two fatty 
acyl chains (see Figure 1.4, A ) . Lipid molecules can be classed according to the differences 
in the various regions such as varying head groups and linkage regions (sphingolipids and 
phospholipids (Figure 1.4, B ) , fatty acyl chain length and degree o f saturation. 
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Figure 1.4: A schematic picture of a typical lipid molecule is given in A. B shows the chemical structure of the 
most common lipid types in cell membranes (sphingo- and phospholipids) with their major differences 
highlighted in orange. C depicts DMPC, as a typical example of a choline phospholipid; the polar choline head 
group (red), the phosphate group (green), the glycerol linker (blue) and the two fatty acid chains (black) are 
highlighted. 
The hydrocarbon chains differ in their chain lengths from Cu to C26 including 
significant, but not predominating chains o f odd carbon numbers.3 5 In mammalian 
cerebrosides, typically sphingosine is linked to fatty acids o f 16-24 carbons, which may be 
a-hydroxylated. 3 6 In yeast, longer chain fatty acids of 26 carbons predominate, the majority 
o f which are hydroxylated at the a-position. 3 7 In plants saturated Ci6, C20, C22 and C24 a-
hydroxylated fatty acids are the most abundant.36 
1.3.4.b 1,2-Dimyristoyl-sn-glycero-phosphocholine (DMPC) 
The lipid used in this study (1,2-dimyristoyl-sw-glycero-phosphocholine, DMPC) is a neutral, 
zwitterionic, ful ly saturated lipid with two C14 hydrocarbon tails (Figure 1.4, C). Depending 
on the temperature and other, external factors (such as the degree o f hydration), aqueous 
dispersions o f DMPC can exist under at least three lamellar phases.38 In both the gel phase, 
Lp>, and the 'rippled' phase, Pp>, in which the membrane adopts a wave-like interface, the 
phospholipids are tilted with respect to the lamellar plane. In the liquid crystalline lamellar 
phase L a , the molecules align themselves perpendicular to the lamellar plane. The main 
transition temperature from the gel to f luid phase for pure DMPC was found to be at 24 ° C . 3 9 
9 
In apolar solvents, such as chloroform, DMPC forms inverse micelles in which the 
hydrophobic lipid tails are directed towards the solvent, burying the polar head groups in a 
central sphere to avoid enthalpically unfavourable solvent contacts o f the latter (Figure 1.5). 
Figure 1.5: Schematic of an inverse micelle, which is formed by certain lipid molecules (such as DMPC) in 
non-polar solvents (e.g. chloroform). Figure was adapted from Ref. 40. 
Haque et al.AX using N M R studies o f DMPC in chloroform, suggested that there are 
three lipids per "micelle". Hydration studies on the closely related l,2-dipalmitoyl-.s'H-
glycero-phosphocholine (DPPC) lipid in chloroform indicated that, contrary to the 
aggregated DPPC, the monomers o f DPPC do not appear to be hydrated. 4 2 Evidence for this 
was given through the *H chemical shift and spin-lattice relaxation time of water and the 3 1 P 
chemical shift o f the phosphatidyl group of DPPC. 
13.5 Membrane Proteins 
Proteins which are interacting with the bilayer can be distinguished into two categories: 
Integral (membrane-spanning) proteins and peripheral proteins, which are bound to the 
surface and are inserted in the bilayer but only traverse one side o f it. It is estimated that 
approximately 30% o f genes may encode membrane proteins. 4 3 ' 4 4 
It was shown that the folding o f membrane proteins into the bilayer can occur 
spontaneously, as is the case for pore-forming toxins 4 5 , or through a series o f protein-
catalysed steps.46 The folding appears to be governed by three steps7b: Binding of the protein 
to the membrane interface, formation o f secondary structure, and insertion o f secondary-
structure elements into the membrane. However, other mechanisms and order might occur. 
The precise nature o f the favourable interactions and the origin o f the free energy gain for 
inverse micelle 
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prospnate head 
hydrophobic (nonpolar) 
fatty acid tail © 2005 Encyclopedia Britannica, Inc. 
proteins upon interaction with lipid bilayer is still being investigated by various groups (see 
§1.2.2.b). 
1.4 An Introduction to Tryptophan - Importance, Synthesis and Uses 
1.4.1 The Amino Acid Tryptophan - An Overview 
Tryptophan is synthesised by bacteria and plants only and, as an essential amino acid, is a 
required ingredient in the diet of all animals. It is the second least abundant of the common 
amino acids, generally constituting 1% or less of the average protein mass.47 Some proteins 
contain no tryptophan residues at all. For example, two of the tryptophan biosynthetic 
enzymes in Escherichia coli, anthranilate synthase (520 residues) and the a subunit of 
tryptophan synthase (268 residues) do not contain any tryptophan residues. 4 8 ' 4 9 However, 
proteins with an unusually high content of tryptophan such as /?-galactosidase (38 of 1021 
residues, 3.7%) are also known. 5 0 
In bioenergetic terms, tryptophan is the most expensive amino acid to produce: each 
mole o f tryptophan requires 78 moles ATP. 5 1 This energy cost is 20% higher than that for the 
biosynthesis of the second most costly amino acid, phenylalanine, and approximately double 
the biosynthetic energy of the average amino acid. The complex biosynthesis of tryptophan is 
split in two parts. The Shikimate pathway describes seven enzyme-catalyzed steps in the 
synthesis of chorismate, the last common precursor of the aromatic amino acids. The 
elaboration into tryptophan requires five more enzyme-catalyzed reactions. 
Tryptophan has the largest nonpolar surface of all of the naturally abundant amino 
acids. However, its side chain is also capable of forming hydrogen bonds through its N H 
group. This gives rise to an ambivalent behaviour of tryptophan, and its hydrophobicity is 
ranked very differently on different hydrophobicity scales, which are generally based on the 
partitioning of single tryptophan molecules between polar and nonpolar solvents. 3 2 , 5 3 
1.4.2 The Role of Tryptophan 
In 1989 the first high-resolution, 3D structure of a membrane protein revealed a statistical 
anomalous over-representation of tryptophan at the putative interface between the polar 
aqueous environment and the more apolar interior of the lipid membrane.5 4 Since then this 
asymmetric pattern has been seen in an increasing number o f membrane peptides, not only 
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for tryptophan, but also for tyrosine and phenylalanine. ' For example, crystal structures o f 
membrane proteins such as the bacterial KcsA potassium channel, 5 7 maltoporin 5 8, 
bacteriorhodopsin5 9, and others show aromatic residues preferentially clustered in a saddle-
like "aromatic belt" around the membrane interfacial region. Statistical studies6 0 o f sequence 
databases (such as the Protein Data Bank (PDB)) and available crystal structure o f integral 
membrane proteins gave further support to this preferred localisation o f tryptophan residues 
in the regions where the protein intersects the membrane interface region (Figure 1.6).1 4 9 
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Figure 1.6: Schematic representation of an cc-helix transmembrane segment inserted in a lipid bilayer. The 
interfacial areas and hydrocarbon core of the bilayer, consisting of D M P C phospholipid molecules, are 
highlighted. The preferred locations of a number of amino acids are illustrated. (Figure adapted and modified 
fromRef. 61) 
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It is believed that the aromatic amino acids can assist in stabilizing the protein in the 
membrane 6 2 ' 6 3 ' 5 6 and that they are essential for the proper function of membrane proteins. 6 4 ' 6 5 
It was further proposed that tryptophans are involved in the ability of trans-membrane a-
helical peptides to induce non-bilayer structures in model membrane systems under 
conditions of hydrophobic mismatch. 6 6 ' 6 7 For membrane-active water-soluble proteins, 
tryptophans are likely to play an important role in membrane interaction. An example of the 
functional importance of tryptophan residues in membrane proteins is the gramicidin A 
channel. Here, tryptophan residues have been shown not only to be important for the 
anchoring of the protein in the membrane6 8, but also to increase the ion permeability through 
the channel. 6 9 This was demonstrated by substitutions of tryptophan residues with a more 
polar tryptophan derivative (5-fluoro-tryptophan), which increased the conductance of the 
channel. Another example is the signalling helix of the aspartate receptor of bacterial 
chemotaxis, where the position of aromatic residues in relation to the membrane interface is 
critical for its activity, as revealed by mutagenesis studies.70 
These examples illustrate the preference of tryptophan residues to reside in the water-
lipid interface of the membrane. This is further corroborated by the observation that 
tryptophan residues, when placed into the centre positions of hydrophobic membrane-
spanning helices, can pull these helices out of transbilayer orientations and into interfacial 
orientations showing a strong disfavour for the hydrocarbon core of the membrane.71 Another 
study by Shank et al.72 concluded that the introduction o f aromatic residues in synthetic 
channel-forming sequences optimized membrane insertion, orientation, and channel activity 
as a result of the efficient anchoring of the sequence at the membrane interface. 
Recent studies have tried to elucidate and analyse the nonuniform distribution of 
tryptophan and its strong preference for the interfacial region in different model systems. The 
most commonly used model system employs glycerophospholipids. 2 4 b ' 7 3 
1.4.3 Synthesis of Tryptophan Derivatives 
There are two basic routes to produce tryptophan derivatives: One is based on the enzyme 
tryptophan synthase and uses biological conditions to express various tryptophan derivatives 
mostly employing simple indole derivatives as substrate. The other methodologies are all 
based on a chemical synthesis. Here, there is a trend to exploit the same general idea of 
coupling indole derivatives to serine, amino acrylate or nitroacetate/paraformaldehyde 
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analogues. Alternatively, tryptophan analogues have been synthesised using metal catalysed 
reactions. Examples of such approaches are highlighted and their advantages/disadvantages 
discussed in the following sections. 
1.4.3. a Biological Approaches 
A l l enzymatic approaches to synthesise tryptophan derivatives are based on tryptophan 
synthase, which can be extracted from various sources. Tryptophan synthase (/.-serine 
hydrolase, EC 4.2.1.20) was first recognized by Tatum and Bonner (1943-1944) who 
demonstrated the ability of extracts of Neurospora crassa to catalyze a condensation between 
indole and L-serine to yield /--tryptophan. The enzyme also catalyses the final step in 
tryptophan synthesis (the replacement o f the triosephosphate side-chain of indole-3-glycerol-
phosphate by Z-serine). Wi lcox 7 4 used this enzyme to produce tryptophan analogues with 
moderate yields (43-85%). 
In the most recent synthesis, tryptophan synthase was extracted from a pellet of E. 
coli pSTB7 by sonification. 7 5 The crude cell lysate was then used as a reagent for the 
conversion of monosubstituted indoles to Z-tryptophan derivatives using L-serine as substrate 
(Scheme 1.1). 
e HO C O , X Cell lysate containing tryptophan synthase NH e 37 °C, 3 days H,N co; 
N N 
H H 
Scheme 1.1: /.-tryptophan derivatives were synthesized using mono-substituted indole derivatives (X = F, CI, 
Br in positions 4, 5, 6 and 7), /.-serine and tryptophan synthase in buffer solution. 
The advantage o f the methodology is the direct, one-pot synthesis of enantiomerically pure 
free amino acid derivatives. However, the scope of the reaction is limited by the substrate 
specificity of the tryptophan synthase. Sterically hindered indole derivatives are only 
converted very poorly or not at all (e.g. 4-bromoindole and 7-chloroindole lead to yields of 
< 10%). Other indole derivatives proved more suitable with yields of up to 82% after one 
cycle (6-fluoroindole). It was found that substrates which have nitrogen for carbon 
replacements adjacent to the position (3-) where condensation occurs are either completely 
unreactive (pyrimidazole) or convert only very slowly (2-azaindole).7 4 The author (Wilcox) 
suggested that the electronegativity of the nitrogen leads to a withdrawal of electrons and 
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hence a deactivation of the reactive 3-position. Methyl substituted indoles are not susceptible 
to conversion either, having reported yields ranging from 4% (5-methylindole) to 24% (7-
methylindole). 7 6 Another limiting factor of the enzymatic methodology is the breakdown of 
serine, either by deamination 7 7 or in a reaction catalysed by some other activity present in the 
enzyme preparation. Even though the yield of the enzymatic reactions can be improved by 
recycling unreacted starting material and submitting it to the reaction more often, this 
methodology does not seem suitable for the large scale production of a varied series of 
tryptophan derivatives due to the restrictions the enzyme places. 
1.4.3.b Chemical Approaches 
A successful chemical synthesis of A^-acetylated tryptophan was introduced by Snyder et al. 
in 19 5 5. 2 2 The authors reported the reaction of indole with a-aminoacrylic acid to yield the 
desired product (Scheme 1.2). 
CO,H 
NHAc 
A c , 0 
AcOH, 96 °C, 20 min 
C O , H 
NHAc 
Scheme 1.2: cc-Amino acrylic acid can be reacted with indole to form A^-acety I-tryptophan in moderate yield. 
Even though the yield was moderate (58%), others : improved the reaction further, also 
demonstrating that substituted indole derivatives could be used in this methodology. 
Recently, Sui et a/.7 8 offered a variation o f the approach in which indole derivatives 
are reacted with nitroacetate and paraformaldehyde to produce ethyl 3-(lH-indol-3-yl)-2-
nitro-propanoate derivatives (Scheme 1.3). 
„ C 0 2 E l + (Cl-10)„ 
4A MolS 
loluene. 70 C 
CO,Et 
NO, 
Scheme 1.3: Schematic reaction scheme of indole reacting with nitroacetate and paraformaldehyde, where 
MolS stands for molecular sieves and R| = H, Br, OH, OMe, C 0 2 M e . 
Molecular sieves had to be added to improve the yield of the reaction by trapping the 
generated water which is liberated in the nitroaldol condensation. The reaction has the 
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drawback that the nitro group needs to be reduced to the amine in order to access free amino 
acid tryptophan analogues. It also requires at least one further step of optical resolution i f one 
is interested in enantiomerically pure products. 
Zembower and Ames 7 9 demonstrated the use of cyclic tryptophan tautomers in the 
derivatisation of tryptophan compounds (Scheme 1.4). The tautomers were treated with 
iodine monochloride resulting in a 5-iodo substituted tautomer. Then, cross-coupling with 
arylboronic acids or 5-alkyl-9-bora-bicyclo[3.3.1]nonane (9-BBN), catalyzed by 3 mol% 
[bis(l,r-di-phenylphosphino)ferrocene]palladium(II) chloride (PdCh (dppf)), afforded 5-
aryl and 5-alkyl cyclic tryptophan tautomers that were decyclised and deprotected to yield L-
tryptophan derivatives in 33% overall yield. 
CO,Me C O , Me H H 
N • CO,Me 
I. 85% H.PO NCO,Me I-CI.DCM NCO,Me 
2. A c O 
N N H N H H Ac Ac 
C O , H 
CO,Me CO,Me H H 
PdCMdppf) NH, NCO,Me NCO,Mc RB(OH), or 
KB-(9-BBN) N H N N Ac K , C O , / D M F , 80 °C Ac H 
Scheme 1.4: Synthesis of 5-substituted tryptophan analogues using tryptophan tautomers and palladium cross-
coupling of boronic acids. 
Even though this synthesis provides an elegant solution to produce a variety of 5-substituted 
tryptophan derivatives, it is limited to this position and with the need of decyclisation and 
deprotection additional steps that lowered the overall yield noticeably. 
Recently, a palladium-catalysed direct annulation reaction of substituted ortho-
haloanilines and aldehydes was shown to be a viable route for the synthesis for tryptophan 
compounds (Scheme 1.5). 
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C0 2Me 
PdfOAcK D A B C O 
CO,Me 
DMF. 85 U C 
N 
N N<B0C), H 
N(Boc)2 
Scheme 1.5: Palladium-catalysed direct annulation of substituted or/Ao-haloanilines and aldehydes to produce 
A/a-Boc2-Z.-tryptophan methyl esters. D A B C O stands for 1,4-diazabicyclo[2,2,2]octane; R, = 4-, 5- or 6-MeO, 
5- or 6-N0 2 , or 6-C1; R 2 = H or Me. 
The authors could synthesise enantiomerically pure A^-Boc-protected Z-tryptophan 
derivatives in good to excellent yield (51-85%) using enantiomerically pure methyl (5)-2-
AyV-di-ter/butoxycarbonyl-5-oxopentanoate. The deprotection of the carboxylic acid and the 
amine functionalities and potentially the indole amine then introduces additional steps for the 
access of free L-tryptophan derivatives using this route. 
1.4.4 Uses of Tryptophan Derivatives 
Apart from its synthetic use as protein and peptide building block, tryptophan provides a 
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biosynthetic precursor for many naturally occurring alkaloids. Furthermore, tryptophan 
analogues have been used extensively to probe biological systems: a-Tryptophan was 
reported to inhibit the growth of Bacterium coli82 and can be used as IDO inhibitor. 8 3 Methyl-
substituted indoles inhibit the biosynthesis of tryptophan and are employed to elucidate the 
mechanism and detail of tryptophan biosynthesis.7 6 6-Chlorotryptophan has been identified 
• • 84 
as a non-nutnttve sweetener. 
The physical properties of tryptophan were also exploited extensively: Tryptophan 
molecules absorb strongly in the region between 275 and 280 nm and make up a large 
contribution to the ultraviolet absorption of protein molecules. These luminescence 
properties can be employed to study membrane-interactions (tryptophan is arguably the most 
frequently used tool for examining the interactions of proteins and peptides with vesicular 
unilamellar model membranes).85 The fluorescence lifetime and quantum yield, are 
environmentally dependent, and can be used to determine its membrane/water partition 
coefficient. 8 6 ' 8 7 In addition, spectral shifts undergone by the emission spectra of tryptophan 
residues, as well as changes in accessibility to aqueous quenchers can be exploited to 
characterize peptide membrane binding. The peptides either naturally contain one or more 
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tryptophan residues or are engineered (e.g. mutated) accordingly. Tryptophan has also been 
found to be an ideal optical probe for hydration dynamics and protein-water interactions.8 8 
1.5 The Model Peptide AcWL WLL 
Biomembranes present a complex environment in terms of the diversity and size of their 
components. It is therefore difficult to obtain detailed and unambiguous information about 
individual interactions of peptides with the lipid bilayer. Therefore, simplified model systems 
need to be established, where structural parameters (such as the lipid size, type and 
composition) can be systematically altered allowing the various effects of these alterations to 
be studied in detail. Analogously, the interacting peptides can be adjusted and the resulting 
effects analysed at a molecular level. A simplified membrane system should consist of a 
model lipid bilayer consisting of only one or two lipid species. Model peptides should be 
small enough to avoid the formation of complicated tertiary structures or aggregates and 
ideally interact with the membrane in a well-defined manner. The interactions between a 
peptide and the lipid interface wi l l be easier to study i f there are no side effects such as 
partitioning and/or aggregation of the peptide on the membrane which w i l l have significant 
effects on the binding and interaction with the membrane and would complicate any direct 
measurements. The peptides may also include reporter amino acid residues (such as 
luminescent tryptophan) or tags to allow a detailed experimental analysis. 
The pentapeptide Ac-Trp-Leu-Trp-Leu-Leu-OH (AcWLWLL, Figure 1.7) fulf i l ls all 
these requirements. 
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Figure 1.7: Model peptide A c W L W L L . A depicts two major confomers of the A c W L W L L as determined by 
molecular dynamics simulations of the pentapeptide in SPC water (§5.1.4.c). B shows the chemical structure of 
A c W L W L L . 
The lack o f secondary structure o f this peptide was determined by White and 
Wimley. 8 9 The authors showed A c W L W L L to be strictly monomeric and random coil in 
aqueous phases using CD spectroscopy, which showed minima at -200 nm and intensities o f 
about -20,000 deg dmol" cm" f both strongly characteristic o f random coil peptides. 
Isothermal titration calorimetry indicated that there is no significant aggregation o f the 
peptide even in a saturated solution as no detectable heat change was observed when the 
concentrated solutions were injected into buffer solution. 9 0 Further support was given 
through fluorescence spectroscopy and quenching studies.90 
It was shown previously that A c W L W L L partitions into a lipid bilayer and the 
partitioning is independent o f the peptide concentration.9 0 The partition coefficient is around 
0.025 at room temperature. It was also demonstrated that the partitioning o f A c W L W L L 
depends only weakly on temperature and decreases with increasing temperature with the 
partition coefficient changing only from -0.038 at 5 °C to -0.018 at 65 ° C . 8 9 White and 
Wimley could calculate the partitioning free energy o f A c W L W L L from water into octanol 
(AGwater-octanoi = 2.96±0.01 kcal mol" 1) and into a POPC bilayer phase (AGwater.Popc = -
1.85±0.06 kcal m o f 1 ) by comparison to the free energy o f the partitioning o f other 
pentapeptides o f the A c W L - X - L L family, where X stands for any o f the 20 amino acid 
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residues.91 Contents leakage of lipid membranes that can be induced by some pore-forming 
peptides was shown to be very inefficient and low for AcWL W L L . 9 2 
The peptide under investigation (AcWLWLL) is very similar in sequence, length and 
hydrophobicity to the hexapeptide A c W L 5 , which was extensively analyzed by the 
researchers mentioned above. 9 0 ' 9 3 While A c W L 5 assembles cooperatively into /^-sheets upon 
partitioning into a lipid bilayer from an aqueous phase where the peptide is strictly 
monomeric and random coil, the A c W L W L L pentapeptide does not aggregate nor form 
j 90 
secondary structure. 
/ . 6 Computational Studies of Peptide-Lipid Interactions 
1.6.1 Introduction 
The advantage of computational studies is the ability to describe both detailed 
thermodynamic and fast kinetic aspects o f binding interactions. Binding interactions between 
pairs of atoms, molecules and entire complexes can be simulated and analysed with relative 
ease. Molecular dynamics simulations also give a unique insight into binding conformations 
of complexes and their dynamics on a time scale from pico- to sub microseconds. The main 
disadvantage is the computational cost associated with the simulation of larger systems (such 
as wide arrays of lipid bilayers). This often leads to a compromise between a) the level of 
atomic detail of the lipid representation (e. g. all atom vs. united atom or coarse grained 
approaches), and b) the computed internal degrees of freedom for proteins and the number of 
simulated particles. In this section, the main parameters used in computational studies are 
introduced and discussed. A detailed break-down of the parameters used in this thesis are 
given in the appropriate sections (§5.1 and following). 
Here, molecular dynamics simulations were used to simulate i) the binding of 
tryptophan derivatives to DMPC lipid molecules in chloroform at varying concentrations, i i) 
the importance of water on these interactions, i i i) the self-association of tryptophan 
compounds in the absence of lipid, and iv) to simulate peptide-lipid interactions of model 
peptides with a DMPC bilayer in SPC water. Details of set-ups and results can be found in 
(§5.2 and §2.5 respectively). 
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1.6.2 Molecular Dynamics (MD) Simulations 
1.6.2.a General Overview 
In molecular dynamics simulations, all atoms are treated as classical particles with their 
elemental mass. The interactions between atoms are expressed as non-bonded interactions, 
for any pair of atoms within a pre-defined cut-off radius, and bonded interactions between 
atoms connected by a chemical bond. Each atom gets assigned a partial charge (usually 
derived from ab initio calculations of the molecule) and parameters for repulsion and 
attraction (such as Lennard-Jones parameters) to compute non-bonded interactions. Bonded 
interactions are usually described by harmonic oscillators for bonds and angles and by a 
suitable cosine expansion for dihedral angles. The parameters and equations used in the 
simulations of this thesis are described in detail in §5.1. The following assumptions are 
commonly employed: 
1) Only pair-additive interactions are taken into account. This means that non-bonded 
interactions involving three or more atoms (multi-body interactions) are neglected. 
2) Atoms are represented as partial charges. This assumption neglects the effects of 
electronic polarizability which could be introduced using dummy atoms that are 
coupled to electronegative atoms by a harmonic oscillator and represent a partial 
charge in close proximity, approximating dipolar effects. 
3) Simple harmonics are used represent bonds and angles. Other models (such as a 
Morse potential94 or other anharmonic descriptions) give better descriptions of bond 
lengths and angles at an increased computational cost. 
The potential functions are combined in the so-called force field (§1.6.3) and then used to 
solve Newton's equations of motions for all atoms in the system by calculating the forces on 
all atoms and integrating with respect to time. Such treatment, in principle, allows simulating 
the dynamics of any system that can be described in terms of a simple interaction potential.95 
The output (trajectory) of a molecular dynamics simulation contains the xyz coordinates of 
all atoms and their respective velocities as a function of the number of integration steps (i.e. 
time). 
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1.6.2.b Limitations 
Parameter isation 
The limitations of molecular dynamics simulations originate from the need to parameterize. 
The parameters used to describe, for example the Lennard-Jones potential, are mainly 
derived from experimental values. A parameter set for a given system will be adjusted to 
reproduce macroscopic, experimentally detectable quantities including density, heat of 
vaporisation, and in the case of lipid bilayers area per lipid and lipid order parameters. These 
empirically adjusted parameters are therefore able to reproduce the averaged global factors of 
a system, but it is difficult to estimate and represent local effects. This holds especially true 
for assumption 2) (§1.6.2.a); the assignment of partial charges and their parameterisation 
leads to the effect that atomic polarizability is not accounted for properly and even though 
the average effects of polarizability are retained in the system, detailed effects are not 
properly represented. Furthermore, the height of barriers in the dihedral potentials and exact 
values for the representation of van der Waals forces are difficult to determine exactly. This 
makes extensive testing of the parameters necessary. In this study, the parameters used were 
obtained from the literature and have been tested extensively elsewhere (as described in 
§1.6.3). 
Time Step 
Another limitation in molecular dynamics simulations is the integration of the equations of 
motions. If the time step with which an integration is performed is chosen to be too large, the 
system becomes unstable. A typical value is 2 fs (as chosen in this study). However, the use 
of constraints can potentially increase the time step to up to 5 fs. In any case, a reasonably 
long (10-100 ns) molecular dynamics simulation will still require hundreds of thousands of 
computationally expensive integration steps, limiting the length and system size of the 
calculation. Typically, MD simulations do not exceed 100 000 simulated particles and are 
restricted to about 100 ns. 
Classical Treatment 
The approximation of bonded interactions to be described by harmonic oscillators makes the 
study of chemical reactions by pure molecular dynamics simulations impossible: The 
harmonic description prevents the breaking of bonds (dissociation of atoms). This problem 
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might be overcome by using more appropriate descriptions of bonded interaction at a 
computational expense or by describing at least part of the system quantum mechanically. 
1.6.3 Force Fields 
Atomistic simulations require expressions for the potential energies between all atoms in the 
system as input parameters, including the energies between bonded pairs of atoms and non-
bonded pairs of atoms (Equation 1.1). Generally, harmonic potentials model chemical bonds 
(Vb) and angles (Va) whereas non-bonded interactions are approximated using coulombic 
(Vc) and Lennard-Jones potentials (Vu), which model interactions due to polarization effects 
between atomic electron clouds. Dihedral functions (proper Vpj and improper dihedral 
potentials Vi(j respectively) model interactions between next-nearest neighbour atoms on the 
same molecule. The potential function Vpo, of a system can be described as 
V^-Vt + V.+V^ + Vy + Vc + Vu. (1.1) 
The set of functions, and the parameters characterizing the strengths of the various 
interactions, is commonly referred to as a 'force field'. Most common force fields share 
common assumptions such as a simplified treatment of electrostatic interactions as point 
charges centred on atoms, which probably poses the most serious simplification as it ignores 
higher multiple interactions and the details of electronic polarizability, limiting the accuracy 
of properties such as the relative orientation of aromatic residues, interactions with ions, and 
likely the solvation free energy of amino acid side chains in solvents of different dielectric 
constants. 
Simulation packages such as A M B E R 9 6 , C H A R M M 9 7 , G R O M O S 9 8 , and special force 
fields have been introduced to analyse different kind of structures such as lipid bilayers and 
are generally developed independently from each other and tested against experimental data. 
There are only two phospholipid force fields in common use today: The official all-atom 
CHARMM distribution and a parameter set that was developed by Berger et al." using 
parameters taken from united-atom versions of O P L S 1 0 0 and AMBER. Both force fields 
simulate lipids that reproduce experimental information on the structure and dynamics of 
phospholipid bilayers reasonably well, particularly for phosphatidylcholine bilayers. None of 
the force fields seem to perform substantially better or worse than the other in terms of 
reproducing benchmark parameters such as the lipid order parameter or the area per lipid. 1 0 1 
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There are also differences in the detail of the atomistic descriptions: An all-atom description 
has been used extensively102 as well as a unified description of C H n groups, which may be 
further separated into the united atom 1 0 3 or the anisotropic united atom 1 0 4 model. 
1.6.4 The Canonical Ensemble 
Three alternative canonical ensembles have been used in simulations of lipid bilayers so far: 
constant number of particles at constant volume and constant temperature (NVT); constant 
isotropic pressure {NPT); and constant surface tension which is equivalent to a constant 
anisotropic pressure (NyT). Different methods of implementation of the ensembles have been 
used by Feller et al.W2d and Zhang et al.105 As reviewed by Berger et al." and Tieleman and 
Berendsen95 the most appropriate method seems to be an NPT ensemble as detailed briefly 
below. 
In the NVT ensemble constant volume requires that the dimensions of the simulation 
box are constant. Although this is the standard condition for simulations of a protein in a 
crystal lattice,99 it is less appropriate for a lipid bilayer, because the dimensions of the box are 
determined by the area and length per lipid, which are not well known. Moreover, the bilayer 
can undergo phase transitions which involve changes in dimensions that would not be 
represented accurately within such an ensemble. 
In the constant pressure ensemble (NPT) one has to consider that the pressure might 
be better represented as being anisotropic. The symmetry of the surface and the condition of 
mechanical equilibrium leads to a diagonal pressure tensor with a constant normal pressure 
that is equal to the external pressure and a pressure P t in the two transverse directions, 
which may depend upon the depth of the bilayer. 
The NyT as used by Chiu et al.106 has the disadvantage that it may not accurately 
represent the fact that lipid bilayers are free to adjust their surface area to attain equilibrium 
with the surroundings. Surface tension y is defined by the work hW= ydA that is required to 
change the surface area by <L4. The area will adjust so that the free energy becomes minimal. 
For systems with a positive surface tension (like oil and water), the free energy increases 
monotonously with area. I.e. the system tries to minimize the contact area (at constant 
volume). If the surface tension is negative the two fluids mix and there is no phase 
separation. Lipid bilayers exhibit a behaviour that can not be modelled accurately by either of 
these situations. The hydrophobic effect, as for oil and water, will give rise to an increase in 
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free energy with surface area. The bilayer would minimize its area at all temperatures and go 
into the ordered gel phase. However, in reality there are other contributions to the free energy 
that increase with decreasing surface area. A small surface area forces the lipid chains into a 
more ordered state and thus reduces the entropy of the system. Therefore, the free energy no 
longer increases monotonously with area but has a minimum. The bilayer adjusts its area to 
attain this minimum in thermodynamic equilibration, which implies by definition that the 
surface tension is zero and the average transverse pressure is equal to the external pressure, 
as claimed by Jahnig" in response to Chiu et al.m 
1.6.5 Lennard-Jones ( L J ) Parameters 
The interaction between two atoms is governed by a long-ranged attractive van der Waals 
force and a short ranged repulsive coulombic force which arises when the electronic clouds 
of these atoms start to overlap. The latter is also referred to as Pauli repulsion (from the Pauli 
Exclusion Principle). The Lennard-Jones potential, as shown schematically in Figure 1.8 
describes the strength of these two forces with respect to the distance between them and thus 
the separation of them. The Lennard-Jones potential is commonly also referred to as the 6-12 
potential due to its mathematical expression: 
K(r) = £ 4 * 
•>j 
(1.2) 
where epsilon (e) is the well depth and sigma (cr) the hard sphere diameter, and / and j denote 
two particles. These two parameters (zander ) are known as the Lennard-Jones (L-J) 
parameters. The first term in Equation 2 describes the repulsive and the second term the 
attractive force. 
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Figure 1.8: Schematic drawing o f the Lennard-Jones potential between two atoms or molecules. The distance r 
and the interaction energy V(r) are in arbitrary units. The depth o f the well is defined by the parameter e. 
The Lennard-Jones potential is a good approximation of the interaction between two 
particles and is used extensively due to its simplicity. It reflects the real potential very well at 
short and long distances. Small deviations arise due to an incorrect treatment o f the long-
range part of the repulsion term. 
The Lennard-Jones parameters are fitted to experimental data or deducted f rom 
quantum chemistry calculations. In computational chemistry these parameters are also used 
not only to describe the interactions between two atoms, but also between groups o f atoms. 
A n example is the united atom model, where heavy atoms and attached hydrogens can be 
grouped together and treated as one unit rather than individually. Although the interaction 
potential can be approximated to a higher accuracy by extending the Lennard-Jones model 
(e.g. Stockmayer equation, Moller-Plesset perturbation theory, and coupled cluster 
approach), the computational demand increases so much that the Lennard-Jones model 
remains the most widely used description of inter-atomic potentials. 
Different sets of Lennard-Jones parameters have been used in simulations. Tieleman 
and Berendsen1 0 7 studied the influence of the Lennard-Jones interactions of the CH2 and CH3 
groups of the acyl chains with the oxygen water atom. At constant sigma value (a) smaller 
parameters for epsilon (e) resulted in a more defined and smaller interface region in lipid 
bilayer/water systems and a smaller area per lipid head group. The order of the tails along the 
interface is less than found in experimental data for higher values of epsilon. The authors 
suggested the use of e = 0.529 kJ/mol for the CH 2-Ow, s = 0.637 kJ/mol for the CH 3 -Ow and, 
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< t = 0.310 nm for both interactions. This corresponds to 53% of the original values used in the 
simulation o f a decane/water interface. 1 0 8 
1.6.6 Treatment of Electrostatic Interactions 
Electrostatic interactions between two charged particles are described by a coulombic force 
between them. The charges are generally obtained as partial atomic charges via ab initio 
computer calculations and quantum physical considerations. Especially in the united atom 
models groups of atoms are combined and assigned such a charge. Typical groupings might 
include methylene (CH2) and methyl (CH3) units as well as chemical groups such as 
phosphate or ammonium. Alternatively, in simulations, groups of atoms can be combined in 
charge groups as part of an electrostatic treatment (e.g. by the particle mesh Ewald 
summation (PME)) and then in turn interact with each other. 
Electrostatic interactions play an important role in the interaction (e.g. solvation) of 
solutes with solvent. This parameter has not only great influence on the dimensions and 
characteristics of the bilayer/water interface region but also on the bulk properties of the 
solvent itself. A careful assignment of partial charges is crucial for an accurate calculation of 
solvation free energies and binding constants. 
In current M D force fields, electronic polarizability is not treated explici t ly; 1 0 9 rather 
polarizability is included implicitly in the form of partial atomic (electrostatic) charges that 
typically overestimate molecular dipoles. 1 1 0 Although the polarizability of the /r-electron 
distribution is not accounted for explicitly, current pairwise additive electrostatic (Coulomb) 
forces capture the basic physics of the cation-;r interaction. 1 "'" 2 
The area per lipid is strongly influenced by the methodology used in the treatment o f 
electrostatics. Lipid areas obtained with PME are significantly higher than those obtained 
with an abrupt truncation of the electrostatic interactions. 1 1 3 The difference between cut-off 
method and PME becomes larger as the cut-off radius increases. For example, in a model 
system of a DPPC bilayer in water, a small cut-off of 1.4 nm produced the largest average 
area, which dropped by 4% when the cut-off radius was increased to 1.8 nm and a further 
2.5% when increased to 2 .4nm. 1 1 3 The total volume, volume per lipid, and especially the 
area per lipid decrease as the cut-off is increased. Further evidence that cut-off treatments o f 
the electrostatic interactions should be avoided when simulating bilayer/water systems was 
given by Patra and Karttunen" 4 in 2004 in their review of electrostatic methodologies used in 
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bilayer simulations. The authors reported that the lateral diffusion coefficients obtained by 
PME and cut-off truncation at 1.8 nm, for example, differed by a factor of 10, while the PME 
results are consistent with experimental values. 
Different choices of charge group sizes and the charge they are representing have a 
strong influence on the simulation. It has been shown 1 1 3 , that a change from larger to smaller 
charge groups result in an increase o f the area per lipid by 2% with a Coulomb cut-off 
treatment and in a decrease by 2% with PME. The effect seen in PME can be attributed to the 
effect of changing the effective cut-off for the Lennard-Jones interactions because the 
electrostatic cut-off in PME serves only as a numerical device to separate direct- and 
reciprocal-space sums. 
1.6.7 Long-range electrostatics 
Coulomb cut-off methods often show an artificial ordering o f water in bulk solution resulting 
in a higher viscosity. 1 1 5 As an artefact, the water dipoles are anti-correlated slightly below the 
cut-off and correlated above the cut-off value. The long-range dipole interactions decrease 
significantly when using the reaction field (RF) and especially when using the particle mesh 
Ewald (PME) methodology. Short- and intermediate-range correlations are still stronger with 
RF than with PME. This trend is also seen in interfacial water/lipid systems. 1 0 2 3 ' 1 1 5 b However, 
the PME method may induce artificial effects due to the infinite periodicity implied by this 
technique. Such periodicity artefacts were found to be particularly important in systems 
involving a solvent of low dielectric permittivity, a small unit cell, or a solute with a net 
charge or dipole. Ewald-enhanced stability of peptides, for instance, has been reported in 
some simulations." 6 ' 1 1 7 
In conclusion, none of the methods mentioned above seem to be very well suited for 
membrane calculations: simple cut-off treatments induce artificial ordering; the RF method 
ignores the heterogeneous nature of the membrane and dielectric constants for the latter are 
difficult to justify; and the PME technique enhances periodicity. In a recent comparison of 
electrostatic methodology in the simulation of a water/lipid interface Anezo et a/." 3 
concluded that PME and RF techniques would both be suitable methods for such simulations. 
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1.6.8 Solvent Models 
1.6.8.a Chloroform Model 
In 1994, Tironi and van Gunsteren 1 1 8 compared three different models used for chloroform 
simulations. The authors concluded that an all-atom representation as used by Dietz and 
Heinzinger 1 1 9 reproduced a variety of experimental properties such as isothermal 
compressibility, constant volume heat capacity, and dielectric constant o f chloroform the 
best. 
1.6.8.b Water Models 
Tieleman et a l . m ' n o compared the three most widely used water models in molecular 
dynamics simulation. These are the single point charge (SPC) 1 2 1 model, the single-point 
extended charge (SPC/E) 1 2 2 ' 1 2 3 model, and the transferable intermolecular potential model 
with 4 points (TIP4P) 1 2 4 (Figure 1.9). 
B) A ) 
• 
Figure 1.9: Commonly used water models. A depicts an SPC type water model; B represents a TIP4P type 
water representation. Here, q, and q2 are the partial charge associated with the hydrogen atoms, and the oxygen 
atom respectively. The latter is represented either on the atom itself (A) or on a dummy particle a distance r2 
away from the oxygen atom (B); r, is the distance between the oxygen and hydrogen atoms, the latter being at 
an angle &, 0 is the angle between the oxygen-hydrogen bond and the oxygen-dummy particle bond, a stands 
for the Lennard-Jones parameter. 
Although the differences in partial charges and geometry for a single molecule 
between these models are small, they accumulate to give noticeable effects on the total 
system. SPC/E was originally developed because previous models did not take the self-
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energy due to polarization into account. This also limits the model as the thermodynamic 
potential for SPC/E is only correct i f the proper polarization self-energy correction is applied. 
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In simulations where water is in equilibrium in different environments such corrections 
cannot be applied and the effective free energy of SPC/E is too low (-27.6 kJ/mol), compared 
to -24.3 kJ/mol for SPC, the latter being close to the experimental value. 1 2 3 ' 1 2 5 This means 
that the liquid state is thermodynamically too favoured for SPC/E. Since solubility is 
important at interfaces, the SPC water model seems preferable. Furthermore, SPC leads to a 
slightly broader (i.e. wider) interface, which can be rationalised by the increased partial 
charge of the water oxygen atom in the SPC/E model. In experimental work the area per lipid 
is typically larger than in simulations. This favours the SPC model since it results in larger 
values for the area per lipid than SPC/E as has been reported for a DPPC/water interface by 
Tieleman and Berendsen.1 0 7 Although SPC/E results in a better density, radial distribution 
function, self-diffusion constant and dielectric constant than SPC in bulk solution, 1 2 6 it was 
concluded that SPC water performs generally better than the SPC/E model for interface 
simulations where these trends are not seen as such. 1 0 7 
The TIP4P model uses a 4 point model to simulate water (Figure 1.9, B). Three atoms 
represent the oxygen and two hydrogen atoms in the water molecule and a fourth atom is 
introduced that does not carry mass but partial charge. This so-called dummy atom is 
intended to reproduce the lone pair on the water oxygen. Although bulk quantities are 
simulated more accurately with the TIP4P model than with either SPC or SPC/E, simulations 
are computationally more demanding because of the additional site. In bilayer simulations 
the SPC model is therefore preferred." 
In calculations of hydration free energies of amino acid side chain analogues using 
different force fields and conditions, Tieleman and MacCallum 1 2 0 reported that both water 
models (SPC and TIP4P) give comparable results. 
1.7 Factors important in Peptide-Lipid Interactions 
1.7.1 Non-polar Effects 
1.7. J.a Hydrophobic Effect and Mismatching 
The hydrophobicity of amino acid residues in proteins and peptides is suggested to be one of 
the driving forces responsible for their association and insertion in lipid bilayers and 
membranes. Model peptides of known length, 3-dimensional structure and hydro-phobicity 
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can be used to assess the importance and strength o f the hydrophobic effect by analysing 
their interactions with model membranes o f various thickness and composition. 
The hydrophobic lengths and mismatch effects o f model peptides (e.g. the WALP and 
KALP polypeptide series) have been studied extensively both experimentally and 
computationally in the past. 1 2 7 The family o f the WALP a-helical transmembrane peptides 
(Table 1.1) contains two flanking tryptophan residues (W) on either side o f an alternating 
arrangement o f alanine (A) and leucine (L) residues. The peptide inserts into the bilayers as 
shown schematically in Figure 1.10. 
Peptide Family General Sequence Hydrophobic length" / nm 
WALP Ac-G W W(LA) 5 . io .5 WWA-Etn 1.5-3.75 
KALP A c - G K K L A 8 5-i2 sKKA-amide 2.55-3.75 
Table 1.1: Amino acid sequences of the W A L P and K A L P peptides and calculated length of the leucine-alanine 
stretch when present as an cc-Helix. aIt is assumed that each amino acid has a length of 0.15 nm. 
1 
i r 1 
Figure 1.10: Schematic figure of a WALP23 a-helix orientation in a lipid bilayer. The bilayer-water interface 
is indicated by a dashed line. (Adapted from Ref. 127a) 
The bilayer could adjust to mismatched peptides in various ways (as reviewed in Ref. 
128), but the main response was found to be the exclusion o f peptide material from the planar 
bilayer. 1 2 7 3 The authors showed by circular dichroism, Fourier transform infrared (FTIR), and 
fluorescence spectroscopy that peptides are less likely to insert themselves into the bilayer, 
when they have a positive or negative hydrophobic mismatch. Depending on the hydrophobic 
mismatch o f the length o f the protein with respect to the depth and length o f the lipid, non-
bilayer structures were induced, whose nature depended on the precise extent o f the 
mismatch. De Planque et al.12™ determined by fluorescence measurements on a set o f 
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WALP/phospholipid combinations that the inserted peptides adopt an orientation, in which 
the tryptophan side chains are located at the lipid-water interface, characterized by a broad 
maximum around 337 nm, typical for a relatively deep interfacial partitioning of the indole 
rings. This was further supported by a combination o f mass spectrometry and 
hydrogen/deuterium exchange which showed that the tryptophan residues in WALP peptides 
in DMPC vesicles though buried in the bilayer region were still accessible for deuterium 
exchange over t ime. 1 2 9 It was concluded, that the tryptophan side chains preferred to reside in 
a rather narrow positional range at the membrane-water interface and resisted displacement 
in either direction away from that position. Energetically favourable interactions were 
thought to be more important than hydrophobic matching for this resistance. 
1.7.Lb Lipophobic Effect 
The lipophobic effect is the analogue of the hydrophobic effect. It is a purely empirical 
property o f amino acid side chains which, according to their lipophilicity, wi l l either try to 
avoid unfavourable contacts with lipid molecules or to be exposed to them. 1 3 0 A contribution 
to the lipophobic effect arises from an unfavourable loss of entropy o f lipid molecules 
interacting with the peptide, instead of freely diffusing in the bilayer. 
Tryptophan side chains, due to their rigidly planar geometry, may exhibit favourable 
localisation of the indole ring in the lipid bilayer. Such orientations were detected for 
tryptophan residues in WALP model peptides (see §1.7.1.a, Figure 1.10) by solid state N M R 
experiments' 3 1, where it was shown that the indole moieties of the tryptophan residues 
resided approximately at the same level as the glycerol group and below the choline moiety 
and close to the carbonyl region of the DMPC phospholipid. The authors further report that 
the tryptophan side chains are oriented roughly parallel to the bilayer surface instead of 
pointing toward the aqueous phase (as Seelig et al. suggested132). Preferred localisations and 
orientations were further supported by the studies of small water-soluble mimics of the 
tryptophan side chain that were found to be positioned close to the lipid carbonyls using 
fluorescence quenching methods 7 3 3 and lipid-directed and analogue-directed NMR 
studies 2 ' 7 3 6. Recently however, the importance o f the lipid carbonyls in anchoring tryptophan 
side chains in the bilayer was challenged by van der Wei et A / . 1 3 3 The authors studied the 
interactions of WALP peptides with the ether-linked DMPC analogue 
ditetradecylphosphatidylcholine (DTPC), which misses the lipid carbonyls using solid-state 
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NMR. The very similar dynamics of the aromatic amino acid side chain in both, DMPC and 
DTPC bilayers suggested that the tryptophan side chains adopt similar orientations and that 
the lipid carbonyls therefore play at most a minor role in the anchoring o f tryptophan side 
chains in the interfacial region. 
1.7.2 Electrostatic Effects 
1.7.2.U Hydrogen bonds 
Even though the backbone of amino acids is often involved in the formation of secondary 
protein structure (helix and sheet), exposed segments in turns and loops could participate in 
hydrogen bonding interactions. In a typical lipid/water interface, possible candidates with 
which tryptophan residues can form hydrogen bonds are water molecules, the phosphate of 
the lipid head group and the carbonyl groups that link the acyl chains to the glycerol 
backbone of the ester lipids. Previously, measurements of the free energy of transfer of 
tryptophan analogues from water into cyclohexane suggested that the N H group in 
tryptophan was considerably less polar than expected which implied that hydrogen bond 
formation o f the tryptophan indole N H to water was particularly weak. 1 3 4 In lipid bilayers, 
the importance and involvement of hydrogen bonding of the indole NH was previously 
investigated by comparing the binding behaviour of free NH analogues to both ether and 
ester lipid bilayers with that of analogues where the NH group was masked by an alkyl 
chain.2 I f hydrogen bonding to lipid carbonyls is important for the ordering of solubilised 
tryptophan analogues, a large decrease in the ordering o f tryptophan and no appreciable 
effects on TV-methyl tryptophan would be expect when the ester lipids are substitute for ether 
lipids. However, experiments showed a similar change in the ordering of indole and N-
methyl indole as tryptophan analogues when the lipid type was altered, suggesting that 
hydrogen bonding interactions are not likely to play a major role in the interfacial preference 
of tryptophan. 2 , 3 This was supported by linear dichroism spectroscopy of various different 
indole derivatives (indole, 3-methylindole, 1-methylindole and tryptophan octyl ester) 
suggesting that the adopted orientation is independent of the protein the tryptophan residue is 
part of and that they are directed by dipole-dipole interactions and steric constraints in the 
membrane hydrocarbon region with hydrogen bonding and cation-7t-interactions with lipid 
head groups being less important. 1 3 5 
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1.7.2.b Cation-n interactions 
Cation-7r interactions are increasingly recognized as an important non-covalent binding 
interaction relevant to structural biology, where they are considered to be one of the driving 
forces in molecular recognition. 1 3 6 The main contribution to cation-Ji binding is the 
interaction between the quadrupole moment of aromatic rings and an external charge 
distribution. Additionally, cation-7i interactions can also be affected by induced dipoles, 
polarizabilities, dispersion forces, and charge transfer effects. 1 3 7 In biological systems, the 
role of cation-;r interactions in protein and peptide conformational states has been studied by 
means of interactions between positively charged lysine and arginine residues (the 
ammonium NH3 + and guanadinium C(NH2)3 + groups, respectively) and the aromatic six-
membered ring centres of phenylalanine, tyrosine, and tryptophan. , 3 6 d ' 1 3 8 Following work by 
Levitt and Perutz 1 3 9 who suggested a hydrogen bond between aromatic and amino groups, 
Burley and Petsko 1 4 0 identified the "amino aromatic" interaction, in which NH-containing 
groups tend to be positioned near aromatic rings within proteins. It is now appreciated that 
the interaction of a cationic group with an aromatic ring is much more favourable than the 
analogous interaction involving a neutral amine. ' 4 1 ' 1 4 2 A cation-7i interaction with an aromatic 
can be attractive or repulsive. The indole part of tryptophan may participate in attractive 
cation-7r binding with positively charged residues of the lipids (such as the choline head 
group of phosphocholine lipids). 
Theoretical and experimental studies have shown that cation-7i interactions can be 
quite strong, both in the gas phase and in aqueous media, and a number of possible 
applications to biological systems have already been suggested.136 In globular proteins, a 
cation-7t interaction is more stabilizing than an analogous salt bridge. 1 4 3 The strengths of the 
interactions are strongly dependent on the dielectric constant of the medium, as would be 
expected for interactions with large electrostatic components. Interestingly, the cation-7i-
interaction maintains its strength across a range of solvents. Whereas the strength of the salt 
bridge is reduced over 50-fold on moving from the gas phase to water, the strength of a 
cation-7r interaction is weakened by less than a factor of 3 . 1 4 3 
The strength of cation-7i-interactions of tryptophan molecules exceeds that of other 
aromatic amino acids. 1 3 6 Its strength towards the binding of choline has been estimated to be 
~2 kcal mol"1 by studying the effects of substitutions on tryptophans indole ring and its 
implications for the ligand recognition by serotonergic (5-HT3A) and nicotinic acetylcholine 
receptors.1 4 4 The authors used 4-fluoro-tryptophan as an electrostatically neutral benchmark. 
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Ratios of relative ligand binding o f the derivative with respect to the natural tryptophan 
compound allowed an estimation of binding free energies, which the authors correlated to 
cation-rc interactions. 
The face of the aromatic ring can also act as an acceptor in hydrogen bonding 
interactions with donors such as amide N H groups 1 4 2 1 4 5 with considerable free energy 
contributions (-4.5 ± 0.5 kJ m o l ' 1 ) . 1 4 6 Cation-7i interactions can thus provide strong, specific 
interactions on the surfaces of proteins. Consistent with this prediction, cation-7r interactions 
are rarely buried within proteins found in the Protein Data Bank, and more often than not, are 
exposed to water. The Protein Data Bank also yields that one favourable cation-7i interaction 
can be expected for every 77 amino acid residues. This takes into account any interactions 
between an aromatic side chain (Phe, Tyr, or Trp) and a cationic one (Lys or Arg). A strong 
bias toward Trp was found, as over one-quarter (26%) of all tryptophans in the data bank 
experienced at least one energetically significant cation-7i interaction. 1 4 7 Computer 
simulations had postulated that tryptophan would be overrepresented at cation-7i-sites 
because, in the gas phase, indole binds cations more tightly than either benzene or 
pheno l . 1 3 6 1 4 8 
The statistical significance and abundance of tryptophan residues in the water/lipid 
interfacial region in lipid bilayers was reviewed in detail by Caffrey et a/. 1 4 9 Cation-7i 
interactions for interfacial tryptophan residues were reported to depend on both the 
tryptophan position relative to the bilayer-water interface and on the chemical nature of the 
lipid headgroup.1 5 0 In molecular dynamics simulations, ethanolamine headgroups (POPE) 
were favoured over choline headgroups (POPC), whereas the hydrogen-bonding ability 
between tryptophan and lipid carbonyls was found to be largely independent of the chemical 
nature of the headgroup.1 5 0 Cation-7t interactions have been suggested to be involved in the 
localization of indole in the choline region,3 but the factors primarily responsible for the 
preference are still unknown. Recently, computer simulations suggested that electrostatic 
interactions are the main reason for the preferred localization of indoles. 7 3 0 
Classical additive force fields perform poorly when quantitatively reproducing the 
strength of cation-rc interactions, primarily because they do not include the explicit 
polarizability of the aromatic molecule and its bound cation. 1 5 1 However, Norman and 
Nymeyer 4 successfully reproduced the localisation of indoles at a POPC/water interface 
using a GROMACS G45A3 force field. The authors further demonstrated (by alternation o f 
the indole partial charges) that non-specific electrostatic effects, cation-rc and dipolar 
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interactions between the indole and the bilayer as well as hydrogen bonding to the bilayer 
carbonyl groups play a role in this preferred localisation. 
I.7.2.C Dipolar interactions 
The lipid interface is a region with varying sources of dipoles. The phosphatidylcholine 
headgroup carries a dipole moment of 18.5-25 D, oriented nearly parallel to the membrane 
surface. 1 5 2 Additional dipoles in the order of 2.0 D arise from the lipid carbonyls; the dipole 
of the carbonyl on the sn\ chain is oriented preferentially in the plane of the bilayer, while 
the carbonyl on the snl chain is oriented toward the water phase.1 3 3 Furthermore, interfacial 
water shows a dipole moment of 1.8 D, with the hydrogen atoms of the first water layer 
pointed preferentially toward the membrane. This arrangement of dipoles results in a positive 
electrical potential in the membrane interior. 1 5 4 
Polarizability does not contribute significantly to the total dipole moment. Persson et 
al.2 speculated that dipolar interactions may be dominant for the molecular ordering of 
tryptophan analogues. However, the situation may be different for transmembrane proteins 
with interfacially localized tryptophans, as in these cases the indole ring may be situated 
closer to the hydrocarbon interior, where it is less exposed to water. 
It has been suggested that the indole dipole moment and hydrogen bonding do play a 
role in localization, but do not by themselves result in the interfacial preference. 2 ' 3 : 7 3 b 
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Chapter 2: Synthesis of Tryptophan Derivatives and Analysis of 
their Binding to DMPC 
2.1 Overview 
The results of the experimental and computational analysis of the binding interactions o f a 
series of 5-monosubstituted A^-acetyl tryptophan ethyl amide derivatives (6a-g, 6n) with 
DMPC are presented and discussed in this chapter. First, the synthesis of the products used 
w i l l be reported (§2.2). Subsequently, the data from the experimental techniques used to 
quantify binding interactions wi l l be presented, starting with N M R host-guest titrations. The 
binding models used in the data analysis of the titrations (§2.3.1), the influence and effects 
of water in the system (§2.3.2.a) and micellisation of DMPC in chloroform (§2.3.2.b) wi l l be 
evaluated and discussed. This follows an analysis o f N M R titration experiments o f 
tryptophan derivatives (host) and DMPC lipid (guest) in chloroform (§2.3.3). The 
observations made in the titrations w i l l be presented in §2.3.3.a, followed by an investigation 
into the binding stoichiometry (§2.3.3.b), data analysis and discussion (§2.3.3.c). Kinetic 
effects and the importance of hydrogen bonding in the amino acid-lipid interactions are 
investigated using deuterium exchange NMR titrations (§2.3.5). 
The results of the second analytical technique used in this study (isothermal titration 
calorimetry) are presented in §2.4. After a general introduction to the technique and the 
theory of the data analysis (§2.4.1), results for the titration o f hydrated DMPC into 
chloroform (§2.4.2.a) to assess the critical micelle concentration (CMC) of DMPC in this 
solvent (§2.4.2.b) and for host-guest titrations of concentrated lipid solutions into tryptophan 
derivative containing chloroform solutions are shown (§2.4.2.c). 
Finally, binding events were investigated using molecular dynamics simulations of 
the system (§2.5). Various adduct formation of the tryptophan derivatives (6a-g, 6n) with 
lipid molecules (§2.5.2 & §2.5.4) and water (§2.5.3) as well as the adduct formation of two 
amino acid derivatives (6a) themselves (§2.5.5) (without any lipid present) w i l l be presented 
and critically analysed. Free energy calculations of some of the binding interactions are 
evaluated and compared to empirical results in §2.6. §2.7 analyses peptide-lipid interactions 
as studied via model peptides (of the general type A c W L W L L ) and DMPC lipid bilayers in 
aqueous solutions by molecular dynamics simulations. 
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2.2 Synthesis of Tryptophan Derivatives 
2.2.1 Synthesis of Racemic Tryptophan Derivatives (la-l) 
A series of racemic A^-acetyl tryptophan derivatives was produced by reaction of the 
corresponding indoles with L-serine in a mixture of acetic acid and acetic anhydride (Scheme 
2.1). 
HO,C NHAc 
NH HO,C NH NH 
5 5 Ac-,0 AcOH, 73 °C, 2 h OH la-
Scheme 2.1: Reaction o f substituted indoles with /.-serine to produce racemic A^-acetyl-tryptophan compounds 
(la-l) . 
Products were isolated in good yields (Table 2.1) and cover a broad spectrum of 
electron density on the indole ring, from electron rich (Table 2.1, entries V and XI ; 
R = MeO) to electron poor (Table 2.1, entries VI and X I I ; R = N02), demonstrating the 
applicability of this reaction to the preparation of a broad range of analogues. 
Entry R Pos. [Serine]" Yield (%) Entry Pos. Yield (%) 
I F 2.0 82 ( la) V I I 98 (lg) 
I I CI 2.0 88 (lb) V I I I 86 (lh) 
I I I Br C5 
2.0 77 (lc) I X 
C6 
73 ( l i) 
I V I 1.5 84 (Id) X 73 ( l j ) 
V MeO 1.0 92 (le) X I 50 ( lk) 
VI N 0 2 2.5 44 (If) X I I 52 (11) 
Table 2.1: Data for the reaction o f monosubstituted indoles with L-serine. "molar equivalents o f /.-serine with 
respect to indole. 
The relative success of the electrophilic substitution depends on the electron density 
distribution on the indole ring. The less electron rich nitro-substituted indoles were of lower 
reactivity and gave moderate yields. More electron rich indoles were found to be highly 
reactive towards electrophilic attack, leading to double-substitution at positions C2 and C3 
(see also §2.2.3). Reaction yields were therefore maximised by adjusting the stoichiometry 
accordingly, either by increasing or decreasing the amount o f indole for electron deficient 
and electron rich compounds respectively. The highest yields were observed for substituents 
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2.2 Synthesis of Tryptophan Derivatives 
2.2.1 Synthesis of Racemic Tryptophan Derivatives (la-l) 
A series of racemic A^-acetyl tryptophan derivatives was produced by reaction of the 
corresponding indoles with Z,-serine in a mixture of acetic acid and acetic anhydride (Scheme 
2.1). 
H 0 2 C . ,NHAc 
NH HO,C NH NH 
5 5 Ac,0 AcOH, 73 °C, 2 h OH 
la-l 6 
Scheme 2.1: Reaction of substituted indoles with /.-serine to produce racemic 7V"-acetyl-tryptophan compounds 
(la-l). 
Products were isolated in good yields (Table 2.1) and cover a broad spectrum of 
electron density on the indole ring, from electron rich (Table 2.1, entries V and X I ; 
R = MeO) to electron poor (Table 2.1, entries V I and X I I ; R = NO2), demonstrating the 
applicability of this reaction to the preparation of a broad range of analogues. 
Entry R Pos. [Serine]0 Yield (%) Entry Pos. Yield (%) 
I F 2.0 82( la) V I I 98 (lg) 
I I CI 2.0 88 ( lb) V I I I 86 (lh) 
I I I Br 
C5 
2.0 77(lc) I X 
C6 
73 (li) 
I V I 1.5 84 (Id) X 73 ( l j ) 
V MeO 1.0 92 (le) X I 50 ( lk) 
V I N 0 2 2.5 44 (I f ) X I I 52 (11) 
Table 2.1: Data for the reaction of monosubstituted indoles with Z,-serine. "molar equivalents of I-serine with 
respect to indole. 
The relative success of the electrophilic substitution depends on the electron density 
distribution on the indole ring. The less electron rich nitro-substituted indoles were of lower 
reactivity and gave moderate yields. More electron rich indoles were found to be highly 
reactive towards electrophilic attack, leading to double-substitution at positions C2 and C3 
(see also §2.2.3). Reaction yields were therefore maximised by adjusting the stoichiometry 
accordingly, either by increasing or decreasing the amount of indole for electron deficient 
and electron rich compounds respectively. The highest yields were observed for substituents 
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with intermediate electron releasing ability (Table 2.1, entries I I & I I I , and V I I & V I I I ; 
R = CI, F). The total conversion of indole to product could be further improved by recycling 
unreacted indole recovered from the reaction. 
2.2.2 Racemisation 
A drawback of the substitution reaction (Scheme 2.1) is racemisation o f the amino acid 
stereocentre. As the reaction between indole and /--serine is conducted under acidic 
conditions, it is probable that the observed racemisation precedes neither via oxazolone 
formation, nor via a classical direct enolisation, both of which require the presence of base. 
On the other hand, azlactone formation is promoted under the conditions used in this 
synthesis, which wi l l undoubtedly contribute to the formation of racemates.1 It also seems 
likely that racemisation can occur during the formation o f reactive intermediates from serine. 
Interestingly, N-acetyl dehydroalanine (A, Scheme 2.2) was isolated as a by-product in 
reactions with less reactive indoles. 
o® 
Me 
- C 0 2 H e 
NH 
C 0 2 H 
NH 
Me B 
C 0 2 H A c q 9 
®0' 
Me 
C 0 2 H 
NH 
AcOH 
NH 
© 
C 0 2 H 
AcO 
AC NH 
C 0 2 H 
B 2 > NH 
Me A c 0 9 Me' 
Scheme 2.2: Proposed equilibria established by the reaction o f /V-acetyl /.-serine with acetic anhydride in acetic 
acid. 
This is consistent with the known reaction between indole and A to produce 
tryptophan, which occurs under acidic conditions. 2' 3 Formation o f A from either Z-serine or 
D,L-senne by heating with acetic anhydride in acetic acid has been described.1 0 However, on 
repeating this reaction we found the major component of the mixture to be N, Odiacetyl An-
serine (C2). 
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A plausible mechanism for the formation of A is through acid-promoted loss of acetic 
acid from the acetylated /.-serine intermediate Ci (Scheme 2.2). This may be assisted by 
neighbouring group participation from the /V-acetyl group, leading to the formation of the 
cationic species B i as a transient intermediate, before loss of a proton to form A. These kinds 
of neighbouring group effects have been observed for serine in the gas phase4 and are likely 
to persist to a lesser extent in solution. Under the conditions used, /V-acetyl dehydroalanine 
would be susceptible to addition of acetic acid across the olefinic double bond to form C2 
(the racemic counterpart of C i ) . Protonation of the olefinic bond of A as a precursor to 
addition o f acetic acid wi l l form B2 (the racemic counterpart of B i ) , with neighbouring group 
participation again helping to stabilise the cationic species. It may be anticipated that reaction 
of indoles with the electrophile B 2 is the product forming step in the conversion to tryptophan 
analogues. Under the experimental conditions used, the steady-state concentration of the 
electrophile B 2 is expected to be extremely low, but nevertheless sufficient for product 
formation. Direct reaction of /V-acetyl dehydroalanine (A) with indoles in the presence of 
acetic anhydride and acetic acid tends to give significantly lower yields than the 
corresponding reaction with serine,5 which suggests that the equilibrium between A and B 2 
lies in favour of the former. This would also suggest that a significant amount o f product 
from the reaction arises from reaction with B | and is subjected to subsequent racemisation 
via an azlactone route. 
2.2.3 Multiple Electrophilic Substitutions 
Electron rich indole derivatives were found to be susceptible to multiple substitutions. In 
addition to the 3-position, the 2-position was prone for an electrophilic attack from both L-
serine compounds and other suitable electrophiles (such as excess acetic anhydride). Doubly 
substituted products were observed in particular for the reaction with methoxyindoles. These 
side products were preliminarily identified via N M R and mass spectrometry, but being only 
of minor interest in the scope of the study, a ful l characterisation was not pursued. 
2.2.4 Enzymatic Resolution of Racemic Tryptophan Derivatives (2a-m, 2'a-m) 
The racemic /V^-acetyl tryptophan derivatives were then optically resolved using an 
enzymatic approach (Scheme 2.3). 
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H O , C H O , C HO^C Nil \ N H A c NHAc 
NH NH NH 
5 5 5 Acylase 4-borate buffer pH 8. 37 °C, 48 h 
2 'a -m 2a-m la-in 
• 
Scheme 2.3: Enzymatic resolution o f tryptophan derivatives ( la-m) using acylase Amano in buffered 
conditions. 
Enzymatic resolution o f the racemates using Acylase "Amano" made both the free L-
amino acid (2) and the corresponding A^-acetyl D-enantiomer (2*) readily available (Table 
2.2). The yield o f 2' exceeds the theoretical yield slightly as the crude product contained 
traces o f starting material, as determined by optical rotation measurements. However, 
isolation o f the A^-acetyl Z)-enantiomer (2') provided a means for preparing similar 
analogues o f the naturally less abundant stereoisomer. In addition, 2' could potentially be 
racemised and recycled to produce more Z-enantiomer (2) following enzymatic resolution. 
R Y i e l d 2 ( % )
a ee* Yield 2' (%) a 
I F 
C5 
99 (2a) 100 76(2 'a» 
I I CI 80 (2b) 100 >100*(2'b) 
III Br 96 (2c) 100 83 (2'c) 
I V I 79 (2d) - 93 (2'd) 
V Me 98 (2e) 89 98 (2'e) 
V I MeO 99 (2f) 100 95 (2*f) 
VII NO, 68 (2g) 92 >100* (2'g) 
V I I I F 
C6 
99 (2h) 91 74 (2 'h) 
I X CI 63 (2i) 91 84 (2'i) 
X Br 97 (2j) 93 71 (2 ' j ) 
X I Me 94 (2k) 93 78 (2'k) 
X I I MeO 95 (21) - 84 (2'1) 
X I I I N 0 2 61 (2m) - 63 (2'm) 
Table 2.2: Data for the isolation o f free L-tryptophan analogues and V-acetyl-D-tryptophan derivatives 
fo l lowing resolution. "Yield calculated based on the maximum theoretical recovery from resolution o f a racemic 
mixture. bEnantiomeric excesses were estimated f rom optical rotation measurements and literature data (when 
available) and have an error o f ± 5 % . *The reported yield exceeds 100% as the reaction did not proceed to the 
theoretical maximum that can be achieved by resolution o f a racemic mixture and reflects impurities o f starting 
material. 
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2.2.4.a The Enzyme Amano Acylase 
The enzyme used for the enantiomeric resolution of the A^-acetyl-AZ-tryptophan derivatives 
belongs to the class of amino acylase 1 (/V-Acylamino acid aminohydrolase; EC 3.5.1.14). It 
catalyses the deacetylation of acetylated L-amino acids to the free amine (Scheme 2.4). 
C 0 2 H O C 0 2 H O C 0 2 H 
Acylase 
+ 
buffer 
R R R N R N R NH 1 H H 
Scheme 2.4: Enzymatic cleavage of an acetyl group from an amino acid, generating the free amino acid and 
acetic acid, where R| is any /.-amino acid side chain other than /.-aspartic acid and R 2 an alkyl chain. 
The specific acylase used in this study (acylase Amano ) was provided as a slightly 
yellow to yellow-brownish powder. It is an extremely stable enzyme in the dry state, in 
buffer solution ( p H 6 - I 0 ) and at high temperatures (70 °C) with optimum conditions for 
enzymatic activity at pH 8.0 and 50 °C. Below pH 5 the enzyme is rapidly and irreversibly 
inactivated. The enzyme shows a high degree of optical specificity toward its substrates and 
cleaves the acetyl group selectively from Z-amino acids. For this reason, it has been used 
extensively for the resolution of racemic amino acids, 6 , 7 which are easily converted to N-
acetyl derivatives. 
The enzymatic resolution of the /V-acetyl Z),I-tryptophan derivatives (1) was achieved 
in good to excellent yields for both, the free /,-amino acid derivatives (2) and the TV-acetyl-D-
compounds (2') (Table 2.2). Enantiomeric excesses were estimated from optical rotation 
measurements and literature data (when available) and have an error of ± 5 % . A similar 
optical resolution of /Va-acetyl-/),/,-tryptophan derivatives had previously been demonstrated 
o 
by Yamada et al. using D-amino acylase. 
2.2.5 Synthesis of Fmoc-Tryptophan Analogues (3a-m) 
The /--tryptophan derivatives were used for further functionalisation, either through 
introduction of an Fmoc protecting group, or conversion to the corresponding /V^-acetyl N-
ethyl amides (Scheme 2.5). 
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NH NHFmoc 
Fmoc-OSu 
acetone/H,0, Na 2 CO 3 a & 3 f 2a&2f N N H H 
Scheme 2.5: Preparation of Fmoc-L-tryptophan derivatives (3a & 3f) using jV-(9-Fluorenylmethoxy-
carbonyloxy) succinimide (Fmoc-OSu). R stands for a 5-F or 5-MeO substituent respectively 
The applicability of the protection reaction was exemplified on two model compounds (2a & 
2f) (Table 2.3) (Table 2.3). 
R Pos. Yield (%) 
3a F C5 96 
3f MeO 90 
Table 2.3: Fmoc protection of compounds 2a-m and respective yields. 
Purification of the desired products was achieved by HPLC chromatography. A 
typical trace can be seen in Figure 2.1. 
1500-
Fmoc-5-MeO-Z,-tryptophan 
1 f 
I 
1000-
500-
5-MeO-I-tryptophan Fmoc-OSu 
\ . 
. . A . 
1 2 3 < 5 6 7 S 9 I 0 1 1 1 2 1 3 M 1 S 1 6 17 1B 19 20 21 22 23 24 25 26 27 2S 29 30 3 1 X 3 3 34 35 3S 37 3 B 3 9 4 0 41 42 43 44 
Tlmo (n*l) 
Figure 2.1: Typical H P L C trace of crude Fmoc-5-MeO-Z,-tryptophan (3f). A linear gradient system with 0.1% 
trifluoracetic acid ( T F A ) in water and acetonitrile respectively was used with an analytical reverse phase C I 8 
column at a flow rate of 0.5 ml/min. The detection wavelength was 254 nm. The major peak at 21.05 min 
corresponds to Fmoc-5-MeO-L-tryptophan (3f). 
The remaining Fmoc-protected amino acids (from 2b-e and 2g-m) could be 
synthesised in good to excellent yields, but due to problems with the HPLC system, an 
appropriate purification and characterisation of the products could not be achieved. 
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2.2.6 Conversion of Tryptophan Analogues to /V-Acetyl Ethyl Amide Derivatives 
(6a-g, 6n) 
The free amino acid analogues were first acetylated using standard conditions, providing jV"-
acetyl-Z,-tryptophan derivatives (4) in excellent yields (Table 2.4, Scheme 2.6), which were 
further derivatised by conversion to a methyl ester on the carboxylic acid functionality via an 
acidic Fisher methyl esterification to produce 5. The starting material for 4n was racemic 
AZ-tryptophan (2n) as purchased from Sigma Aldrich. 
R Pos. Yield 4 (%) Yield 5 (%) 
F 93(4a) 88 (5a) 
CI 83 (4b) 93 (5b) 
Br 87 (4c) 89 (5c) 
I C5 85(4d) 91 (5d) 
Me 83(4e) 93 (5e) 
MeO 92 (4f) 92 (5f) 
N 0 2 44 (4g) 88 (5g) 
H 75(4n) 98(5n) 
Table 2.4: Yields of the tryptophan derivatives A^-acetyl-L-tryptophan (4a-g, 4n) and A^-acetyl-Z-tryptophan 
methyl esters (5a-g, 5n). 
/ 
o 
4 4 N MeOH. N H cat H,SO 0 
: ! 
AcOH reflux, I h. 
RT, 2 h 2a-g + 2n 4a-e,4n 5a-g, 4n N -i 
H - H 
Scheme 2.6: Methyl esterification of tryptophan derivatives. R stands for H, F , CI , Br, I, Me, MeO, or N 0 2 . 
The outcome of the esterification was evaluated by the purification and analysis of 
examples of the electron rich (5f), electron poor (5g), and intermediate iV^-acetyl-Z-
tryptophan methyl esters (5a and 5n). The esterification was not expected to be influenced by 
the electron density on the indole ring system as the reaction was taking place on the 
somewhat remote carboxylate group. The remaining compounds were converted into ethyl 
amide derivatives (6a-g, n) without further purification (Scheme 2.7). 
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r i 
o 
4 N EtNH H H MeOH 
S«-g , 5n 6a-g, 5n 2-1 h 
N N H 
Scheme 2.7: Ethyl amidation of A^-acetyl-L-tryptophan methyl ester derivatives (5). 
Purification of the final derivatives by chromatography yielded compounds of good 
purity, as confirmed analytically by polarimetry (Table 2.5) and HPLC (Figure 2.2). 
ID Yield 6 (%) M a 2 5 Conditions 
6a 82 +29.8 c = 0.1, MeOH 
6b 86 +24.3 c = 0.1, MeOH 
6c 77 + 19.2 c = 0.1, MeOH 
6d 74 +28.6 c = 0.5, MeOH 
6e 80 +28.6 c = 0.4, MeOH 
6f 44 +32.8 c = 0.1, MeOH 
6g 98 +8.7 c = 0.15, MeOH 
6n 99 +4.1 e = 0.7, MeOH 
Table 2.5: Yields and optical rotation data for A^-acetyl-L-tryptophan ethyl amides (6a-g, 6n). 
V -Ac-i-tryptophan ethyl amide 
Figure 2.2: H P L C trace of crude A^-acetyl-L-tryptophan ethyl amide (6n) obtained using a linear gradient 
system with 0.1% trifluoracetic acid ( T F A ) in water and acetonitrile respectively with an analytical reverse 
phase C I 8 column at a flow rate of 0.5 ml/min. The detection wavelength was 254 nm. 
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2.2.7 Synthesis of AcWLWLL 
AcWLWLL was produced in near quantitative yield as calculated by the mass difference of 
the resin before and after the coupling reaction. The peptide was then cleaved from the resin 
and submitted to HPLC purification as described in §4.2.2. Purified peptide was obtained in 
92 % yield (by mass) and in good purity (determined by LC-MS, Figure 2.3). 
i AcWLWLL 
/ 
-i Injection peak 
i V 
] V 
1.0 2.0 3.0 1.0 5.0 6.0 7,0 6.0 9.0 1D.0 11.0 12.0 13.0 14.0 15.0 16.0 17.0 1B.0 19.0 20.0 21.0 22.0 23.0 21.0 25.0 26.0 27.0 2B.D 29.0 30.0 
Time (min) 
Figure 2.3: Typical H P L C trace of crude A c W L W L L after cleavage. A mixture of acetonitrile and water (both 
containing 0.1% T F A ) was used on a C18 analytical column with a linear gradient system and the 
chromatogram recorded at 254 nm (see §4.2.2 for more details). 
As illustrated in Figure 2.3, the crude product from the peptide cleavage contained the 
desired peptide. The product, eluting at about 9.5 min, was recovered in as the predominant 
component. 
2.3 NMR Titrations 
Binding interactions of A^-acetyl-Z-tryptophan ethyl amides (6a-g, 6n) and DMPC lipid 
molecules were analysed in chloroform using 'H NMR host-guest titrations. The time 
averaged NMR signal is a combination of the chemical shifts of the unbound, freely solvated 
molecules, and the bound species. Using a 200 MHz spectrometer, these signals were present 
as a single coalesced signal. At 300 MHz, significant line broadening was observed for 
tryptophan, making the signal unsuitable for monitoring during the course of a titration. 
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2.3.1 Binding Models 
Various association events need to be accounted for. A general overview of selected 
equilibria is given in Scheme 2.8. 
a (DMPC) n 
+ DMPC, Km 
(DMPC) 2 
+ DMPC, Kd 
+ Trp, Ki +Trp, K 2 / T v ^ . . ^ • w • TrpDMPC • K • (Trp) 2DMPC 
+Trp, 
+ H 2 0 , K 1 l v ' 
Trp DMPC H 2 0 
DMPC 
+ H 2 0 , K 1 l v , 
D M P C H 2 0 
+ H 2 0 , K2wi 
D M P C ( H 2 0 ) 2 
Scheme 2.8: Equilibria and binding constants that were analysed. Box A accounts for the micellisation of 
DMPC molecules (binding constant K ( / for dimerisation and K,„ for further micellisation); box B encompasses 
the association of water to the lipid (Ki„,, and K2„./) and to a TrprDMPC 1:1 complex (K|„,'). The interactions of 
one ( K | ) or two ( K 2 ) tryptophan molecules with a DMPC molecule is described in box C . 
The association model needed to be accurate in the description of all important 
equilibria whilst keeping the number of variables at a reasonable level to enable their 
determination by regression analysis. The model uses an isodesmic description of DMPC 
self-association in chloroform. It is assumed that the binding constant for this micellisation 
process (K m ) remains the same for dimerisation and oligomerisation (i.e. = K m ) . The 
explicit inclusion of allowed the evaluation of the accuracy of the isodesmic (non-
cooperative) model, which could be compared to an anti-cooperative model (Kj > K,„) and a 
cooperative model (K^ < K m ) . Furthermore, a previous study of DMPC molecules in 
chloroform suggested DMPC-trimers to be the predominant species in solution.9 An explicit 
calculation of the dimer concentration was therefore a compromise between the number of 
fittable variables and level of detail in the model. The evaluation of the various models and 
51 
the determination of the micellisation constant K„, could be achieved by titrations of DMPC 
into chloroform (§2.3.2). 
The experimental conditions made titrations in the presence of water unavoidable due 
to the working conditions, i.e. continuous additions of small aliquots of a solution of 
hydrated lipid to the host. Water concentrations determined by integration of the 'H NMR 
signals for lipid and water (see §2.3.2.a) showed that the commercial sample of DMPC 
contained 2.2 water molecules per DMPC molecule. 
Polar water molecules that are initially complexed to the lipid molecules will be in 
equilibrium with unbound water and compete with tryptophan analogues in binding 
interactions with DMPC molecules. Previous work on l,2-diacety]-s«-3-phosphocholine 
(DAPC) interacting with A^-acetyl-L-tryptophan ethyl amide in chloroform showed that the 
binding constant for the amino acid-lipid association was very sensitive to the concentration 
of water in the sample.10 DAPC produced lower binding constants than DMPC because of 
the competitive nature of the water binding. Reverse titrations of A^-acetyl-L-tryptophan 
ethyl amide into DMPC containing chloroform also showed that the water signal tended to 
that of free water in CDCI3 as the concentration of derivative increased. This could be seen as 
evidence that water and tryptophan derivatives bind competitively for DMPC. 
The binding model used here accounts for some of these interactions but is limited to 
a 2:1 interaction of water with lipid and a 1:1:1 interaction of water-lipid and tryptophan to 
keep the number of variables reasonable. The 2:1 binding of water to DMPC was essential to 
represent the initial starting complexation of the lipid (as it contained approximately 2 water 
molecules per molecule of lipid). Although higher-order (3:1, 4:1, etc) water-lipid complexes 
are likely, the water concentration in the sample justifies the decision not to consider these. 
Of the possible interactions, the interaction of water with a 1:1 DMPC-tryptophan complex 
was incorporated in the model as this equilibrium had the potential to influence the observed 
complexation-induced chemical shifts during the course of a titration. Water-water and 
water-tryptophan adduct formation was not considered. In the former case, this was because 
of difficulties associated with the determination of water oligomerisation in chloroform. In 
the latter case, the low concentrations of free water (due to association with lipid) and 
tryptophan allowed this approximation to be made without being detrimental to the analysis. 
The micellisation binding constant K„, and the water to lipid binding constants K|„,/ and Fow 
for a 1:1 and 2:1 binding respectively were determined using titrations of hydrated DMPC 
into chloroform. The binding constant for water to a tryptophan-lipid 1:1 complex K|H. ' was 
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accounted for during the evaluation of the host-guest titrations. Job plots performed both, in 
the current work and in a previous study,10 suggest a 2:1 tryptophan-lipid to be the 
predominant adduct of the two in chloroform. The model accounts for this species explicitly. 
Due to the low concentration of tryptophan derivatives used and the low percentage of their 
binding to DMPC the omission of higher order adducts (3:1,4:1, etc) is justified. 
2.3.2 Titrations of Hydrated DMPC into Chloroform 
2.3.2. a Water Presence - Its Importance and Associated Equilibria 
A blank titration of a chloroform solution of hydrated DMPC into wet chloroform allowed 
the amount of water present after each addition to be extrapolated by integration of the NMR 
signals. Four signals, belonging to the water protons, the lipid choline head group methyl and 
glycerol .SH-CH2 protons, exhibited observed complexation-induced chemical shift changes. 
This allowed the number of water molecules per lipid to be calculated by fitting the data to 
the straight line described by [W]0 = x[L] o + c. An initial watenlipid ratio of approximately 
2:1 (x = 2.20 ± 0.04) was determined by this method and the concentration of free water in 
the CDCb solvent was calculated to be c = 5.4 ± 0.3 mM(Figure 2.4). 
0 050 
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\L J» / M 
0 025 
Figure 2.4: Determination of lipid hydration. Graphical analysis of water [W\0 to lipid [L]0 concentration ratios 
allowed the extrapolation of the initial water concentration in neat chloroform (the intercept of a linear 
regression) and the water per lipid ratio (given by the slope). 
This water was found to partake in adduct formation as its chemical shift changed 
from the typical value of bulk water in chloroform (1.57 ppm) to approximately 4ppm 
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during the course of a titration (Figure 2.5). This implied that water molecules were either 
released from their association site in the lipid or replaced by the tryptophan derivatives. 
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Figure 2.5: Observed chemical shift change of water protons 8ohs as a function of the total lipid concentration 
[L]0. Experimental data is indicated by points on the graph, a line represents the binding isotherm of water as 
calculated by fitting the experimental data to Equation 2.4. 
2.3.2.b Critical Micelle Concentration (CMC) 
A previous study suggested that water associates with DMPC in chloroform and that the lipid 
is able to form inverse micelles.9 The authors estimated a trimeric DMPC inverse "micelle" 
to be the most stable form. In order to mitigate against the possibility that higher-order 
micelles were able to form, general micellisation was accounted for during analysis of the 
binding constants for tryptophan adducts. The titration of hydrated DMPC into chloroform 
permitted the estimation of the critical micelle concentration (CMC) of the lipid in this 
solvent. This assumes that the lipid exists in a fully dissolved, monomeric form with a 
chemical shift of Smonomer, in equilibrium with a micellar form. At low total concentrations of 
DMPC, the observed chemical shift can then be approximated as arising mainly from 
monomers; at high total concentrations the equilibrium will have shifted mostly towards a 
micellar form of the lipid giving rise to a chemical shift of The observed chemical 
shift S0bs could than be fitted against the reciprocal total lipid concentration [Z]o allowing the 
determination of the critical micelle concentration (CMC) 9: 
^obs ~ ^micelle + T^ J^  (fimicetle ^monomer) (2-1) 
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The graphical analysis of Equation 2.1 (Figure 2.6) and the introduction of two linear 
regressions, one at low total lipid concentrations and another at high total lipid concentrations 
allowed the CMC to be calculated. 
4.00 
3 50 • 
} I K ) 
2.50 
• 
2 no 
1.50 -I 1 1 1 1 1 
0 200 400 600 800 1000 
[L\. ' / M~' 
Figure 2.6: Graphical determination of the C M C of DMPC in chloroform. The graph shows the observed 
chemical shift change of water protons Sohs as a function of the reciprocal of the total lipid concentration [L]0~l. 
Two linear regressions were added at the D M P C concentration ranges where the lipid could be assumed to be 
either fully in monomelic or micellar forms respectively. Their intersection, the estimated C M C , is marked with 
a red star. 
The regression for the monomeric concentration regime was performed for the first 
two data points of the NMR titration when the lipid concentration was below 2 mM and the 
calculated dimer and trimer concentrations of DMPC micelles were virtually zero. The 
regression for the micellar region was obtained by fitting the last six points of the NMR 
titration, where it was assumed that most of the lipid was in the micellar phase. The 
calculated concentrations of micellar lipid in this concentration regime with respect to the 
concentration of monomeric lipid justified this assumption (Figure 2.7). The intersection of 
these two regression lines could be used to estimate the CMC at the temperature of the 
measurement (21 °C). The complexation-induced chemical shifts of several lipid protons 
from two independent titrations were averaged to calculate a CMC of 13.73 ± 0.17 mM), 
which is in good agreement to the previously reported value of 16 m M at 24 °C. 9 However, 
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when the complexation-induced chemical shifts of the water protons, which were more 
pronounced than those o f the lipid, were included a slightly higher value o f 20.54 m M for the 
CMC was obtained. A weight averaged value over all the signals analysed predicts the CMC 
at 19.71 ± 3.28 m M at 21 °C. The evolution of the various concentrations of free, unbound 
and bound species is depicted in Figure 2.7. 
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Figure 2.7: Concentration profiles. Concentrations o f unbound l ipid and water molecules ([L] and [W] 
respectively), l ipid micelles ([L]„) and water-lipid 1:1 and 2:1 adducts ([fVL] and [W2L\ respectively), as 
function o f the total lipid concentration, calculated using the equations in §7.2. 
As expected, the concentration of free l ipid molecules [L] increased at a slower rate 
than the concentration of micellar lipid [L]n. The crossover from the calculated curves for the 
free lipid and the micellar l ipid concentrations (at 18.43 mM) lies within experimental error 
of the approximated value for the CMC. The concentration of water-lipid adducts increases 
steadily with increasing concentrations of total lipid. The concentration of the 2:1 complex 
[W2L] increased more significantly than the concentration of the 1:1 complex [WL]. A l l 
concentrations of l ipid originate at 0, as the starting solution only contains chloroform and 
approximately 5 m M free water molecules, whose concentration increases steadily during the 
course of the titration as each added molecule of lipid introduced two molecules of water to 
the system. 
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2.3.2.C Data Analysis 
Titrations of hydrated DMPC into chloroform allowed the evaluation for the binding 
constants of lipid-lipid self-association and water-lipid association (see Scheme 2.2). The 
concentrations of the bound and free species can be expressed in terms of the known total 
concentration of water [W]Q and lipid [Z,]0 (Equations 2.2 and 2.3): 
[ ^ ] 0 = [ ^ ] + [ ^ ] + 2[^ 2 Z] (2.2) 
[ 4 = {L] + [WL] + [fVtL] + 2[li + " f>[A , l (2-3) 
Here, [W\, \ WL\ and [W2L] correspond to the concentrations of free water, 1:1 water:DMPC 
and 2:1 watenDMPC respectively. The parameter n indicates the size of the lipid micelle [L„] 
and assumes values between n = 3 and N°, the total number of the assembly. The individual 
binding constants are summarised in Table 2.6: 
^ ' - [ W \ L ] *™-[WL\w] m~[L„_M 
Table 2.6: Equations for water-lipid and lipid-lipid binding constants. K.h„, and K2„./ refer to the binding 
constant for the adduct formation of a 1:1 and 2:1 water:DMPC complex respectively; K m refers to the binding 
constant for lipid micellisation; [L,,.,] refers to the lipid (;;-l)-mer. Description of the remaining constants is 
given in the text. 
The observed complexation-induced chemical shifts were calculated using Equations 
2.4 and 2.5 and values for the binding constants K|M./, K2,w and K,„ as well as the values for 
the limiting chemical shifts d),\w, <$,2w, Sm and cyobtained by simultaneous, multiple, non-
linear fitting of the calculated to the observed data. 
K ^ L ] ( 8 b u - S f ) + 2 K 2 w , [ W L ] { S h 2 w - S f ) 
^ohsL 
\ + K w [ L ] + 2K^[WL] 
+ S f . (2.4) 
Here, S0bSw corresponds to the observed chemical shift change of the water signal; b\\w and 
Sb2W are the limiting chemical shifts of the water protons in the 1:1 and 2:1 water-lipid adduct 
respectively, Sf corresponds to the limiting chemical shifts of micellar lipid and 8/ the 
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chemical shift of free, unbound water molecules; [L] stands for the concentration of DMPC 
monomers, [WL] for the concentration of the water-lipid 1:1 complex; [L]o stands for the 
total concentration of lipid molecules in the solution, [W2L] for the concentration of 2:1 
water-lipid complex, and [L„] for the concentration of micellar lipid molecules. The 
equations used to calculate the concentrations of the individual species present can be found 
in §7.2. 
The resulting values for the binding constants and limiting complexation-induced 
chemical shifts are summarised in Table 2.7. 
H20 -N(Ctf 3 )3 sn -CH2 sn-CH2 sn-CH 
1.468 3.402 4.294 4.501 5.256 ppm 
3.326 3.430 2.450 3.619 5.151 ppm 
5.759 3.270 3.934 4.272 5.202 ppm 
5m - 3.399 4.504 4.616 5.180 ppm 
1.858 0.028 -1.844 -0.882 -0.105 ppm 
&52wi 4.291 -0.132 -0.359 -0.229 -0.054 ppm 
ASm - -0.003 0.210 0.115 -0.076 ppm 
31.73 31.73 32.05 31.73 31.73 A/"1 
122.09 122.09 117.99 122.09 122.10 AT1 
143.78 143.78 146.16 143.79 143.73 AT1 
Tabic 2.7: Binding constants and complexation-induced chemical shifts for the binding of water to DMPC and 
DMPC self-association in C D C I j . A5 entries refer to chemical shift changes of the chemical shift indicated by 
the subscript referenced against 5f.. 
The values obtained for the association constants (K|M./ = 31.86 ± 0.11 AT1, 
K 2 m . / = 121.80 ± 1.47 Af 1 , and K„, = 144.06 ± 0.86 A f 1 ) and the complexation-induced 
chemical shifts (8\wi = 3.326 ppm, and &,w = 5.759 ppm of the water proton signal) were 
used as constants in the analysis of tryptophan-DMPC binding isotherms. The calculated 
complexation-induced chemical shifts for the water proton signals (Sm) was found to be 
negligibly small in respect to the accuracy of the NMR instrument. 
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chemical shift of free, unbound water molecules; [L] stands for the concentration of DMPC 
monomers, [WL] for the concentration of the water-lipid 1:1 complex; [L]o stands for the 
total concentration of lipid molecules in the solution, [W2L] for the concentration of 2:1 
water-lipid complex, and [L„] for the concentration of micellar lipid molecules. The 
equations used to calculate the concentrations of the individual species present can be found 
in §7.2. 
The resulting values for the binding constants and limiting complexation-induced 
chemical shifts are summarised in Table 2.7. 
H20 - N ( d r 3 ) 3 sn -CH2 sn-CH2 sn-CH 
1.468 3.402 4.294 4.501 5.256 ppm 
3.326 3.430 2.450 3.619 5.151 ppm 
5.759 3.270 3.934 4.272 5.202 ppm 
s m - 3.399 4.504 4.616 5.180 ppm 
1.858 0.028 -1.844 -0.882 -0.105 ppm 
4.291 -0.132 -0.359 -0.229 -0.054 ppm 
- -0.003 0.210 0.115 -0.076 ppm 
31.73 31.73 32.05 31.73 31.73 M'] 
122.09 122.09 117.99 122.09 122.10 M~l 
K» 143.78 143.78 146.16 143.79 143.73 MA 
Table 2.7: Binding constants and complexation-induced chemical shifts for the binding of water to DMPC and 
DMPC self-association in C D C I 3 . A<5 entries refer to chemical shift changes of the chemical shift indicated by 
the subscript referenced against fy. 
The values obtained for the association constants ( K ) w / = 31.86 ± 0.11 Af\ 
K 2 w / = 121.80± 1.47M\ and K m = 144.06 ±0 .86Af 1 ) and the complexation-induced 
chemical shifts (S\w/ = 3.326 ppm, and Szw/ = 5.759 ppm of the water proton signal) were 
used as constants in the analysis of tryptophan-DMPC binding isotherms. The calculated 
complexation-induced chemical shifts for the water proton signals (Sm) was found to be 
negligibly small in respect to the accuracy of the NMR instrument. 
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2.3.3 Host-Guest Titrations 
2.3.3. a Observed Complexation-Induced Chemical Shifts 
NMR host-guest titrations with DMPC as guest permitted the identification of the parts of the 
molecules that were affected by binding interactions. In the guest molecule, the lipid DMPC, 
some protons in the polar head group region of the molecule showed small observed 
complexation-induced chemical shifts: the methyl protons of the amine shifted by about -
0.08 ppm, the protons of the glycerol moiety by about -0.05 to -0.08 ppm during early stages 
of the titration, when the concentration of tryptophan was greater than that of the lipid. This 
is to be expected as most of the lipid is unbound at all concentrations and the observed 
chemical shifts are not limiting or maximal complexation induced changes, but arise from a 
coalesced signal. On the other hand, most of the protons in the guest molecules, the 
tryptophan derivatives, showed a change in chemical shift upon addition of the lipid. Up to 
seven protons exhibited a complexation-induced chemical shift change > 0.05 ppm. The 
chemical environment of the indole amine and backbone amide protons changed dramatically 
during the course of a guest-host titration resulting in complexation-induced chemical shift 
changes of the indole amine proton between +1.78 ppm (6n) to +3.31 ppm (6g). The two 
other protons that could participate in hydrogen bonding, the amide protons, shifted typically 
by about +1.5 ppm (EtN/V) and +0.7 ppm (AcN//). The indole ring protons were shifted both 
positively and negatively by approximately 0.1 ppm, suggesting that the indole ring itself 
was partaking in binding probably through cation-7t electron or n-facial interactions. The 
remaining protons of the tryptophan derivative were only affected slightly (<0.05 ppm) 
rendering them less useful for the determination of binding constant. These results are 
consistent with an involvement of the tryptophan analogues in binding interactions with 
DMPC. 
2.3.3.b Adduct StoichiomeUy 
Job plots of A^-acetyl-Z-tryptophan ethyl amide (R = MeO (6f) and N 0 2 (6g)) mixtures with 
DMPC were produced. Complexation-induced chemical shifts were observed for various 
protons of both molecules. The plots showed maxima at mole fractions, of -0.70 - 0.76 for 
the indole amine, ethyl amide and acetyl amide NT/ protons respectively (Figure 2.8). 
Complexation-induced chemical shifts changes arising from protons in the lipid (choline-
59 
(CHi)i and glycerol CH2) were found to produce a maximum response at a mole fraction of 
0.4. 
0.5 
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Figure 2.8: Job plot for /V-acetyl-S-MeO-L-tryptophan ethyl amide (6f) with DMPC. The plots show the 
observed chemical shift change AS o f a proton as a function o f mole fraction (x) o f the species bearing the 
proton. 
These data reflect an adduct formation that possibly exhibits some non-ideal 
behaviour of 2:1 association, or the formation of multimeric structures (2:2, 2:3 etc). The 
titration data produced a considerably better fit for the 2:1 adduct than for other 
stoichiometries however, suggesting a 2:1 adduct to be a predominant species. This 
observation is also in good agreement with previously published data,1 0 where A^-acetyl-Z-
tryptophan ethyl amide was clearly shown to form 2:1 adducts with l,2-diacetyl-s«-3-
phosphocholine (DAPC) in chloroform. 
2.3.3. c Data A nalysis 
Multiple, simultaneous non-linear fitting of the N M R host-guest titration data allowed 
calculation of the binding parameters for the complexation of 5-monosubstituted A^-acetyl-
Z-tryptophan ethyl amides to DMPC ( K i , K 2 , K, ' , and K | W ' , and the limiting chemical shifts 
Sfreei &bound\i ^boundl)-
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' " M M 
[LT2] 
K* \LT\T] 
,_\LTW] ,_ [LTW] 
,W~[LT\W] Kl~[LWlT] 
Table 2.8: Equations for binding constants for lipid-tryptophan adducts. K , and K 2 refer to the binding 
constants for the formation of 1:1 and 2:1 Trp:DMPC adducts respectively. K ) w ' refers to the binding constant 
for the association of water to the Trp:DMPC 1:1 complex and to the binding constant for the association of 
tryptophan to the 1:1 water-lipid complex. [7], [L], and [W\ are the concentrations of free tryptophan, lipid and 
water molecules, respectively; the concentrations of lipid-amino acid complexes are given by [LT\ and [LT2] for 
the 1:1 and 1:2 adduct respectively; the concentration of the lipid-amino acid-water 1:1:1 complex is given by 
[LTW]. 
K] W ' was calculated using: 
a:, 
(2.6) 
The variables (Kj, K 2 , Kj', and Ki w ' , and the limiting chemical shifts Sfree, ShOUfUj\, Shouma) 
were then adjusted to fit Equation 2.7 to the experimental data: 
Sobs = 
(/:,[L\Shound, -Sfree)+ K,'[WLT\5h 
oundY ^^free 
)+2K2[LT2lS, 
hound2 free )) + <W2-7) 
(l + Kx [L]+ K, '[WLT]+ 2K2 [LT2 ]) 
Subsequently, regressions on the binding isotherm arising from each individual signal 
allowed refinement of the data and an estimation of error. The variance between pairs of 
experimental data set was typically below 8%. Full equations for the calculation of the 
concentrations of species present are given in §7.2.1. The parameters evaluated are given in 
Table 2.9. A full listing of the chemical shift data can be found in Appendix §7.3.1. 
ID K 2 K i w ' 
MI M" ML 
6n 11.5 ±0.2 210.0± 1.0 164.7 ±23.6 453.6 ±6.2 
6a 17.9 ±0.9 276.6 ± 11.6 159.8 ±2.4 285.9± 15.1 
6b 24.0 ± 0.3 239.5 ± 7.2 257.7 ±3.7 336.5 ± 10.3 
6c 26.3 ± 2.0 214.5 ± 19.9 257.4 ± 40.6 310.3 ±25.2 
6d 34.6 ± 2.2 210.0 ±6.3 340.1 ±28.6 319.8 ±7.4 
6e 35.6 ± 2.1 157.9 ±4.4 216.8 ±23.6 205.1 ± 18.7 
6f 61.1 ± 1.3 296.1 ±3.7 167.8 ±3.6 87.1 ± 1.8 
6g 88.2 ± 1.4 447.3 ± 8.6 381.0±8.1 136.8 ± 1.4 
Table 2.9: Experimentally obtained binding constants for complex formation between tryptophan and DMPC. 
Binding constants were subsequently converted into binding free energies (Table 2.10) using 
Equation 2.8. 
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AG = - R T l n K , (2.8) 
where R is the universal gas constant and T the temperature. Figure 2.9 shows a plot o f the 
binding free energies for the formation of 1:1 and 2:1 complexed o f the 5-substituted 
tryptophan analogues (6a-g, 6n) to DMPC vs. the Hammett parameter, <rp.11 
» R AG, A G 2 AG, AG,„, 
k J mol 1 kJ mol 1 k J mol"1 k J mol"1 
N 0 2 0.78 -11.03 ± 0 . 5 2 -15 .19± 0.64 -14.63 ± 0.22 -12.11 ± 0 . 6 4 
6d I 0.23 -8.72 ± 0 . 1 2 -13.17 ± 0 . 4 0 -14.20 ± 0 . 2 0 -14.35 ± 0 . 4 4 
6c Br 0.23 -8.05 ± 0.62 -13.22 ± 1.22 -14.13 ± 2 . 2 3 -13.67 ± 1.11 
6b CI 0.18 -7.83 ± 0.50 -13.49 ± 0 . 4 1 -14.33 ± 1.20 -13.67 ± 0 . 3 2 
6a F 0.06 -7.11 ± 0 . 1 3 - 1 3 . 8 4 ± 0 . 1 2 -13.93 ± 0 . 3 2 -12.49 ± 0 . 1 7 
6n H 0.00 -6.01 ± 0 . 3 5 -11.66 ± 0 . 3 2 -15.06 ± 1.64 -12.57 ± 1.15 
6e Me -0.17 -8.79 ± 0 . 1 8 -12 .46± 0.15 -13.11 ± 0 . 2 8 -13.24 ± 0 . 2 7 
6f MeO -0.27 -10.13 ± 0.16 -14.01 ± 0 . 2 5 -12.61 ± 0 . 2 7 -11.00 ± 0 . 2 0 
Table 2.10: Free energies of association as determined by NMR host-guest titrations. AG) and AG2 refer to the 
association free of Trp:lipid 1:1 and 2:1 adducts respectively, the free energy of the association of water to the 
LT complex is described by AG,' and the free energy of the association of a tryptophan derivative to the WZ, 
complex is described by AG, W ; ap refers to the Hammett parameter. 
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Figure 2.9: Binding free energies of 5-monosubstituted tryptophan analogues plotted against the Hammett 
parameter erp. AG] corresponds to the binding free energy for the adduct formation of Trp:DMPC 1:1; AG 2 is the 
binding free energy for the further complexation to Trp:DMPC 2:1. 
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When plotting the binding free energies against the Hammett parameters of the 
corresponding /?ara-substituted compounds, a non-linear relationship with respect to the 
electron density of the indole ring was found (Figure 2.9). Interestingly, an n-shaped pattern 
was observed, indicating that not only one electronic factor affects binding free energies. A l l 
derivatives showed binding interactions with the lipid under experimental conditions, with 
the unsubstituted A^-acetyl-Z-tryptophan ethyl amide (6n) being the one interacting the 
weakest. The strongest influence was observed for 6g (R = NO2) showing a marked increase 
in binding compared when with A^-acetyl-Z.-tryptophan ethyl amide 6n (R = H). It is 
interesting to note that the free energy of binding decreased with increasing electron density 
from fluorine to iodine, reflecting a trend for more favourable binding for more electron-rich 
halogen derivatives. For electron-releasing substituents (6e, 6f; R = Me, MeO), increased 
electron density on the indole ring system also led to more favourable binding in free-energy 
terms. The break in the trends either side of tryptophan (R = H) is consistent with as least two 
factors influencing the observed binding. 
The free energies of association for Trp:lipid 2:1 adduct formation from the 1:1 
complex (AG2) were found to be approximately 4.91 ± 1.02 kJ mol"1 more favourable than a 
corresponding 1:1 adduct formation (AGi) and comparable in size to the free energies of 
tryptophan:water:lipid 1:1:1 adduct formation (AGi w ) and the association o f tryptophan to a 
lipid:water 1:1 complex (AG\) (Table 2.10, Figure 2.10). These results predict a preferred 
Trp:lipid adduct stoichiometry of 2:1 in equilibrium, which corresponds to the preferred 
stoichiometry found using Job plots (§2.3.3.b). 
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Figure 2.10: Comparison of free energies of association of Trp:DMPC and Trp:DMPC:water adduct 
formations as determined by NMR guest-host titrations. AG] and AG 2 refer to the binding free energies for the 
adduct formation of 1:1 and 2:1 Trp:DMPC adducts respectively; AG,* and AG,' refer to the binding free 
energies of the association of a tryptophan derivative to a DMPC:water 1:1 complex and the association of 
water to the 1:1 Trp:DMPC complex respectively. 
It is noteworthy that inverse trends are to be expected for interactions involving 
cation-Tt and hydrogen bonding interactions with indole as a function o f electron-donor or 
releasing ability o f the 5-substituent. Electron withdrawing groups, such as nitro, w i l l reduce 
the 7i-electron density o f the indole ring system and produce a higher <?*" charge on the indole 
N H . Electron releasing groups w i l l have the effect o f increasing the 7t-electron density o f the 
ring but reducing the & charge on the indole N H . The observed trend may therefore reflect 
binding that is dominated by cation-7t interactions for crp < 0, and hydrogen bonding 
interactions at ap > 0. The position o f the tryptophan in the trend is such that neither cation-7t 
nor hydrogen bonding effects w i l l be predominant. 
The macroscopical free energy o f association is the sum o f all free energy 
contributions o f microscopic associations o f individual molecules. Here, it can be 
approximated by the sum o f AGi and AG2 (Figure 2.11). 
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Figure 2.11: Sum of free energies ofTrp:lipid 1:1 and 2:1 adduct formation. 
The n-shaped pattern is mostly preserved. The association of the fluoro-substituted 
tryptophan analogue (6a) to DMPC was found to be more favourable than expected from an 
n-shaped pattern. A similar pattern was observed in the ITC data analysis (§2.4.2.c). 
2.3.4 Water Equilibria 
2.3.4. a Representation of Water Equilibria 
As expected, the observed chemical shift changes for the water signal were slightly smaller 
in the presence of tryptophan analogues, suggesting that the model is valid for these 
equilibria. The observed complexation-induced chemical shift of water protons during the 
course of the N M R host-guest titrations could be fitted extremely well (deviations typically 
< 3%) using the binding constants ( K | w / and Bow/) and limiting chemical shifts (d}, Sbound\w, 
Sboundiw) derived from the titration of hydrated DMPC into chloroform (Figure 2.12). A fu l l 
listing of the chemical shift data can be found in Appendix §7.3.1. 
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Figure 2.12: Induced chemical shifts for binding of water to DMPC in the presence (±) and absence ( • ) of iV°-
acetyl-5-fluoro-L-tryptophan (6a). A solid line shows the calculated chemical shift change for water in the 
titration with 6a. 
The explicit treatment o f water in the modelling o f the N M R titration data was found 
to be highly successful in reproducing the observed chemical shift changes arising from 
water protons. Water equilibria have been widely neglected in the analysis o f N M R host-
guest titrations so far 1 2 , but are shown here to be accountable. It was shown that such water 
equilibria have an important influence and a considerable free energy contribution to the 
association equilibria o f tryptophan derivatives interacting with DMPC lipids in chloroform. 
2.3.5 D 2 0 Titrations 
The importance and strength o f hydrogen bonding in the Trp:DMPC adducts were evaluated 
by deuterium exchange kinetic studies. A sample with equimolar concentrations (55 \xM) o f 
A^-acetyl-Z-tryptophan ethyl amide (6n) and DMPC was titrated with aliquots o f deuterated 
water (D2O). The addition o f deuterium to the system w i l l establish new equilibria and 
perturb existing ones (Scheme 2.9, c.f. Scheme 2.8). 
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Scheme 2.9: Extended equilibrium scheme. The equilibria established in Scheme 2.8 needed to be extended by 
the highlighted equilibria (Box D, E , and F) when deuterium is introduced to the system. Box D accounts for 
the deuterium exchange in water molecules. Box F shows equilibria of D 2 0 and various complexes in the 
system. Box E describes the successive deuteration of the amino acid analogue by heavy water (which is a 
slight simplification, as there are also three potential bisdeuterated Trp species). 
The heavy water wi l l exchange deuterium atoms with free water molecules on a very 
fast time scale. The exchange wi l l affect all the remaining equilibria, according to Le 
Chatelier's principle (a system that is at chemical equilibrium w i l l change in such a way as to 
counteract effects o f external stress). Equilibria that are likely to be perturbed immediately 
after the addition w i l l include all the existing equilibria that involve H 2 0 (i.e. K i W | , K i w ' , and 
K2 W i ) . Additionally, deuterium exchange with the three potentially labile protons of the amino 
acid derivatives (AcN/7, EtN/ / , indN//) w i l l be occurring. The rate o f the exchange w i l l 
depend on the lability and accessibility o f the hydrogen atoms. I f they were involved in 
hydrogen bonding, the strength o f such an interaction could be estimated from the speed of 
the exchange. 
The added D2O mixed completely with the chloroform as determined by visual 
inspection, i.e. no phase separation was observed. 
2.3.5. a Changes in Observed Complexation-Induced Chemical Shifts 
In the experiment a proton N M R spectrum was taken immediately after each addition and 
subsequent agitation o f the sample (Figure 2.13). This gave a response that was directly 
related to the fast exchange of residual water in the sample with deuterium and its effect on 
the existing equilibria. Chemical shift changes, AS, were obtained by subtraction o f the 
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corresponding chemical shift of the free tryptophan derivative in the absence of both lipid 
and D 2 0 (Sfree), f rom the observed chemical shifts 50bs '• 
AS = S ohs free ' 
(2.9) 
A progressive decrease in the intensity of the signals for the indole NT/and the acetyl 
amide protons was observed as the quantity of D2O added increased. Figure 2.13 shows the 
normalised signal intensities ~I of selected protons, which were derived by dividing the 
individual signal intensities observed in the presence of D 2 0 , IDIO, by the corresponding 
intensities of the signals in the free tryptophan derivative prior D 2 0 addition, IQ 
The indole C-H protons are unlikely to be subjected to deuterium exchange in these 
conditions and their intensity should therefore remain near constant throughout experiment. 
Fluctuations in their intensity (-12%) may be used as an indicator of the error associated 
with the general determination of intensities. 
Within experimental error (AS± 0.005), the chemical shift o f the indole C-H proton 
was unaffected by the addition of deuterium, while the normalised signals of the protons 
typically associated with hydrogen bonding (indole NH and the two amide NH protons) 
decreased noticeably upon addition of D 2 0 (Table 2.11). A decrease in the values for the 
observed complexation-induced chemical shifts reflects a perturbation of the equilibria for 
non-deuterium labelled tryptophan analogues towards the free (non-complexed) form. 
no (2.10) 
0 
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Figure 2.13: Effects of D 2 0 additions on tryptophan-lipid samples as a function of D 2 0 added. A shows the 
observed chemical shift chage AS of A^-acetyl-I-tryptophan ethyl amide (6n) protons in a 1:1 solution of the 
tryptophan derivative and DMPC in chloroform (55 uM each) (see Equation 2.9). Measurements were taken 
immediately following D 2 0 addition. B shows the normalised intensities associated with the signals in A (see 
Equation 2.10). 
It is noteworthy, that the observed chemical shift changes are considerably smaller 
than the observed complexation-induced chemical shift changes o f these protons following 
the addition o f DMPC (see §2.3.3.a). 
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Entry 
D 2 0 A4«i 
pM ppm ppm ppm ppm 
- 8.402 6.600 5.846 7.686 
1 0 1.243 0.388 0.728 0.044 
11 50 1.087 0.347 0.631 0.041 
III 100 1.092 0.35 0.632 0.041 
IV 150 1.093 0.35 0.636 0.042 
V 200 1.098 0.351 0.637 0.042 
VI 250 1.098 0.352 0.64 0.041 
II-I - 0.145 0.036 0.088 0.003 
Table 2.11: Chemical shift change after D 2 0 additions. The chemical shift change after addition of 100 \i.M 
D 2 0 (entry II) with respect to the chemical shift change prior addition (entry I) is highlighted. The chemical 
shift of the signal in the absence of both DMPC and D 2 0, Sfree is given as reference. 
As expected, the intensities associated with the indole C-H signals (Figure 2.13) were 
not affected following the addition of deuterium. The normalised intensity of the ethyl amide 
proton seemed rather unaffected by the addition of D2O, while the intensities of both, the 
indole amine and the acetyl amide protons decreased. This can be rationalised by a relative 
fast exchange of these protons with deuterium. The precise nature and rate of the exchange is 
detailed in §2.3.5.b 
2.3.5.b Exchange Kinetics 
The functional groups of A/a-acetyl-Z--tryptophan ethyl amide (6n), the indole NH, the ethyl 
and acetyl amide protons, can participate in hydrogen bonding. The kinetics of these 
exchanges can give an indication of the presence and strength of such hydrogen bonds. 
Therefore, chemical shifts were recorded over time following the addition of 100 \iM D2O 
(Figure 2.14). The kinetic effects observed were small (Figure 2.14, Table 2.12). 
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Figure 2.14: Effects of 100 \iM D 2 0 addition on a tryptophan-lipid sample as a function of time. A shows the 
chemical shift change of A^-acetyl-L-tryptophan ethyl amide (6n) protons immediately after addition of 
100 nA/D 2 0 to a 1:1 solution of 6n and DMPC in chloroform (55 \iM each). B shows normalised values of the 
changing signals in A (see Equation 2.11). C shows the normalised intensities associated with the signals in A. 
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Entry 
time A4lN A«U 
min ppm PPm ppm ppm 
1 0 -0.156 -0.041 -0.097 0.004 
11 0.4 -0.151 -0.038 -0.096 0.003 
HI 1.0 -0.150 -0.038 -0.092 0.003 
IV 1.4 -0.145 -0.037 -0.091 0.004 
V 1.8 -0.145 -0.036 -0.088 0.003 
VI 4.3 -0.142 -0.033 -0.087 0.003 
V I I 0.014 0.008 0.010 0.001 
v n A4hiftl 1.243 0.388 0.728 0.044 
Table 2.12: Time-evolution of the chemical shift change AS after addition of 100 \iM D 2 0. The difference in 
chemical shift change over 4.3 min is highlighted. Ar5,h,fti refers to the chemical shift change from the signal 
upon addition of 100 \iM D 2 0 with respect to the signal of free tryptophan derivative in the absence of both, 
DMPC and D 2 0. 4o is the chemical shift change immediately after the addition of 100 uA/ D 2 0. 
As expected, the normalised observed chemical shift for the indole C-H proton did 
not change over time, as such a proton is unlikely to be exchanged by deuterium. The 
variation in its absolute value could therefore be used as a measure of the accuracy of the 
other observed chemical shift changes (± 0.001 ppm). In contrast, the proton chemical shift 
values for the indole amine, ethyl amide and acetyl amide protons were slowly increasing 
over time, shifting back towards the value of the free tryptophan derivative prior addition of 
D2O, Sfree- This can be visualised by normalising the chemical shift change using 
A<? = (2.11) 
norm C c* v ' 
d , o - d / m 
where A<5y,,;#i refers to the chemical shift change from the signal upon addition of 100 \xM 
D2O with respect 5free, and Sto refers to the chemical shift change immediately after the 
addition of D2O. It was observed that dg> was very small given the accuracy of the 
spectrometer (Table 2.12, Entry V I - I ) . Also, given the large complexation-induced shift 
changes, this almost amounts to no change over this period. 
No clear trend was observed for the time-evolution of the intensities associated to the 
proton signals. Within experimental error, the intensities remained constant during the 
analyzed time span. This suggests that no deuterium exchange occurred while the 
measurements were taken, as this would lead to a reduction in intensity. A deuterium 
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exchange with the observed hydrogens had not occurred in the time the 'H NMR spectra 
could be taken (i.e. the 30 seconds sample preparation). To test for slow exchange equilibria, 
the amount of D2O was increased to 495 jiAf and the chemical shift change observed over a 
longer time span (Figure 2.15). An increase in deuterium will perturb existing equilibria 
towards deuterated species, increasing the probability that exchangeable hydrogens will be 
replaced. 
The observed chemical shift changes AS of the analysed protons did not change 
significantly (AS< 0.04 ppm) over time (Table 2.13). However, the normalised intensities of 
the observed signals indicate a trend. Both, the signal for the acetyl amide and for the ethyl 
amide protons decrease over time to approximately 12 and 30% of their original value at 
t = 0 min respectively, suggesting that a deuterium exchange has taken place. The slow rate 
of the exchange (half-life, t>/2 ~40 min and -200 min respectively) suggests that both protons 
are involved in hydrogen bonding interactions. 
Entry time 
miji ppm ppm P P m ppm 
I 0 -0.512 -0.064 -0.264 0.012 
II 8 -0.505 -0.06 -0.256 0.011 
in 20 -0.496 -0.058 -0.254 0.012 
rv 32 -0.497 -0.057 -0.248 0.011 
V 45 -0.498 -0.059 -0.251 0.01 
VI 59 -0.494 -0.057 -0.248 0.011 
VII 110 -0.521 -0.058 -0.257 0.011 
V III 243 -0.527 -0.057 -0.261 0.011 
IX 301 -0.534 -0.06 -0.26 0.011 
X 518 -0.485 -0.029 -0.223 0.01 
X-I - 0.027 0.035 0.041 -0.002 
Table 2.13: Time-evolution of the chemical shift change AS after addition of 495 \iM D 2 0. The difference in 
chemical shift change after 518 min with respect to Entry I is highlighted. 
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Figure 2.15: Effects of 495 \iM D 2 0 addition on a tryptophan-lipid sample as a function of time. A shows the 
observed chemical shift change AS of A^-acetyl-L-tryptophan ethyl amide (6n) protons in a 1:1 solution of the 
tryptophan derivative and DMPC in chloroform (55 \iM each) as a function of time immediately after addition 
of 495 pA/D 20. B shows the normalised intensities associated to the signals in A. 
The indole amine proton does not show a further reduction in signal intensity. The 
drop in intensity o f its signal after each successive addition o f D2O indicate a fast 
proton/deuterium exchange, which is in agreement o f previous studies o f an exchange of the 
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indole amine proton. 1 3 In water the indole amine proton of WALP16 peptides was reported to 
exchange with a life-time < 3 min . 1 4 
The data for the chemical shift changes and their associated changes in signal 
intensity provide an insight into possible kinetic and thermodynamic events that characterise 
binding. Upon addition of D2O, protons of free, unbound water are expected to exchange 
quickly and lower the effective concentration of unbound water. This can be seen directly by 
a reduction of the signal arising from water protons (-20%). Protons of bound water 
molecules can potentially undergo exchange as well, especially i f the waters are coordinating 
the ammonium group of the lipid, but unbound water protons are expected to exchange the 
most rapidly. 
This wi l l affect all the association equilibria o f H2O with DMPC and tryptophan-
DMPC complexes: bound H2O w i l l be perturbed in favour of water-free adducts, and D2O is 
expected to bind with a higher binding association constant than HbO or HOD (order D2O, 
HOD, H 2 0 ) . These fast exchanges were most likely completed before a spectrum could be 
recorded. 
After these fast equilibria are established, the hydrogen bonding protons of the indole 
N / / and the two amide functional groups are likely to be exchanged for deuterium. The 
indole amine (indole NH) exchanged the fastest (//, < 30 s) and had already equilibrated 
within the time of the mixing of the sample with D 2 0 and the recording of the first 'H NMR 
spectrum (-30 s). Although no exchange kinetics (i.e. time-dependent shifts in the 
complexation induced chemical shift of the indole N H proton) were observed, a fast 
exchange of the proton could be inferred from the recorded drop in signal intensity of the 
indole N H peak after each successive addition of deuterium. 
The acetyl amide proton (AcNH) was the next fastest to exchange. The initial 
exchange occurs relatively quickly and similarly to the indole amine proton as the AcNH 
signal intensity dropped markedly between the times D2O was added to the sample and a 
spectrum had been run. However, an equilibrium had not been reached with respect to the 
AcNH signals as its intensity further decreased over time suggesting further exchange 
reactions with deuterium or unbinding of the deuterated species from adducts that contribute 
towards the observed complexation induced chemical shift The slow rate of this further 
decrease in signal intensity could be associated with an estimated half-life of tVl -40 min after 
addition of 496 m M D 2 0 . 
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The ethyl amide proton (EtNH) was initially virtually unaffected by the addition of 
D2O to the sample. No noticeable drop in intensity was observed with increasing D2O 
concentration, suggesting that no immediate exchange had taken place. Only when the 
sample was studied over a longer period o f time (/ > 30 min) was a gradual decrease in signal 
intensity with an estimated half-life of ty, -200 min observed. The slow decrease in signal 
intensity is indicative of a slow proton/deuterium exchange which could be caused by either 
strong hydrogen bonding interactions of EtNH or by an inaccessibility of the proton for an 
exchange. 
2.3.6 Relationships between experimentally determined AG values and physical 
properties of the tryptophan derivatives (6a-g, 6n) used 
Calculated and experimentally determined free energies of the binding interactions were also 
plotted against parameters of the tryptophan compounds other than the Hammett parameter, 
such as dipole moment of the indole ring, solvent accessible area, and log P, a measure of 
relative solubility in octanol and water. A l l of these parameters were computed for 5-
monosubstituted 3-ethyl indoles, which were used as model compounds for the tryptophan 
analogues, using ab initio calculations with the software package GAUSSIAN 1 5 . The total 
dipole moment of the compounds was found to point parallel to the indole amine nitrogen-
hydrogen bond and assume magnitudes between 1.8 and 7.5 D (§2.5.1 .b). 
No simple pattern was found when any of these parameters were plotted against the 
free energy of 1:1 or 2:1 complex formation of the derivative with DMPC (for more details 
see §7.4). 
2.4 ITC studies 
2.4.1 General Considerations and Theory of the Analysis of Isothermal Titration 
Calorimetry Data 
Isothermal titration calorimetry experiments can potentially give access to thermodynamic 
data for the association process between A^-acetyl-L-tryptophan ethyl amide derivatives 
interacting and DMPC in chloroform. A rather high level of noise was observed during initial 
experiments even though the reference cell of the calorimeter was filled with chloroform, 
which prevented the measurement of the reaction heats of single compounds in dilute 
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samples. The addition of concentrated lipid solutions to a measuring cell containing 
tryptophan analogues lead to dissolution and de-micellisation effects that gave intense heat 
signals with an acceptable signal-to-noise level. The heat associated with these processes 
could be accounted for by subtractions of the heats of injections from a DMPC blank titration 
from signals of the DMPC-tryptophan titration. This allowed the heat of reaction due to the 
interactions between the lipid and tryptophan derivatives to be measured as an added effect 
on the demicellisation isotherm. Typical values were a heat flow of around 30 ucal s"1 for an 
injection of 8 ul of DMPC (26 mM) into neat chloroform and approximately 20 ucal s"1 for 
an injection of 8 ul into a measuring cell containing a tryptophan analogue at about 4 m M 
concentration. This implies that the binding of tryptophan derivatives to DMPC is 
exothermic, as expected. 
Initial data analysis was performed using the MicroCal Systems analysis software 
(MicroCal Origin, version 5.0). The base line was automatically generated by the program 
and was used except when it was obviously accepting an errant data point as reference, in 
which case these base-line points were corrected by hand before further analysis. The 
software then integrated each peak to yield integrated heats, which were normalized to the 
moles of lipid in the injectant. 
2.4.1. a Model for Fitting 
There are three different types of model for self-assembly that allow consideration of 
dimerisation (with binding constant Kd) and oligomerisation (binding constant Km). 1) The 
isodesmic model assumes that all binding constants are equal (K,i = Km); 2) in cooperative 
binding, the formation of smaller complexes is slower than the formation of larger aggregates 
(Kd< Km); 3) the anti-cooperative model assumes the opposite of the cooperative model such 
that the binding constant decreases with growing complex (Kd > Km). In this simplified 
approach, these models do not account for the aggregation of oligomers or other secondary 
effects that might influence the binding constants (such as competing processes e.g. water 
binding). However, they do serve as a good model description for the data within the 
limitations of a reasonable number of variables for fitting. Different self-association models 
containing adjustable parameters were fitted to the observed heat change versus 
concentration data via a Marquardt-Levenberg minimization of ^ 2 . 1 6 
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2.4.l.b Theory 
At the beginning of the experiment, all lipid molecules are contained in the syringe 
(superscript syr). The total concentration of lipid molecules, Losyr w i l l be present in micellar 
and monomer forms and can be accounted for by 
z,r = | > r , (2.i2) 
where L„sy' stands for the concentration of lipid aggregates with size n. 
The concentration of all lipid micelles with size n (L„) can be expressed by applying 
the mass action law: 
L„=KdK,;-\Ly. (2.13) 
I f micelle-micelle aggregation is neglected, conservation of mass yields a cubic equation 
Km{Km-Kcl)L2 +(2K„-2Km-Km2L0)L2 + (l + 2KmL0)L - L0 = 0 (2.14) 
from which the free monomer concentration L can be determined, i f Kj, Km, and the overall 
concentration Lo are known (see §7.1 for details of how to solve the cubic equation). 1 7 ' 1 8 
Through equation (2.13), all lipid concentrations can be determined. 
During the course of an ITC experiment, the volume of the measuring cell is kept 
constant at V0. When /' injections of volume V-, have occurred, the total volume injected is 
F , = 5 > K , (2.15) 
and the total solute concentration in the cell is Loce"(i). Let L„ce"(i) be the concentration of 
micelles with size n in the cell, then the total concentration after the / l h injection is: 
C(o = x<r"(0- (2.16) 
Because o f the total-fill nature of the measuring cell, each injection drives liquid out of the 
cell. Consequently, the concentration of the cell is given by equation 2.17, 1 9 which contains 
an according correction of the volume: 
2VC 
(2.17) 
o J 
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The heat exchanged [QObs(0] during the / t h injection is the sum of two terms: 
a , v ( / ) = A 2 ( 0 + a , , - (2.18) 
AQ(i) results from the dissociation of micelles with size n into smaller sized micelles and 
monomers; Qdu accounts for both the mechanical heat related to the flow of the solution 
(which is independent of /') and the heat of dilution of solutes (i.e. the micelles). This heat o f 
dilution does not involve dissociation and can be considered to be independent o f /', i f the 
concentration in the syringe is so low that nonideality effects are negligible. 2 0 AQ(i), which 
corresponds to the injection of volume AV, = V, - Vi.\, can be expressed as: 
(2.19) 
2 
where Q(i) is the heat exchanged when a micellar solution of volume V, and concentration 
Losyr is injected into the cell containing pure solvent. The last term in equation 2.19 takes the 
displaced volume into account that overflows the cell but contributes partially to the heat 
measured.19 The heat Q(i) corresponds to the dissociation of micelles when the concentration 
of a solution is reduced from LQW to Locell(i). It can be evaluated by considering the fictitious 
process of first diluting the solution from concentration Loxyr to infinite dilution, where only 
monomers are present, and then concentrating back to Locell(i): 
2 ( 0 = 2 ( 0 / ^ 0 + 2 ( 4 ^ < < ( , , - (2-20) 
These hypothetical heats are related to the molar enthalpies of association corresponding to 
dimerisation (AHj) and micellisation (AHm) (Scheme 2.10, with n = 2 or n > 2, respectively): 
K,n>2L„. 
In 
Scheme 2.10: Self-association of lipid molecules L forming a lipid aggregate L„ with size n and an associated 
binding constant K (which corresponds to K d for n= 2, and K m for n>2) 
(XOr ' .o = -A / / „ 2 > - 2 ) C , 
n=3 
e(0o^,;r»(o = ^ f > - 2 ) C W 
- A / / . , 
+ AH. 
Y VyrV 
/ . n i 
n=2 
(2.21) 
(2.22) 
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V- is a hypothetical volume such that the concentration of solutes fictitiously diluted and 
concentrated back are identical: 
Combining Equations 2.13 and 2.20-2.22 yields: 
(2.23) 
0(i) = -WmKdKmVt 
(LrJ Lr\Lr"{i)] 
[\-KmLr) L:"{ii\-KmLr"i}) 
(2.24) 
which is then introduced in equations 2.19 and 2.18. The observed heat of change, Q0bs(i), is 
then normalised by the amount of solute injected: 
LTAVi 
(2.25) 
Consequently, five unknown constants (Kj, Km, AHj, AHm, and QJU) are necessary to describe 
such a calorimetric experiment completely. 
2.4.2 Analysis of Isothermal Titration Calorimetry Data 
2.4.2.a Titrations of Hydrated DMPC Solutions into Chloroform 
The observed heat in titration experiments of DMPC into chloroform wi l l include 
contributions from various processes. 1) An endothermic heat exchange arising from the 
unbinding of water that was associated with the lipid (which is expected to be a major 
contribution as the lipid used contained approximately 2 water molecules per lipid molecule, 
see §2.3.2.a). 2) There wi l l be an endothermic process consistent with the disruption of 
molecular interactions between monomers in the micelle (such as hydrogen bonds, van der 
Waals and electrostatic interactions) during demicellisation; and 3) heat o f dilution. At 
concentrations far below the critical micelle concentration (CMC) of the lipid, the heat of 
demicellisation wi l l be negligible. 
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Figure 2.16: Enthalpograms of hydrated DMPC titrated into chloroform, measured at 25 °C as a function of 
lipid added. The starting lipid concentrations were 26 mM for A, 14 mA/for B, 1.4 mM for C and 0.14 mA/for 
D 
Using dilute solutions of DMPC in chloroform wi l l render the heat of dilution to be 
relatively low. Therefore, injections of dilute DMPC samples into chloroform allowed an 
estimation of the contribution of the unbinding of water (Figure 2.16, D). 
A sigmoidal curve was observed when a very dilute (140 u.M) solution of hydrated 
DMPC was titrated into chloroform. Estimates of the relative concentrations of the species 
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present could be made using the equations derived for the N M R host-guest titrations (§7.2), 
suggesting that 2% of the lipid molecules belong to a micellar form, 57% as free, unbound 
lipid monomers, and - 4 1 % as present in watenlipid adducts. The observed heat o f injection 
dropped by about -6 cal mol"' and may be associated with the heat change of unbinding water 
from the lipid. The error at this low concentration is likely to be large due to the small heats 
observed and the critical influence of the accuracy of the starting concentration. 
At higher starting concentrations (> 1.4 mM) the total observed heat change increased 
significantly. Now, the contributions from demicellisation and dilution processes are 
expected to become more and more significant. At a syringe concentration of 1.4 mM 
DMPC, the observed heat was two orders of magnitude larger than the observed heat o f the 
ten times less concentrated starting solution and followed a more exponential trend (Figure 
2.16, C) . In comparison with the syringe concentration of 0.14 m M DMPC, the amount of 
micellar lipid has increased by 11% reducing the amount of watenlipid adducts and free, 
unbound lipid monomers by 8% and 4% respectively. 
At 14 mM lipid solution in the syringe, a sigmoidal step-like pattern was observed in 
the heat flow profile (Figure 2.16, B). This pattern is likely to be an artefact from rather than 
distinct sequential unbinding events. The absolute heat change per injection was 
approximately one order of magnitude higher than the heat change observed for a ten times 
less concentrated lipid starting solution (1.4 mM). 
When 26 mM DMPC solution was injected into the sample cell, the maximum 
response level was achieved (Figure 2.16, A and Figure 2.17 ), i.e. the heat f low change upon 
injection was approaching the upper detection limit of the instrument (40 peal s"1). The 
associated observed heat adopted a linear pattern with respect to the moles of injectant 
(Figure 2.17, B) and the sequential sigmoidal shape observed when using \4mM DMPC 
solution was no longer detected. The concentrations of micellar lipid, unbound, monomeric 
lipid, and lipid:water adducts were calculated to be 75%, 15% and 11% respectively. The 
observed endothermic process and associated heats are now likely to be dominated by heats 
of demicellisation and dilution and add to the heat of water unbinding, which wi l l now be 
less significant. 
With the maximum response level (and the best signal-to-noise ratio) achieved, a 
concentration o f 26 mM was chosen as concentration for the DMPC guest solution in 
tryptophan-lipid host guest titrations. The lipid concentration was approximately 25% of the 
typical concentration used in the N M R host-guest titrations, which made a comparison of the 
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obtained results possible. A l l runs were performed in duplicate to ensure consistency. Five 
repeat runs were carried out for the DMPC solution at 26 mMconcentration. A typical run is 
shown in Figure 2.17. 
It is noteworthy that it is not possible to obtain the ful l sigmoidal curve for DMPC 
demicellisation in a single experiment. 
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Figure 2.17: Enthalpogram of a titration of hydrated DMPC (26.26 mM) into chloroform. A depicts the heat 
flow curve at 25 °C. B shows the normalised observed heat associated with the signals in A. 
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2.4.2. b CMC Determination of DMPC using ITC 
With a complete loading o f the syringe at the highest feasible lipid concentration 
(~26 mM), the total concentration o f lipid in the measuring cell reached a maximum of about 
4.5 mM, which is below the critical micelle concentration (CMC) of DMPC in chloroform at 
25 °C (16 mM, §2.3.2.b). To reach such a concentration range required the injection o f highly 
concentrated (> 100 mM) DMPC solutions. However, the heat associated with the first 
injections exceeded the maximum upper detection limit o f the instrument at these 
concentrations when using the original settings (8 p i injections over 16 s). By reducing the 
injection volume and the duration o f the injection, the heat f low peaks could be somewhat 
lowered through broadening. However, even at 5 pi injections over 25 s, the signals for the 
first 27 injections exceeded the upper detection limit o f the instrument. Any associated heat 
of these injections is likely to be underestimated, making them less useful for the analysis o f 
the data. This lack o f data could be compensated by the injection o f less concentrated DMPC 
solutions. Furthermore, the CMC of DMPC in chloroform is expected to be at lower lipid 
concentrations at lower temperatures.9 Therefore, the heat o f dilution o f concentrated 
(100 mM) l ipid solutions was also measured at a lower temperature (21 °C) (Figure 2.18). 
This also allowed a direct comparison to the CMC obtained by extrapolation o f data gained 
in the N M R titrations o f hydrated DMPC into chloroform (§2.3.2.b). 
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Figure 2.18: Enthalpogram of DMPC solutions being diluted into chloroform, measured at 21 °C as a function 
of lipid added. A titration of 25 mM hydrated DMPC into chloroform was added as reference, however as the 
heats of injections were too large and exceeded the upper detection limit of the calorimeter they are likely to be 
underestimated and are therefore highlighted in red. 
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Due to the intense heats of injections, it proved to be difficult to obtain the ful l 
expected sigmoidal curve for titrations of hydrated DMPC into chloroform. The graph was 
complemented by measurements of the heat of injection for hydrated DMPC solutions into 
less concentrated DMPC solutions. The curve obtained showed a significant change in the 
observed heat for injections when the total concentration of lipid in the cell, [L]ocdl, was 
<5 mM. This heat change is likely to be associated with the dissociation o f water molecules 
from the lipid, as this concentration is far below the expected CMC (~20 mM). The 
concentration range in which the CMC was anticipated would require injections o f highly 
concentrated lipid solutions into solutions of DMPC with a starting concentration of 
>14 mM. These conditions were well removed from the conditions used for the titration of 
DMPC to chloroform solutions of tryptophan derivatives. 
2.4.2. c Analysis of Tryptophan-Lipid Isothermal Host-Guest Titrations 
Tryptophan-lipid isothermal host-guest titrations were performed using 26.26 mM DMPC 
guest solution, containing tryptophan analogue (6n, 6a-6g) at a typical concentration of about 
3 mM (for ful l details of the procedure see §4.3.3). The set-up used a concentration of 
tryptophan analogue similar to the one used for the N M R host-guest titrations (~7 mM). The 
DMPC concentration had to be adjusted to -26% of the concentration used in the NMR 
titrations as a higher lipid concentration lead to signals that exceeded the upper detection 
limit of the ITC instrument. The heat signals arising from demicellisation, dilution and 
unbinding of water from water-lipid adducts had been determined in five blank titrations of 
the hydrated lipid into chloroform using the same starting concentration (26.26 mM). These 
heat signals were subsequently subtracted from the heat signals observed during the 
isothermal titration measurements resulting in heat signals that are likely to be caused by 
binding of tryptophan compound to lipid and water species (Figure 2.19). 
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When the normalised heat change ~Q0bs was then plotted against the total lipid 
concentration in the measurement cell, a near linear pattern of the resulting enthalpograms 
was obtained. At low lipid concentrations deviations from this linear behaviour were noted: 
Some of the tryptophan analogues (6n, R = H, Figure 2.20 ; 6c, R = Br Figure 2.20 and 6d, 
R = I) exhibited an exothermic incline at lipid concentrations below 0.75 m M (Figure 2.19, 
A) . 
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Figure 2.20: Enthalpogram of DMPC (26.26 mM) titrated to a solution of A^-acetyl-L-tryptophan 6n (4.9 mM) 
in chloroform at 25 °C. A depicts the heat flow curve; B shows the normalised observed heat associated with 
the signals in A. 
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Figure 2.21: Enthalpogram of DMPC (26.26 mM) titrated to a solution of A^-acetyl-S-bromo-Z.-tryptophan 6c 
(2.2 mM) in chloroform at 25 °C. A depicts the heat flow curve; B shows the normalised observed heat 
associated with the signals in A. 
The fluoro-substituted tryptophan analogue (6a) showed heat changes that followed a 
near perfect linear pattern. The heat changes associated arising from titrations with the 
methyl- (6e) and methoxy-substituted (6f) amino acid derivatives followed a more 
exponential pattern (Figure 2.19, B; Figure 2.22). 
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Figure 2.22: Enthalpogram of DMPC (26.26 mM) titrated to a solution of A^-acetyl-S-methoxy-Z.-tryptophan 6f 
(2.0 mM) in chloroform at 25 °C. A depicts the heat flow curve; B shows the normalised observed heat 
associated with the signals in A. 
At higher lipid concentrations (>1 mM), the observed heat changes of all compounds 
analysed could be described by a linear regression with >96% confidence (Table 2.14). 
ID R Gradient Intercept R 2 
cal mol"1 Mx cal mol"1 
6n N 0 2 -0.52±0.01 3493±348 0.9907 0.78 
6d 1 -0.49±0.02 4828±42 0.9990 0.23 
6c Br -0.46±0.14 5467±1313 0.9957 0.23 
6a F -0.63±0.02 5737±582 0.9980 0.06 
6n W -0.41 ±0.01 3495+216 0.9615 0 
6e Me -0.57+0.05 3872±290 0.9885 -0.17 
6f MeO -0.67±0.03 3142±357 0.9583 -0.27 
Table 2.14: Parameters for the linear regression of normalised observed heat signals from tryptophan-lipid 
isothermal titrations. The regressions were performed for signals at total lipid concentration >1.0 mM. 
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The gradient of the linear regressions might be used as an indicator for the strength of 
the observed interactions and associated heat signal changes. When plotted against the 
Hammett parameter, a familiar n-shaped pattern was observed (Figure 2.23). 
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Figure 2.23: Gradient of the linear regression of the heat signals from tryptophan-lipid isothermal titrations 
plotted against the Hammett parameter. 
The fluoro-substituted tryptophan analogue (6a) was found not to fit onto an n-shaped 
pattern. The macroscopic association free energies for tryptophan derivatives binding to 
DMPC observed in the NMR host-guest titrations (Figure 2.11) compares extraordinarily 
well with the binding seen in the ITC experiments, suggesting the same approximations made 
in the data analysis were justified and did not affect the outcome of fitting significantly. 
Due to the necessarily low total DMPC concentration during the isothermal titration 
experiments, a full binding isotherm for tryptophan-lipid interactions could not be obtained. 
Instead the data was found to lie within the near-linear incline of the binding isotherm prior 
to the micellisation event and allowed at best a semi-quantitative analysis. A ful l binding 
isotherm might be obtained by injections of very small aliquots (<3 |j.l) of more concentrated 
lipid solutions (- lOOmM) using a long injection duration (>90 s) and a large spacing 
(>240 s) between injections. 
Accordingly, the observed heat changes in the ITC experiments are likely to contain 
contributions due to water equilibria in the system. This was demonstrated with ITC 
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measurements of hydrated DMPC titrations into chloroform (Figure 2.19). The importance of 
water in all association events and its competitiveness with tryptophan derivatives for 
association with the lipid was also shown by the N M R titrations and (as seen later in §2.5.3) 
in the computational analysis of binding events. The observed heat changes o f the ITC 
experiments are likely to contain an according contribution due to equilibria established with 
water. It wi l l be difficult to separate the observed heats into the individual contributions. 
The unbinding of water from lipid molecules due to competition with the tryptophan 
compounds, is likely to exhibit an endothermic heat associated with the disruption of 
molecular interactions. This leads to an intrinsic underestimation o f the heat signal arising 
from tryptophan-lipid interactions. The amount of water and water-associated adducts in the 
system could be estimated using the equations derived for the NMR titration experiments 
(§7.2). At the last injection, the highest total water concentration w i l l be reached (19 mM). 
The total concentrations of lipid and the tryptophan analogue at this point wi l l be 4.5 mM and 
~4 mM respectively. Most (79%) of the water molecules were determined be free and 
unbound in solution, while -21 % are associated with lipid molecules in lipid-water adducts, 
and only < 1 % are involved in tryptophan:water:lipid 1:1:1 adduct formation. A perturbance 
of the water-lipid equilibrium in favour of interactions with tryptophan analogues might 
therefore expected to be small. With respect to the total tryptophan concentration, 13% of the 
amino acid analogue was calculated to be present as the 1:1:1 species, compared with 3% and 
4% as the 1:1 and 2:1 TrpMipid adducts respectively. 
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2.5 Molecular Dynamics Simulations of Tryptophan - DMPC Interactions 
2.5.1 General Considerations 
2.5. La Treatment of Charges 
Two sets (A and B, see Table 2.15 and Table 2.16) for the representation of partial charges 
on the tryptophan analogues (§1.6.6) were evaluated in this study. 
21 
rHF - calculated using Jaguar aad implicit CHCI 3 
6n 6a 6b 6c 6d 6e 6f 
cP -0.17 -0.29 -0.27 -0.23 -0.21 -0.14 -0.31 -0.24 
2 ^vyv^ 
HN V\ 
\ 1 
7a) (3a 
< > 
Nl -0.58 -0.54 -0.57 -0.56 -0.59 -0.49 -0.52 -0.53 
C2 -0.02 -0.04 -0.04 -0.04 -0.03 -0.13 -0.08 -0.02 
C3 -0.33 -0.20 -0.21 -0.25 -0.24 -0.17 -0.18 -0.29 
C3a 0.26 0.23 0.10 0.13 0.00 0.17 0.27 0.31 
C4 -0.36 -0.54 -0.19 -0.20 0.02 -0.47 -0.66 -0.45 
C5 -0.18 0.42 -0.10 -0.13 -0.40 0.25 0.56 0.10 
C6 -0.12 -0.35 0.01 0.03 0.25 -0.28 -0.36 -0.25 
C7 -0.39 -0.28 -0.47 -0.47 -0.62 -0.34 -0.32 -0.29 
C7a 0.30 0.20 0.35 0.35 0.46 0.22 0.18 0.24 
H s l 0.15 0.16 0.16 0.16 0.15 0.11 0.15 0.17 
Hp2 0.08 0.11 0.11 0.10 0.09 0.07 0.13 0.11 
HI 0.43 0.42 0.43 0.43 0.43 0.40 0.42 0.43 
H2 0.22 0.23 0.23 0.23 0.23 0.23 0.23 0.23 
H4 0.22 0.26 0.19 0.20 0.15 0.24 0.26 0.26 6 V 
R R 0.16 -0.23 -0.12 -0.11 -0.03 -0.42 -0.47 0.80 
H6 0.16 0.21 0.14 0.14 0.09 0.19 0.21 0.22 
H7 0.20 0.22 0.24 0.24 0.26 0.20 0.22 0.22 
X I 0.13 0.02 -0.50 
X2 0.12 0.09 -0.50 
X3 0.11 0.10 
X4 0.11 
Table 2.15: rHF partial charges used (Set A). Charges are given as fractions of the charge on an electron (e); 
XI-X2 correspond to atoms that are attached onto the substituent atom R. They are X I , X2, X3 = H for6e; XI 
= O and X2, X3, X4 = H for 6f; X I , X2 = O for 6g. 
Additionally, two cut-off values (1.2 and 1.9 nm) were used for the treatment of the 
real-space part of the electrostatic interactions via PME. These do not have a direct effect on 
the treatment of long-range electrostatic interactions (as PME energies and forces are 
independent of the cutoff),2 2 but the truncation for the van der Waals terms was increased 
accordingly as well which might influence the calculated parameters. The two sets and their 
influence on binding interactions between tryptophan analogues (6a-g, 6n) and a DMPC lipid 
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molecule were studied in simulations containing both species at equimolar concentrations 
(28rruW)(§5.2.1.a). 
MP2 calculated iisin g Gaussian, fitted with the CHelpG scheme 
6D 6a 6b 6c 6d 6e 6f 
2 ^X/yv / , 
yS _ tJB 
HN vT^ 
\ / 
7a) (3a 
Cp 0.28 0.26 0.28 0.32 0.30 0.29 0.24 0.27 
Nl -0.59 -0.55 -0.56 -0.57 -0.56 -0.59 -0.54 -0.55 
C2 0.01 -0.11 -0.08 -0.08 -0.07 -0.08 -0.07 -0.08 
C3 -0.41 -0.19 -0.24 -0.25 -0.23 -0.25 -0.20 -0.23 
C3a 0.28 0.12 0.11 0.10 0.10 0.15 0.18 0.11 
C4 -0.33 -0.39 -0.26 -0.22 -0.22 -0.38 -0.43 -0.21 
C5 -0.06 0.40 0.13 0.05 0.02 0.12 0.49 -0.07 
C6 -0.18 -0.27 -0.14 -0.11 -0.09 -0.24 -0.30 -0.09 
C7 -0.23 -0.23 -0.29 -0.30 -0.29 -0.24 -0.23 -0.30 
C7a 0.22 0.21 0.26 0.26 0.26 0.23 0.20 0.29 
HB1 0.00 -0.04 -0.04 -0.05 -0.06 -0.05 -0.04 -0.03 
Hp2 -0.07 -0.02 -0.02 -0.03 -0.05 -0.03 -0.03 -0.01 
HI 0.40 0.40 0.39 0.39 0.39 0.40 0.40 0.40 
H2 0.17 0.19 0.18 0.18 0.17 0.17 0.18 0.19 
H4 0.21 0.24 0.20 0.17 0.17 0.20 0.22 0.21 6 V 
R R 0.10 -0.35 -0.24 -0.15 -0.10 -0.13 -0.58 0.80 
H6 0.14 0.18 0.15 0.12 0.11 0.14 0.17 0.16 
H7 0.14 0.16 0.16 0.16 0.16 0.14 0.16 0.17 
X I 0.04 0.28 -0.50 
X2 0.04 0.04 -0.51 
X3 0.04 -0.01 
X4 0.00 
Table 2.16: MP2 partial charges (Set B). Charges are given as fraction of the charge on an electron (e): X1-X2 
correspond to atoms that are attached onto the substituent atom R. They are X I , X2, X3 = H for 6e; XI = O and 
X2, X3, X4 = H for 6f; X I , X2 = O for 6g. 
2.5. Lb Dipolar Interactions 
Tryptophan analogues carry a considerable dipole moment which was approximated by 
calculating the permanent dipole moment of 5'-monosubstituted 3-ethyl indole analogues 
(Figure 2.24) using the program library M O P A C 2 3 and different Hamiltonians (AMI, PM3, 
and PM5). These compounds were used as mimics of the tryptophan derivatives, to simplify 
the computation. Since the backbone structure and polarity will be similar for the analogues 
this simplification was justified. The permanent dipole moment was calculated to range from 
1.6 D (R = Me) to 7.5 D (R = N02) (Table 2.17). AMI dipole moments have an average 
difference between experimental and observed values of ±0.35 D.24 
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3-ethyl 
5'-R-indole 
Dipole Moment / D 
A M I PM3 PM5 
R = H 1.784 1.532 1.191 
R = F 3.517 3.625 3.736 
R = C1 3.250 3.021 2.819 
R = Br 3.401 2.252 2.740 
R = I 3.385 2.573 2.192 
R = Me 1.607 1.350 0.997 
R = MeO 2.548 2.066 1.877 
R = NQ 2 7.548 7.676 8.037 
Table 2.17: Permanent dipole moments of 3-ethyl indole derivatives as calculated using MOPAC using A M I , 
PM3 and PM5 parameters respectively. 
The directions of the dipole are roughly parallel to the bond between the nitrogen and the 
proton in the NH group of indole (Figure 2.24). 
N 
H 
Figure 2.24: Figure showing the permanent dipole of 5'-monosubstituted 3-ethyl indole derivatives. 
When plotted against calculated binding constants, no linear trend was found with respect to 
the dipole moment the molecules carried. (See §7.4, Figure 7.1) 
2.5.2 Simulation of Amino Acid - Lipid Interactions at a Ratio of 1:1 
Simulations of one tryptophan derivative interacting with one DMPC molecule were 
performed under the conditions described in §5.2.1. The simulation box contained one 
molecule of DMPC and one tryptophan analogue (+ 450 chloroform molecules) 
corresponding to an equimolar concentration of 28 m M This allowed the direct observation 
of 1:1 adduct formation over the course of a series of 100 ns simulations. 
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2.5.2. a Analysis of Binding Events 
Regardless o f the initial starting configuration and relative position o f the two molecules with 
respect to each other, all tryptophan analogues (Tip) analysed were found to interact with a 
DMPC lipid molecule favourably, forming an Trp:DMPC adduct (Figure 2.25). Adducts 
were defined by the distance o f the centre o f mass o f the tryptophan analogue from the centre 
of mass o f the lipid molecule, rAB: 
1) r A B < 0.5 n m , 
2) 0 . 5 < 1.0nm, 
3) rm>i.dmm. 
Here, case 1) corresponds to a bound state, case 3) corresponds to an unbound state, and in 
case 2) the molecule is considered to be neither bound nor unbound. 
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Figure 2.25: Distance profiles showing the distance between the centre of mass of an amino acid derivative (6n 
R = H, 6a R = F, & 6g R = N 0 2 ) and the centre of mass of the DMPC molecule as a function of time. The 
compounds are typical examples for weak (6n), intermediate (6a) and strong (6g) associations. 
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Figure 2.25 shows the time evolution of r A B for three selected tryptophan derivatives, 
showing an example of strong binding (R = NO2, 6g), intermediate (R = F, 6a), and weak 
association behaviour (R = H, 6n). The graphs show distinct periods of time during which the 
two molecules remain at approximately the same distance with the durations varying between 
0.5 and 12.5 ns for the different amino acids derivatives. 
The distance profile allowed the estimation of the minimum distance of rAB by 
determining the average distance rAB during the times when rAB <0.5 nm. It was found, that 
the interaction distance between the amino acid derivative and the lipid molecule was 
approximately the same (rAH = 0.35 ± 0.05 nm) for all compounds analysed. 
2.5.2.b Radial Distribution Functions for selected atoms in Amino Acid - Lipid 1:1 
Adducts 
Binding events could be visualised by analyzing the radial distribution functions, g(r), for 
various atom pairs. The radial distribution function describes the probability of finding atom / 
within a distance r of atom j relative to an ideal gas. Exemplary, Figure 2.26 shows a 3-
dimensional expansion of the radial distribution function for the distance between the centre 
of mass of A/a-acetyl-5-N02-^-tryptophan ethyl amide and the centre of mass of the DMPC 
molecules, with time being the third dimension. 
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Figure 2.26: Time evolution of g(r). A shows the radial distribution function for the A^-acetyl-S-nitro-L-
tryptophan ethyl amide (6g) indole centre of mass with respect to the choline nitrogen of DMPC over a 100 ns 
molecular dynamics simulation. B) shows a contour map of A). 
The time-evolved radial distribution function helps to identify times when two 
molecules (or a pair of atoms) are far apart from each other {i.e. the probability o f finding an 
atom i within a radius r o f atom / is low, corresponding to a valley region in Figure 2.26). 
Additionally, the analysis of g(r) provides information about the preferred distance between 
two atoms during times when they are close to each other. A time-averaged radial 
distribution function helps to identify the distances at which two atoms are most likely found 
with respect to each other (Figure 2.27). 
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Figure 2.27: Time averaged radial distribution functions (<g(r)>,) between hydrogen bond acceptors of the 
lipid molecule and hydrogen bond donors from A^-acetyl-L-tryptophan ethyl amide (6n). A shows the <g(»")>, 
of the lipid carbonyl oxygens (denoted as COl and C02 respectively), non-bridging lipid phosphate oxygens 
(POI and P02 respectively) and the acetyl amide hydrogen (AcNH) of 6n. B and C show the <g(r)>, of the 
lipid atoms as defined in A and the ethyl amide proton (EtNH) and the indole amine hydrogen (indNH) 
respectively. The radial distribution function between the centre of mass of the tryptophan indole ring and the 
choline nitrogen is shown in D. 
The time averaged radial distribution function shows, that the minimum distance 
between all the atom pairs analysed is > 0.35 nm. The g(r) between the tryptophan side chain 
and the choline head group exhibits a distinct maximum (r = 0.57 nm) and a broader shoulder 
( r -1 .00 nm) (Figure 2.27, D). This is indicative of a specific interaction at 0.57 nm which 
might include cation-n interactions. 
For the remainder of the data depictured, the radial distributions show a broad signal 
distribution with a roughly Gaussian distribution around r = 0.9 nm for interactions of the 
two amide hydrogens with hydrogen bond acceptors of the DMPC lipid molecule (Figure 
2.27, A-C) . The undefined nature and the lack of a clear peak are suggestive that no 
hydrogen bonding interactions were established, as hydrogen bonds normally span only a 
very short distance (r <0.35nm). However, there might be short-lived hydrogen bond 
formations that are obscured by the averaging of the data. The underlying peak at around 
1.0 nm might be an indicator of specific interactions at this distance. Adducts were therefore 
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analysed via cluster analysis and the hydrogen bonding distance evaluated through the 
software (§5.2.1 .e for experimental set-up and §2.5.2.c for results). 
A similar picture can be seen when looking at the radial distribution functions of the 
other tryptophan derivatives with respect to the lipid (Figure 2.28). 
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Figure 2.28: <s(r)>, functions between hydrogen bond acceptors of the lipid molecule and hydrogen bond 
donors of A^-acetyl-5-F-L-tryptophan ethyl amide (6a). Same descriptions are used as in Figure 2.27 
Here, the same observations about the minimum interaction distance and the 
interacting character of the indole with the choline head group can be made (Figure 2.28, D). 
A striking difference can be seen in Figure 2.28, B. A peak in the g(r) at r - 0.5 nm (roughly 
the same distance as for the indole - lipid nitrogen peak) is indicative of a specific 
interaction. A high probability to find the ethyl amine hydrogen close to one of the lipid 
carbonyl oxygens of the lipid molecule is suggestive of the establishment of a reasonably 
strong, long-lasting interaction, which might include hydrogen bonding interactions at short 
distances. The same results can be seen in more detail for the interactions of A^-acetyl-5-
nitro-Z,-tryptophan ethyl amide with DMPC (Figure 2.29). 
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Figure 2.29: <g0')>/ functions between hydrogen bond acceptors of the lipid molecule and hydrogen bond 
donors from A^-acteyl-5-nitro-Z.-tryptophan ethyl amide (6g). Same descriptions are used as in Figure 2.27. 
Figure 2.29 exhibits a more refined structure for the radial distribution functions of 
the amide protons. There are clear maxima in the g(r) (at r = 0.50 ± 0 . 1 nm) for the 
distribution of ethyl amide hydrogen and the lipid carbonyl oxygens, and well-defined, 
broader peaks at r -0.9 nm (Figure 2.29, B). Additionally, the radial distribution function of 
the acetyl amide proton with respect to a lipid carbonyl oxygen exhibits a peak r~0.75 nm 
(Figure 2.29, A). No clearly defined structures can be seen for interactions between the 
indole amine hydrogen and the lipid hydrogen bond acceptors (Figure 2.29, C) , while the 
indole-lipid head group (i.e. the choline nitrogen) is well-defined. 
The time averaged radial distribution function between the hydrogen bond acceptors 
of the lipid molecule and hydrogen bond donors from the remaining tryptophan derivatives 
exhibited a similar behaviour to the one seen in Figure 2.28. Preferred distances of various 
intermolecular distances vary between the different tryptophan analogues and were observed 
for 0.35 < r < 1.4 nm. No clear hydrogen bonding interactions between the tryptophan 
derivative and the lipid in the 1:1 Trp: 1 ipid complexes were observed, as all time-averaged 
preferred interaction distances between hydrogen bond donors and acceptors in the 
tryptophan derivative and lipid respectively were found for distance r > 0.35 nm. The centre 
of mass of the indole side chain of all tryptophan derivatives was found to be at a preferred 
distance of r -0.75 nm to the lipid choline nitrogen. This might be indicative of a long-range 
cation-rc interaction. 
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The specific orientations o f the various groups and their interactions could be 
visualised by using a cluster analysis o f the bound complexes as detailed in §2.5.2.c. 
2.5.2.C Cluster Analysis of 1:1 Adducts of Tryptophan Analogues with DMPC 
The time averaged radial distribution functions o f atom-atom distances o f the tryptophan 
derivative and the lipid were indicating preferred interaction distances, which could be 
associated with preferred orientations o f the molecules during the adduct formation. To 
evaluate this further, a cluster analysis o f the bound species was performed, using the 
procedure described in §5.2.I.e. Figure 2.30 shows representative examples o f the most 
populated (up to 19% for 6a) preferred binding conformations. 
Figure 2.30: Examples of the most populated binding conformations of 6n (frame A), 6a (frame B), 6f (frame 
C), and 6g (frame D). 
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In some cases (e.g. 6f, 6g), the shown confirmations are the two most populated states 
found for the compound (Table 2.18). The remaining binding conformations could not be 
clustered to a common structure or were populated in less than 2% of the total number of 
binding conformation. 
Cluster 6n 6a 6b 6c 6d 6e 6f 6g 
A 4% 19% 2% 11% 5% 3% 2% 3% 
B 9% 15% 2% 3% 5% 5% 8% 
C 4% 2% 3% 2% 2% 7% 
D 5% 2% 
E 2% 2% 
total 17% 19% 17% 15% 12% 10% 16% 25% 
Table 2.18: Most populated Trprlipid 1:1 clusters as obtained from a 100 ns MD simulation. Cluster A-E do not 
refer to a common structure of the bound conformations of the 1:1 Trp:lipid complexes, but labels individual 
clusters according to appearance in time in the individual simulations. 
The <g(r)>, distributions of the choline head group nitrogen with respect to the indole 
ring had already indicated a close relationship between the two, which can now be visualised 
in the binding conformations, which show the amine nitrogen oriented towards the 
tryptophan compounds in most cases. No preferred orientations of the ethyl amide proton 
with respect to the lipid carbonyl oxygen atoms was observed, suggesting that the preferred 
interaction distance, as seen in the <g(r)>, distributions of these atom pairs, might be an 
artefact of the preferred interaction distance between the indole ring and the choline head 
group. 
2.5.2.d Calculation of Binding Constants and Associated Free Energies for the 1:1 
Adduct Formation of Tryptophan Analogues with DMPC - Theory 
The association of molecule A and molecule B to form the complex AB in the solvent (s) can 
be described as 
t 
"•on 
A(s) + B(s) AB(s). 
*off 
Scheme 2.11: General scheme for a bimolecular association-dissociation process in a solvent (s). 
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Here, kon and k0n refer to the association and dissociation rate constant, respectively. The 
standard free energy o f the association process AG° a ( s ) is given b y 2 5 
/ a b a b = -RT\nKZ, (2.26) 
' A * B ^ A ^ - ' B J 
where /u° is the standard chemical potential, C, and # are, respectively, the concentration and 
the activity coefficient of species /. A deviation of the activity coefficient # from a value o f 1 
is in essence due to the interaction with other solutes in solution, choosing # as one is usually 
a good approximation when the interaction is weak. C° refers to the standard concentration, 
with 1 mol/1 standard concentration as 1 molecule/1.66 nm 3 . K"'B refers to the association 
constant of AB at equilibrium. R is the gas constant and T the absolute temperature. With 
Equation 2.25, the association and dissociation rate constants can be related to the 
equilibrium association constant: 
K ^ B = C 0 ^ . (2.27) 
The unit for C is M, for kon is M1 s~l, and for ka^ is s"'. 
The criteria for the formation of an AB complex is that the distance between the 
centre of mass of A and B be less than a critical value, i.e. rAB < Rc. Each plot in the minimum 
distance profile between tryptophan analogues and DMPC (see Figure 2.25, page 95) shows 
many distinct association and dissociation events. It appears that the simulations have 
effectively explored the configurational space open to the two molecules, providing 
confidence in the statistical significance of the results. 
Survival Function 
Following a previously reported methodology, 2 6 the association constant K"'B can be 
expressed by the survival function SAB(I) of the AB complex. In the general case, assuming 
there are initially nAB(0) complexes AB and no separate molecules A and B present in a the 
solvent s with volume V, the survival function is defined as 
M 0 = - N £ . (2-28) 
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where / I A BW is the number of complexes left after a time /. The numbers of particles A and B 
in the system were equal 
n . A t ) = '»«(') = n A B ^ ) - n A i f ) . (2.29) 
With 
dC: AB =kwCACB-korrCAB, (2.30) 
dt 
and equation 2.28 it follows that 
= 0 - SAH(t)f ^ - k0„SAB ( / ) . (2.31) 
Here, V is in the units of 1.66 nm 3 and kon is in 1.66 nm 3 / (molecules), i.e. A f ] s"1. At 
equilibrium dS(t)/dt = 0, the association constant becomes 
K A B ~ L -j - C 7 y " 77y ( ^ - ^ ) 
S"'B is the survival function of the complex AB at equilibrium. 
Probability of AB Complex Formation 
S"'B can also be interpreted as the average probability for either a molecule A or a molecule 5 
to form the complex AB. A and B can be considered being in a complex when there centres of 
mass are sufficiently close together (i.e. rAB < Rc). Assuming both particles are spherical, and 
one molecule A is positioned in the centre, the probability of finding a molecule B at distance 
r from A is given by the radial distribution function 
G{r) = 4m-2pg{r) (2.33) 
with 
\G{r)dr = n,B(0). (2.34) 
o 
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Here, p is the bulk density of B and g(r) is the pair distribution function, which can be 
computed. The probability S"'B for a molecule A to form the complex AB is the probability 
for the molecule A to have a nearest neighbour B inside a sphere with ^?c: 
SZ = )c(r)dr = A n ^ Jg(/>2rfr. (2.35) 
0 ^ 0 
A/ea/i Survival Time - a Measure of the Dissociation Constant k0ff 
Analysing the distance profile, the mean survival time T™m of the complex AB can be 
calculated from the times when the molecules can be considered being associated, i.e. rAB < 
Rc. The dissociation rate £ 0rrcan then be expressed as 
A-0(T = — 1 — . (2.36) 
1 AB 
Calculating the Equilibrium Association Constant by the Ratio of Bound and Unbound 
States 
The association constant can also be approximated as the ratio of the number of states in 
which the tryptophan analogue and the lipid can be considered as being bound (WL) and the 
number o f states when they can be considered unbound (Wand L respectively) 2 7 
^ = M = r i > (2-41) 
where / refers to the ratio of the number of states when tryptophan derivatives and 
DMPC are bound and the number of states when the tryptophan derivative is unbound; the 
bound and unbound states follow the same criteria as defined above (§2.5.2.a), i.e. rAR < 
0.5 nm for bound and rAB > 1.0 nm for unbound states. Table 2.19 shows computationally 
determined binding constants and associated free energies for the 1:1 Trprlipid adduct 
formation in chloroform. 
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ED A B c A B C 
M ' MA M'x kJ mol 1 kJ mol 1 kJ mol 1 
6n 48.21 ±4.29 40.71 ± 12.50 46.43 ± 8.38 -9.54 ± 0.85 -9.13 ± 2 . 8 0 -9.45 ± 1 . 7 0 
6a 52.14 ±7.86 67.86 ± 17.14 75.66 ±2.65 -9.74 ± 1 . 4 7 -10.38 ± 2 . 6 2 -10.65 ± 0 . 3 7 
6b 64.29 ± 7.50 71.07 ±20.71 65.73 ± 11.02 -10.25 ± 1 . 2 0 -10.5 ± 3 . 0 6 -10.31 ± 1 . 7 3 
6c 105.36 ±5.36 55.36 ± 13.57 48.79 ±5.53 -11.47 ± 0 . 5 8 -9.88 ± 2.42 -9.57 ± 1 . 0 9 
6d 206.07 ±46.79 47.50 ±15.36 38.15 ±4.76 -13.12 ± 2 . 9 8 -9.51 ± 3.07 -8.97 ± 1 . 1 2 
6e 78.21 ±5.36 41.07 ±8.93 42.89 ±7.55 -10.73 ± 0 . 7 4 -9.15 ± 1 . 9 9 -9.25 ± 1 . 6 3 
6f 66.07 ±7.14 77.14 ± 16.43 55.18 ± 12.98 -10.32 ± 1 . 1 2 -10.7 ± 2 . 2 8 -9.87 ± 2.32 
6g 57.14 ± 11.79 54.29 ± 8.57 164.58 ±39.78 -9.96 ± 2.05 -9.83 ± 1 . 5 5 -12.57 ± 3 . 0 4 
Table 2.19: Comparison of calculated Trp:lipid 1:1 binding constants obtained by different treatments of 
electrostatic interactions. Column A describes the binding constants and associated free energies obtained when 
using Hartree-Fock derived partial charges for the tryptophan compound. Columns B and C used partial charges 
derived from MP2 calculations using 1.2 and 1.9 nm as cut-off radius for the truncation of electrostatic 
interactions respectively. 
HF was computed from a set-up where the partial charges of the tryptophan 
derivative were derived from restricted Hartree-Fock ab initio calculations (Table 2.15); 
MP2a was derived by using partial charge parameters derived from calculations using 
Moller-Plesset perturbation theory MP2 (Table 2.16); MP2b used the same partial charges as 
the set-up for the system for MP2a but used a larger cut-off radius (1.9 nm) in the treatment 
of long-range interactions. 
The error estimates reflect the standard deviation of the analysed parameter in its 
values obtained from the 6 starting configurations. Repeat runs using the same starting 
configuration typically gave smaller errors (±5%). 
Calculating the Equilibrium Association Constant using the Survival Function of the 1:1 
Complex 
Using Equation 2.32, the association constant can be calculated when the survival function of 
the complex at equilibrium, SeAqB, the number of initial complexes «AB(0), and the volume V 
of the solvent are known. In the specific case of this study, «AB(0) = 1, as there can only be a 
1:1 complex formation resulting from the simulation set-up (see §5.2.1.a); the volume Fcan 
be calculated from the dimensions of the simulation box, and the survival function at 
equilibrium, SeAqB, can be computed using the radial distribution function of the distance 
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between the centres of mass of the tryptophan analogue with respect to the centre of mass of 
the DMPC molecule in equation 2.35. The dissociation constant &0ff was determined using 
Equation 2.36. With the knowledge of ^ and S^B, the association constant ko„ can be 
calculated as given in equation 2.32. The standard concentration C° was expressed in 
molecules/ 1.66 nm 3. The calculated parameters are summarized in Table 2.20. 
ID 
V T *0fT >*AB 
1.66 nm3 ps ns"' i l O 3 1.66 am 3 / (molecule.ns) 
6n 36.04±0.19 411±68 2.58±0.34 10.89±1.53 1.04±0.20 
6a 36.12±0.15 386±40 2.65±0.24 16.69±3.69 1.64±0.10 
6b 36.13±0.19 347±16 2.92±0.14 15.89±2.44 1.75±0.16 
6c 35.96±0.30 417±20 2.42±0.11 15.22±4.08 1.37±0.32 
6d 35.86±0.26 449±55 2.34±0.30 12.65±1.59 1.11 ±0.25 
6e 35.96±0.11 460±38 2.23±0.18 11.70±2.55 0.99±0.15 
6f 36.14±0.20 442±30 2.38±0.13 24.19±4.24 2.22±0.27 
6g 36.14±0.23 494±45 2.63±0.52 24.20±4.29 2.44±0.91 
Table 2.20: Calculated dissociation and association constants for the formation of a tryptophan analogue-lipid 
complex. 
The resulting association constants could then be converted into association free 
energies for the 1:1 adduct formation of a tryptophan derivative and DMPC ( A G i M P 2 b 2 ) using 
Equation 2.26. 
ID R Op 
K , | £ MP2h2 AG, A C I M K U 
Af 1 AT' kJ moF1 kJ mol' 
6g NO, 0.78 88.22 ± 1.39 6.28 ± 0.75 -11.03 ±0.52 -6.98 ± 0.84 
6d I 0.23 34.56 ±2.21 10.09 ±0.82 -8.72 ±0.12 -4.91 ±0.39 
6c Br 0.23 26.28 ± 2.02 10.54 ±0.96 -8.05 ±0.62 -5.14 ±0.67 
6b CI 0.18 24.01 ±0.32 8.08 ± 1.05 -7.83 ± 0.50 -5.80 ± 0.53 
6a F 0.06 17.93 ±0.85 7.37 ± 0.58 -7.11 ±0.13 -5.69 ±0.46 
6n H 0.00 11.50 ±0.21 8.17 ±0.86 -6.01 ±0.35 -4.52 ± 0.54 
6e Me -0.17 35.59 ±2.06 17.03 ±2.06 -8.79 ±0.18 -5.17 ±0.54 
6f MeO -0.27 61.13 ± 1.28 17.03 ±2.06 -10.13 ± 0.16 -6.98 ± 0.84 
Table 2.21: Computed and experimentally determined binding constants for 1:1 adduct formation of a 
tryptophan analogue with DMPC. 
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2.5.2.e Comparison of Computed Binding Constants with the Experimentally 
Determined Values 
Free Energies of Association Determined by the Ratio of Bound and Unbound States 
Experimentally determined free energies of association for the 1:1 adduct formation of 
tryptophan derivatives with DMPC, AG| , (§2.3.3.c) and computed values were found to be in 
very good agreement. 
rH F 
The computed values using the partial charge set A (AGi ) generally overestimated 
the experimentally determined free energy values by 1.87 ± 0.85 kJ mol"' (Figure 2.31, A) . 
The overall pattern o f the free energies observed in the N M R titration experiment was 
conserved. However, association free energies for the most electron rich and most electron 
poor compounds (6f, R = MeO and 6g, R = NO2) were underestimated indicating that the 
molecular dynamics simulations and the calculation of free energies of association are 
sensitive to the treatment and size of the partial charges on the indole ring. 
This importance was investigated using a partial charge set that had been derived 
from MP2 calculations (Set B). Two sets of runs (Set Ba and Bb) were performed using this 
partial charge model. One employed a truncation o f long-range interactions at 1.2 nm the 
other used a truncation at 1.9 nm. The derived free energies of association ( A G | M P 2 a and 
A G , M P 2 b respectively) were almost identical except for the electron poor 5-nitro tryptophan 
derivative (6g), where the variation was found to be outside experimental error (Table 2.19, 
B and C; Figure 2.31, B). Both treatments show an excellent agreement for the free energies 
of association for electron rich species (6e, R = Me and 6f, R = MeO) and for compounds 
carrying a heavy halogen atom (6c, R = Br and 6d, R = I) with a deviation o f 0.73 ± 
0.51 kJmol" 1 . The free energies of association of the unsubstituted tryptophan derivative 
(6n), the 5-fluoro (6a) and 5-chloro (6b) substituted analogues were slightly underestimated 
by 1.92 ± 0.59 kJ mol"1 with respect to the experimental values. The two treatments varied 
the most in the description of the free energy of association of the 5-nitro amino acid 
analogue (6g). Here, the model employing a shorter truncation radius underestimates, while 
the model using 1.9 nm as truncation radius overestimates with respect to the values obtained 
experimentally. However, both lie within experimental error of the latter. 
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Figure 2-31: Comparison of calculated and experimentally obtained free energies of association for the 1:1 
adduct formation of tryptophan derivatives (6a-g, 6n) with DMPC in chloroform. 
The data for the halogen-substituted tryptophan compounds deviate more from the 
pattern found in experiment. Within the error of the simulations and the approximations in 
the force field of the simulations (e.g. lack of polarizability), this might be an exaggerated 
deviation. Such polarization effects could be incorporated in the description of the system 
using massless, virtual sites that carry some partial charge of the adjacent polarisable atom to 
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which they are bound by a harmonic potential. It should be noted however, that the 
introduction of such virtual sites would increase the computational costs and make the long 
simulations that were performed in this study prohibitively expensive. 
Free Energies of Association Determined by the Survival Function of the 1:1 Complex 
As the partial charge Set B and simulations using a truncation at 1.9 nm were found to 
approximate experimentally obtained free energies of association for the 1:1 adduct 
formation of tryptophan derivatives (6a-g, 6n) and DMPC extremely well, the data from 
these simulations were used to derive association free energies using the survival function of 
the complex (Equation 2.32, Table 2.21). The computed free energies ( A G ] M P 2 b 2 and AG) 
respectively) followed the experimentally determined n-shaped pattern when plotted against 
the Hammett parameter (Figure 2.32). The calculation generally under-estimated the free 
energy of association by 2.81 ± 0.98 kJ mol"1. The observed pattern for the calculated data 
resembles the data for the free energies of associations obtained by the ratio of bound and 
unbound states (AGi M P 2 a and A G , M P 2 b respectively). 
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Figure 232: Calculated (AG, ) and experimentally (AG,) determined values of the association free energies 
for the 1:1 adduct formation of tryptophan derivatives (6a-g & 6n) and a DMPC lipid in chloroform at 25 °C. 
110 
2.53 Simulation of the Influence of Water on the 1:1 Trp: Lipid Adduct Formation 
2.5 3.a Evaluation of Minimum Distances between the Molecules 
The experimental analysis o f the binding o f tryptophan derivatives to DMPC in chloroform 
showed a significant influence o f the water present in the system (§2.3 .2 .a) . Therefore, a 
simulation o f an amino acid analogue (6a), D M P C and a water molecule was undertaken to 
investigate the specific molecular interaction of water with the system. A detailed description 
of the setup can be found in § 5 . 2 . l .b. Briefly, a single point charge ( S P C ) representation o f a 
water molecule was added near the polar head group of the lipid molecule. This resulted in 
an equimolar concentration of 2 8 U J V / for D M P C , tryptophan derivative, and water in 
chloroform ( 4 2 3 molecules). A molecular dynamics simulation was performed over 100 ns 
and the relative distances between the centres o f mass between the molecules evaluated 
(Figure 2 . 3 3 ) . 
^DMPC-water — 'Yrp-water ''Trp-DMPC 
" 4.00 
2 3.00 
time 1 I ns 
Figure 2.33: Distances between DMPC-water, Trp-water and Trp-lipid. A displays the intermolecular distances 
between A'a-acetyl-5-fluoro-Z--tryptophan ethyl amide (6a) and the DMPC molecule; the distances between the 
water molecule and A^-acetyl-S-fluoro-L-tryptophan ethyl amide (6a) molecule and the DMPC molecule are 
shown in B and C respectively. The graphs in B and A are shifted by +2.5 and +5 nm respectively to aid 
visualisation. 
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As with the distance profiles of the tryptophan analogue in the absence of water 
(Figure 2.33, C) , there are distinct time periods (e.g. 18.0 <t < 24.0 ns) at which the centres 
of mass of the amino acid derivative and the lipid are sufficiently close together (rTrp. 
D M P C S 0.5 nm) that the two molecules can be considered being associated with each other. 
The minimal interaction distance between the centres of mass of the tryptophan compound 
and the lipid respectively was found to be 0.35 ± 0.5 nm, which equals the minimal 
interaction distance found when no water molecule was present. 
Figure 2.33, B shows, that there are distinct periods of time, when the water molecule 
and the amino acid molecule remain at a constant distance (rjrp-water = 0.20 ± 0.5 nm). This 
behaviour can be seen at times when the tryptophan analogue is bound to the lipid (e.g. 
18.0 < / < 24.0 ns) and at times when it is not (e.g. 8.0 <t < 10.0 ns) indicating that an adduct 
formation between water and amino acid derivative occurs independently from any 
interactions of the tryptophan compound with the lipid. 
Interestingly, the distance between the water and lipid molecules respectively does 
only fall below 0.5 nm when the amino acid is bound to the lipid molecule at the same time 
(e.g. 18.0 < / < 24.0 ns). This suggests that the water and tryptophan binding to DMPC is 
cooperative, i.e. binding of one enhances binding of the other. This is further supported by 
the observation that there are no hydrogen bonds being formed between the lipid and the 
water molecule (assuming a maximum hydrogen bond length o f 0.35 nm). In contrast, in the 
water-tryptophan analogue adduct there is at least 1 hydrogen bond present at all times. 
Three main clusters, which account for 46.7% of all adduct structures between the 
water and tryptophan molecule, were identified when analysing the water-tryptophan adduct 
(Figure 2.34). 
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Figure 2.34: Figure showing the three most abundant clusters as found by a cluster analysis (see §5.2. l.e) of the 
water-amino acid adduct. Cluster A) was found in 11.5%, B) in 8.7% and C) in 26.5% of all analysed adduct 
structures. 
2.53. b Hydrogen Bonding Interactions in the Trp. DMPC water 1:1:1 Complex 
The simulations showed a preference o f the water molecule towards the tryptophan 
compound. Hydrogen bonding was seen between the acetyl and ethyl amine hydrogens to the 
water oxygen atom. The water molecule was also interacting with the 7t-electron system of 
the indole ring (as seen in Figure 2.34, B and C). 
Hydrogen bonding interactions could be visualised using the radial distribution 
function o f the water oxygen (OW) to hydrogen bond donors in the amino acid analogue 
(Figure 2.35). 
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Figure 2.35: Hydrogen bonding interactions between OW and hydrogen bond donors of the amino acid 
analogue (6a). A shows the time averaged radial distribution function for the distances between OW, and the 
acetyl and ethyl amide protons (AcNH and EtNH respectively) as well as to the indole amine hydrogen 
(indNH). B shows the cumulative number of the radial distribution functions displayed in A. 
Peaks in the time averaged radial distribution <g(r)>, function at short distances 
(r = 0.21 ± 0.03 nm and r = 0.20 ± 0.02 nm respectively) indicate hydrogen bonding 
interactions o f the water oxygen (OW) to occur preferentially with the acetyl amide and the 
indole amine hydrogens. Secondary preferred interaction distances were observed at 
r = 0.53 ± 0.05 nm and r = 0.44 ± 0.06 nm for the distances to the acetyl amide and the 
indole amine hydrogens respectively. The latter coincides with the preferred interaction 
distance between the OW and the ethyl amide proton ( r = 0.39 ± 0.03 nm). These distances 
are slightly too large to be considered as classical hydrogen bonds. The second, less 
pronounced interaction distance between the ethyl amide proton and OW 
(r = 0.57 ± 0.03 nm) was found at the same distance where a secondary preferred interaction 
distance between the acetyl amide hydrogen and the OW was observed (r = 0.53 ± 0.05 nm). 
The <g(r)>t o f the distance between the indole amine proton and OW reflects the pronounced 
favourable interaction distances between OW and the acetyl amide proton with a small 
elevation at r = 0.81 ± 0.08 nm. 
Hydrogen bonding interactions o f the water molecule with the lipid were not 
observed (Figure 2.36, A and C) . 
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Figure 236: Time averaged radial distribution functions between water oxygen (OW) and selected sites in the 
DMPC lipid molecule. A shows the radial distribution function between OW and the lipid choline nitrogen 
(DMPC_N), the hydrocarbon chain tail atoms (DMPC C I N and DMPC_C2N) and two lipid hydrocarbon tail 
midsection atoms (DMPC_C1E and DMPC_C2E). The functions are off-set by +41, 31, 21, 11, and 1 units 
respectively to aid visibility. B shows the cumulative number of the radial distribution functions depicted in A. 
C shows the <g(r)>, for the distance between a water hydrogen (HW) and the two lipid carbonyl groups 
(DMPC_CO! and DMPC C02 respectively). 
Only the time averaged radial distribution function between OW and the l ipid choline 
nitrogen shows distinct preferential locations for the two atoms with respect to each other. 
The more pronounced of these preferred distances was observed at (r = 0.53 ± 0.05 nm), the 
other, less distinct at r = 0.93 ± 0.08 nm. 
These interaction distances are likely to be due to electrostatic interactions of the 
charged choline head group and the electron negative OW. It is noteworthy that the intensity 
of these peaks is about an order o f magnitude lower than the intensities found in the radial 
distribution functions o f OW and hydrogen bond donors in the tryptophan derivative. 
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2.5.3.C Determination of Binding Constants 
Analogous to the method described above (§2.5.2.d), the binding constant for adduct 
formation between the lipid and the tryptophan molecules ( K i S P C ) and the binding constant 
for the association o f water to DMPC ( K i w / S P C ) could be determined (Table 2.22). 
exp. 
computed 
with SPC without* 
K , 1 7.93 ± 0.85 45.09 ± 11.41 75.66 ±2 .65 M
 1 
A C , -7.11 ±0 .13 -9.31 ± 0 . 6 7 -10.65 ± 0 . 3 7 kJ mol' 
31.86 ± 0.11 5.95 ± 1.53 - M
l 
-8.53 ± 0.03 -4.33 ± 0.70 - kJ mof 1 
Table 2.22: Comparison of computed and experimental binding constants and associated free energies for the 
adduct formation of A^-acetyl-5-fluoro-Z,-tryptophan ethyl amide (6a) with DMPC in the absence and presence 
of water. The first column refers to the binding constants and free energies of association obtained via NMR 
host-guest titrations; column 2 and 3 list these values as obtained by using Equation 2.41 for the simulations of 
6a and DMPC in the presence and absence of water.* Values cited were obtained in the simulations using partial 
charge Set B and 1.9 nm truncation of electrostatic interactions. 
The computed values for the binding constant and the association free energy o f the 
adduct formation o f A^-acteyl-S-F-I-tryptophan ethyl amide (6a) with DMPC are improving 
slightly towards the experimentally obtained value when the presence o f water is accounted 
for in the simulation. The error estimates for K j and AG\ were obtained by three repeat 
runs o f the simulation with identical starting configuration. 
Furthermore, the binding constant ( K i w / S P C ) and association free energy o f the 1:1 
adduct formation o f DMPC and water (AG\wiSPC) could be determined. The calculation 
underestimates the experimentally determined value by ~4 kJ mol" 1. It seems likely, that the 
introduction o f more water molecules in the simulation set-up might improve the calculated 
values further. 
2.5.4 Simulation of Amino Acid - Lipid Interactions at a Ratio of 2:1 
2.5.4.a Minimum Distance Profiles for Trpl, Trp2 and DMPC 
A molecular dynamics simulation o f the 2:1 binding o f two A^-acetyl-5-fluoro-Z,-tryptophan 
ethyl amide molecules (6a), T rp l and Trp2, interacting with one molecule o f DMPC lipid 
was performed using the set-up described in (§5.2. l .c) . The system with 4024 chloroform 
molecules in a cubic box with a length o f 8.2 nm corresponds to a lipid concentration o f 
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6 mM and an amino acid concentration o f 3 mM. The level of binding at these concentrations 
could be estimated from the N M R host-guest titrations to be about 13% for the 2:1 and about 
14% for the 1:1 species. 
The size o f the system was necessary to allow fu l l solvation of all compounds, but 
slowed the computation down to 22 hours per 1 ns simulated time. This limited the run time 
for the simulations to 50 ns and due to the long-lasting nature o f the binding interactions, 
restricted their assessment to a qualitative analysis. 
Adduct formation was analysed by plotting the distance profiles for the mean distance 
between the centres o f mass o f the two tryptophan derivatives, rtrpi-Trp2, and their individual 
distances to the centre of mass o f the lipid molecule, rnpi-DMPc and r T r p 2 - D M P C respectively, as 
a function o f time t (Figure 2.37). 
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Figure 2.37: Distance profiles for the distances between two tryptophan derivatives (6a) and a DMPC molecule 
respectively. A shows the intermolecular distance between the centres of mass of two amino acid analogues, 
rTrpi-Tn)2; B shows the distance r T r p , . D Mpc and ' ' T ^ - D M P C respectively between the centre of mass of Trpl and 
Trp2 and the centre of mass of a DMPC molecule over the course of a 50 ns molecular dynamics simulation. 
The distance rTtp2-DMPc was shifted by +1.0 nm for clarity. 
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The r T r pi-Trp2 distance profile (Figure 2.37, A) shows that the two amino acid 
molecules, once they came into close contact (>Trpi-Trp2 < 0.5 nm), remained at a distinct 
minimal interaction range of /"Trpi-TrP2 = 0.19 ± 0.02 nm. The two molecules maintained this 
distance for over 39 ns. Figure 2.37, B displays the close relationship of the distances 
between the centres of mass of the two tryptophan derivatives and centre of mass o f the lipid 
molecule ( m - p i - D M P C and A T ^ . D M P C respectively). 
The minima] interaction distance of the centres of mass of the tryptophan derivatives 
with respect to the centre of mass of the lipid molecules could be determined as 
0.34 ± 0.05 nm. This value equals the minimal interaction distance found in the analysis o f 
the 1:1 binding of the same amino acid derivative with DMPC (§2.5.2). This suggests a 
similar interaction mechanism for the DMPC-amino acid adduct formation. The occurrence 
of only a few distinct binding events during the 50 ns simulation meant that the calculation of 
binding constants for the 2:1 adduct formation was not possible. 
Interestingly, the time at which the two amino acid derivatives first move close 
enough to each other be considered as bound ( / = 10.6 ns, Figure 2.37, A) occurs within 
100 ps after the time at which both tryptophan compounds and the lipid centres of mass are 
within 0.5 nm of each other. In fact, one of the tryptophan derivatives (Trp l ) could already 
be considered interacting when the second amino acid analogue (Trp2) approaches 
(/ = 10.5 ns, Figure 2.38). At this point, the centres of mass of the amino acid analogues are 
still too far away from each other to be considered being in an associated state ( r T r p | . 
Trp2 > 0.50 nm). However, after a short time span (100 ps) the distances between the centres 
of mass of the amino acids falls below that threshold and stay there for the remainder of the 
simulation. This suggests that the lipid promotes or even initiates the formation of an amino 
acid-amino acid complex. To validate this hypothesis further, the two amino acid derivatives 
were simulated under the same conditions as this simulation but in the absence of DMPC 
(see §2.5.5). 
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Figure 238: Distance profiles for the distances between the centres of mass of the two tryptophan analogues 
(6a) and the DMPC molecules respectively. The region around 10.5 ns is enlarged to allow a more detailed 
picture of the sequence of association events. 
At least two modes o f interactions between the amino acid complex and the lipid appear as 
likely from the radial distribution data: In the first mode {e.g. 11.0 < / < 14.0 ns), one of the 
tryptophan derivatives is close to the centre o f mass o f the lipid molecule (r-rrp-
D M P C 5 0.34 nm), and the centre o f mass o f the other is approximately 0.71 ± 0 . 1 4 nm away 
from the lipid (and the two tryptophan derivatives are 0.37 ± 0.14 nm away from each other). 
In the second mode {e.g. 19.0 < / < 20.0 ns), both centres of mass o f the amino acid 
derivatives are approximately equidistant from the centre o f mass o f the DMPC molecule 
(both rrrpi-DMPc and rrrp2-DMPC = 0.34±0.05 nm respectively) at the same time. The relative 
occurrence o f these modes can be visualised by plotting the root mean squared (rms) 
difference o f the rnp-DMPc distances (Figure 2.39). 
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Figure 2.39: Figure displaying the root mean squared distance of the difference in the distances between the 
centres of mass of the DMPC molecule and the amino acid derivatives Trpl and Trp2 respectively. 
2.5.4.b Analysis of <g(r)>, for distances between Trpl, Trpl and DMPC atoms 
Hydrogen bonding interactions between the two amino acid derivatives were evaluated using 
radial distribution functions of the distances between hydrogen bond donors (indole amine, 
acetyl and ethyl amide protons) and hydrogen bond acceptors (acetyl and ethyl carbonyl 
oxygen) of both (Figure 2.40). Preferred interaction distances between indole amine proton 
of Trpl and the ethyl amide proton o f Trp2 to the ethyl amide carbonyl o f the corresponding 
other tryptophan derivative were observed at rAB < 0.35 nm, which might indicate hydrogen 
bonding interactions between these atom pairs. Another set o f preferred interaction distances 
for the between these atoms that was seen at larger distances (rAB -0.65 nm and rAB -0.95 nm 
respectively). 
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Figure 2.40: <g(r)>, of the distance between hydrogen bond donors and acceptors of the two tryptophan 
derivatives (6a), Trpl and Trp2. A depicts the distances of hydrogen bond donors (the acetyl amide (AcNH), 
ethyl amide (EtNH) and indole amine protons (indNH) respectively) of Trpl and Trp2 with respect to ethyl 
amide carbonyl oxygen (EtCO) of the other Trp molecule. In B the distances of the hydrogen bond donors were 
evaluated with respect to the acetyl amide carbonyl (AcCO) of the other Trp molecule. C displays 
intermolecular distances of selected indole ring atoms of the amino acid analogues with respect to each other. 
The labeling of atom names follows the one introduced in Table 2.16. 
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For the ethyl amide proton this second preferred distance can be rationalised by the 
strongly preferred interaction distance o f this proton with the acetyl amide oxygen of Trpl 
(Figure 2.40, B). These hydrogen bonding interaction are likely to be contribute to 
interactions that fix the conformation of the two tryptophan derivatives with respect to each 
other, causing these distinct preferential interaction distances. Various other preferred 
interaction distances at larger distances (rAB >0.50 nm) were observed in the time averaged 
radial distribution functions of the intermolecular distances of hydrogen bond donors and 
acceptors of both tryptophan derivatives, but these interactions are less likely to be involved 
in hydrogen bonding interactions. However, they indicate specific orientations and 
interaction distances between the two amino acid analogues. 
This occurrence of preferred orientations and interaction distances is further 
supported by the time averaged radial distribution functions of the distance between indole 
ring atoms of the two tryptophan derivatives with respect to each other (Figure 2.40, C) . 
Preferred interaction distances could be seen at distances rAB -0.70 ± 0 . 1 nm, which could 
indicate n-n interactions between the two aromatic ring systems. The fact that the preferred 
interaction distances are highly preserved (i.e. strong peaks in the <g(/-)>,) indicates that such 
interactions are likely. 
No strongly preserved preferred interaction distances between hydrogen donors of 
either of the tryptophan derivatives to hydrogen bond acceptors of the lipid molecule were 
observed (see §7.5), indicating that no long-lasting hydrogen bond bridges were established 
between the amino acid analogues and DMPC. However, interactions between the polar 
choline head group and the indole side chain of at least one of the tryptophan derivatives 
were observed (Figure 2.41). 
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Figure 2.41: Interaction distances between the lipid choline nitrogen and selected sites of two amino acid 
analogues (6a). These are the acetyl amide and ethyl amide carbonyl oxygens (AcCO and EtCO respectively) 
and the centre of mass of the indole aromatic side chains. 
The observed peak for at a distance rAS -0.60 nm for the distance between the choline 
head group nitrogen (DMPC N) and the indole side chain of one o f the tryptophan 
derivatives (Trpl ) indicates a preferential interaction distance between these to sites, which is 
likely to be a cation-7i interaction. Interestingly, this preferred distance is only observed for 
one o f the tryptophan compounds while the other shows a broader distribution with an 
elevation at rAB -0.60 nm and subsequent gradual decline. This might indicate a less defined 
interaction distance between the choline nitrogen and the aromatic rind o f Trp2. 
2.5.4.C Analysis of hydrogen bonds between the Trpl, Trp2 and DMPC Molecules 
A hydrogen bond analysis using GROMACS software revealed that up to 4 hydrogen 
bonds were established between the two amino acid tryptophan derivatives upon 
complexation (Figure 2.42). No hydrogen bonding interactions between the tryptophan 
compounds and the lipid were observed at any time 
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Figure 2.42: Number and occurrence of hydrogen bonds between Trpl and Trp2. B depicts a histogram of the 
number of hydrogen bonds established between the two amino acid analogues (6a). A shows the distance 
between the centres of mass of the two tryptophan derivatives with respect to each other as a reference. 
The occurrence o f hydrogen bonds being established between the two tryptophan 
derivatives coincides with the cluster formation o f the two molecules as can be seen clearly 
in Figure 2.42. On average, the cluster is held together by 2 hydrogen bonds. These are likely 
to involve the hydrogen donor/acceptor atom pairs with preferred interaction distances 
rAB < 0.35 nm (Figure 2.40). Hydrogen bonds between the ethyl amide proton o f Trp2 
(EtNH2) and the acetyl amide carbonyl oxygen o f Trp l (AcCOl) , the indole amine proton o f 
Trp2 (indNH2) and the ethyl amice carbonyl oxygen o f Trp l (EtCOl), and the ethyl amide 
proton o f T r p l (E tNHl ) and the acetyl amide carbonyl oxygen of Trp2 (AcC02) are likely 
candidates. 
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2.5.4.d Analysis of Trp: DMPC 2: J Clusters 
A cluster analysis of the bound conformations observed in the minimum distance profiles of 
the two tryptophan derivatives Trpl and Trpl with respect to each other and with respect to 
the lipid molecule were analysed for the occurrence of clusters (Figure 2.43). The analysis of 
clusters revealed structures that exhibited face-to-face (Figure 2.43, A) and edge-to face 
(Figure 2.43, B) 7i-stacking interactions between the two aromatic indole side chains o f the 
tryptophan derivatives (6a). The most populated clusters are depicted in Figure 2.43, C - E in 
increasing occurrence (9.5%, 14%, 42% respectively). As expected, distinct hydrogen 
bonding interactions between the two amino acid analogues can be observed with the ethyl 
amide proton of one Trp hydrogen bonding with the acetyl amide carbonyl oxygen of the 
other Trp. To the latter two hydrogen bonds could be established as seen in Figure 2.43, D. 
The visual inspection supports the conclusions drawn in §2.5.4.b. 
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Figure 2.43: Trp-.DMPC 2:1 clusters as seen in molecular dynamics simulations. A and B show clusters that 
show Tt-stacking interactions of the two amino acid derivatives (6a), face-to-face interactions in A and edge-to-
face interactions in B. C , D, and E display the more common clusters 
2.5.5 Simulation of Amino Acid - Amino Acid Interactions at a ratio of 1:1 
A 50 ns simulation o f two A^-acetyl-5-fluoro-Z,-tryptophan ethyl amide molecules (6a) in 
chloroform was performed using the experimental set-up described in §5.2.l .d. This control 
experiment was used to determine any background binding between the two analogues and to 
access the importance o f the presence o f the lipid. It was found that the two molecules were 
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not interacting strongly with each other as shown in Figure 2.44, which depicts the average 
distance between the two centres o f mass o f the two tryptophan derivatives with respect to 
each other over time. 
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Figure 2.44: Distance profile of the distance between the centres of mass of two A^-acetyl-S-fluoro-L-
tryptophan ethyl amide molecules (6a) over a 50 ns molecular dynamics simulation. Adduct formation towards 
the end of the analysed time span is highlighted by a red circle. 
During 95% of the simulated time span, the two molecules were apart from each 
other. Only during the last 2.5 ns was an association at an average distance o f 
rAB - 0-18 ± 0.02 nm visible. These data indicate that the two amino acid derivatives were 
freely solvated in solution and not associated for longer period o f times during the time span 
analyzed. This contrasts with the case when DMPC was present in the simulations, when the 
two amino acid derivatives were found to be associated during most (78%) o f the 50 ns, with 
the lipid molecule being in close proximity (rAB - 0.34 nm). This further supports the finding 
that the lipid is essential for the fostering and stabilisation o f the amino acid - amino acid 
complex (see also §2.5.3). 
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2.6 Free Energy Calculations 
The following section describes the calculation of solvation free energy o f tryptophan 
derivatives in chloroform (§2.6.1) and their free energy o f association with a DMPC lipid 
molecule in chloroform at 25 °C (§2.6.2). As outlined in §5.2.3, free energies were computed 
by employing a thermodynamic cycle (Scheme 2.12), where the tryptophan analogue is 
represented as Tip when fully interacting with its environment or as dummy particle Trp' 
when all its non-bonding interactions with the environment have been turned off: 
System 1 i System 2 N 
AG 3 
' AG, A G 2 
' ' - j _ r P ' . - ' 
A G 4 
i s J 
Scheme 2.12: General scheme for the calculation of a free energy of interest by using the thermodynamic 
integration method. AG, and A G 2 refer to the free energy associated with the gradual fading of all non-bonded 
interactions of Trp with its environment in System 1 and 2, respectively; A G 4 describes the free energy 
contribution of the transfer of the dummy Trp' from System 1 to System 2; A G 3 describes the free energy 
contribution of the transfer of the fully interacting Trp from System 1 to System 2. 
In the calculation of solvation free energies, the particle were represented once in 
vacuum and once in solvent (System 1 and System 2 in Scheme 2.12 respectively). 
2.6.1 Calculation of Solvation Free Energies of Tryptophan Analogues in C H C b 
The simulations o f A^-acetyl-Z-tryptophan ethyl amide molecules (6a-g & 6n) were set up 
using the procedure described in (§5.2.3.a). For the representation o f System 1 (see Scheme 
2.12), the molecules were positioned in a simulation box with infinite box lengths and non-
bonding interactions were gradually and linearly turned o f f over 21 steps. The free energy o f 
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the transition between the ful ly interacting and the dummy particle was evaluated by 
integration o f the free energies at each step (Equation 4.24, §5.1.1.d). The free energy 
contribution in vacuo, AGi , and the free energy of the transfer from a ful ly interacting 
particle in solution into a dummy particle, A G 2 , could be calculated (Table 2.23) with small 
estimated errors (< 1% and < 3.5% respectively).The accuracy o f the calculations was further 
assessed by the inversion o f the change in A to produce a simulation for the change of the 
tryptophan derivative from a dummy to a ful ly interacting molecule (A = 1 —* A = 0). The 
obtained values o f the reverse-simulation were within experimental error identical to the 
values for the corresponding simulation where A was changed from 0 to 1. 
It is proposed, 2 8 that the free energy of transferring a ful ly non-interacting particle 
from vacuum into solution, AG4 is zero. Applying Equation 2.42, the free energy o f solvation 
AGsoiv can be expressed as the sum of the free energies (AG/ to AG 4): 
AGsoh = AG, - A G 2 + A G 4 = A G 3 (2.42) 
Assuming AG4 = 0, the free energy o f solvation A G s o i v o f a compound could be 
determined (Table 2.23). The calculated free energies o f solvation ranged from 
approximately -11.9 ± 5.46 kJ mol"1 (R = Me, 6e) to -22.2 ± 7.9 kJ mol" 1 (R = N 0 2 , 6g). 
ID 
A G , AG 2 A G s o h , 
kJ mol 1 kJ mol 1 kJ roof' 
6a 269.48 ± 0 . 1 4 283.73 ± 4 . 8 0 -14.25 ± 4 . 8 0 
6b 238.91 ± 0 . 2 8 257.50 ± 5 . 8 0 -18.59 ± 5 . 8 0 
6c 220.56 ± 0.46 241.33 ± 5 . 5 4 -20.77 ± 5.54 
6d 215.51 ± 1.60 236.10 ± 6 . 5 5 -20.59 ± 6 . 5 5 
6e 239.45 ±0 .71 251.36 ± 5 . 4 6 -11.91 ± 5 . 4 6 
6f 296.57 ± 1.44 313.04 ± 5 . 8 9 -16.47 ± 5 . 8 9 
H 222.97 ± 0.35 245.13 ± 7 . 8 9 -22.16 ± 7 . 8 9 
6n 208.66 ± 0.33 229.60 ± 5 . 2 1 -20.94 ± 5 . 2 1 
Table 2.23: Free energy contributions AG, and A G 2 of A^-acetyl-I-tryptophan ethyl amide compounds (6a-g & 
6n) being transferred from a fully interacting state to a fully non-interacting state in vacuum and in solution 
respectively. 
129 
When plotted against electron density of the indole ring, the pattern shown in Figure 
2.45 was observed. No clear pattern was observed. The negative solvation energies are 
consistent with a favourable solvation of the compounds in chloroform. 
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Figure 2.45: Solvation free energies o f 5-monosubstituted /V°-acetyl-L-tryptophan ethyl amides (6a-g, 6n) 
plotted against the Hammett parameter. 
Villa et al.29 calculated the free energy of solvation for 3-methylindole as a mimic of 
the tryptophan side chain in chloroform as being -39.6 ± 1.4 kJ mol"1 at 20 °C. The authors 
used the standard rigid model for chloroform as implemented in the GROMOS96 (43a2) 
force f i e ld . 3 0 The reported experimental value for the free energy o f solvation of 3-
methylindole in chloroform at 20 °C (-36.8 kJ mol ' 1 ) was somewhat smaller.3 1 
In comparison, the calculated free energy of solvation for iV^-acetyl-Z,-tryptophan 
ethyl amide (6n) in chloroform (-20.94 ± 5.21 kJ mol"1) is about half the reported value for 3-
methylindole. However, the polar backbone o f the tryptophan derivative is likely to decrease 
favourable interactions with the non-polar solvent chloroform, decreasing the free energy o f 
solvation. The free energy contribution of the backbone can be estimated from studies by 
Daura et al.32 The authors used the united atom GROMOS87 force field to calculate the free 
energy difference of the alchemistical transformation of yV-acetyltryptamine into 3-
methylindole in chloroform to be 73.3 ± 2.2 kJ mof ' at 27 °C. The implemented partial 
charges on the iV-acetyl functional group were smaller than the values for the all-atom 
description in this study. This difference in partial charges is likely to have a strong effect on 
calculated free energy differences as a scaling factor o f 1.1 for the partial charges on the N-
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acetyl functional group reportedly decrease the free energy of solvation by -6.02 kJ mol"1.32 
The partial charges used here differed from the values employed in Dauras study by a factor 
of approximately 2. 
Recently, the importance of partial charges for hydration free energies was further 
investigated by Xu et al.2Sa In their study of 3-methylindole, two new sets of partial charges 
for the aromatic ring atoms were derived from density functional calculations by natural 
population analysis (NPA) and fitting of the electrostatic surface potential (ESP) (Table 
2.24). 
The authors suggested reparameterised partial charges that were a combination of the 
original OPLS-AA force field charges and the partial charges derived by NPA. Partial 
charges that were derived by ESP were found to be more exaggerated and to vary in a greater 
range of negative values. This suggested that the NPA charges were more transferable than 
ESP charges and thus potentially more suitable in nonpolarizable force fields. Furthermore, 
the calculations in this study were performed at 22 °C accounting for a slight deviation in the 
AGsoiv value. 
O P L S - A A NPA E S P O P L S - A A / m Set A S e t B 
C G 0.075 -0.10 0.05 -0.100 -0.331 -0.407 
C D 1 -0.115 -0.04 -0.16 -0.040 -0.020 0.013 
HD1 0.115 0.23 0.16 0.230 0.220 0.166 
C D 2 -0.055 -0.09 0.04 -0.090 0.258 0.284 
NE1 -0.570 -0.57 -0.50 -0.570 -0.582 -0.587 
H E I 0.420 0.42 0.39 0.420 0.300 0.402 
C E 2 0.130 0.15 0.28 0.150 0.298 0.221 
C E 3 -0.115 -0.24 -0.18 -0.115 -0.356 -0.330 
H E 3 0.115 0.24 0.13 0.115 0.218 0.208 
C Z 2 -0.115 -0.24 -0.29 -0.115 -0.388 -0.229 
H Z 2 0.115 0.24 0.14 0.115 0.204 0.142 
C Z 3 -0.115 -0.24 -0.18 -0.115 -0.184 -0.061 
H Z 3 0.115 0.24 0.12 0.115 0.155 0.096 
C H 2 -0.115 -0.24 -0.08 -0.115 -0.123 -0.179 
HH2 0.115 0.24 0.11 0.115 0.163 0.137 
Table 2.24: Comparison of indole partial charges. The column O P L S - A A displays the partial charges used in 
the original force field; columns 2-4 display partial charges used by Xu et a / . 2 8 a calculated by natural population 
analysis (NPA) or fitting of the electronic surface potential (ESP) and their adapted charges obtained by a 
combination of O P L S - A A and NPA derived partial charges (OPLS-AA/m). The last two columns present the 
partial charges used in this study as determined by restricted Hartree-Fock ab initio calculation (Set A) and 
MP2 calculation with subsequent fitting using CHelpG (Set B). 
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Finally, the free energy simulations wi l l depend to a certain extend on the starting 
conformation of the molecule. More compact conformations w i l l exhibit a smaller exclusion 
volume for solvent molecules, decreasing the calculated free energy o f solvation. More 
extended molecules, and particularly exposed polar functional groups, might influence the 
calculated free energy o f solvation. This is also likely to contribute to the somewhat higher 
error associated with the free energy calculations o f the tryptophan derivatives observed in 
this study in comparison to free energy calculations o f the more rigid 3-methylindole, which 
is very restricted in it conformational space. 
2.6.2 Analysis of Binding Free Energies of Amino Acid - Lipid Interactions at a Ratio 
of 1:1 
Similar to the determination o f free energies o f solvation, binding free energies were 
calculated using the thermodynamic cycle as shown in Scheme 2.13. Here, all the simulations 
were performed in chloroform (see §5.2.3.b for more details). 
System 1 
A G , 
/ S y s t e m 2 
A G , 
oWPc 
Scheme 2.13: General scheme for the calculation of the association free energy of Tip with D M P C . In System 
1, both molecules are freely solvated, whereas in System 2, they are associated with each other. In both systems, 
the non-bonding interactions of one of the molecules (Trp in this case) are gradually and linearly turned off, 
resulting in the generation of a dummy molecule (Trp') which no longer interacts with its environment. The free 
energy associated with both processes (AG, and A G 2 ) can be computed with relative ease. 
AGi corresponds now to the free energy contribution of the phasing out of non-
bonding interactions o f a ful ly solvated, free A^-acetyl-L-tryptophan ethyl amide derivative 
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(6a-g, 6n) in the presence o f DMPC and was calculated with an error o f <9% (Table 2.25). 
The free energy contribution of the associated A^-acetyl-X-tryptophan ethyl amide derivative 
losing its non-bonding interactions to the environment AG3 were calculated within an error 
margin o f <5.5%. 
ID 
A G , A G 2 AG bj,,,, 
kJ mol 1 kJ mol 1 kJ mol 1 
6n 241.52 ± 10.84 236.62 ± 10.68 4.90 ± 10.84 
6a 293.44 ± 2 5 . 8 2 312.83 ± 9 . 7 9 -19.39 ± 2 5 . 8 2 
6b 324.16 ± 12.65 285.95 ±10.21 38.20 ± 12.65 
6c 264.93 ± 1 0 . 8 1 254.11 ± 13.79 10.82 ± 13.79 
6d 252.23 ± 11.86 253.91 ± 13.17 -1.68 ± 13.17 
6e 273.85 ± 12.02 333.49 ± 10.38 -59.64 ± 12.02 
6f 337.85 ± 13.95 320.47 ± 14.31 17.37 ± 14.31 
6g 281.88 ± 12.05 258.33 ± 13.22 23.54 ± 13.22 
Table 2.25: Free energy contributions AGi and A G 2 of Ara-acetyl-Z,-tryptophan ethyl amide (6a-g, 6n) 
compounds being transferred from a fully interacting state to a fully non-interacting state in vacuum and in 
solution respectively. 
The resulting binding free energy AGbind was approximated as the difference between 
A G ] and A A G 2 . The obtained free energies o f association vary considerably including 
strongly favourable interactions (AGbind = -59.64 ± 12.02 kJ mol"1, 6e), weak associations 
(AGbind = -1-68 ± 13.17 kJ mol" 1, 6d) and unfavourable interactions (AGbind = +38.20 
± 12.65 kJ mol" 1, 6b). The associated error in these free energies was large. This discrepancy 
might be caused by the limited conformational sampling used in the free energy calculations 
o f the bound complex. Only one average structure o f a bound complex was used in each of 
the calculations, while experimentally observed and calculated free energies o f calculations 
were derived from an ensemble average over a large conformational space. The free energy 
calculations should be performed with a selection o f bound state configurations. 
Furthermore, biasing potentials that restrain translation, orientation, and conformation of the 
molecules could help enhance the convergence o f the calculations.3 3 
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2.7 Molecular Dynamics Simulation of Peptide - Lipid Interactions 
Molecular dynamics simulations of model peptides of the general structure A c W L W L L were 
performed using the procedure described in §5.2.2. A confomer o f the peptide was inserted 
1 nm away from a pre-equilibrated bilayer surface, replacing SPC water molecules in its 
place. Simulations were then run between 20 and 50 ns and the orientation of the peptide 
with respect to the bilayer normal analysed. A cluster analysis o f the peptide revealed 
confomers relevant for association with the bilayer. 
2.7.1 Bilayer Structure 
2.7. La Area per lipid 
In molecular dynamics simulations o f lipid bilayers, distances between certain atoms across 
the membrane, and the orientational order parameter o f the lipid hydrocarbon chains are used 
to benchmark the calculation. Comparison with experimentally obtained values for these 
parameters can help assess the quality o f the simulation at hand. One o f the most commonly 
employed tests is the area per lipid molecule, A, which can be measured accurately via both 
experiment and simulation. In the simulation, the area per lipid can be assessed by following 
the dimensions of the lipid bilayer plane over time. The division o f this area by the number o f 
lipids per leaflet {i.e. 64 in this study) gives the area per lipid. Table 2.26 shows the relevant 
experimental data for the area per lipid A of DMPC bilayers (measured at 27 °C), in 
comparison to the values obtained in this study: 
Entry Ref Method used 
I 34 gravimetric x-ray method (GX) 0.652 
I I 35 corrected gravimetric x-ray method (GXC) 0.617 
I I I 36 corrected value for entry I 0.676 
IV 36 corrected value for entry I I 0.634 
V 37 Start o f the equilibration: teq = 0 ns (Figure 2.46) 0.734 
V I End o f the equilibration: teq = 10 ns 0.586 
V I I A c W L W L L production run (Figure 2.48) 0.579 ± 0 . 0 3 
Table 2.26: Table showing experimentally and computationally determined values of the area per lipid A for a 
D M P C bilayer at 27 °C. These values are compared to the values obtained at various stages of the molecular 
simulation, using the procedure described in §5.2.2. 
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Figure 2.46: The evolution o f the area per l ipid during the equilibration phase of the calculations. 
The starting conformation of the lipid bilayer equilibration was found to represent 
experimentally obtained values for the area per lipid A well (Table 2.26). However, the area 
per lipid dropped significantly during the first nanosecond of the equilibration, with 
accompanying expansion of the simulation box in the direction of the bilayer normal and 
contraction along the bilayer plane. 
A variation the experimentally determined area per lipid values of up to 20% is not 
unknown, 3 6 ' 3 8 yet the observed fast and significant reduction in A (-16%) is likely to be due 
to artificial ordering. 
The area per l ipid is very sensitive to simulation details and large thermal fluctuations 
in the lipid area around its average value have been observed with correlation times of 1 to 
10 ns. 3 9 ' 4 0 ' 4 1 These fluctuations can be attributed to the contribution from a hierarchy of 
motions, including isomerisation (in saturated lipids), rotation, and diffusion of individual 
lipids, as well as collective motions of the bilayer itself such as the appearance of 
undulations. Such thermal fluctuations in A could potentially induce a phase transition from 
the liquid crystalline phase Lp to a more ordered gel-phase ( L a ) . The reported transition 
temperature for the phase transition (24 °C, Ref. 42) is not far f rom the temperature the 
simulations were performed at (27 °C). 
The equilibration of the area per lipid value to a relatively low value, suggests that the 
force field and long-range treatment of electrostatic interactions used for the description of 
the bilayer underestimate this parameter. Such artificial ordering o f lipid bilayers has been 
3 4 5 6 7 8 9 10 
time / ns 
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described previously, and a small decrease in the area per lipid value was to be expected, 
as small charge groups were used for the representation of the lipid charges. Anezo et al.41 
had shown that the area per lipid decreases by 2%, when smaller charge groups were used 
with a PME treatment of electrostatic interactions. The effect seen in PME can be attributed 
to the effect of changing the effective cut-off for the Lennard-Jones interactions (as the 
electrostatic cut-off in PME serves only as a numerical device to separate direct- and 
reciprocal-space sums). 
The lipid parameters used were adapted from Ref. 44 and were originally 
parameterised for the use of the GROMOS force field gmx. 4 5 In this study, the lipid 
parameters were converted into an OPLS-AA notation as the A c W L W L L peptides used were 
parameterised for this force field. This conversion of the lipid parameters into OPLS-AA 
notation might have caused a further drop in the area per lipid value due to the slightly 
different operation of both force fields. 
A control run o f an identical starting configuration of the hydrated bilayer using the 
same treatments for long-range interactions using the GROMOS gmx force field lead to an 
area per lipid value (A = 0.594 ± 0.06 nm 2 ) that showed considerable fluctuations but that 
was consistent with experimentally determined values (Figure 2.46). 
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Figure 2.47: Area per l ipid A as observed in a control equilibration o f a DMPC bilayer using a molecular 
dynamics simulation employing the GROMOS force f ield gmx. 
136 
Although the area per lipid parameter was not represented with high accuracy, the 
simulation of A c W L W L L type peptides with the bilayer were pursued using the OPLS-AA 
description of the lipid bilayer as this force field had been implemented in the set-up of the 
peptides and the discrepancy between the simulated area per lipid and experimentally 
obtained values was acceptable given the uncertainty in A of up to 2 0 % . 3 M 6 
The water to lipid ratio in the simulation was chosen to allow fu l l hydration of the 
bilayer (3655 molecules of water to 128 molecules of lipid, i.e. 57:2), allowing for the 
replacement of some (-20) water molecules by the peptide. Nagle et a/.3 6 suggested that a 
ratio o f 51:2 water molecules per molecule of lipid would ensure ful l hydration. 
2.7.2 Simulations of Binding Interactions between A c W * L W L L and a D M P C Bilayer 
Binding of A c W * L W L L peptides (where W* refers to 5-monosubstituted derivatives of the 
tryptophan residue) to a DMPC lipid membrane was simulated using the procedure described 
in §5.2.2. The analysed substituents on the indole ring span the halogen series from F to CI. 
Peptides are described by the abbreviation A c X L W L L (where X stands for W, F, CI, Br, or I) 
indicating the substituent on the 5-position of the indole ring in Trp 1 . 
2.7.2.a Area per Lipid during Peptide-Lipid Simulations 
During the peptide calculations the area per lipid value was found to be stable and 
equilibrated (A = 0.579 ± 0.03 nm 2) and not markedly influenced by the presence of the 
peptides (Figure 2.48). This consistency in A was seen for all the analysed peptide types. 
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Figure 2.48: Area per lipid development for a 50 ns simulation of the bilayer in the presence of A c W L W L L 
peptide (see §5.2.2 for experimental conditions). 
2.7.2.b Conformations of AcWL WLL 
A conformational analysis o f the preferred orientations o f the peptide was conducted using 
the procedure as described in §5.1.4.c. Two distinct major clusters (Figure 2.49) were 
observed in both, the cluster analysis o f a molecular dynamics simulation (30 ns) and the 
cluster analysis using the Maestro software package. 
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Figure 2.49: Overlay of the two major confomers of A c W L W L L . The confomers were obtained by cluster 
analysis of the structures of the explicitly solvated peptide structures generated via a 30 ns molecular dynamics 
simulation at 30 °C, 1 bar (§5.2.2). Carbon atoms in confomer 1 are depicted in green, in confomer 2 in blue. 
Confomer 1 adopted an N-shaped conformation o f the backbone with the two 
tryptophan sidechains, Trp 1 and Trp 3 being on opposite side to each other. In the other 
observed conformation, confomer 2, Trp 3 had flipped to the other side (with respect to the 
orientation o f Trp 1 ) the two were aligned with one another (Figure 2.49). 
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Influences o f the confirmation o f the peptide on its binding interactions with the lipid bilayer 
were evaluated by separated molecular dynamics simulations o f both confomers. A snapshot 
of a simulation containing A c W L W L L can be seen in Figure 2.50. 
Figure 2.50: Snapshot of a simulation of A c W L W L L interacting with a DMPC bilayer. For clarity, solvent 
molecules were omitted; lipid molecules are shown as green (united atom C H groups), red (oxygen), orange 
(phosphor) and blue (nitrogen) spheres that represent the van der Waals radius of the group displayed. 
A c W L W L L is represented using coloured spheres with van der Waals radii for hydrogen atoms (white), carbon 
atoms (pink), oxygen (red) and nitrogen (blue). Simulation conditions are described in §5.2.2. 
2.7.2.c Peptide Orientation with Respect to the Bilayer 
Peptide orientations with respect to the bilayer surface were evaluated by plotting distribution 
functions, p(r) o f backbone atoms to planes through the bilayer which were defined by the 
average position the phosphate phosphorous atoms P, the choline nitrogens N , and an 
carbohydrate methyl end group carbons C1N of the leaflet nearest to the peptide respectively 
(Confomer 2, Figure 2.51, Confomer 1, Figure 2.52). 
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Figure 2.51: Distribution functions for various atoms ( C a of Trp 1 , L e u 2 and Leu 4 ) of the peptide confomer 2 
with respect to the lipid bilayer (phosphate P, choline nitrogen N and carbon tail methyl end group C I N ) . The 
centre of the bilayer was set to 0 nm. The description A c X L W L L , where X = W, F , CI , Br, I , refers to 
substituent on the 5-indole position of Trp 1 . 
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Figure 2.52: Distribution functions for various atoms ( C a of Trp', Leu 2 and Leu 4 ) of the peptide confomer 1 
with respect to the lipid bilayer (phosphate P, choline nitrogen N and carbon tail methyl end group C I N ) . The 
centre of the bilayer was set to 0 nm. The description A c X L W L L , where X = W, F , CI, Br, I , refers to 
substituent on the 5-indole position of Trp 1 . 
It can be seen, that in most cases (except for the chlorine containing peptide) the 
peptide is preferably in close inserted in the head group region o f the lipid bilayer. 
A c C l L W L L confomer 2, was found preferentially approximately 1 nm away from the peaks 
in the distribution of some of the lipid head group atoms of the nearest leaflet. This behaviour 
was exceptional from all the peptides and confomers analyzed and was not seen for the 
A c C l L W L L confomer 1. 
The distribution functions of the atoms of some of the peptides {e.g. A c W L W L L , 
AcFLWLL confomers 2, and A c I L W L L confomer 1) exhibited two peaks, which is likely to 
correspond to two preferred locations or orientations o f the particular peptide, which might 
indicate the presence o f more than one preferred and stable conformation of the peptide. 
The extent o f the insertion o f the peptides in the bilayer interfacial region was 
assessed by plotting the minimum distance o f the peptide (defined by its minimum z-
coordinate) to a plane through the nearest leaflet o f the bilayer defined the averaged position 
of the choline nitrogens o f the lipid (Figure 2.53). 
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Figure 2.53: Distance from peptide confomers I (—) and 2 (—) to lipid bilayer planes defined by the averaged 
position of the D M P C nitrogen atoms. Distances are displayed as minimum z-coordinate of the peptide to the 
plane of the nearest leaflet of the bilayer. 
The minimum distances between the peptide and the choline head group of the 
bilayer were found to be very similar between the clusters of a peptide with the exception o f 
AcClLWLL, which had already been noticed in the distribution functions as being an 
exception to the general trends. The minimum distances o f the peptides appear to converge to 
the same value for both o f the confomers o f each peptide suggesting that there is a preferred 
interaction distance between the peptides and the bilayer, which is established over time. 
This ideal interaction distance was found to approach the average position of the choline 
head group of the lipid, which could indicate short-range interactions between the peptide 
and the interfacial lipid atoms. Such favourable interactions could include cation-7t 
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interactions o f the tryptophan side chains with the charged choline functionality, hydrophobic 
effects, and hydrogen bonding interactions between hydrogen bond donors in the peptide 
(e.g. the indole amine) and hydrogen bond acceptors in the lipid molecule (e.g. the carbonyl 
oxygens). A detailed sampling o f radial distribution functions of the distances between these 
atom pairs could elucidate the importance o f hydrogen bonding interactions further. 
It was further analysed, i f the peptide assumes a preferred conformation upon 
interaction with and inserting in the lipid bilayer. Distances o f selected backbone atoms of 
the peptide ( C a o f the residues and the indole nitrogen o f the two tryptophans) to a plane 
through the bilayer which was defined by the average position o f the nitrogen atoms 
respectively were analysed (Figure 2.54). 
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Figure 2.54: Interaction distances between peptide backbone atoms and a plane through the lipid bilayer, which 
was defined by the average position of the lipid nitrogen atoms. The figure shows the distance profile for the 
A c W L W L L and A c B r L W L L confomers 1. 
The distances between the bilayer and the selected backbone atoms did not vary 
greatly over time. For the A c W L W L L and A c B r L W L L confomers 1, a slightly increased 
flexibility was observed for the C terminal Leu 4 and Leu 5 residues after about 10 ns was 
observed, with the residues tending to approach the choline head group region o f the bilayer 
further than the remainder o f the peptide which appeared to maintain a constant distance to 
the plane defined by the average position o f the lipid nitrogen atoms (rAB ~0nm for 
A c W L W L L l rAB -1.0 nm for A c B r L W L L 1 respectively). 
2.7.2. d Cluster Analysis of Simulated Peptides 
The simulated peptides were analysed for the occurrence of clusters in their structures when 
interacting with the lipid bilayer (Table 2.27, Figure 2.55). 
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A c W L W L L A c F L W L L A c C I L W L L A c B r L W L L A c I L W L L 
Confomer 1 2 1 2 1 2 1 2 1 2 
Clusterl (%) 13.0 93.7 89.1 15.5 97.4 15.2 26.7 14.6 22.8 3.9 
Cluster2 (%) 82.2 81.9 79.2 66.6 84.7 10.7 95.9 
Cluster3 (%) 63.8 
sum (%) 95.2 93.7 89.1 97.4 97.4 94.4 93.3 99.3 97.3 99.8 
Table 2.27: Peptide clusters as observed in molecular dynamics simulations of A c W * L W L L peptides and 
D M P C bilayer in water. Parameters for the simulation are given in §5.2.2. Clusterl-3 refer to the occurrence of 
a particular cluster of the peptide in time and do not indicate that the clusters between the A c W * L W L L peptides 
are identical. 
B) A) 
Figure 2.55: Overlay of peptide clusters. A and B show the overlay of the most populated observed peptide 
clusters for A c X L W L L (confomer 1 in A and confomer 2 in B), where X corresponds to a tryptophan residue 
Trp 1 carrying a monosubstitution R on position 5 of the indole ring. The colour code is the same for both 
pictures with dark green R = H; blue R = F , pink R = CI , light green R = Br, and purple R = I. Clusters were 
superpositioned using the Trp 1 as a reference point. 
Confomer 1 o f the peptide appears to be well-conserved throughout the homologous 
series, while confomer 2 displays greater variance. Confomer 2 displayed a greater flexibility 
particularly in the backbone bonds between residue Leu 2 and Trp 3 . A change from confomer 
1 into 2 was not seen during the 50 ns o f simulation. The peptides appear to mostly preserve 
their conformation upon interaction with and insertion into the bilayer. The observed clusters 
accounted for >93% of all the sampled structures indicating that the peptide adopts a stable 
conformation quickly and efficiently. Minor clusters for some of the peptides analysed were 
observed during the initial stage o f the simulation (/ < 5 nm). This is consistent with the 
observation o f minor, secondary peaks in the distribution function o f the peptides. (§2.7.2.c). 
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Chapter 3: Summary and Discussion of Results 
3.1 Introduction and Overview 
A facile synthesis for tryptophan compounds was employed to produce a wide range of 
tryptophan derivatives in good yield and optical purity. Indole derivatives were converted to 
A^-acetyl tryptophan amino acids (1) using L-serine. The racemic products were then 
subjected to acylase resolution, generating I-tryptophan (2) and A^-acetyl-D-tryptophan 
derivatives (2'). The /--amino acids were then converted to A^-acetyl ethyl amides (6) to 
mimic non-terminal tryptophan residues in proteins and peptides (§2.2.6). The binding of 
these A^-acetyl ethyl amides (6a-g, 6n) to DMPC molecules was studied by NMR host-guest 
titrations and isothermal titration calorimetry, and modelled via molecular dynamics 
simulations. 
The following sections wi l l summarize and discuss the key findings of this thesis. The 
use of the binding model employed for the fitting of the experimental data obtained via NMR 
host-guest titrations is evaluated in (§3.2). The importance of hydrogen bonding (§3.3.1) and 
cation-n interactions (§3.3.2) in Trp:DMPC and DMPC:water complexes is reviewed. 
Subsequently, the experimentally and computationally obtained binding constants and 
associated free energies of adduct formation are discussed (§3.4). Data acquired by 
isothermal titration calorimetry and free energy calculations are then compared with the 
results from the other techniques for the analysis of peptide-lipid analysis (§3.5 and §3.6 
respectively). §3.7 presents a discussion of the results obtained from molecular dynamics 
simulations o f the interactions of A c W L W L L type peptides with a DMPC bilayer in water. 
3.2 Discussion of the Binding Model Used for the Analysis of NMR 
Titration Data 
N M R titrations gave detailed information about the micellisation of DMPC in chloroform 
and could be used to estimate the critical micelle concentration (CMC) of DMPC to be 
19.71 ± 3.28 mA/ at 21 °C (§2.3.2.b), which was in good agreement with the previously 
reported value of 1 6 m M at 24 °C. 9 ITC measurements of the hydrated DMPC into 
chloroform supported the finding that the CMC is >15 m M at 21 °C (§2.4.2.b). The precise 
CMC was not determined due to the limitations placed by the experimental set-up. Given the 
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value determined for the CMC, the injected samples o f DMPC in both the N M R host-guest 
and the isothermal calorimetry titrations were at concentrations above the CMC. This made 
the inclusion of the self-association (and hence by default also dissociation) of lipid 
molecules in the binding model desirable. 
Job plots o f selected tryptophan derivatives (6f, R = MeO representing the most 
electron dense and 6g, R = N O 2 representing the most electron deficient compounds 
analysed) determined a preferred association stoichiometry o f the interaction between the 
amino acid analogues and DMPC in chloroform to be approximately 2:1 (§2.3.3.b). This was 
found to be in good agreement of a previous study that clearly showed A^-acetyl-L-
tryptophan ethyl amide (6n) to form 2:1 adducts with l,2-diacetyl-5«-3-phosphocholine 
(DAPC) in chloroform. 1 
Water also played an important role for binding interactions as observed by the 
significant chemical shift of the water proton signal during the course of the NMR guest-host 
titrations. During the course of a titration, the value shifts towards that o f the DMPQwater 
adduct. This is expected, as by the end of the titration the concentrations of both were 
significantly higher than that of tryptophan. Given these relative concentrations and the 
observation that the water chemical shift is close to that for water in CDCI3 at the start of the 
titrations (i.e. in the absence of DMPC, with tryptophan only), water interactions are more 
significant with DMPC than with tryptophan. This justifies not considering tryptophan:water 
interactions. It was clearly demonstrated that water in the sample strongly influenced binding 
interactions and needed to be accounted for in the model. Previously, hydration studies on the 
closely related l,2-dipalmitoyl-s«-glycero-phosphocholine (DPPC) lipid in chloroform via 
N M R indicated that, contrary to the aggregated DPPC, the monomers of DPPC do not appear 
to be hydrated.2 This is supported by the intense observed heat changes in the ITC 
experiments upon injection o f low concentrations of hydrated DMPC into chloroform that are 
likely to arise from the endothermic unbinding of water from the lipid. Further evidence for 
the lack o f association between lipid monomer and water could be seen in the molecular 
dynamics simulations of a system containing water, tryptophan derivative (6a) and lipid at 
equimolar concentrations. No binding interactions between the water molecule and the lipid 
were observed, while association interactions of water to the amino acid analogue were 
noticed. 
The model employed for the fitting of the data to a binding isotherm accounted 
therefore for lipid self-aggregation and micelle formation, Trp:DMPC 1:1 and 2:1 adducts, 
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and hydrated species (Water: DMPC 1:1 and 2:1 and Trp: D M PC: water 1:1:1). The 
corresponding binding constants could be determined using N M R host-guest titrations of 
hydrated DMPC into chloroform and titrations of the lipid into chloroform solutions of the 
tryptophan derivatives. Observed chemical shifts of up to seven key protons were plotted 
against lipid concentration and multiple, simultaneous non-linear fi t t ing of the data allowed 
the calculation of a binding isotherm. The fitting of a binding isotherm to the experimental 
data of the N M R titration experiments was found to give best results when an isodesmic 
model was assumed (i.e. the binding constant for lipid-lipid dimerisation = K,„, the 
binding constant for micellisation). 
The quality and accuracy of the model could be assessed by the accuracy and 
reproducibility of the obtained fits and was found to be working extremely well (observed 
error <8% between repeat runs). Water equilibria were accounted for with high confidence 
and the observed complexation-induced chemical shift change of the water proton signals 
could be reproduced within 3% of the experimentally determined values. 
3.3 Factors Important for Lipid-Tryptophan Associations 
3.3.1 Hydrogen Bonding Interactions 
Proton/deuterium exchange experiments pointed out the labile hydrogen atoms in the 
tryptophan derivatives and provided indications to the relative strength of hydrogen bonding 
interaction in Trp:DMPC and Trp:water:DMPC adducts. The indole amine hydrogen and the 
acetyl and ethyl amide protons were determined as being susceptible to deuterium exchange 
under the experimental conditions used. The data suggest an order of accessibility and 
availability for the exchanged protons to be indNH > AcNH » EtNH. This trend could also 
be related to the involvement of these protons in hydrogen bonding interactions. 
In agreement, Bordwell et al. determined the pKa for the dissociation of an amide 
proton for a related compound (./V-methylacetamide) to be 25.9 in DMSO 3 and the pKa for 
the dissociation of the indole amine hydrogen as 21.0 in DMSO 4 . This indicates that the 
amide protons are slightly less likely to exchange for deuterium than the indole amine proton. 
Additionally, indole amine protons have previously been shown to exhibit particular weak 
hydrogen bonding interactions to water in measurements of the free energy of transfer of 
tryptophan analogues from water into cyclohexane.5 It was also reported that there are no 
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significant hydrogen bonding interactions between the indole N H and lipid molecules.6 This 
was demonstrated by comparing the ordering of indole and TV-methylindole in both ether and 
ester lipid bilayers, which was found to be identical with experimental error of the linear 
dichroism and N M R studies that gave rise to these results.7 
Further evidence of the lack of hydrogen bonding interactions of the indole amine 
proton to both water and lipid molecules was shown in the molecular dynamics studies o f the 
system containing water, lipid and tryptophan derivative at equimolar concentrations. No 
hydrogen bonding interactions between the indole N H and any of the lipid hydrogen bond 
acceptors nor any significant interactions to the water oxygen were detected. Although, the 
time averaged radial distribution function, <g(r)>h for the distance between the indole amine 
proton and the water oxygen (OVV) exhibited a peak in the distribution at rAB -0.20 nm, no 
such interactions were seen in the most populated clusters o f the water-Trp interactions. The 
peak is likely to be due to weak association of the water molecule to the indole N H as 
suggested by Ref. 5. In contrast, defined hydrogen bonding interactions were seen for the 
ethyl amide proton (EtNH) with the water oxygen both in the <g(r)>, for the distances 
between OW and EtNH and upon visual inspection of the clusters observed. 
In the D 2 O experiments, the hydrogen of the acetyl amide functionality exchanged 
with an approximate half-life of ty2 = 40 min. This is consistent with the strong preference for 
hydrogen bonding interactions with water as observed in the simulations (§2.5.3.b), which 
would slow an exchange of the proton down. The exchange of the ethyl amide proton was 
found to be very slow (tVz = 200 min) suggesting that it is involved in strong hydrogen 
bonding interactions. No such hydrogen bonding interactions were seen in the molecular 
dynamics simulations with water. However, the D 2 O experiments followed the averaged 
hydrogen signals of bound tryptophan compounds. As the preferred stoichiometry of the 
Trp:lipid complex was found to be 2:1 (§2.3.3.b), there might be hydrogen bonding 
interactions between the two tryptophan derivatives in the complex that prevent a fast 
deuterium exchange. Indeed, the simulation of amino acid-lipid interactions at a ratio of 2:1 
(§2.5.4) showed a significant hydrogen bonding interaction between the ethyl amide proton 
and the acetyl amide carbonyl oxygen of a nearby tryptophan derivative (6a) (§2.5.4.c). 
Hydrogen bonding between two amino acids derivatives (6a) were shown to be a 
significant driving force of the formation of a Trp:Trp 1:1 complex (§2.5.4.c), appearing at 
the same time when complex formation was observed (Figure 3.1). A very stable complex 
was formed, that exhibited 2 hydrogen bonds on average. These could be related to time 
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averaged radial distribution functions of hydrogen bond acceptors and donors in the 
respective tryptophan derivatives. 
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Figure 3.1: Distance between the two centers of mass of two tryptophan derivatives (6a) overlaid with a 
histogram of hydrogen bonds being established between them. 
No hydrogen bonding interactions between the lipid and any o f the tryptophan 
derivatives were observed at any time during the simulation. This indicates, that for the 2:1 
and the 1:1 Trp:DMPC complexes, hydrogen bonding interactions to the lipid play a minor 
role. 
Interestingly, the self-association of the tryptophan derivatives (6a) was only seen in 
the presence of DMPC. In a control simulation with an identical starting configuration of the 
two amino acid derivatives but in the absence o f the lipid molecules did not show any 
significant association between the two amino acid analogues. During >95% of the 
simulations the molecules seemingly diffused freely in the chloroform simulation box, and 
only at the end of the 50 ns simulation was association between the two molecules observed. 
This suggests that the lipid molecule enhances the formation o f the Trp:Trp 1:1 complex, 
potentially by providing a local environment that fosters the establishment of hydrogen 
bonding interactions to each other similar to a nucleation site. However, this result is to be 
seen with caution due to the restricted analysis time frames. Longer simulations of the 
control run w i l l be necessary to substantiate the observations made. Furthermore, due to the 
long-lasting nature o f Trp:Trp interactions the analysis was restricted to a qualitative 
assessment. 
151 
In conclusion, hydrogen bonding interactions are likely not significantly important for 
the interactions in 1:1 Trp:DMPC complexes. Accordingly, hydrogen bonding interactions 
between single tryptophan residues and lipid molecules in the bilayer might be less 
significant. This is consistent with observations made in solid-state NMR, where the 
hydrogen bonding interactions of WALP peptides to DMPC lipid carbonyl groups were 
found to be of minor importance as the orientation o f the peptide were found to be near 
identical to orientation adopted in the DMPC analogue ditetradecylphosphatidyl-choline 
Q 
(DTPC) that misses the carbonyl linker. 
In higher order complexes of the amino acid derivatives, hydrogen bonding 
interactions were seen to have a significant contribution to binding interactions between the 
tryptophan analogues. The importance of the presence of DMPC in the establishment of 
hydrogen bonds in the Trp:Trp 1:1 complex remains to be investigated further. 
3.3.2 Cation-7i interactions 
The importance o f cation-7t interactions for the preferred localisation of tryptophan residues 
and analogues of the aromatic amino acid is still debated. 
Norman and Nymeyer 9 reported that both hydrogen bonding to lipid carbonyl groups 
and cation-7r and dipolar interactions between the indole and the POPC bilayer played a role 
in the its preferred localisation at the water/lipid interface. Further support for the 
involvement of cation-7t interactions in the localization of indole in the choline region was 
given by Gaede et al.w Cation-7t interactions for interfacial tryptophan residues were also 
reported to depend on both, the tryptophan position relative to the bilayer-water interface, 
and on the chemical nature of the lipid headgroups seen in molecular dynamics simulations, 
where ethanolamine headgroups (POPE) were favoured over choline headgroups (POPC)." 
The strength of the cation-n interaction to a lipid choline head group has been 
estimated to be ~8.4 kJ mol"1 by studying the effects of substitutions on tryptophans indole 
ring and its implications for the ligand recognition by serotonergic (5-HT3A) and nicotinic 
acetylcholine receptors in water. 1 2 Others estimated the strength of cation-u interactions to be 
-23.0 kJ mol"1 in water using ab initio calculations.1 3 A typical cut-off for cation-7r 
interactions is a distance of 0.5 ran between the centre of the indole ring and a charged 
atom. 1 4 However, due to the relative orientation to each other, this value might vary by 
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±0.2 nm to include distances between the charged atom and the nearest atom of the aromatic 
ring. A truncation at 0.7 nm has also been used before by Petersen et al.u 
In contrast in a recent study using linear dichroism spectroscopy, cation-7i interactions 
with lipid head groups (POPC and POPC/POPE) were reported to be less important and that 
localisation of indole derivatives (indole, 3-methylindole, 1-methylindole and tryptophan 
octyl ester) instead would be directed by dipole-dipole interactions and steric constraints in 
the membrane hydrocarbon region. 1 5 
3.3.2.a Cation-n Interactions in Trp:DMPC complexes 
The importance of cation-7i interactions between the tryptophan derivatives and the lipid 
molecules were evaluated using molecular dynamics simulation of the compounds dissolved 
in chloroform. The strengths o f the cation-7i interactions are strongly dependent on the 
dielectric constant of the medium, as would be expected for interactions with large 
electrostatic components, but cation-7i interactions were reported to maintain their strength 
across a range of solvents.1 3 Therefore, conclusions drawn from the data obtained in the 
molecular dynamics simulations in chloroform, are comparable to information gained about 
cation-n interactions in aqueous media. 
Cation-Ti interactions between tryptophan derivatives and the lipid were evaluated by 
analysis of the time averaged radial distribution functions <g(r)>, f ° r the distance between 
the charged lipid choline nitrogen atom and the centre of mass of the indole side chain of the 
amino acid analogue. 
A l l of the tryptophan derivatives analysed exhibited a peak in the <g(r)>, f ° r this 
intermolecular distance with a maximum -0.6 nm (Figure 3.2). The interaction distance did 
not change significantly with varying electron density of the indole ring, but slight deviations 
(±0.2 nm) of the position the maximum peaks were observed. Preferred binding interactions 
could not be visualized directly via cluster analysis of the Trp:DMPC 1:1 complex as the 
cluster populations for this complex were found to be small (<19%), which complicated a 
statistically relevant analysis of preferred binding conformations. The peak observed in the 
<g(r)>,, however, is likely to arise from a cation-Ti interaction between the indole ring and the 
choline head group. 
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Figure 3.2: Time averaged radial distribution functions of the distance between the DMPC choline nitrogen and 
the centre of mass of the indole ring of a selection of tryptophan derivatives (6a, 6f, 6g and 6n). 
The <g(r)>, for the distance between the centre o f mass of the indole ring of one o f 
the two tryptophan derivatives and the lipid choline nitrogen in the 2:1 Trp:DMPC complex 
displayed a similar pattern to the 1:1 Trp:DMPC complex with a broad peak at rAe ~0-6 nm 
(§2.5.4.b, Figure 2.41). This is likely to be indicative o f a cation-7t interaction between the 
indole ring and the choline head group. The cluster analysis visualised the interaction 
distance to some extend showing the choline head group in proximity to the aromatic ring o f 
the nearest tryptophan compound (Figure 2.43, p. 126). 
This adds further evidence to the observation that cation-7i interactions might be 
involved in tryptophan-lipid interactions. Only minor changes in the preferred distance o f the 
peaks in the time averaged radial distribution function and its relative intensity were 
observed for the varying tryptophan derivatives indicating that the change in electron density 
on the indole ring did not alter cation-7i interactions between the lipid choline head group and 
the indole side chain significantly. 
In conclusion, cation-7t interactions between the DMPC and tryptophan derivatives 
were observed. Interestingly, their strength (as estimated from the intensity of radial 
distribution functions and minimum interaction distances between the two groups) was found 
to be only loosely associated with the electron density of the indole ring. The occurrence o f 
lipid-tryptophan cation-7t interactions has been suggested to be a contributing factor for the 
preferred localisation and interaction o f tryptophan residues in and with lipid bilayers. This 
study adds further evidence to this observation adding that the electron density o f the indole 
ring system appears to have only minor influences on strength and average distance of these 
interactions. 
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3.4 Discussion of Determined Binding Constants for Adduct Formation 
Using titrations o f hydrated DMPC into chloroform (§2.3.2) and the binding model detailed 
in §2.3.2.c, binding constants for the association of water to DMPC molecules could be 
calculated. The constants of the watenlipid 1:1 and 2:1 adducts could be approximated as 
K ! W = 31.86 ± 0.11 A f 1 and K 2 l v / = 121.80 ± 1.47 A f 1 respectively. Additionally, the binding 
constant for the micellisation of DMPC molecules could be determined as 
Km = 144.06 ± 0.86 M~]. These values were used as constants in the calculation of the binding 
constants of tryptophan derivatives to DMPC molecules and DMPC-water complexes. The 
binding constants of the sequential addition of water and tryptophan derivatives to the DMPC 
complexes (K | , K2 , KY, K|M, ') could be established. 
3.4.1 Free Energies of Association of the 1:1 TrprDMPC Adduct 
3.4.1.a Comparison between Experimentally Derived and Computed AG 1 Values. 
Binding constants and associated binding free energies for the Trp:DMPC 1:1 could be 
calculated using two different approaches (§2.5.2.a). The importance of electrostatic 
interactions could be evaluated by using two different charge sets (Set A and B) for the 
representation of partial charges on the indole side chain (Table 2.15, Table 2.16, p.92). 
These charge sets had been derived either by fitting the electrostatic potential obtained via 
restricted Hartree-Fock ab initio calculations or by Moller-Plesset type MP2 perturbation 
theory. This allowed a direct evaluation of the influence of partial charges and hence 
electrostatic interactions for association processes. 
The Hammett parameter could be used as an approximation of the electron density of 
substituted indole rings. When observed and calculated free energies for the Trp:DMCP 1:1 
complex formation were plotted against the Hammett parameter, an n-shaped (parabolic) 
trend was displayed (see §2.5.2.e). 
The experimentally determined and computed values of the association free energy 
for the 1:1 Trp:DMPC were found to be in excellent agreement. Both treatments of the partial 
charges (using Set A and B respectively, §Table 2.15 and Table 2.16, p.93) gave comparable 
results, with the models employing Set B were generally representing the experimental data 
and the n-shaped trend better. The discrepancy of the rHF method to experimentally obtained 
values was particularly pronounced for the electron dense and deficient tryptophan 
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compounds (6f and 6g respectively). The treatment of partial charges was seen to directly 
influence the calculated free energies of binding suggesting that electrostatic interactions are 
important for their correct representation. The differences in the carbon atoms of the indole 
were significant (±0.2 e) between the two sets. 
Set B represented the experimentally observed pattern for the electron rich 
compounds better. The extension of the treatment of long-range interactions from a 
truncation value from 1.2 nm to 1.9 nm did not lead to any noticeable improvement. Values 
derived f rom both methodologies were identical within experimental error. When binding 
free energies were derived using the survival function of the complex (MP2b2), the binding 
was not slightly overestimated but instead underestimated by approximately 
1.92 ± 0.59 kJ mol"1 with respect to the experimental values. The same pattern as for the free 
energies determined by both MP2a and MP2b was observed for MP2b2 derived values. 
Calculated free energies of association obtained from molecular dynamics 
simulations using the partial charge set that was derived by Hartree-Fock calculations (Set A) 
was found to imitate the general pattern for the association free energies seen in NMR host-
guest titrations very well for tryptophan derivatives with moderate alterations of the electron 
density of the indole ring (6a-e, 6n). However, electron rich or poor systems (6f, 6g) were 
approximated less well. 
The brute force approach of calculating binding constants from the ratio of bound 
versus unbound states represented experimental data better than the methodology employing 
the survival function of the complex. The long molecular dynamics simulation allowed a 
sufficient sampling of the conformational space accessible to the compounds involved in 
complex formation. The occurrence of many binding and unbinding events with varying 
durations gave further evidence of a statistically significant sampling, justified the 
implementation of the calculation of the binding constants via the ratio o f bound and 
unbound states. The methodology using the survival function of the complex could be 
improved by consideration of re-crossing events and better defined cut-off values for the 
distances that determine when a state can be considered as being bound or unbound. 1 6 This 
was not attempted here as the method using the ratio of bound and unbound states was in 
excellent agreement with the experimental results and no further improvement was seen to be 
necessary. 
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3.4.1.b The n-Shaped Pattern of AGi versus Hammett Parameter Plots 
When observed and calculated free energies for the Trp:DMCP 1:1 complex 
formation were plotted against the Hammett parameter, an n-shaped trend was displayed 
(Error! Reference source not found.). Binding interactions were found to be enhanced 
regardless o f the substituent and electron density of the indole ring when compared to the 
unsubstituted tryptophan derivative (6n). The non-linear shape of the binding free energies 
AGi with respect to the electron density on the indole ring of the compound analysed 
indicates that binding interactions are likely to follow more complex, second-order 
electrostatic interactions. It is interesting to note that the free energy of binding decreased 
with increasing electron density from fluorine to iodine, reflecting a trend for more 
favourable binding for more electron-rich halogen derivatives. For electron-releasing 
substituents (6e, 6f; R = Me, MeO), increased electron density on the indole ring system also 
led to more favourable binding in free-energy terms. 
Other factors that might influence the free energy of association were investigated in an 
attempt to elucidate the origin for the observed pattern. 
1) The molecular dynamics simulations suggested that binding interactions were not 
influenced by hydrogen bonding interactions between a single tryptophan molecule and lipid. 
2) In the non-polar solvent chloroform, additional forces such as the minimisation of 
solvent accessible surface area (SAS) to avoid unfavourable exposure of polar functional 
groups could be envisaged. To assess this, the SAS for 3-methylindole 5-monosubstituted 
derivatives mimicking the tryptophan compounds analysed was calculated (§2.3.6). When 
plotted against the observed free energies of Trp:DMPC 1:1 adduct formation, no clear trend 
was observed (§7.4). 
3) Similarly, no clear trends were seen for the relation o f the determined free energies 
to the dipole moments or a measure of hydrophobicity of the compounds, log P (which both 
could be calculated for the 5-monosubstituted 3-methylindole derivatives as well) (§7.4). 
3.4.2 Free Energies of Association for the Higher Order Complexes 
The binding free energy for the 2:1 Trp:DMPC complex was found to be 4.91 ± 1.02 kJ mol"1 
more favourable than the corresponding 1:1 adduct formation (AGi) and comparable in size 
to the free energies o f tryptophan:water:lipid 1:1:1 adduct formation (AGu) and the 
association o f tryptophan to a lipid:water 1:1 complex (AG/) (Table 2.10, Figure 2.10, p.64). 
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This is in agreement with the Job plots of selected compounds (6f, 6g) that indicated the 
predominant stoichiometry for Trp:DMPC to be approximately 2:1 (§2.3.3.b). Further 
evidence was observed in molecular dynamics simulations of a tryptophan derivatives and 
DMPC at a 2:1 ratio. Here, strong, favourable binding interactions between the two amino 
acid analogues and the lipid were observed qualitatively (as the duration of binding events 
>39 ns prevented a statistically relevant quantitative analysis) (§2.5.4). 
The binding free energy associated with the adduct formation of a watenlipid 1:1 
complex (AG|„,/) could also be determined experimentally via N M R titrations of hydrated 
DMPC into chloroform and related to the calculated value obtained from molecular dynamics 
simulations of tryptophan, water and lipid being dissolved in chloroform with equimolar 
concentrations (§2.5.3). The simulations underestimated AG|„./ by approximately 4 k j mol ' 1 
(Table 2.22 p . l 16). Within the limitations of the simulation such as the limited amount of 
water present this is a reasonably good approximation. The same molecular dynamics 
simulation also allowed evaluating the influence o f water on AG\. The calculated value for 
A d in the presence of a water molecule approximated the experimentally observed value 
slightly better than a calculated value derived from a simulation of Trp-DMPC interactions in 
the absence of water. 
3.5 Isothermal Titration Calorimetry 
Isothermal titration calorimetry could be used to estimate the importance of the heat 
associated with the dissociation of water from hydrated lipid molecules. At very low 
concentrations (0.14 mM) of hydrated DMPC in the injection syringe, heat changes that are 
likely to be mainly attributed to dehydration of lipid molecules could be determined in a 
semi-quantitative way (as the errors associated with the small observed heats of injection and 
the small concentration of the lipid solution are likely to induce a fairly large error of 
observables). At higher lipid concentrations the observed heats are likely to include 
contributions arising from the heats o f demicellisation, dehydration and dilution. In the 
titration experiments, the observed heats additionally wi l l contain the heat associated with the 
interactions of tryptophan derivatives to the species present in the measurement cell and in 
particular the heat of interest, i.e. the heat associated with the binding of the amino acid 
analogues to DMPC. Blank titrations of hydrated DMPC into chloroform with absolute lipid 
concentration of 26 mM maximised the observed signal-to-noise ratio and established 
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conditions that were comparable to the experimental conditions used in the N M R host-guest 
titrations. The enthalpograms obtained by subtraction o f the heats of injection o f the blank 
titration from the heats of injection of the titrations involving the tryptophan analogues 
showed the contributions of heat that could be attributed to the presence of tryptophan. This 
observed heat w i l l be comprised partially by the heat o f the binding of Trp to DMPC, as well 
as by contributions arising from the competitive nature o f this binding and its affect on 
watenlipid complexes. The heat associated with the disassociation of water from watenlipid 
complexes can not be accounted for easily and is likely to result in an endothermic 
contribution to the observed overall change in heat. This meant that the obtained heats o f 
injections are likely to represent an underestimated heat of the binding associated with 
Trp:DMPC and Trp:DMPC:water complexes. 
A fitting of the obtained enthalpograms to a binding isotherm was found to be 
complicated by the near-linear pattern of it. The software (MicroCal Origin) of the isothermal 
calorimeter used was unable to account for the number of equilibria and processes likely to 
be present in the measuring cell and could not be used for data analysis. The observed heats 
were therefore analysed qualitatively by comparison of the observed difference in heat 
patterns and of the gradients of first order regressions of the parts o f the enthalpograms that 
were seen to behave near-linearly (typically for heats of injections obtained at a total 
concentration of lipid in the measurements cell Loce" > 1.0 mM). 
The heats of injections for electron dense compounds (6e, 6f) exhibited a steeper 
decline at LQCC!I < 1.0 mM {i.e. a greater endothermic contribution) than seen for following the 
near-linear pattern at higher L§e>1. In contrast, heats o f injections for more electron deficient 
compounds (6a, 6c-d, 6g, and 6n) showed an exothermic contribution at L§eil < 1.0 mM then 
went through a transition point at concentrations that varied for the compounds analysed and 
then followed a near-linear pattern at higher Loce" >1.0 mM. 
The difference in the behaviour o f the enthalpograms indicates that different 
interaction processes take place for electron dense and electron deficient tryptophan 
derivatives respectively. A more detailed analysis of the nature of this difference was 
complicated due the limited amount of data points at the Loce" < 1.0 mM. 
The gradients of the near-linear part of the enthalpograms could be used in the 
qualitative assessment of the observed heats of injections. When plotted against the Hammett 
parameter, the gradients exhibited an n-shaped pattern that was comparable to the pattern 
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observed for the macroscopical binding free energies of the compounds as observed in the 
N M R host-guest titrations (Figure 2.23, p.90). 
3.6 Calculation of Free Energies by a Thermodynamic Cycle 
The free energy of solvation and particularly hydration of tryptophan analogues has received 
some interest in the past. Often, indole derivatives such as methylindole were used as a 
simple approximation for tryptophan. MacCallum and Tieleman 1 7 compared experimentally 
determined hydration free energies of the latter with computed values and found that the 
GROMOS96 and OPLS-AA force field descriptions they used underestimated the free 
energies and gave the largest errors for the tryptophan analogue as compared with the other 
amino acid analogues they had studied. This might be due to the experimentally determined 
large hydrophobicity and high absolute magnitude of the free energy of solvation of this 
compound. 1 8 
Here, free energy calculations of the association free energy of the 1:1 Trp:DMPC 
adduct formation in chloroform were performed. First, the free energy of solvation of the 
amino acid analogues was calculated with a reasonable accuracy using a thermodynamic 
cycle in which the non-bonding interactions of the compounds in vacuum and in solvent {i.e. 
chloroform) were determined. The obtained, slightly negative free energies of solvation 
reflect the empirically observed poor solubility of the tryptophan compounds in chloroform. 
The calculation of the free energy of binding had high errors associated with it, arising 
partially from the difficulty to represent a sufficient number of bound configurations with 
high accuracy - the clustering of 1:1 Trp:DMPC adducts gave numerous individual binding 
conformations that, combined into clustered average structures, were only accounting for up 
to 19% of all observed binding conformations. This made the choice of the appropriate 
starting conformation essential but difficult. Multiple starting configurations for some of the 
derivatives were analysed but the overall error could not be reduced significantly. Another 
reason for the rather poor performance of the free energy calculations is the flexibility of the 
molecules. For accurate free energy calculations, the ful l or at least a significant part of the 
conformational space available to the molecules involved should be undertaken. 
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3.7 Interactions ofAcWL WLL with a DMPCBilayer 
Two statistical important conformations for the peptides of the family A c W L W L L were 
observed in molecular dynamics simulations o f the peptide in water. This is in contrast with 
the lack of secondary structure o f this peptide in solution as determined by White and 
Wimley using circular dichroism (CD) . 1 9 However, the very short time spans used in the 
simulations with respect to an averaged ensemble sampling in CD might overestimate the 
importance o f short-lived conformations. 
Wimley and White used A c W L W L L as a benchmark in their experiments o f 
partitioning of peptides into lipid bilayers. 2 0 The authors could demonstrate by fluorescence 
spectroscopy and quenching studies that A c W L W L L inserts and partitions in the bilayer with 
a near constant partition coefficient over varying peptide concentrations. In another study, 
White and Wimley could estimate the free energy associated with interaction of A c W L W L L 
with a POPC bilayer phase (AGwa,er-popc = -1.85 ± 0.06 kcal mol"1) by comparison to the 
free energy of the partitioning of other pentapeptides of the A c W L - X - L L family, where X 
stands for any of the 20 amino acid residues.21 The native peptide and its derivatives used 
here exhibited such favourable partitioning into a lipid bilayer, representing the experimental 
observations well. 
The peptides analysed in this study exhibited preferred binding conformations when 
interacting with the lipid. These were adopted quickly (<5 ns) and retained for long times 
(accounting for up to 99% of all sampled configurations.) 
3.8 References 
1 Sanderson, J. M . , Whelan, E. J., Phys. Chem. Chem. Phys., 2004, 6, 1012-1017 
2 Kovac, A., Kidric, J., Hadzi, D., J. Mol. Struct., 1992, 267, 399-404 
3 Bordwell, F. G., Harrelson, J. A. , Lynch, T. Y.,J. Org. Chem., 1990, 55(10), 3337-3341 
4 Bordwell, F. G., Drucker, G. E., Fried, H. E., J. Org. Chem., 1981, 46(2), 632-635 
5 Wimley, W. C., White. S. H . , Biochemistry, 1992, 5/(51), 12813-12818 
6 Persson, S., Kil l ian, S. A., Lindblom, G., Biophys. J., 1998, 75(3), 1365-1371 
7 Gaede, H. C , Yau, W . - M . , Gawrisch, K.,J. Phys. Chem. B., 2005, /09(26), 13014-13023 
8 Van der Wei, P. C. A. , Reed, N . D., Greathouse, D. V. , Koeppe, R. E., Biochemistry, 2007, 46(25), 7514-
7524 
9 Norman, K. E., Nymeyer, H., Biophys. J., 2006, 91, 2046-2054 
1 0 Gaede, H. C , Yau, W . - M . , Gawrisch, K., J. Phys. Chem. B., 2005, 109(26), 13014-13023 
" Petersen, F. N . R., Jensen, M . 0 , Nielson, C. H. , Biophys. J., 2005, 89, 3985-3996 
1 2 Beene, D. L. , Brandt, G. S., Zhong, W. G., Zacharias, N . M . , Lester, H. A., Dougherty, D. A. , Biochemistry, 
2002 ,4/(32), 10262-1069 
1 3 Gallivan, J.P., Dougherty, D. A. , J. Am. Chem. Soc, 2000,122, 870-874 
1 4 Gallivan, J. P., Dougherty, D. A., Proc. Natl. Acad. Sci. USA, 1999, 96, 9459-9464 
161 
1 5 Esbjomer, E. K., Caesar, C. E. B., Albinsson, B., Lincoln, P., Norden, B., Biochim. Biophvs. Acta, 2007, 
56/(3), 645-650 
1 6 Zhang, Y., McCammon, i.A.J. Chem. Phys., 2003, 118(A), 1821-1827 
1 7 MacCallum, J. L. , Tieleman, D.P., J. Comp. Chem.,2003, 24(15), 1930-1935 
1 8 Wolfenden, R., Anderson, L., Cullis, P., Southgate, C , Biochemistry, 1981, 20, 849-855 
1 9 Wimley, W. C , Hristova, K., Ladokhin, A. S., Silvestro, L., Axelsen, P. H., White, S. H., J. Mol. Biol., 1998, 
277(5), 1091-1110 
2 0 Wimley, W. C , Creamer, T. P , White, S. H., Biochemistry', 1996, 35(16), 5109-5124 
2 1 White, S. H. , Wimley, W. C , Biochim. Biophys. Acta, 1998, 1376, 339-352 
162 
Chapter 4: Experimental Part 
4.1 Overview 
The following chapter details the synthesis of tryptophan derivatives and their incorporation 
into peptides. §4.2 contains the general methods and techniques used in the production and 
analysis of the compounds. §4.3 describes the experimental procedures for the individual 
experiments. Experimental data for the compounds prepared are given in §4.4. 
4.2 General Methods 
4.2.1 Chemicals 
Chemicals and reagents were obtained from Sigma Aldrich or Fisher Scientific U K unless 
stated otherwise. A l l reagents were of the highest quality and were used without further 
purification. Deuterated solvents were used as supplied from GOSS. The enzyme "Amano 
Acylase" was used as purchased from Amano Enzyme Inc., Nagoya, Japan. Indole 
derivatives, A^-acetyl-5-Me-A^-tryptophan, and general purpose reagents were obtained 
from Sigma Aldrich. Wang resin (loading 0.75 and 0.30 mmol g"' respectively) was used as 
purchased from Nova Biochem. For peptide synthesis, solvents were o f HPLC grade, with 
reagents of biochemical purity (> 98 %) and were used as purchased from Fisher Scientific. 
The lipid DMPC (biochemical grade) was obtained from Avanti Lipids Inc. (Alabama) or 
Bachem (UK) and used as purchased. 
4.2.2 High Pressure Liquid Chromatography ( H P L C ) 
The HPLC set-up consisted of a pump, autosampler, diode array detector, and Peltier column 
oven (from the Perkin Elmer Series 200), plus an Anachem fraction collector. A Hypersil Cis 
column (250 x 4.6 mm, 4 u particle size) was used for analytical runs and a Hypersil C\% 
column (250 x 10 mm, 4 u particle size) for semi-preparative purifications. The column 
temperature was adjusted to 25 °C and chromatograms were recorded at a wavelength o f 
254 nm. A linear gradient system between two eluents was used. These were HPLC grade 
acetonitrile and water respectively, each containing 0.1% biochemical grade (99.6%) 
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trifluoracetic acid (TFA) as additive, used as purchased from Fisher Scientific UK. 
Analytical runs used sample injection volumes of 10 ul with a 10 ul air cushion and 2 ul 
excess-volume. Semi-preparative runs used sample injection volumes of 30 - 150 ul with a 
10 ul air cushion and 2 u.1 excess-volumes. 
Optical separation conditions for the purification of A^-acetyl-tryptophan ethyl amides, /V01-
acetylated tryptophan methyl esters, and Fmoc-protected tryptophan analogues were found 
by using a linear gradient. Analytical separation was achieved using an elution mixture of 
70% water and 30% acetonitrile that was changed linearly to 40% water and 60% acetonitrile 
over 25 min at a f low rate of 1 ml/min. The initial mixture ratio was restored in a linear 
fashion over 1 min and eluted for further 5 min. The same gradient system was employed for 
semi-preparative purification changing the ratio over 45 min at a flow rate of 2 ml/min, 
restoring initial conditions over 5 min and equilibrating the column for further 10 min. 
4.2.3 Melting Point Analysis 
Melting point analysis was performed on Gri f f in melting point apparatus and transition 
temperatures determined by visual inspection. A l l measurements were performed in duplicate 
and are uncorrected. 
4.2.4 Polarimetry 
The optical rotation of enantiomers was determined using a Jasco P-1020 polarimeter at a 
wavelength of 589 nm. Aqueous cc-glucose solution ( lOmg/ml, c = 1 . 0 ) was used as 
standard, measuring the optical rotation in a cell of lOOx 1.8 mm dimensions. Sample 
solutions (typical concentrations c = 0.15 to 1.0) were prepared with HPLC grade methanol 
or other appropriate solvents as specified in the literature. The optical rotation was measured 
against the pure solvent background. A l l measurements were performed in duplicate. 
4.2.5 Mass Spectrometry (MS) 
Liquid chromatography coupled with mass spectroscopy was employed for the mass analysis 
of compounds. A Micromass LCT mass spectrometer in electrospray (ES+) ionisation mode 
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and a Waters 2795 LC instrument were used. Samples were analysed at a concentration of 
approximately 1 mg/ml. 
4.2.6 Nuclear Magnetic Resonance (NMR) Spectroscopy 
300 MHz and 400 MHz Varian spectrometers were used for compound analysis. The 
following abbreviations are used to describe multiplicities: s for singlet; d for doublet; t for 
triplet; q for quartet; m for multiplet; and br for a broad signal. Chemical shift data are 
reported in parts per million (ppm) with respect to the residual protons of the solvent as 
internal reference (3.30 ppm for CH 3 0 / / /CD 3 OD; 2.50ppm for (CD 3 )C#D 2 SO/ (CD 3) 2SO; 
2.05 ppm for CM) 2 COCD 3 /CD 3 COCD 3 ; 7.26 ppm for C / /CI3 /CDCI3) . I 3 C N M R spectra 
were referenced to solvent as internal reference (49.0 ppm for CD 3 OD; 39.5 ppm for 
(CD 3) 2SO; 29.9 ppm for CD 3 COCD 3 ; 77.2 ppm for CDC13). COSY and NOESY 2D-NMR 
spectra were used for the assignments of signals. 
4.3 Synthesis and Experimental Descriptions 
4.3.1 Synthesis of 5- and 6-monosubstituted Tryptophan Derivatives 
4.3.1.a Reaction of Indoles with Serine: General Method' 
L-serine (21 mg, 0.2 mmol) was dissolved in a solution of the substituted indole (0.1 mmol) 
in acetic acid (0.24 ml) and acetic anhydride (0.9 mmol). The mixture was stirred under 
argon at 73 °C for 2 h. Upon cooling, the solution was treated with diethyl ether (2 ml), 
adjusted to pH 11 using 30% sodium hydroxide solution and further diluted with ether (3 ml). 
The layers were partitioned and treated separately. The ether layer was extracted with 1 N 
sodium hydroxide solution ( 2 x 2 ml) and a small amount of sodium thiosulphate Na 2S 204 
(~5 mg) was added. The aqueous solutions were combined, neutralized to pH 7 using 
concentrated hydrochloric acid and the volume reduced to 50% by evaporation under 
vacuum. I f precipitation occurred, samples were stored at 4 °C for 24 hours to allow further 
precipitation. Precipitates were filtered and dried under vacuum. The filtrate was further 
concentrated to half its original volume and any further precipitates collected. Otherwise the 
filtrates were acidified to pH 3 with 5% hydrochloric acid, extracted with ethyl acetate 
( 3 x 7 ml) and the combined organic extracts dried over magnesium sulphate. After filtration, 
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the solvent was removed under vacuum and the residue treated with benzene and re-
evaporated to yield the desired mono-substituted Z),^-tryptophan derivative. The crude 
product was further purified by silica flash chromatography using a chloroform/methanol 
mixture (95:5) as eluent. 
The ether layer was dried over magnesium sulphate. Removal o f the solvent under vacuum 
recovered unreacted indole starting material. 
4.3. Lb Enzymatic resolution of Pf-Acetyl-D^-Tryptophan Analogues 
Borate buffer solution A was prepared from-sodium tetraborate decahydrate (1.9 g, 0.05 M) 
in deionised water (100 ml). The pH was adjusted to pH 8.00 using concentrated 
hydrochloric acid. Cobalt(II) chloride hexahydrate (0.5 mg, 3.1 umol) was added to a final 
concentration of 0.125 mM. 
The A^-acetyl-D.L-tryptophan analogue (0.40 mmol) was dissolved in borate buffer solution 
A (5 ml). A solution of amino acylase (100 mg) in borate buffer A (10 ml) at pH 8 was added 
with stirring. The reaction mixture was stirred at 37 °C for 48 hours and then quenched by 
adjusting to pH 5 using 10% hydrochloric acid. Subsequently the mixture was filtered 
through a celite pad and the filtrate extracted into ethyl acetate (3 x 25 ml). The combined 
organic extracts were dried over magnesium sulphate, filtered and the solvent removed under 
vacuum to afford the crude unreacted A^-acetylated-D-tryptophan derivative. The aqueous 
phase was purified by ion-exchange chromatography using DOWEX® Resin 50X2-200. The 
resin was prepared prior to the run through deprotonation and protonation via 0.1 M sodium 
hydroxide solution and 0.1 M hydrochloride (HC1) solution respectively. Water and methanol 
eluents were used to wash the resin before its application. The column was prepared for 
loading by protonation of the acceptor sites with 0.1 M HC1 solution. The product, dissolved 
in the aqueous phase, was then applied to the column and eluted first with water (150 ml) and 
then with 10% ammonia in methanol (200 ml). Fractions which showed UV activity and 
responded positively to a ninhydrin test were collected and the solvent removed under 
vacuum to afford the Z-enantiomer of the free amino acid. 
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4.3.1.C Acetylation of L-Tryptophan Analogues 
Acetic anhydride (1.4 ml, 1.6 mmol) was added to a solution of the amino acid (0.8 mmol) in 
acetic acid (5 ml). The reaction mixture was stirred at room temperature for 1 h and 
subsequently quenched by the addition of ice-cold water (2 ml). The solvents were removed 
under vacuum and the crude products recrystallized from ethyl acetate/ petroleum ether 
(60/80). Alternatively, the reaction mixture was adjusted to pH = 2.5 with 0.1 /V sodium 
hydroxide solution. The product was then extracted into ethyl acetate (3 x 10 ml) and the 
organic solvent removed under vacuum to yield the crude product. 
4.3. l.d Preparation of Methyl-Esters2 
The /V-Acetyl-Z,-tryptophan analogue (0.1 mmol) was dissolved in methanol (5 ml). 
Concentrated sulphuric acid (0.15 ml) was added and the reaction mixture refluxed for 
2 hours. After adjustment to pH 7 using 0.5 M aqueous sodium carbonate solution, the 
solvents were removed under vacuum and the residues redissolved in deionised water (2 ml). 
The product was extracted from the aqueous phase using dichloromethane ( 3 x 2 ml). The 
organic layer was separated and washed with 0.5 M aqueous sodium carbonate solution 
(2 ml) and deionised water ( 2 x 2 ml). The combined dichloromethane extracts were then 
dried over magnesium sulphate, filtered and the solvent removed under vacuum to yield the 
crude product, which was used without further purification for the ethyl amidation reaction. 
4.3.1.e Ethyl Amidation3 
The A^-Acetylated-L-tryptophan methyl ester (0.1 mmol) was dissolved in a solution of 
ethylamine in methanol (50% v/v, 5 ml). The solution was stirred at 0 °C for 24 hours. 
Solvents were removed under vacuum and reaction was repeated. The crude product, 
following concentration in vacuo, was purified by silica flash column chromatography (95% 
DCM, 5% EtOH). 
4.3. I f Determination of Resin Loading 
3.0 mg of leucine-loaded Wang resin were suspended in a solution of 20% (v/v) of piperidine 
in DMF (3 ml). The solution was transferred into a 3 ml UV/Vis cell and the absorbance was 
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measured against a solution of 20% (v/v) solution of piperidine in DMF at 290 nm. The 
measuring cell was agitated and stirred for 2 - 3 minutes and particulate material allowed to 
settle prior to the measurement. The loading was calculated using Equation 3.1: 
r A' ( A b W - A b s r e r ) 
Loading = ! , (3.1) 
(1.75 * mass resin [mg]) 
where Abs s a mpic and Abs r Cf are the absorbance of sample and reference respectively. The 
factor 1.75 was derived by using 5253 M" 1 cm"1 as extinction coefficient at 290 nm. The 
theoretical substitution A of a peptidyl resin was calculated from the substitution of the base 
resin using Equation 3.2 
A = g*iooo ( 3 2 ) 
[l000 + ( f l * ( M - 1 8 ) ) ] ' 
where B is the initial substitution of the starting resin (mmol g*1), and M the molecular weight 
of the target peptide, plus all protecting groups, in mg. 
4.3.2 NMR Guest-Host Titrations 
4.3.2.a General 
NMR titration spectra were recorded on a Varian Unity 200 MHz N M R spectrometer. 
Tetramethylsilane (TMS) was used as internal standard (0 ppm). The quantities for the 
stepwise addition of guest solution in the N M R host-guest titrations were 5, 5, 10, 10, 25, 50, 
50, 50, 100, 100, 100, 100, 100, and 200 ul. A l l titrations were performed in duplicate. Data 
were fitted to a 2:1 binding isotherm that allowed for DMPC micellisation and water adducts 
at various stages (see §2.3). 
4.3.2. b DMPC Blank Titrations 
A solution of DMPC (75 mg, 110 mM) in CDC1 3 (1 ml) was added portionwise to CDC1 3 
(0.5 ml) in an N M R tube. Following each addition, a 'H spectrum was recorded, typically 
providing fifteen data points. Observed complexation-induced N M R signals for the water and 
lipid protons were integrated when clearly distinct from nearby signals. Titrations were 
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performed in duplicate using TMS (5 = 0.0) as internal standard. The data were analysed by 
plotting the intensities of the water protons against calculated lipid concentration enabling the 
estimation o f the free water content of the chloroform and the water per lipid molecule ratio 
(see §2.3.2.a). 
4.3.2.C NMR Job Plots 
A series of solutions (0.5 ml each) of constant total molar concentration (10 mM) were 
prepared containing varying molar ratios of lipid (DMPC) and amino acid analogue (6f or 
6g). Job plots were then made of the observed chemical shift change (x x AS0bs) against mole 
fraction (x). 4 
4.3.2. cl Tryptophan-DMPC Host-Guest Titrations 
Host solution was prepared by dissolving A^-acetyl-monosubstituted ethyl /.-tryptophan 
derivatives (typical concentration 4 mM) in deuterated chloroform (2 ml). Host solution 
(0.5 ml) was placed in an N M R tube and the remainder used to generate the guest solution by 
solvation of DMPC in it giving at a typical concentration of 100 mM. Guest solution was 
added stepwise, agitated thoroughly and a 'H NMR spectrum recorded after each addition, 
typically providing fourteen data points. A l l NMR titrations were performed in duplicate. 
Data were analysed by least squares curve fitting to a calculated binding isotherm, as 
described in §2.3.1. 
4.3.2.e Tryptophan-DMPC DiO Titrations 
Host solution was prepared by dissolving A^-acetyl- /.-tryptophan ethylamide (15 mg, 
55 mM) and DMPC (37 mg, 55 mM) in deuterated chloroform (2 ml). Deuterated water 
(D2O) was added in 1 ul steps and 'H NMR spectra recorded immediately after each 
addition. The titration was repeated as a kinetics experiment, with 'H N M R spectra recorded 
at 30 second intervals after a single injection of D?0. Spectra were recorded until changes in 
the spectrum were undetectable. 
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4.3.3 Isothermal Titration Calorimetry ( I T C ) 
Isothermal titration calorimetry was performed on a computer-assisted VP 2000 ITC 
instrument using MicroCal control software (version 7.0). The measuring cell was loaded 
with a solution of A^-acetyl-monosubstituted /.-tryptophan ethylamide derivative in 
chloroform (1.5 ml, typical concentration 4 vaM). Chloroform was also used in the reference 
cell. The temperature was adjusted to 25 °C and aliquots of DMPC guest solution (typical 
concentration 26 mM) were injected into the cell with stirring at 307 rpm. A first injection of 
2 ul was followed by aliquots of 8 ul DMPC solution over 32 seconds, with 180 seconds 
between injections, until the syringe loading of approximately 275 ul was exhausted. This 
resulted typically in 32 injections. The heat of reaction was recorded as a function of time 
and lipid concentration. The reference power was chosen to be 10 u.cal per second. The initial 
time delay o f the first injection was 60 seconds. A blank titration of lipid into neat 
chloroform was also performed. The subtraction o f the signal of this DMPC blank titration 
from the measured values of DMPC-tryptophan titrations gave the desired heat profiles of the 
interaction between the two molecules. 
4.4 Analytical Data for Compounds Prepared 
AAA Overview 
The following section lists the physical and spectroscopic properties of all compounds 
synthesised. Colouration of products change upon hydration and are given here as the colour 
of the dry compound. Mass spectrometry data is given as mass of identified ion, relative 
abundance in () brackets and the identified ion in [] brackets. Rr values given were obtained 
by TLC. Conditions are given in brackets. 
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4.4.1.a 5-substituted I^f-acetyl-D.L-Uyptophan derivatives (la-J) 
ID Substituent Z-serine & AC2O (eq.) Yield (%) 
l a R = F 2.0 85 0 
lb R=C1 2.0 86 
A c H N ^ 
l c R = Br 2.0 77 
Id R = I 1.5 87 n ; 
le R = MeO 1.0 84 
I f R = N 0 2 2.5 44 
H 
Table 4.1: Table o f Na-Ac-5-D,/--tryptophan derivatives that were produced via the indole synthesis. 
A^-Acetyl-S-fluoro-D/.-tryptophan (1 a) 
Using the general method above (§4.3.1.a), the title compound was synthesised as an orange-
brown powder. 
'H NMR (400 MHz, MeOH - d 4 ): 5 1.90 (s, AcC/ / 3 , 3H), 3.11 (dd, J = 7.6, 15.6 Hz, Z/ p, 
1H), 3.26* (d, J = 7.6 Hz, Z/ p , 1H), 4.68 (dd, J = 5.2, 7.6 Hz, Ha, 1H), 6.84 (dt, J = 2.8, 
8.4 Hz, ind//6, 1H), 7.14 (s, indf/4, 1H), 7.21 (dd, J = 2.0, 10.0 Hz, ind//7, 1H), 7.26 (dd,J = 
3.6, 8.4 Hz, ind/Z2, 1H); l 3 C NMR (100 MHz, MeOH - cU): 5 22.38 (AcCH 3 ) , 28.44 (C p ) , 
54.71 (C a ) , 103.77 (indC3), 110.31 (indC4), 110.57 (indC7), 112.95 (indC6), 126.38 
(indC2), 129.26 (indC3a), 134.56 (indC7a), 160.11 (indC5), 173.18 (AcCO), 175.12 
(COOH); MS (ES+): mle 287.1 (100%) [m+Na] + , 288.1 (15%); Mp.: 180-183 °C (dec); 
C H N analysis (calcd %) C, 59.09; H, 4.96; N , 10.60; (found %) C, 58.99; H, 4.99; N , 10.58 
' f u l l assignment of coupling constants not possible due to signal overlap with residual 
protons o f solvent. 
(L i t . 5 Mp.: 189-192 °C) 
A^-Acetyl-5-chloro-A^-tryptophan (lb) 
Using the general method above (§4.3.1.a), the title compound was synthesised as an orange-
brown powder. 
'H NMR (400 MHz, MeOH - d 4): 5 1.90 (s, AcCr7 3, 3H), 3.17 (dd, J = 7.0, 15.0 Hz, / / p , 
1H), 3.30 (d, J = 5.5, 15.0 Hz, 7ZP, 1H), 4.77 (dd, J = 5.5, 13.0 Hz, Ha, 1H), 7.06 (d, J = 
7.5 Hz, indrY6, 1H), 7.24 (s, ind//4, 1H), 7.27 (d, J = 7.5 Hz, ind//7, 1H), 7.60 (s, ind//2, 
1H); 1 3 C NMR (100 MHz, MeOH - (LJ: 5 22.40 (AcCH 3 ) , 28.32 (Cp), 54.75 (C a ) , 108.27 
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(indC3), 111.51 (indC4), 112.19 (indC7), 120.35 (indC6), 124.35 (indC2), 124.44 (indC3a), 
124.75 (indC7a), 136.02 (indC5), 173.18 (AcCO), 175.11 (COOH); MS (ES+): mle 281.1 
(24%) [ m 3 5 C l + H ] + , 283.1 (7%) [ m 3 7 C l + H ] + , 303.1 (100%) [m 3 5 Cl+Na] + , 305.2 (35%) 
[m 3 7 Cl+Na] + ; Mp.: 215-217 °C (dec); C H N analysis (calcd % ) C, 55.62; H, 4.67; N , 9.98; 
(found %) C, 55.60; H, 4.69; N , 9.97 
(L i t . 6 Mp.: 212 °C) 
hT-Acetyl-5-bromo-Z),Z-tryptophan (1 c) 
Using the general method above (§4.3.1.a), the title compound was synthesised as a 
yellowish white powder. 
'H NMR (400 MHz, MeOH - d 4 ): 5 1.91 (s, AcC/ / 3 , 3H), 3.12 (dd, J = 6.4, 12.0 Hz, / / p , 
1H), 3.30* (d, J= 4.4, 11.6 Hz, / / p , 1H), 4.70 (dd, J = 4.4, 6.0 Hz, Ha, 1H), 6.98 (dt, J= 1.6, 
6.8 Hz, ind//6, 1H), 7.10 (s, ind//4, 1H), 7.31 (d, J= 1.2 Hz, ind//7, 1H), 7.49 (d, J = 2.8 Hz, 
mdH2, 1H); , 3 C NMR (100 MHz, MeOH - d^ : 8 22.41 (AcCH 3 ) , 28.28 (C p ) , 54.81 (C a ) , 
111.02 (indC3), 112.99 (indC4), 113.92 (indC7), 121.94 (indC6), 125.08 (indC2), 125.93 
(indC3a), 130.76 (indC7a), 136.62 (indC5), 173.18 (AcCO), 175.23 (COOH); MS (ES+): 
mle 347.1 (100%) [m 7 9 Br+Na] + , 349.1 (95%) [m 8 l Br+Na] + , 325.1 (35%) [ m 7 9 B r + H ] + , 327.1 
(32%) [ m 8 1 B r + H ] + ; Mp.: 201-204 °C; C H N analysis (calcd % ) C, 48.02; H, 4.03; N , 8.62; 
(found %) C, 47.89; H, 4.11; N , 8.57 
(Li t . 7 6 Mp.: 212-214 °C, 193 °C) 
N°--Acetyl-5-iodo-D,Z-tryptophan (1 d) 
'H NMR (400 MHz, MeOH - o%): 5 1.92 (s, AcC/ / 3 , 3H), 3.10 (dd, J = 8.0, 14.8 Hz, / / p , 
1H), 3.31 (d, J = 5.2, 14.8 Hz, tfp, 1H), 4.67 (dd, J = 5.2, 8.0 Hz, Ha, 1H), 7.07 (s, ind//4, 
1H), 7.14 (d, J = 8.4 Hz, ind//6, 1H), 7.32 (dd, J = 1.6, 8.4 Hz, ind//7, 1H), 7.88 (d, J = 
1.6 Hz, indLf/2, 1H); 1 3 C NMR (100 MHz, MeOH - d 4 ) : 5 22.46 (AcCH 3 ) , 28.23 (Cp), 54.83 
(C a ) , 82.75 (indC3), 110.69 (indC4), 114.43 (indC7), 125.58 (indC6), 128.37 (indC2), 
130.67 (indC3a), 131.61 (indC7a), 137.01 (indC5), 173.18 (AcCO), 174.95 (COOH); MS 
(ES+): mle 395.1 (100%) [m+Na] + , 396.1 (16%) [m+Na] + ; Mp.: >280 °C (dec); C H N 
analysis (calcd % ) C, 41.96; H, 3.52; N , 7.53; (found %) C, 42.19; H, 3.60; N , 7.55 
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A^-Acetyl-S-methoxy-D^-tryptophan (1 e) 
Using the general method above (§4.3.1.a), the title compound was synthesised as a yellow 
powder. 
'H NMR (400 MHz, MeOH - cU): 6 1.91 (s, AcCf7 3 , 3H), 3.12 (dd, J = 7.6, 14.8 Hz, Hp, 
1H), 3.30 (d, J= 5.2, 14.8 Hz, / / p , 1H), 3.82 (s, C/ / 3 0-Ar , 3H), 4.70 (dd, J= 5.2, 7.2 Hz, Ha, 
1H), 6.74 (dd, J= 2.0, 8.8 Hz, ind//6, 1H), 7.05 (s, ind//4, indrV7, 2H), 7.20 (d, J= 8.8 Hz, 
ind//2, 1H); 1 3 C NMR (100 MHz, MeOH - d 4): 5 22.44 (AcCH 3 ) , 30.68 (Cp), 54.74 (C a ) , 
56.23 (CHjO-Ar), 101.09 (indC3), 110.82 (indC4), 112.72 (indC7), 112.92 (indC6), 125.06 
(indC2), 129.06 (indC3a), 133.23 (indC7a), 155.09 (indC5), 173.19 (AcCO), 175.28 
(COOH); MS (ES+): m/e 299.1 (100%) [m+Na] + ; Mp.: 187-189 °C 
( L i t . 8 6 Mp.: 182-183 °C, 170 °C); C H N analysis (calcd % ) C, 60.86; H, 5.84; N , 10.14; 
(found % ) C, 60.79; H, 5.91; N , 10.10 
A^-Acetyl-5-nitro-A£-t r yptophan ( I f ) 
Using the general method above (§4.3.1.a), the title compound was synthesised as a yellow 
powder. 
'H NMR (400 MHz, MeOH - d,): 5 1.92 (s, AcC/ / 3 , 3H), 3.22 (dd, J = 7.6, 14.8 Hz, / / p , 
1H), 3.39 (d, J= 5.2, 14.8 Hz, / / p , 1H), 4.74 (dd, J = 5.2, 1.6 Hz, Ha, 1H), 7.31 (s, ind//4, 
1H), 7.43 (d, J = 7.2 Hz, indf/6, 1H), 8.01 (dd, J = 2.0, 8.8 Hz, m d f f l , 1H), 8.56 (d, J = 
2.4 Hz, ind//2, 1H); , 3 C NMR (100 MHz, MeOH - d,): 5 22.39 (AcCH 3 ) , 28.14 (Cp), 54.70 
(C a ) , 112.45 (indC3), 114.26 (indC4), 115.82 (indC7), 116.82 (indC6), 117.84 (indC2), 
128.25 (indC3a), 141.01 (indC7a), 142.46 (indC5), 173.21 (AcCO), 174.65 (COOH); MS 
(ES+): m/e 314.1 (100%) [m+Na] + , 315.1 (15%) [m+Na] + ; Mp.: 160-163 °C (dec); C H N 
analysis (calcd %) C, 64.60; H, 6.20; N , 10.76; (found %) C, 64.19; H, 6.29; N , 10.72 
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4.4.1.b 6-substituted Na-acetyl-D,L-t)yptophan derivatives (lg-l) 
ID Substituent Z-serine & A c 2 0 (eq.) Yield (%) 
lg R = F 2.0 98 
0 
l h R=C1 2.0 86 
AcHN 
l i R = Br 2.0 73 
l j R = Me 1.5 73 n y 
l k R = MeO 1.0 77 N 
11 R = N 0 2 2.5 58 
H 
Table 4.2: Table o f /V°-Ac-6-D,Z,-tryptophan derivatives that were produced via the indole synthesis. 
A^-Acetyl^-fluoro-D^-tryptophan (1 g) 
Using the general method above (§4.3.1 .a), the title compound was synthesised as a greenish 
yellow crystalline powder. 
'H NMR (500 MHz, MeOH - d 4 ): 5 1.90 (s, AcC/ / 3 , 3H), 3.12 (dd, J = 8.0, 14.4 Hz, / / p , 
1H), 3.30* (d, J = 8.0 Hz, Hp, 1H), 4.69 (dd, J = 5.5, 10.0 Hz, Ha, 1H), 6.79 (dt, J = 2.5, 
10.0 Hz, indrY5, 1H), 7.01 (dd, ind//4, J= 2.0, 10.0 Hz, 1H), 7.07 (s, indrV7, 1H), 7.45 (dd, J 
= 5.5, 9.0 Hz, ind//2, 1H); , 3 C NMR (125 MHz, MeOH - d 4 ): 5 22.37 (AcCH 3 ) , 28.43 (C p ), 
54.71 (Co), 108.09 (indC3), 110.14 (indC4), 111.40 (indC7), 120.14 (indC5), 124.79 
(indC2), 125.60 (indC3a), 137.87 (indC7a), 160.23 (indC6), 173.18 (AcCO), 175.12 
(COOH); MS (ES+): mle 287.1 (100%) [m+Naf , 288.1 (15%) [m+Na] + , 265.1 (26%) 
[m+H] + , 265.1 (4%) [m+H] + ; Mp.: 179-182 °C; C H N analysis (calcd % ) C, 59.09; H, 4.96; 
N , 10.60; (found % ) C, 59.06; H, 4.98; N , 10.59 
' f u l l assignment of coupling constants not possible due to signal overlap with residual 
protons of solvent. 
(L i t . 9 Mp.: 178-179 °C) 
A^-Acetyl^-chloro-DjL-tryptophan ( lh) 
Using the general method above (§4.3.1.a), the title compound was synthesised as a yellow 
crystalline powder. 
'H NMR (500 MHz, MeOH - d 4 ): 5 1.89 (s, AcC/ / 3 , 3H), 3.12 (dd, J = 8.0, 15.0 Hz, / / p , 
1H), 3.30* (d, J = 8.0 Hz, / / p , 1H), 4.70 (dd, J = 5.0, 7.5 Hz, Ha, 1H), 6.98 (dd, J = 2.0, 
8.5 Hz, indLrY5, 1H), 7.10 (s, ind//7, 1H), 7.31 (d, i nd / /4 , J= 1.5 Hz, 1H), 7.50 (d, J =6.5 Hz, 
174 
ind//2, 1H); , 3 C NMR (125 MHz, MeOH - cU): 5 22.38 (AcCH 3 ) , 28.33 (Cp), 54.69 (C a ) , 
111.50 (indC3), 112.03 (indC4), 120.28 (indC7), 120.34 (indC5), 125.30 (indC2), 127.59 
(indC3a), 128.29 (indC7a), 138.33 (indC6), 173.17 (AcCO), 175.07 (COOH); MS (ES+): 
mle 303.1 (100%) [m 3 5 Cl+Na] + , 305.1 (35%) [m 3 7 Cl+Na] + , 281.1 (24%) [ m 3 5 C l + H ] + , 283.1 
(7%) [ m 3 7 C l + H ] + ; Mp.: 190-194 °C (dec); C H N analysis (calcd % ) C, 55.62; H, 4.67; N , 
9.98; (found % ) C, 55.58; H, 4.73; N , 9.95 
*full assignment of coupling constants not possible due to signal overlap with residual 
protons of solvent. 
A'a-Acetyl-6-bromo-Z),Z,-tryptophan (l i) 
Using the general method above (§4.3.1.a), the title compound was synthesised as a light-
brown/ orange crystalline powder. 
'H NMR (400 MHz, MeOH - d 4): 5 1.89 (s, AcC/ / 3 , 3H), 3.12 (dd, J = 8.0, 14.4 Hz, Hh 
1H), 3.30* (d, J = 8.0 Hz, //p, 1H), 4.69 (dd, J = 4.2, 8.4 Hz, Ha, 1H), 7.09 (s, ind//7, 1H), 
7.11 (dd, J= 2.0, 8.8 Hz, ind//5, 1H), 7.45 (s, ind//4, 1H), 7.47 (m, ind//2, 1H); , 3 C NMR 
(100 MHz, MeOH - d 4 ): 5 22.38 (AcCH 3 ) , 28.30 (Cp), 54.66 (C a ) , 111.80 (indC3), 112.34 
(indC4), 120.97 (indC7), 121.26 (indC5), 125.83 (indC2), 127.92 (indC3a), 128.34 (indC7a), 
138.55 (indC6), 173.18 (AcCO), 175.00 (COOH); MS (ES+): mle 347.2 (100%) 
[m 7 9 Br+Na] + , 349.2 (95%) [m 8 l Br+Na] + ; Mp.: >320 °C (dec); C H N analysis (calcd %) C, 
48.02; H, 4.03; N , 8.62; (found %) C, 47.95; H, 4.10; N , 8.61 
' f u l l assignment of coupling constants not possible due to signal overlap with residual 
protons of solvent. 
A^-Acetyl-6-methyl-.D,Z,-tryptophan ( l j ) 
Using the general method above (§4.3.1.a) the title compound was synthesised as a dark-
brown crystalline powder. 
' H NMR (500 MHz, MeOH - d»): 8 1.89 (s, AcC/ / 3 , 3H), 2.40 (s, C / / 3 - A r ,3H), 3.11 (dd, J = 
8.0, 14.5 H z , / / p , 1H), 3.30* (d, J = 8.0 Hz, Hp, 1H), 4.69 (dd, .7=5.0, 8.0 Hz, Ha, 1H), 6.85 
(d, J = 8.5 Hz, indf/5, 1H), 6.99 (s, m d f f l , 1H), 7.11 (s, ind//4, 1H), 7.42 (d, J = 9.0 Hz, 
ind//2, 1H); , 3 C NMR (125 MHz, MeOH - d,): 5 21.78 (AcCH 3 ) , 22.39 (CH 3 -Ar) , 28.55 
(Cp), 54.80 (C a ) , 110.90 (indC3), 112.12 (indC4), 118.93 (indC7), 121.54 (indC5), 123.61 
(indC2), 126.83 (indC3a), 132.02 (indC7a), 138.49 (indC6), 173.18 (AcCO), 175.28 
175 
(COOH); MS (ES+): mle 283.2 (100%) [m+Na] + , 284.2 (22%) [m+Na] + , 261.2 (23%) 
[m+H] + ; Mp.: >320 °C (dec); C H N analysis (calcd %) C, 64.60; H, 6.20; N, 10.76; (found 
% ) C, 64.61; H, 6.41; N , 10.71 
' f u l l assignment o f coupling constants not possible due to signal overlap with residual 
protons of solvent. 
A^-Acetyl-6-methoxy-Z),Z,-tryptophan ( lk) 
Using the general method above (§4.3.1.a) the title compound was synthesised as a yellow 
crystalline powder. Upon hydration the colour changes to dark blue over green. 
'H NMR (500 MHz, MeOH - d,): 8 1.90 (s, A c C / / 3 , 3H), 3.09 (dd, J = 8.0, 14.5 Hz, % 
1H), 3.29 (dd, J= 5.5, 14.5 Hz, / / p , 1H), 3.78 (C/ / 3 0-Ar) , 4.67 (dd, J = 5.5, 7.5 Hz, Ha, 1H), 
6.67 (d, J = 8.0 Hz, ind//5, 1H), 6.80 (d, J= 8.5 Hz, ind//2, 1H), 7.36 (s, ind//4, 1H), 7.63 (d, 
ind//7, 1H); 1 3 C NMR (125 MHz, MeOH - d 4): 5 22.44 (AcCH 3 ) , 30.68 (C p ) , 55.18 (Co), 
57.12 (CH 3 0-Ar) , 94.50 (indC3), 108.62 (indC4), 110.01 (indC7), 118.78 (indC5), 121.64 
(indC2), 125.06 (indC3a), 136.30 (indC7a), 155.21 (indC6), 169.27 (AcCO), 173.63 
(COOH); MS (ES+): mle 301.2 (100%) [m+Na] + , 302.2 (16%) [m+Na] + ; Mp.: 178-183 °C 
(dec); C H N analysis (calcd %) C, 60.86; H, 5.84; N , 10.14; (found % ) C, 60.79; H, 5.91; N , 
10.10 
(L i t . 9 Mp.: 178-179 °C) 
A^-Acetyl-6-nitro-D^-tryptophan (11) 
Using the general method above (§4.3.1.a), the title compound was synthesised as a yellow 
powder. 
'H NMR (500 MHz, MeOH - d 4 ): 5 1.91 (s, A c C / / 3 , 3H), 3.23 (dd, J = 8.0, 14.5 Hz, 7/p, 
1H), 3.39 (dd, J = 6.0, 14.5 Hz, H$, 1H), 4.70 (dd, J = 6.0, 7.5 Hz, Ha, 1H), 7.34 (d, J = 
8.0 Hz, ind//5, 1H), 7.40 (d, J = 8.5 Hz, ind//2, 1H), 7.96 (s, ind//4, 1H), 8.33 (d, ind#7, 
1H); l 3 C NMR (125 MHz, MeOH - <U): 5 22.40 (AcCH 3 ) , 28.18 (Cp), 55.08 (C a ) , 112.50 
(indC3), 114.62 (indC4), 117.03 (indC7), 118.58 (indC5), 120.13 (indC2), 128.37 (indC3a), 
142.20 (indC7a), 143.21 (indC6), 173.25 (AcCO), 174.55 (COOH); MS (ES+): mle 314.1 
(100%) [m+Naf , 315.1 (15%) [m+Na] + ; Mp.: 290-293 °C (dec); C H N analysis (calcd %) 
C, 64.60; H, 6.20; N , 10.76; (found %) C, 64.52; H, 6.25; N , 10.74 
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4.4.1.C 5-substituted N"-acetyl-D-tryptophan derivatives (2 'a-g) 
ID Substituent Yield (%) 
2'a R = F 58 
2 b R = C 1 71 
2'c R = Br 59 
2'd R = I 58 
2'e R = Me 59 
2'f R = MeO 65 
2'g R = N 0 2 60 
AcHN 
Table 4.3: Table o f /V°-Ac-5-D-tryptophan derivatives that were produced via enzymatic resolution o f a 
racemic mixture o f the parent tryptophan compound. 
A/a-Acetyl-5-fluoro-.D-tryptophan (2'a) 
Using the general method above (§4.3.1 .b), the title compound was synthesised as a cream-
white powder. 
'H NMR (400 MHz, MeOH - cU): 5 1.90 (s, AcC/ / 3 , 3H), 3.11 (dd, J = 7.6, 14.8 Hz, / / p , 
1H), 3.26* (d, J = 6.0 Hz, / / p , 1H), 4.68 (dd, J = 5.2, 7.6 Hz, Ha, 1H), 6.84 (dt, J = 2.4, 
9.2 Hz, ind//6, 1H), 7.14 (s, ind//4, 1H), 7.21 (dd,J = 2.4, 10.4 Hz, indtf7, 1H), 7.27 (dd,J = 
4.8, 8.8 Hz, ind//2, 1H); 1 3 C NMR (100 MHz, MeOH - cM: 5 22.38 (AcCH 3 ) , 28.45 (C p ) , 
54.71 (C a ) , 103.77 (indC3), 110.31 (indC4), 110.34 (indC7), 112.96 (indC6), 126.38 
(indC2), 129.27 (indC3a), 134.57 (indC7a), 157.81 (indC5), 173.18 (AcCO), 175.13 
(COOH); MS (ES+): mle 265.2 (89%) [m+H] + , 287.2 (16%) [m+Na] + ; Mp.: 187-190 °C; 
[a ] d 2 5 : -50.9° (c = 1.0, EtOAc) 
' f u l l assignment o f coupling constants not possible due to signal overlap with residual 
protons of solvent. 
(Li t . 7 Mp.: 192 °C; [ a ] d 2 0 : +54.7° (c = 1.0, EtOAc) (data for Z-isomer)) 
A^-Acetyl-5-chloro-Z)-tryptophan (2'b) 
Using the general method above (§4.3.1 .b), the title compound was synthesised as a cream-
white crystalline powder. 
'H NMR (500 MHz, MeOH - d 4): 5 1.91 (s, AcC/ / 3 , 3H), 3.11 (dd, J = 10.0, 18.5 Hz, / / p , 
1H), 3.29 (dd, J= 5.5, 18.5 Hz, / / p , 1H), 4.69 (dd, J = 6.5, 10.5 Hz, Ha, 1H), 7.11 (dt, J = 
3.0, 11.5 Hz, ind//6, 1H), 7.15 (s, ind//4, 1H), 7.23 (dd, J= 3.0, 12.0 Hz, ind//7, 1H), 7.68 
177 
(dd, J= 6.0, 11.0 Hz, ind#2, 1H); , J C NMR (125 MHz, MeOH - d*): 5 22.42 (AcCH 3 ) , 
28.23 (Cp), 54.76 (C a ) , 110.91 (indC3), 112.98 (indC4), 113.90 (indC7), 121.89 (indC6), 
125.06 (indC2), 125.91 (indC3a), 130.68 (indC7a), 136.53 (indC5), 173.18 (AcCO), 175.27 
(COOH); MS (ES+): mle 282.2 (100%) [ m + H ] \ 284.2 (38%) [m+H] + ; Mp.: 210-213 °C; 
[a] d 2 5 :-40.4° (c = 1.0, EtOAc) 
(Li t . 7 Mp.: 212 °C; | a ] d 2 0 : +48.6° (c = 1.0, EtOAc) (data for L-isomer)) 
A^-Acetyl-5-bromo-Z)-tryptophan (2'c) 
Using the general method above (§4.3.1 .b), the title compound was synthesised as a cream-
white powder. 
'H NMR (400 MHz, MeOH - d 4 ): 5 1.91 (s, AcGr73, 3H), 3.11 (dd, J = 8.0, 14.4 Hz, % 
1H), 3.30 (dd, J= 5.2, 14.8 Hz, / / p , 1H), 4.69 (dd, J = 5.2, 7.6 Hz, Ha, 1H), 7.12 (s, ind//4, 
1H) 7.16 (dd, J = 2.0, 8.8 Hz, ind//6, 1H), 7.24 (d, J = 8.8 Hz, ind//7, 1H), 7.68 (d, J = 
1.6 Hz, ind//2, 1H); 1 3 C NMR (100 MHz, MeOH - cU): 5 22.41 (AcCH 3 ) , 28.27 (Cp), 54.78 
(C„), 111.00 (indC3), 112.99 (indC4), 113.93 (indC7), 121.93 (indC6), 121.09 (indC2), 
125.09 (indC3a), 130.75 (indC7a), 136.61 (indC5), 173.19 (AcCO), 174.98 (COOH); MS 
(ES+): mle 241.2 (100%) [m 7 9 Br+Na] + , 349.2 (95%) [m 8 1 Br+Na] + ; Mp.: 124-127 °C; [ a ] D 2 5 : 
-14.5° (c = 2.0, MeOH) 
( L i t . 1 0 Mp.: 120-122 °C dec; [ a ] D 2 0 : -15.1° (c = 2.0, MeOH)) 
A^-Acetyl-5-iodo-D-tryptophan (2'd) 
Using the general method above (§4.3.1 .b), the title compound was synthesised as a white 
crystalline powder. 
' H NMR (400 MHz, MeOH - d 4): 5 1.92 (s, AcCHh 3H), 3.11 (dd, J = 8.0, 14.8 Hz, % 
1H), 3.32 (dd, J= 5.2, 14.8 Hz, % 1H), 4.69 (dd, 7 = 5.2, 8.0 Hz, Ha, 1H), 7.07 (s, ind//4, 
1H) 7.14 (d, J = 8.4 Hz, ind//6, 1H), 7.32 (dd, J = 1.6, 8.4 Hz, indr77, 1H), 7.88 (d, J = 
1.6 Hz, indrV2, 1H); , 3 C NMR (100 MHz, MeOH - cLJ: 6 22.48 (AcCH 3 ) , 28.25 (Cp), 54.85 
(C„), 82.73 (indC3), 110.71 (indC4), 114.40 (indC7), 125.61 (indC6), 128.39 (indC2), 
130.69 (indC3a), 131.65 (indC7a), 137.05 (indC5), 173.20 (AcCO), 174.91 (COOH); MS 
(ES+): mle 395.1 (100%) [m+Na] + , 396.1 (16%) [m+Na] + ; Mp.: 139-144 °C; [ a ] D 2 5 : -5.2° 
(c = 0.5, MeOH) 
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A^-Acetyl-5-methyl-D-tryptophan (2'e) 
Using the general method above (§4.3.1 .b), the title compound was synthesised as a cream-
white powder. 
' H NMR (400 MHz, MeOH - cLJ: 5 1.90 (s, AcC/ / 3 , 3H), 2.40 (s, C// 3 -Ar, 3H), 3.10 (dd, 7 = 
8.0, 14.8 Hz, / /p, 1H), 3.31 (dd, .7 = 4.8, 14.8 H z , / / p , 1H), 4.69 (dd, J =5.2, 8.0 Hz, Ha, 1H), 
6.91 (dd, J = 2.0 8.0 Hz, ind//6, 1H), 7.03 (s, ind//4, 1H), 7.19 (d, J = 8.0 Hz, ind//7, 1H), 
7.33 (t, .7=0.8 Hz, ind//2, 1H); , 3 C NMR (100 MHz, MeOH - cU): 5 21.69 (CH 3 -Ar), 22.39 
(AcCH 3 ) , 28.49 (Cp), 54.84 (C a ) , 110.53 (indC3), 111.95 (indC4), 118.86 (indC7), 124.00 
(indC6), 124.38 (indC2), 128.80 (indC3a), 129.10 (indC7a), 136.40 (indC5), 173.18 (AcCO), 
175.31 (COOH); MS (ES+): mle 261.2 (94%) [m+H] + ; Mp.: 174-176 °C; [ a ] d 2 S : -40.8° 
(c = 1.0, EtOAc) 
(Li t . 7 Mp.: 171 °C; [a] d 2 0 :+43.8° (c = 1.0, EtOAc) (data for/.-isomer)) 
A^-Acetyl-5-methoxy-D-tryptophan (2'f) 
Using the general method above (§4.3.1 .b), the title compound was synthesised as a cream-
white powder. 
' H NMR (400 MHz, MeOH - d»): 5 1.91 (s, AcC// 3 , 3H), 3.12 (dd, J = 8.0, 14.8 Hz, Hp, 
1H), 3.30 (dd, J= 4.8, 14.8 Hz, Hp, 1H), 3.81 (s, C/ / 3 0-Ar , 3H), 4.69 (dd, J= 5.2, 8.0 Hz, 
Ha, 1H), 6.74 (dd, J= 2.4 8.8 Hz, ind//6, 1H), 7.05 (s, ind//4 and ind/72, 2H), 7.20 (d, J = 
8.8 Hz, ind/77, 1H); 1 3 C NMR (100 MHz, MeOH - d 4 ): 5 20.75 (AcCH 3 ) , 28.52 (Cp), 54.73 
(C a ) , 56.24 (CH 3 0-Ar) , 101.10 (indC3), 110.81 (indC4), 112.72 (indC7), 125.07 (indC6), 
126.17 (indC2), 129.17 (indC3a), 133.22 (indC7a), 155.08 (indC5), 173.19 (AcCO), 175.28 
(COOH); MS (ES+): mle 299.1 (100%) [m+Na] + ; Mp.: 178-180 °C (dec); [ a ] d 2 5 : -10.5° 
( c = 1.0; MeOH) 
(Li t . 7 Mp.: 176 °C; [a ] d 2 0 : +14.3° (c = 1.0; MeOH) (data for /.-isomer)) 
A^-Acetyl-5-nitro-D-tryptophan (2'g) 
Using the general method above (§4.3.1 .b), the title compound was synthesised as a yellow 
crystalline powder. 
'H NMR (400 MHz, MeOH - d 4 ): 6 1.91 (s, AcC// 3 , 3H), 3.21 (dd, J = 7.6, 14.8 Hz, Hp, 
1H), 3.37 (dd, .7= 5.6, 14.8 Hz, //p, 1H), 4.76 (dd, J= 5.6, 7.6 Hz, Ha, 1H), 7.32 (s, ind//4, 
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1H), 7.43 (d, J = 7.2 Hz, ind//6, 1H), 8.01 (dd, J = 2.4, 8.4 Hz, 1H), 8.57 (d, J = 2.4 Hz, 
ind//7, 1H); , 3 C NMR (100 MHz, MeOH - d»): 5 22.41 (AcCH 3 ) , 28.16 (Cp), 54.74 (C a ) , 
112.52 (indC3), 114.28 (indC4), 115.85 (indC7), 116.84 (indC6), 117.86 (indC2), 128.28 
(indC3a), 141.05 (indC7a), 142.44 (indC5), 173.24 (AcCO), 174.63 (COOH); MS (ES+): 
We 314.1 (100%) [m+Na] + ; Mp.: 172 °C; [a] d 2 5 :-14.5° (c = 1.0; MeOH) 
4.4. l.d 6-substituted Tf-acetyl-D-tryptophan derivatives (2'h-m) 
ID Substituent Yield (%) 
2'h R = F 74 0 
2'i R=C1 59 
A c H N ^ 
2'j R = Br 71 
2'k R = Me 64 
21 R = MeO 59 N 
2'm R = N Q 2 63 
H 
Table 4.4: Table of N"-Ac-6-D-tryptophan derivatives that were produced via enzymatic resolution of the 
parent /V"-Ac-5-R-Z).Z.-tryptophan compound. 
A^-Acetyl-e-fluoro-D-tryptophan (2'h) 
Using the general method above (§4.3.1 .b), the title compound was synthesised as a cream-
white powder. 
'H NMR (500 MHz, DMSO - d 6): 5 1.78 (s, AcC/ / 3 , 3H), 2.96 (dd, J = 9.5, 15.5 Hz, / / p , 
1H), 3.11 (dd, J = 5.0, 15.5 Hz, / / p , 1H), 4.43 (m, Ha, 1H), 6.83 (dd, J= 5.0, 9.5 Hz, ind//5, 
1H), 7.09 (dd, ind//4, J = 2.5, 10.0 Hz, 1H), 7.12 (d, J= 2.5 Hz, ind//7, 1H), 7.48 (dd, 7 = 
5.0, 7.0 Hz, ind//2, 1H), 8.15 (d, J= 10.0 Hz, indN// , 1H), 10.90 (s, br, COO//, 1H); , 3 C 
NMR (125 MHz, DMSO - da): 5 20.39 (AcCH 3 ) , 27.03 (Cp), 52.89 (C a ) , 97.19 (indC3), 
97.39 (indC4), 106.71 (indC7), 106.90 (indC5), 119.19 (indC2), 124.08 (indC3a), 135.90 
(indC7a), 157.86 (indC6), 169.20 (AcCO), 173.47 (COOH); MS (ES+): mle 287.2 (100%) 
[m+Na] + ; Mp.: 173 °C 
A^-Acetyl-e-chloro-D-tryptophan (2'i) 
Using the general method above (§4.3.1 .b), the title compound was synthesised as a cream-
white powder. 
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' H NMR (500 MHz, DMSO - d 6): 6 1.78 (s, AcC/7 3, 3H), 2.96 (dd, 7 = 9.0, 15.0 Hz, Hp, 
1H), 3.12 (dd, 7 = 5.0, 15.0 Hz, Hp, 1H), 4.42 (dd, 7 = 5.0, 8.0, Ha, 1H), 6.98 (dd, 7 = 2.0, 
8.5 Hz, ind//5, 1H), 7.17 (d, ind//4, 7 = 2.0 Hz, 1H), 7.36 (d, 7 = 2.5 Hz, ind/77, 1H), 7.51 (d, 
7 = 8.5 Hz, ind/72, 1H), 8.14 (d, 7 = 2.0 Hz, indN/7, 1H), 10.98 (s, br, COO//, 1H); l 3 C 
NMR (125 MHz, DMSO - de): 5 20.78 (AcCH 3 ) , 26.95 (Cp), 52.91 (C a ) , 110.39 (indC3), 
110.98 (indC4), 118.69 (indC7), 119.60 (indC5), 124.74 (indC2), 125.67 (indC3a), 126.06 
(indC7a), 136.42 (indC6), 170.37 (AcCO), 173.45 (COOH); MS (ES+): mle 281.1 (34%) 
[ m 3 5 C l + H ] + , 283.1 (10%) [ m 3 7 C l + H ] + , 303.1 (100%) [m 3 5 Cl+Na] + , 305.2 (36%) 
[m 3 7 Cl+Na] + ; Mp.: 142 °C 
7Va-Acetyl-6-bromo-Z)-tryptophan (2'j) 
Using the general method above (§4.3.1 .b), the title compound was synthesised as a cream-
white powder. 
' H NMR (500 MHz, DMSO - d 6): 5 1.78 (s, AcC/7 3, 3H), 2.96 (dd, 7 = 9.0, 15.0 Hz, Hp, 
1H), 3.11 (dd ,7=5 .0 , 14.0 Hz, Hp, 1H), 4.42 (dd, 7 = 7 . 0 , 11.0, Ha, 1H), 7.10 (dd, 7 = 2.0, 
8.5 Hz, ind/75, 1H), 7.16 (d, ind/74, 7 = 2.5 Hz, 1H), 7.47 (d, 7 = 9.0 Hz, ind//2, 1H), 7.50 (d, 
7 = 1.5 Hz, ind//7, 1H), 8.11 (d, 7 = 7.5 Hz, indN/7, 1H), 10.65 (s, br, COO/7, 1H); l 3 C 
NMR (125 MHz, DMSO - d ,^): 5 20.76 (AcCH 3 ) , 26.92 (Cp), 52.89 (C„), 110.40 (indC3), 
113.68 (indC4), 113.90 (indC7), 120.00 (indC5), 121.21 (indC2), 124.66 (indC3a), 126.29 
(indC7a), 136.92 (indC6), 170.34 (AcCO), 173.40 (COOH); MS (ES+): mle 347.1 (100%) 
[m 7 9 Br+Na] + , 349.1 (97%) [m 8 l Br+Na] + ; Mp.: 176 °C 
7Va-Acetyl-6-methyl-Z)-tryptophan (2'k) 
Using the general method above (§4.3.1 .b), the title compound was synthesised as a cream-
white powder. 
] H NMR (500 MHz, DMSO - d 6): 8 1.78 (s, AcC/7 3, 3H), 2.36, (s, C/7 3-Ar, 3H), 2.93 (dd, 7 
= 8.5, 14.5 Hz, Hp, 1H), 3.10 ( d d , 7 = 5.5, 15.0 Hz, Hp, 1H), 4.42 (dd, 7 = 7.0, 9.5, H a , 1H), 
6.80 (dd, 7 = 4.0, 8.0 Hz, ind/75, 1H), 7.02 (d, ind/74, 7 = 2.0 Hz, 1H), 7.10 (s, ind/77, 1H), 
7.38 (d, 7 = 8.0 Hz, ind/72, 1H), 8.11 (d, 7 = 9.5 Hz, indN/7, 1H), 10.65 (s, br, COO/7, 1H); 
1 3 C NMR (125 MHz, DMSO - d 6 ): 8 20.77 (AcCH 3 ) , 22.41 (CH 3 -Ar) , 27.22 (Cp), 52.98 
(C a ) , 109.80 (indC3), 111.18 (indC4), 117.88 (indC7), 120.12 (indC5), 122.77 (indC2), 
181 
125.16 (indC3a), 129.87 (indC7a), 136.53 (indC6), 170.36 (AcCO), 173.59 (COOH); MS 
(ES+): mle 283.2 (100%) [m+H] + , 284.2 (16%) [m+H] + ; Mp.: 210 °C 
A' a-Acetyl-6-methoxy-/)-tryptophan (2'l) 
Using the general method above (§4.3.1 .b), the title compound was synthesised as a dark-
green crystalline powder. 
] H NMR (500 MHz, DMSO - d 6): 5 1.78 (s, AcCHh 3H), 2.94 (dd, J = 8.5, 14.5 Hz, Hp, 
1H), 3.06 (dd, J = 5.5, 14.5 Hz, # p , 1H), 3.73, (s, C/ / 3 0-Ar , 3H), 4.40 (dd, J = 7.0, 9.5, H a , 
1H), 6.63 (dd, J= 3.0, 11.0 Hz, ind//5, 1H), 6.81 (d, ind//4, J = 3.0 Hz, 1H), 7.30-743 (m, 
ind//7 and ind//2, 2H), 8.11 (d, J= 9.5 Hz, indN// , 1H), 10.62 (s, br, COO//, 1H); 1 3 C NMR 
(125 MHz, DMSO - d 6 ): 5 20.43 (AcCH 3 ) , 27.24 (Cp), 55.15 (C a ) , 59.79 (CH 3 0-Ar) , 94.45 
(indC3), 108.60 (indC4), 109.98 (indC7), 118.77 (indC5), 121.60 (indC2), 122.09 (indC3a), 
136.79 (indC7a), 155.48 (indC6), 170.39 (AcCO), 173.62 (COOH); MS (ES+): mle 299.2 
(100%) [m+Na] + , 300.2 (16%) [m+Na] + ; Mp.: 138 °C 
A^-acetyl-6-nitro-D-tryptophan (2'm) 
Using the general method above (§4.3.1 .b), the title compound was synthesised as a dark-
yellow crystalline powder. 
'H NMR (500 MHz, DMSO - d 6): 5 1.78 (s, AcC/ / 3 , 3H), 2.95 (dd, J = 8.0, 15.0 Hz, / / p , 
1H), 3.09 (dd, J= 5.0, 15.0 Hz, / / p , 1H), 4.41 (dd, J= 7.0, 9.0, H a , 1H), 6.63 (dd, J - 3.0, 
11.0 Hz, ind//5, 1H), 6.81 (d, ind//4, J= 3.0 Hz, 1H), 8.34 (m, ind//7 and ind//2, 1H), 8.89 
(d, J = 9.0 Hz, indN// , 1H), 10.64 (s, br, COO//, 1H); 1 3 C NMR (125 MHz, DMSO - d<0: 5 
20.43 (AcCH 3 ) , 27.24 (Cp), 55.15 (C a ) , 94.45 (indC3), 108.60 (indC4), 109.98 (indC7), 
118.77 (indC5), 121.60 (indC2), 122.09 (indC3a), 136.79 (indC7a), 155.48 (indC6), 170.39 
(AcCO), 173.62 (COOH); MS (ES+): mle 299.2 (100%) [m+Na] + , 300.2 (16%) [m+Na] + ; 
Mp.: 158°C 
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4.4.1.e 5-substituted L-t)~yptophan derivatives (2a-g) 
ID Substituent Yield (%) 
2a R = F 99 
2b R=C1 82 
2c R = Br 96 
2d R = I 81 
2e R = Me 99 
2f R = MeO 99 
2g R = N Q 2 70 
H,N, 
Table 4.5: Table o f 5-Z.-tryptophan derivatives that were produced via enzymatic resolution o f a racemic 
mixture o f the parent jV-Ac -5 -R-D,£- t ryptophan compound ( la-d, I f & 1g). The parent compound of 2e, N°-
Ac-5-Me-D,L-tryptophan, was purchased from Sigma Aldrich. 
5-Fluoro-L-tryptophan (2a) 
Using the general method above (§4.3.1 .b), the title compound was synthesised as a cream-
white crystalline powder. 
'H NMR (400 MHz, MeOH - cU): 5 3.14 (dd, J = 8.8, 15.2 Hz, 77p, 2H), 3.82 (dd, J = 4.0, 
9.2 Hz, Ha, 1H), 6.88 (dt, J = 1.6, 9.2 Hz, ind//6, 1H), 7.24 (s, ind//2, 1H), 7.31 (dd, .7=4.8, 
8.4 Hz, ind//7, 1H), 7.40 (dd, J= 2.4, 10.0 Hz, ind/74, 1H); 1 3 C NMR (100 MHz, MeOH -
cU): 5 28.34 (Cp), 56.54 (C«), 104.05 (indC4), 109.73 (indC3), 110.71 (indC6), 113.24 
(indC7), 127.18 (indC2), 128.83 (indC3a), 134.91 (indC7a), 160.26 (indC5), 174.33 
(COOH); MS (ES+): m/e 223.1 (100%) [m+H] + ; Mp.: 277-279 °C, [ a ] d 2 5 : +7.2° (c = 1; aq. 
HC1); CHN analysis (calcd %) C, 59.45; H, 4.99; N , 12.61; (found %) C, 58.85; H, 5.19; N , 
12.50 
(Lit.: 'H N M R " (300 MHz, M e O H - c^) 5 3.14 (Z/p), 3.84 (//„), 6.87 (ind/76), 7.21 (ind//2), 
7.27 (ind/77), 7.33 (ind/74), 1 3 C NMR" (60 MHz, M e O H - d^ 5 104.2 (indC4), 109.8 
(indC3), 110.9 (indC6), 113.2 (indC7), 127.2 (indC2), 128.9 (indC3a), 134.9 (indC7a), 159.1 
(indC5); Mp.: 275-276 ° C 1 2 ; [ a ] d 2 0 : +5.6° (0.98 g/100 ml; aq. HC1) 1 2) 
5-Chloro-Z-tryptophan (2b) 
Using the general method above (§4.3.1 .b), the title compound was synthesised as a white 
crystalline powder. 
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'H NMR (500 MHz, MeOH - d,): 5 3.14 (dd, J = 9.0, 15.0 Hz, 1H), 3.43 (dd, J = 4.0, 
15.0 Hz, / / p , 1H), 3.83 (dd, J = 4.5, 9.0 Hz, Ha, 1H), 7.07 (d, J = 2.0, 9.0 Hz, ind//6, 1H), 
7.25 (s, ind//2, 1H), 7.32 (d, J= 9.0 Hz, ind//7, 1H), 7.73 (d, J= 2.0 Hz, ind/74, 1H); , 3 C 
NMR (100 MHz, MeOH - d j ) : 5 28.22 (Cp), 57.9 (C a ) , 109.47 (indC3), 113.64 (indC4), 
118.95 (indC7), 122.87 (indC6), 126.00 (indC2), 126.94 (indC3a), 129.68 (indC7a), 136.71 
(indC5), 174.36 (COOH); MS (ES+): 239.1 (100%) [m 3 5 Cl + H ] + , 241.1 (36%) [m 3 7 Cl + H ] + ; 
Mp.: 272-275 °C, [a] d 2 5 : +23.2° (c = 1; aq. HC1); C H N analysis (calcd %) C, 55.36; H, 4.65; 
N , 14.85; (found % ) C, 54.82; H, 4.79; N , 14.71 
(Lit.: 'H N M R 1 3 (300 MHz, MeOD) 5 2.90 (Ha), 3.26 ( / / p ) , 3.54 (//p), 7.05 (ind//6), 7.20 
(ind/72), 7.31 (indi/7), 7.73 (ind//4); MS (EI) m/e 238 [ m ] + , 240 [ m ] + ; Mp.: 268-270 ° C 1 4 ; 
[al d 2 0 :+21.8° (1.00g/100 ml; aq. HC1) 1 4) 
5-Bromo-Z,-tryptophan (2c) 
Using the general method above (§4.3.1 .b), the title compound was synthesised as a sand-
coloured powder. 
'H NMR (400 MHz, MeOH - CI4): 5 3.08 (dd, J = 8.8, 15.4 Hz, //p, 1H), 3.43 (dd, J = 4.0, 
15.4 Hz, / / p , 1H), 3.80 (dd, J = 4.4, 9.2 Hz, Ha, 1H), 7.19 (d, J= 2.0 Hz, ind/76, 1H), 7.21 
(m, ind//2, 1H), 7.28 (d, J = 8.8 Hz, ind/77, 1H), 7.90 (d, J = 1.6 Hz, indtf4, 1H); MS (ES+): 
m/e 283.0 (46%) [ m 7 9 B r + H ] \ 285.1 (44%) [ m 8 l B r + H ] + , 305.1 (100%) [m 7 9 Br+Na] + , 307.1 
(95%) [m 8 l Br+Na] + ; Mp.: 281-283 °C, [al d 2 5 : +34.3° (c = 1; aq. HC1); C H N analysis (calcd 
%) C, 46.66; H, 3.92; N , 9.89; (found %) C, 46.27; H, 4.23; N , 9.80 
(Li t . 7 Mp.: 288-291 °C; [a] d 2 0 : +31.8° (1.0 g/100 ml; aq. HC1)) 
5-Iodo-Z--tryptophan (2d) 
Using the general method above (§4.3.1 .b), the title compound was synthesised as a 
yellowish-white crystalline powder. 
'H NMR (500 MHz, MeOH - d j ) : 5 3.11 (dd, J = 9.0, 15.0 Hz, Hp, 1H), 3.43 (dd, J = 4.0, 
15.0 Hz, tfp, 1H), 3.83 (dd, J = 4.0, 9.0 Hz, Ha, 1H), 7.18 (d,J= 2.0 Hz, indtf6, 1H), 7.19 (s, 
\ndH2, 1H), 7.36 ( d d , y - 2 . 0 , 9.0 Hz, indr77, 1H), 8.09 (d,J= 1.5 Hz, ind//4, 1H); , 3 C NMR 
(100 MHz, MeOH - d 4): 5 28.20 (Cp), 56.56 (C a ) , 83.13 (indC3), 109.10 (indC4), 114.59 
(indC7), 126.35 (indC6), 128.43 (indC2), 130.00 (indC3a), 131.06 (indC7a), 137.36 (indC5), 
174.40 (COOH); MS (ES+): m/e 331.1 (100%) [m+H] + ; Mp.: 170-172 °C, [a] d 2 5 : +40.4° 
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(c = 1; aq. HC1); C H N analysis (calcd % ) C, 40.02; H, 3.36; N , 8.49; (found % ) C, 39.72; H, 
3.51; N , 8.40 
( L i t . 1 5 Mp.: 165-166 °C; | a l d 2 0 : -12.3° (1.08 g/100 ml; CF 3 C0 2 H)) 
5-Methyl-Z,-tryptophan (2e) 
Using the general method above (§4.3.1 .b), the title compound was synthesised as fine white 
needle-like crystals. 
'H NMR (300 MHz, MeOH - d 4 ) : 5 2.42 (s, C// 3 -Ar, 3H), 3.09 (dd, J = 9.0, 15.2 Hz, 
tfp.lH), 3.49 (dd, J =4 .5 , 15.2 Hz, 7/p, 1H), 3.84 (dd, J = 4.5, 9.3 Hz, / / a , l H ) , 6.94 (d, J = 
4.8 Hz, ind//6, 1H), 7.13 (s, indrY2, 1H), 7.23 (d, J = 4.8 Hz, mdHl, 1H), 7.50 (s, indr74, 
1H); 1 3 C NMR (125 MHz, MeOH - oU): 5 21.64 (CH 3 -Ar) , 28.54 (Cp), 56.74 (C a ) , 109.08 
(indC3), 112.15 (indC4), 118.95 (indC7), 124.39 (indC6), 125.18 (indC2), 128.68 (indC5), 
129.26 (indC3a), 136.77 (indC7a), 174.45 (COOH); MS (ES+): 219.1 (100%) [m+H] + , Mp.: 
280-283 °C; [ a ] d 2 5 : +9.4° (c = 1.0; aq. HC1); C H N analysis (calcd % ) C, 66.04; H, 6.47; N , 
12.84; (found %) C, 65.81; H, 6.53; N , 12.77 
(Lit.: 'H N M R 1 6 (300 MHz, MeOD) 5 2.43 (Cr7 3-Ar), 2.85 (tfp), 3.32 ( / / p ) , 3.57 (Ha), 6.94 
(ind//6), 7.09 (ind//2), 7.25 (ind//7), 7.51 (ind//4); MS (EI) m/e 218 [ M + ] 1 2 ; Mp.: 275-
277 ° C 1 4 ; ( a ] d 2 5 : +10.6° (1.00 g/100 ml; aq. HC1) 1 4) 
5-Methoxy-L-tryptophan (2f) 
Using the general method above (§4.3.1 .b), the title compound was synthesised as a brown 
powder. 
'H NMR (400 MHz, MeOH - dU): 5 3.10 (dd, J = 5.6, 15.2 Hz, //p, 1H), 3.47 (dd, J = 3.6, 
15.2 Hz, % 1H), 3.83 (dd, J = 4.5, 9.3 Hz, Ha. 1H), 3.83 (s, C # 3 0 - A r , 1H), 6.76 (dd, J = 2.4, 
8.8 Hz, ind//6, 1H), 7.15 (s, ind//2, 1H), 7.23 (d,J= 0.8 Hz, ind/77, 1H), 7.24 (d,J= 4.8 Hz, 
indrY4, 1H); 1 3 C NMR (100 MHz, MeOH - 0%): 5 28.62 (Cp), 56.25 (CH 3 0-Ar) , 56.51 (C a ) , 
101.09 (indC3), 109.34 (indC4), 113.13 (indC7), 113.24 (indC6), 125.85 (indC2), 128.73 
(indC3a), 133.53 (indC7a), 155.36 (indC5), 174.63 (COOH); MS (ES+): m/e 234.1 (100%) 
[m+H] + ; Mp.: 253-256 °C, [ a ] d 2 5 : -33.7° (c = 1.0; H 2 0 ) ; C H N analysis (calcd %) C, 61.53; 
H, 6.02; N , 11.96; (found %) C, 61.34; H, 6.11; N , 11.93 
(L i t . 1 4 Mp.: 250-252 °C; [ a ] d 2 0 : -28.9° (c = 1.0; H 2 0 ) ) 
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5-Nitro-L-tryptophan (2g) 
Using the general method above (§4.3.1 .b), the title compound was synthesised as a bright 
yellow crystalline powder. 
'H NMR (500 MHz, MeOH - tU): 5 3.27 (dd, 1H, J = 8.5, 15.5 Hz), 3.50 (dd, 1H, J = 4.0, 
15.5 Hz), 3.88 (dd, 3H, J = 4.5, 8.5 Hz), 7.42 (s, 1H), 7.45 (s, 1H), 8.04 (d, 1H, J = 9.0 Hz), 
8.78 (d, 1H, J = 2.0 Hz); 1 3 C NMR (125 MHz, MeOH - d 4): 5 27.91 (Cp), 56.52 (C a ) , 110.56 
(indC3), 112.56 (indC4), 117.09 (indC7), 118.14 (indC6), 126.70 (indC2), 128.07 (indC3a), 
129.02 (indC7a), 142.71 (indC5), 174.08 (COOH); MS (ES+): m/e 250.2 (100%) [m+H] + ; 
Mp.: 267-269 °C, [ a j d 2 5 : +45.4° (c = 1.0; aq. HC1); C H N analysis (calcd %) C, 53.01; H, 
4.45; N , 16.86; (found %) C, 52.95; H, 4.49; N , 16.84 
( L i t . 1 4 Mp.: 266-268 °C; [a] d 2 0 :49.1° (1.0 g/100 ml; aq. HC1)) 
4.4.1.f 6-substitutecl L-tryptophan derivatives (2h-nt) 
No. Substituent Yield (%) 
2h R = F 67 0 
2i R=C1 54 
H 2 N . 
2j R = Br 99 
2k R = Me 94 
21 R = MeO 65 N 
2m R = N 0 2 72 
H 
Table 4.6: Table o f 6-L-tryptophan derivatives that were produced via enzymatic resolution of the parent / V -
Ac-6-R-D,Z.-tryptophan compound (Ih-m). 
6-Fluoro-Z,-tryptophan (2h) 
Using the general method above (§4.3.1 .b), the title compound was synthesised as a pinkish-
white crystalline powder. 
' H NMR (400 MHz, MeOH - d 4): 5 3.11 (dd, J - 9.2, 15.6 Hz, Hp, 1H), 3.45 (dd, J = 4.4, 
15.6 Hz, Hp, 1H), 3.80 (dd, J = 4.0, 9.2 Hz, Ha, 1H), 6.82 (dt, J = 2.0, 6.1 Hz, ind//5, 1H), 
7.04 (dd, J = 2.4, 10.0 Hz, indr77, 1H), 7.17 (s, indrY2, 1H), 7.65 (dd, J= 5.2, 8.8 Hz, indf/4, 
1H); 1 3 C NMR (100 MHz, MeOH - d 4): 5 28.69 (Cp), 56.67 (C a ) , 98.34 (indC7), 108.36 
(indC5), 108.61 (indC3), 120.35 (indC4), 125.26 (indC3a), 125.62 (indC2), 135.26 (indC7a), 
161.45 (indC6), 174.91 (COOH); MS (ES+): m/e 235.1 (100%) [m+H] + ; Mp.: 262-265 °C, 
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[ a l d 2 5 : -17.7° (c = 1.0; H 2 0 ) ; C H N analysis (calcd % ) C, 59.45; H, 4.99; N , 12.61; (found %) 
C, 59.27; H, 5.11; N , 12.57 
(Lit.: 'H N M R ' 6 (300 MHz, MeOH - cU): 5 3.13 (Hp), 3.47 (Hp), 3.84 (Ha), 6.82 (ind/75), 
7.05 (ind/77), 7.17 (ind/72), 7.64 (ind/74); , 3 C NMR (60 MHz, MeOH - d^ : 5 98.3 (indC7), 
108.5 (indC5), 109.8 (indC3), 120.4 (indC4), 125.2 (indC3a), 125.6 (indC2), 138.3 (indC 
7a), 161.4(indC6);Mp.: 255-258 ° C 1 7 ; [ a ] D 2 0 : -19.5° (c = 1.0, H 2 0 ) 1 7 ) 
6-Chloro-I-tryptophan (2i) 
Using the general method above (§4.3.1 .b), the title compound was synthesised as a white 
crystalline powder. 
'H NMR (400 MHz, MeOH - oU): 5 3.15 (dd, 7 = 9.2, 15.6 Hz, Hp, 1H), 3.46 (dd, 7 = 4.0, 
15.6 Hz, Hp, 1H), 3.82 (dd, 1 H , 7 = 4 . 0 , 9.2 Hz), 7.00 (dd, 1H, 7 = 2 . 0 , 8.8 Hz), 7.21 (s, 1H), 
7.35 (d, 1H, 7 = 1.6 Hz), 7.65 (d, 1H, 7 = 8.4 Hz); , 3 C NMR (100 MHz, MeOH - cU): 5 
28.26 (C p ) , 56.58 (C a ) , 110.02 (indC7), 115.26 (indC3), 116.18 (indC4), 120.96 (indC6), 
123.21 (indC2), 126.09 (indC3a), 127.53 (indC5), 139.19 (indC7a), 174.28 (COOH); MS 
(ES+): m/e 239 (100%) [m 3 5 Cl + H ] + , 241.0 (36%) [m 3 7 Cl + H ] + , Mp.: 270-273 °C; [ a ]„ 2 5 : -
25.4° ( c = 1.0, MeOH); C H N analysis (calcd %) C, 55.36; H, 4.65; N , 14.85; (found %) C, 
55.22; H, 4.68; N , 14.83 
(Lit.: 'H N M R 1 3 (300 MHz, MeOH - d 4): 5 2.93, 3.27, 3.55, 6.99, 7.18, 7.35, 7.67; , 3 C 
N M R 1 3 (60 MHz, MeOH - cU): 5 32.5, 57.9, 111.9, 112.9, 120.9, 125.5, 127.8, 128.2, 138.5, 
182.2; MS: m/e (EI) 238.0 [ m + ] l s ; Mp.: 264-265 °C (D-isomer) 1 9; [ c t ] D 2 3 : 28° (c = 1.0, 
MeOH) (D-isomer) 1 9) 
6-Bromo-7-tryptophan (2j) 
Using the general method above (§4.3.1 .b), the title compound was synthesised as a pinkish-
white crystalline powder. 
'H NMR (400 MHz, MeOH - cU): 5 3.15 (dd, 7 = 7.2, 12.4 Hz, Hp, 1H), 3.46 (dd, 7 = 3.2, 
12.4 Hz, Hp, 1H), 3.82 (dd, J= 3.6, 7.2 Hz, Ha, 1H), 7.14 (dd, J = 1.2, 6.8 Hz, ind/75, 1H), 
7.19 (s, ind/77, 1H), 7.52 (d, 7 = 1.2 Hz, ind/72, 1H), 7.61 (d, 7 = 6.8 Hz, ind/74, 1H); 1 3 C 
NMR (100 MHz, MeOH - CI4): 5 28.21 (Cp), 56.49 (C a ) , 109.89 (indC3), 112.22 (indC4), 
120.54 (indC3), 120.60 (indC6), 126.31 (indC2), 127.23 (indC3a), 128.59 (indC5), 138.68 
(indC7a), 174.57 (COOH); MS (ES+): m/e 283.2 (100%) [ m 7 9 B r + H ] 4 , 285.2 (95%) 
187 
[ m 8 I B r + H ] + ; Mp.: 120-122 °C; [ a ] D 2 5 : -11.3° (c = 0.38, AcOH); C H N analysis (calcd %) C, 
46.66; H, 3.92; N , 9.89; (found % ) C, 46.56; H, 3.96; N , 9.87 
(Lit. Mp.: 125-127 °C 1 ; [a] D 2 0 : -12.1 ° (c = 0.38, AcOH) 2 0 ) 
6-Methyl-I-tryptophan (2k) 
Using the general method above (§4.3.1 .b), the title compound was synthesised as an orange-
white crystalline powder. 
'H NMR (400 MHz, MeOH - cU): 5 3.08 (dd, J = 8.0, 12.0 Hz, Hp, 1H), 3.34 (s, Ar -C/ / 3 , 
3H), 3.48 (dd, J = 2.8, 12.0 Hz, Hp, 1H), 3.83 (dd, J= 3.2, 7.6 Hz, Ha, 1H), 6.88 (d,J = 6.4 
Hz, ind//5, 1H), 7.10 (s, ind//7, 1H), 7.15 (s, ind//2, 1H), 7.57 (d, J = 6.4 Hz, indr74, 1H); 
, 3 C NMR (125 MHz, MeOH - cLJ: 5 21.79 (Ar-CH 3 ) , 28.57 (Cp), 56.68 (Ca), 109.41 
(indC7), 112.29 (indC3), 119.07 (indC4), 121.87 (indC5), 124.48 (indC2), 126.39 (indC3a), 
132.47 (indC7a), 138.87 (indC6), 174.48 (COOH); MS (ES+): m/e 219.1 (13%) [m+H] + , 
241.1 (100%) [m+Na] + ; Mp.: 290-293 °C; [ a ] D 2 5 : -18.4° (c = 0.4, MeOH); C H N analysis 
(calcd %) C, 66.04; H, 6.47; N , 12.84; (found %) C, 65.96; H, 6.50; N , 12.81 
(Lit.: 'H N M R 2 1 (300 MHz, MeOH - cLJ: 5 2.43, 2.88, 3.31, 3.56, 6.86, 7.06, 7.14, 7.58; 1 3 C 
NMR (60 MHz, MeOH - d 4): 5 112.0 (indC7), 112.3 (indC3), 119.4 (indC4), 121.4 (indC5), 
124.8 (indC2), 127.0 (indC3a), 131.7 (indC7a); Mp.: 286 °C (D-isomer)9; [ a ] D 2 5 : 19.8° 
(c = 0.4, MeOH) (/J-isomer)9) 
6-Methoxy-L-tryptophan (21) 
Using the general method above (§4.3.1 .b), the title compound was synthesised as white 
planar crystals. 
'H NMR (400 MHz, MeOH - dU): 5 3.11 (dd, J = 6.0, 15.2 Hz, Hp, 1H), 3.44 (dd, J = 4.0, 
15.2 Hz, Hp, 1H), 3.79 (s, Ar-OCtf 3 , 3H), 3.80-3.84 (m, Ha, 1H), 6.76 (dd, J = 2.4, 8.4 Hz, 
indf/5, 1H), 6.86 (s, indrV7, 1H), 7.24 (d, J = 0.8 Hz, ind//2, 1H), 7.26 (d, J = 4.8 Hz, ind//4, 
1H); 1 3 C NMR (100 MHz, MeOH - dk): 5 28.85 (Cp), 55.21 (C a ) , 58.24 (Ar-OCH 3 ) , 101.15 
(indC7), 109.40 (indC3), 113.18 (indC4), 113.27 (indC5), 125.83 (indC2), 128.76 (indC3a), 
133.52 (indC7a), 155.46 (indC6), 174.65 (COOH); MS (ES+): m/e 235.2 (100%) [m+H] + , 
259.2 [m+Na] + ; Mp.: 264-268 °C; [a][>25: -23.7° (c = 0.1, MeOH); C H N analysis (calcd % ) 
C, 61.53; H, 6.02; N , 11.96; (found %) C, 62.04; H, 6.25; N , 12.03 
(L i t . 9 Mp.: 263 -268 °C) 
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6-Nitro-L-tryptophan (2m) 
Using the general method above (§4.3.1 .b), the title compound was synthesised as a dark-
yellow crystalline powder. 
'H NMR (400 MHz, MeOH - oV,): 5 3.09 (dd, J = 5.6, 15.2 Hz, Hp, 1H), 3.42 (dd, J= 5.2, 
15.2 Hz, Hp, 1H), 3.86 (dd, J= 5.6, 8.4 Hz, Ha, 1H), 7.15 (d, J= 0.8 Hz, ind//2, 1H), 7.44 (d, 
J = 4 . 8 Hz, indi/4, 1H), 8.01 (dd, J= 2.0, 8.4 Hz, ind/75, 1H), 8.11 (s, ind//7, 1H); , 3 C NMR 
(100 MHz, MeOH - cU): 5 30.10 (Cp), 56.83 (C«), 105.46 (indC7), 111.26 (indC3), 116.17 
(indC5), 119.48 (indC4), 123.83 (indC2), 130.17 (indC6), 130.92 (indC3a), 135.79 (indC7a), 
174.75 (COOH); MS (ES+): m/e 235.2 (12%) [m+H] + , 259.2 (100%) [m+Na] + , Mp.: 270 °C; 
| a | D 2 5 : -21.6° (c = 0.1, MeOH); C H N analysis (calcd %) C, 53.01; H, 4.45; N , 16.86; (found 
%) C, 52.96; H, 4.48; N , 16.84 
(L i t . 2 2 Mp.: 265 °C (dec.)) 
4.4.I.g 5-substituted I^-acetyl-L-tryptophan derivatives (4n, 4f, 4g) 
A^-Acetyl-L-tryptophan (4n) 
Using the general method above (§4.3.1 .c), the title compound was synthesised as a 
yellowish-white crystalline powder. 
' H NMR (400 MHz, MeOH - cL): 5 1.91 (s, AcC/ / 3 , 3H), 3.13 (dd, J = 8.0, 15.2 Hz, Hp, 
1H), 3.30 (dd, J = 4.8, 15.2 Hz, Hp, 1H), 3.81 (dd, J =5.2 , 8.0 Hz, Ha, 1H), 6.97 (t, 7 = 2 . 4 
Hz, ind/75, 1H), 7.13 (t, J =2.4 Hz, ind//6, 1H), 7.18 (d, J = 1.2 Hz, indr72, 1H), 7.34 (d , J = 
2.4 Hz, ind//7, 1H), 7.58 (dd, J = 2.4, 4.8 Hz, indrY4, 1H); , 3 C NMR (100 MHz, MeOH -
dU): 5 21.89 (AcCH 3 ) , 29.14 (Cp), 56.13 (C„), 109.82 (indC3), 111.35 (indC7), 117.22 
(indC4), 119.46 (indC6), 122.75 (indC5), 123.40 (indC2), 127.67 (indC3a), 135.20 (indC7a), 
174.80 (COOH); MS (ES+): m/e 247.2 (14%) [m+H] + , 270.2 (100%) [m+Na] + , Mp.: 178-
181 °C; [ a ] D 2 5 : +24.7° (c = 1.00, MeOH) 
(Lit. Mp.: 2 3 174-179 °C , [ a ] D 2 0 : +26.0° (c = 1.00, MeOH) 2 4 ) 
A^-Acetyl-S-methoxy-L-tryptophan (4f) 
Using the general method above (§4.3.1 .c), the title compound was synthesised as a light-
brown crystalline powder. 
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'H NMR (400 MHz, MeOH - d 4): 5 1.91 (s, AcC/ / 3 , 3H), 3.12 (dd, J = 8.0, 14.8 Hz, Hp, 
1H), 3.30 (dd, J = 4.8, 14.8 Hz, / / p , 1H), 3.81 (s, Ar-OC// 3 , 3H), 4.69 (dd, J = 5.2, 8.0 Hz, 
Ha, 1H), 6.74 (dd, J= 2.4, 8.8 Hz, indf/6, 1H), 7.05 (s, ind//2 & ind/f7, 2H), 7.20 ( d , J = 8.8 
Hz, ind//4, 1H); l 3 C NMR (100 MHz, MeOH - d,): 5 20.75 (AcCH 3 ) , 28.52 (Cp), 54.73 
(Ca), 56.24 (Ar-OCH 3 ) , 101.10 (indC7), 110.81 (indC3), 112.72 (indC4), 122.34 (indC5), 
125.07 (indC2), 129.17 (indC3a), 133.22 (indC7a), 155.08 (indC6), 173.19 (AcCO), 175.28 
(COOH); MS (ES+): m/e 276.2 (15%) [m+H] + , 298.2 (100%) [m+Na] + ; [ a ] D 2 5 : 14.2° 
( c = 1.22, MeOH) 
( L i t . 1 4 [ a l D 1 6 : 16° ( c = 1.22, MeOH)) 
A^-Acetyl-5-nitro-Z,-tryptophan (4g) 
Using the general method above (§4.3.1 .c), the title compound was synthesised as a yellow 
crystalline powder. 
' H NMR (400 MHz, MeOH - d 4): 5 1.92 (s, AcC/ / 3 , 3H), 3.15 (dd, J = 8.4, 14.8 Hz, / / p , 
1H), 3.31 (dd, .7=5.2, 14.8 Hz, % 1H). 4.65 (dd, .7=5.6, 8.4 Hz, Ha, 1H), 7.19 (dd, J= 2.4, 
8.8 Hz, ind//6, 1H), 7.45 ( d , 7 = 2.4 Hz, ind//2, 1H), 8.08 (s, ind//4, 1H), 8.13 (d, J = 8.8 Hz, 
ind//7, 1H); l 3 C NMR (100 MHz, CDC13): 5 23.74 (AcCH 3 ) , 29.97 (Cp), 55.18 (C„), 109.79 
(indC7), 112.15 (indC3), 114.60 (indC4), 122.52 (indC5), 125.78 (indC2), 129.12 (indC3a), 
132.72 (indC7a), 144.16 (indC6), 171.67 (AcCO), 174.44 (COOH); MS (ES+): m/e 314.1 
(100%) [ m + N a f 
The remaining A^-acetylated tryptophan derivatives were not further analyzed. This was 
justified as the most electron-rich and the most electron deficient tryptophan derivatives both 
reacted successfully in this standard acetylation. The electron density is not thought to have a 
strong impact on the reaction as the reaction takes place at the rather remote position. 
4.4. l.h 5-subsituted frf-acetyl-L-tryptophan methyl ester derivatives (5a, 5f+g, 5n) 
A^-Acetyl-L-tryptophan methyl ester (5n) 
Using the general method above (§4.3.1 .d), the title compound was synthesised as a light-
brown crystalline powder. 
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'H NMR (500 MHz, MeOH - dU): 5 1.91 (s, AcCW 3, 3H), 3.14 (dd, J = 8.0, 14.5 Hz, / / 3 , 
1H), 3.27 (dd, J = 6.0, 14.5 Hz, //p, 1H), 3.64 (s, Ax-CH3, 3H), 4.71 (dd, J= 6.0, 7.5 Hz, Ha, 
1H), 7.00 ( d t , y = 1.0, 7.5 Hz, ind//6, 1H), 7.08 (dt, J= 1.0, 7.5 Hz, ind//2, 1H), 7.31 (d,J = 
8.0 Hz, ind//7, 1H), 7.50 (d, J= 8.0 Hz, ind//4, 1H); 1 3 C NMR (125 MHz, MeOH - d*): 5 
22.31 (COOCH 3), 28.50 (Cp), 52.64 (AcCH 3 ) , 55.02 (C a ) , 110.73 (indC3), 112.30 (indC4), 
119.09 (indC7), 119.80 (indC6), 122.43 (indC2), 124.32 (indC5), 128.72 (indC3a), 138.04 
(indC7a), 173.21 (AcCO), 174.05 (COOH); Mp.: 144 °C; CHN: 63.40% C, 5.73% H, 
11.38% N (theoretical 62.04% C, 5.87% H, 11.03% N) 
( L i t . 2 5 Mp.: 155-156 °C), R f: 0.52 (using EtOH 5% v/v in CHC13) 
A^-Acetyl-S-fluoro-L-tryptophan methyl ester (5a) 
Using the general method above (§4.3.1 .d), the title compound was synthesised as a light-
brown crystalline powder. 
'H NMR (500 MHz, CDCI3): 5 1.97 (s, AcC/ / 3 , 3H), 3.23 (dd, J = 5.0, 15.0 Hz, //p, 1H), 
3.28 (dd, J= 5.5, 15.0 Hz, / / 3 , 1H), 3.69 (s, COOC//3, 3H), 4.92 (quart, J = 5.5, 15.0 Hz, Ha, 
1H), 6.12 (d, J = 7.0 Hz, AcNH, 1H), 6.92 (dt, J= 2.5, 9.0 Hz, ind//6, 1H), 7.00 (d, J = 2.5 
Hz, ind//2, 1H), 7.13 (dd, J= 2.5, 10.0 Hz, ind//4, 1H), 7.24 (t, J = 4.5 Hz, ind//7, 1H), 8.46 
(s, br, indN// , 1H); l 3 C NMR (125 MHz, CDCI3): 5 23.16 (AcCH 3 ) , 27.60 (Cp), 52.41 
(COOCH3), 52.95 (C a ) , 103.44 (indC3), 110.13 (indC4), 110.49 (indC7), 112.017 (indC6), 
124.55 (indC2), 128.07 (indC3a), 132.57 (indC7a), 158.84 (indC5), 169.88 (AcCO), 172.33 
(COOH); MS (ES+): m/e 279.1 (14%) [m+H] + , 301.1 (100%) [m+Na] + ; R f : 0.68 (using 
EtOH 5% v/v in DCM) 
A / a-Acetyl-5-methoxy-Z.-tryptophan methyl ester (5f) 
Using the general method above (§4.3.1 .d), the title compound was synthesised as a brown 
crystalline powder. 
'H NMR (400 MHz, CDCI3): 5 1.98 (s, AcC7/ 3, 3H), 3.24-3.34 (m, Hp, 2H), 3.71 (s, AcC/ / 3 , 
3H), 3.82 (s, A r - O C # 3 , 3H), 4.95 (dd, J= 2.4, 6.8 Hz, Ha, 1H), 6.02 (d, J= 8.8 Hz, AcN/ / , 
1H), 6.86 (dd, J = 2.4, 8.8 Hz, \ndH6, 1H), 6.95 (d, J= 2.4 Hz, ind//2, 1H), 6.98 (d, J= 2.4 
Hz, ind//4, 1H), 7.24 (d, J = 8.8 Hz, ind//7, lH), 8.01 (s, br, indN// , 1H); 1 3 C NMR (100 
MHz, CDCI3): 5 25.30 (AcCH 3 ) , 29.61 (Cp), 54.40 (COOCH3), 55.00 (C a ) , 56.57 (Ar-
OCH3), 102.13 (indC3), 111.85 (indC4), 114.01 (indC7), 114.68 (indC6), 125.33 (indC2), 
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130.14(indC3a), 133.18 (indC7a), 156.29 (indC5), 171.75 (AcCO), 174.42 (COOH); MS 
(ES+): m/e 291.1 (9%) [m+H] + , 313.1 (100%) [m+Na] + ; R f : 0.52 (using EtOH 5% v/v in 
DCM) 
A^-Acetyl-5-nitro-Z,-tryptophan methyl ester (5g) 
Using the general method above (§4.3.1 .d), the title compound was synthesised as a yellow 
crystalline powder. 
'H NMR (400 MHz, CDC13): 5 1.97 (s, AcC/ / 3 , 3H), 3.22-3.32 (m, //p, 2H), 3.68 (s, AcC/ / 3 , 
3H), 4.96 (dd, J= 2.4, 6.8 Hz, Ha, 1H), 7.18 (d, J = 8.8 Hz, A c N / / , 1H), 7.38 (dd, J = 2.4, 
8.8 Hz, ind//6, 1H), 7.44 (d, J = 2.4 Hz, ind//2, 1H), 8.05 (s, ind//4, 1H), 8.11 (d, J = 8.8 Hz, 
ind//7, 1H), 8.33 (s, br, indN// , 1H); 1 3 C NMR (100 MHz, CDCI3): 5 23.98 (AcCH 3 ) , 30.01 
(Cp), 52.43 (COOCH3), 54.81 (C a ) , 109.74 (indC3), 112.11 (indC4), 114.57 (indC7), 122.43 
(indC6), 125.87 (indC2), 129.15 (indC3a), 132.68 (indC7a), 144.13 (indC5), 171.64 (AcCO), 
174.43 (COOH); MS (ES+): m/e 306.1 (11%) [m+H] + , 328.1 (100%) [m+Na] + ; R f : 0.42 
(using EtOH 5% v/v in DCM) 
The remaining A^-acetylated tryptophan methyl esters were not further analyzed but used 
directly for the ethyl amidation. 
4.4. Li 5-substituted hf-acetyl-L-tryptophan ethyl amide derivatives (611, 6a-g) 
A^-Acetyl-L-tryptophan ethyl amide (6n) 
Using the general method above (§4.3.1 .e), the title compound was synthesised as a cream-
coloured crystalline powder. 
'H NMR (200 MHz, CDCI3): 5 0.85 (t, J =7.4 Hz, C / / 3 CH 2 N, 3H), 1.96 (s, AcC// 3 , 3H), 
3.02 - 3.13 (m, C H 3 C / / 2 N & l / / p , 3H), 3.27 (dd, J = 5.2, 14.2 Hz, //p, 1H), 4.65 (quart., J = 
5.2 Hz, Ha, 1H), 5.55 (s, br, E fN/ / , 1H), 6.46 (d, J= 5.2 Hz, AcN/ / , 1H), 7.02 (d, J= 2.4 Hz, 
ind//2, 1H), 7.10 (dt, J= 1.2, 7.0 Hz, ind//5, 1H), 7.18 (dt, J= 1.2, 7.0 Hz, ind//6, 1H), 7.34 
(d, J = 7.2 Hz, ind//4, 1H), 7.68 (d, J = 7.2 Hz, indtf7, 1H), 8.26 (s, br, indN// , 1H); 1 3 C 
NMR (125 MHz, MeOH - d^: 5 14.81 (NCH 2 CH 3 ) , 22.56 (AcCH 3 ) , 30.12 (Cp), 54.25 
(NCH2CH3), 54.71 (C a ) , 110.73 (indC3), 111.38 (indC4), 119.09 (indC5), 119.82 (indC6), 
122.45, 124.30, 128.75, 138.07, 173.25 (AcCO), 174.07 (CONEt); MS (ES+): m/e 296.1 
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(100%) [m+Na] + ; HRMS (FT-MS) calcd for C s H i g N ^ N a , : 296.1370, found: 296.1372; 
Mp.: 160-162 °C; [ a ] d 2 5 : (MeOH, c = 0.7) +4.1°; R f: 0.41(using MeOH 10% v/v in DCM) 
A^-Acetyl-5-fluoro-L-tryptophan ethyl amide (6a) 
' H NMR (500 MHz, CDC13): 5 0.87 (t, J = 7.5 Hz, C / / 3 CH 2 N, 3H), 2.00 (s, AcC/ / 3 , 3H), 
3.01 (dd, 7 = 9 . 5 , 14.5 H z , / / p , 1H), 3.04-3.17 (m, C H 3 C / / 2 N , 2H), 3.28 (dd, J = 5 . 0 , 14.5 Hz, 
Hp, 1H), 3.87 (3H, s), 4.60-4.65 (m, Ha, 1H), 5.39 (s, br, EfN/ / , 1H), 6.39 (d, J = 7.5 Hz, 
AcN/ / , 1H), 6.85 (dd,J = 2.5, 9.0 Hz, ind//6, 1H), 7.01 ( d , J = 2 . 5 H z , ind//2, 1H), 7.22 (d, J 
= 2.5 Hz, ind//4, 1H), 7.24 (d, J = 9.0 Hz, ind//7, 1H), 8.00 (s, br, indN// , 1H); , 3 C NMR 
(100 MHz, CDCI3): 5 16.43 (NCH 2 CH 3 ) , 25.36 (AcCH 3 ) , 30.96 (C p ) , 54.34 (C a ) , 55.81 
(NCH 2 CH 3 ) , 102.28 (indC3), 112.88 (indC4), 114.01 (indC7), 115.01 (indC6), 125.58 
(indC2), 130.14 (indC3a), 133.17 (indC7a), 156.35 (indC5), 170.56 (AcCO), 172.87 
(CONEt); MS (ES+): >w/<? 314.1 (100) [m+Na] + , 314.1 (17) [m+Na] + ; H R M S (FT-MS) calcd 
for C | 5 H , 9 N 3 0 2 F | N a i : 314.1277, found: 312.1275; Mp.: 190-195 °C (dec); [ a ] d 2 5 : (MeOH, 
c = 0.1) +29.8°; R f: 0.39 (using EtOH 5% v/v in DCM) 
A^-Acetyl-5-chloro-L-tryptophan ethyl amide (6b) 
' H NMR (500 MHz, CDC13): 5 0.90 (t, J = 7.5 Hz, C / / 3 CH 2 N, 3H), 2.01 (s, AcC/ / 3 , 3H), 
3.00-3.14 (m, C H 3 C / / 2 N & l / / p , 3H), 3.32 (dd, J = 9.5, 14.5 Hz, / / p , 1H), 4.95 (quart, J = 
5.5, 13.0 H z , / / a , 1H), 6.12 ( d , 7 = 7.5 Hz, AcN/ / , 1H), 7.01 ( d , J = 2 . 0 Hz, ind//2, 1H), 7.14 
(dd, J = 2.5, 9.0 Hz, ind//6 , 1H), 7.28 (d, J= 3.5, ind//4, 1H), 7.49 (d, J = 2.0 Hz, ind//7, 
1H), 8.45 (s, br, indN//, 1H); 1 3 C NMR (125 MHz, CDC13): 5 15.37 (NCH 2 CH 3 ) , 23.19 
(AcCH 3 ) , 27.53 (Cp), 52.44 (C a ) , 52.94 (NCH 2 CH 3 ) , 109.83 (indC3), 112.93 (indC4), 118.12 
(indC7), 122.48 (indC6), 124.16 (indC2), 125.42 (indC3a), 128.76 (indC7a), 134.40 (indC5), 
169.84 (AcCO), 172.25 (CONEt); MS (ES+): m/e 330.1 (100%) [m 3 5 Cl +Na] + , 331.1 (17%) 
[m 3 5 Cl +Na] + , 332.1 (33%) [m 3 7 Cl +Na] + , 333.1 (6%) [m 3 7 Cl +Na] + ; H R M S (FT-MS) calcd 
for C,5H 1 9 N 3 0 2 Cl |Na, : 330.0980, found: 330.0982; | a ] d 2 5 : (MeOH, c = 0.1) +24.3°; R f : 0.34 
(using EtOH 5% v/v in DCM) 
A^-Acetyl-S-bromo-Z-tryptophan ethyl amide (6c) 
'H NMR (500 MHz, CDC13): 8 0.93 (t, J= 7.5 Hz, C / / 3 CH 2 N, 3H), 1.98 (s, AcC/ / 3 , 3H), 
3.07-3.20 (m, C H 3 C / / 2 N & l / / p , 4H), 4.65 (dd, J= 7.5, 14.0 Hz, Ha, 1H), 5.98 (t, J = 6.0 
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Hz, EtN// , 1H), 6.56 (d, .7=8.0 Hz, AcN/ / , 1H), 7.03 ( d , J = 2 . 0 Hz, ind/76, 1H), 7.19-7.25 
(m, ind7/4 & ind7/7, 2H), 7.76 (s, ind//2, 1H), 8.47 (s, br, indN/7, 1H); , 3 C NMR (125 MHz, 
CDC13): 5 14.38 (NCH2CH3), 23.23 (AcCH 3 ) , 26.47 (Cp), 34.43 (NCH 2 CH 3 ) , 54.00 (C a ) , 
108.74 (indC3), 110.59 (indC4), 112.71 (indC7), 112.94 (indC6), 121.42 (indC2), 124.32 
(indC6), 129.20 (indC5), 131.85 (indC3a), 134.71 (indC7a), 170.21 (AcCO), 170.98 
(CONEt); HRMS (FT-MS) calcd for C i 5 H | 9 N 3 0 2 B r | N a i : 374.0475, found: 374.0473; l a ] d 2 5 : 
(MeOH, c = 0.1) +19.2°; R f : 0.36 (using EtOH 5% v/v in DCM) 
A^-Acetyl-S-iodo-L-tryptophan ethyl amide (6d) 
'H NMR (200 MHz, MeOH - d,): 5 0.94 (t, J= 7.2 Hz, C/7 3 CH 2 N, 3H), 1.94 (s, AcC/ / 3 , 
3H), 3.00-3.20 (m, C H 3 C / / 2 N & l / / p , 4H), 4.52 (t, J= 7.0 Hz, Ha, 1H), 7.08 (s, ind//2, 1H), 
7.14 (d, J= 8.6 Hz, ind//7, 1H), 7.34 (dd, J = 1.6, 8.6 Hz, ind//6, 1H), 7.93 (d, J = 1.6 Hz, 
ind774); , 3 C NMR (100 MHz, CDC13): 5 15.45 (NCH 2 CH 3 ) , 24.23 (AcCH 3 ) , 31.56 (Cp), 
35.65 (NCH 2 CH 3 ) , 54.17 (C a ) , 105.81 (indC3), 114.84 (indC4), 115.58 (indC7), 117.31 
(indC6), 123.64 (indC2), 126.44 (indC3a), 133.37 (indC7a), 136.35 (indC5), 170.39 (AcCO), 
171.11 (CONEt); MS (ES+): m/e 422.1 (100%) [m+Na] + ; H R M S (FT-MS) calcd for 
C i 5 H i 8 N 3 0 2 I | N a i : 422.0336, found: 422.0338; [ a ] d 2 5 : (MeOH, c = 0.5) +28.6°; R f : 0.40 
(using EtOH 5% v/v in DCM) 
A'a-Acetyl-5-methyl-Z,-tryptophan ethyl amide (6e) 
' H NMR (400 MHz, CDC13): 5 0.91 (t, J= 7.2 Hz, C/7 3 CH 2 N, 3H), 2.01 (s, AcC/ / 3 , 3H), 
2.47 (s, Ar -C/ / 3 ) , 3.00-3.12 (m, CH 3C77 2N & l / / p , 3H), 3.30 (dd, J= 5.2, 13.6 Hz, 77p, 1H), 
4.62-4.67 (m, Ha, 1H), 5.44 (s, br, EtN/ / , 1H), 6.34 (d, J = 6.8 Hz, AcN/ / , 1H), 7.03-7.05 (m, 
ind//6 & ind//7, 2H), 7.24-7.26 (m, ind//4, 1H), 7.51 (s, ind//2, 1H), 8.00 (s, br, indN// , 1H); 
, 3 C NMR (100 MHz, CDC13): 5 15.31 (NCH 2 CH 3 ) , 23.23 (Ar-CH 3 ) , 27.60 (AcCH 3 ) , 32.42 
(Cp), 53.06 (NCH 2 CH 3 ) , 55.85 (C a ) , 100.13 (indC3), 109.80 (indC4), 112.02 (indC7), 112.69 
(indC6), 123.34 (indC2), 128.14 (indC3a), 131.16 (indC7a), 154.32 (indC5), 170.01 (AcCO), 
172.35 (CONEt); MS (ES+): m/e 310.2 (100%) [m+Na] + ; H R M S (FT-MS) calcd for 
C | 6 H 2 1 N 3 0 2 N a , : 310.1526, found: 310.1528; Mp.: 228 °C; [ a ] d 2 5 : (MeOH, c = 0.4) +25.6 °; 
R f : 0.36 (using EtOH 5% v/v in DCM) 
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A^-Acetyl-S-methoxy-L-tryptophan ethyl amide (6f) 
'H NMR (400 MHz, CDCI3): 5 0.89 (t, J= 7.4 Hz, C / / 3 CH 2 N, 3H), 2.02 (s, AcC/ / 3 , 3H), 
3.03 (dd , J=9 .2 , 14.4 Hz,//p, 1H), 3.06-3.19 (m, C H 3 C / / 2 N , 2H), 3.30 (dd, J= 4.8, 14.4 Hz, 
//p, 1H), 3.89 (s, Ar-OC// 3 , 3H), 4.62-4.67 (m, / / a , 1H), 5.41 (s, br, EtNtf, 1H), 6.41 (d, J = 
12 Hz, A c N / / , 1H), 6.87 (dd, J= 2.4, 8.8 Hz, ind//6, 1H), 7.03 (d, J = 2.4 Hz, ind//2, 1H), 
7.24 (d, J = 2.4 Hz, ind//4, 1H), 7.26 (d,J= 8.8 Hz, ind//7, 1H), 8.02 (s, br, indN// , 1H); 1 3 C 
NMR (100 MHz, CDC13): 8 16.43 (NCH 2 CH 3 ) , 25.36 (AcCH 3 ) , 30.96 (Cp), 36.34 
(NCH 2 CH 3 ) , 54.34 (C«), 55.81 (Ar-OCH 3 ) , 102.28 (indC3), 112.88 (indC4), 114.01 (indC7), 
115.01 (indC6), 125.58 (indC2), 130.14 (indC3a), 133.17 (indC7a), 156.35 (indC5), 170.57 
(AcCO), 172.87 (CONEt); MS (ES+): m/e 326.1 (100%) [m+Na] + ; H R M S (FT-MS) calcd 
for C | 6 H 2 , N 3 0 3 N a i : 326.1475, found: 326.1477; I a ] d 2 5 : (MeOH, c = 0.1) +32.8°; R f: 0.40 
(using EtOH 5% v/v in DCM) 
A^-Acetyl-S-nitro-L-tryptophan ethyl amide (6g) 
'H NMR (500 MHz, MeOH - cLi): 8 0.94 (t, J = 7.5 Hz, C / / 3 CH 2 N, 3H), 1.93 (s, AcC/ / 3 , 
3H), 3.01-3.15 (m, C H 3 C / / 2 N & l / / p , 3H), 3.27 (dd, J = 7.0, 7.5 Hz, / / p , 1H), 4.59 (t, J = 7.0 
Hz, Ha, 1H), 7.30 (s, ind//2, 1H), 7.43 (d, J= 9.0 Hz, ind//7, 1H), 8.02 (dd, J= 2.0, 9.0 Hz, 
ind//6, 1H), 8.62 (d, J = 2.0 Hz, ind//4); l 3 C NMR (125 MHz, MeOH - d 4): 8 14.53 
(NCH 2 CH 3 ) , 22.51 (AcCH 3 ) , 28.89 (Cp), 35.25 (NCH 2 CH 3 ) , 55.69 (C a ) , 112.42 (indC3), 
114.24 (indC4), 117.03 (indC7), 117.85 (indC6), 128.35 (indC2), 131.03 (indC3a), 132.48 
(indC7a), 142.52 (indC5), 173.08 (AcCO), 173.30 (CONEt); MS (ES+): m/e 341.3 (65%) 
[m+Na] + , 342.3 (12%) [m+Na] + ; HRMS (FT-MS) calcd for C s H i s N ^ N a , : 341.1223, 
found: 341.1225; Mp.: 220-224 °C; [ a ] d 2 5 : (MeOH, c = 0.15) +8.7°; R f: 0.27 (using EtOH 
5% v/v in DCM) 
4.4.1.j 9-Fluorenylmethyloxy-carbonyl (Fmoc) Protection of 3a and 3 f 2 6 , 2 7 
Free amino acid (0.5 mmol) was dissolved in water (1.9 ml). A solution of sodium 
bicarbonate (50 mg, 0.5 mmol) containing 9-fluorenylmethyloxycarbonyl succinimide 
(170 mg, 0.5 mmol) in acetone (1.9 ml) was added. The suspension was stirred at room 
temperature overnight and the clear solution subsequently quenched by addition of 
concentrated hydrochloric acid to pH 2, forming a white precipitate. The acetone was 
removed under vacuum and the product was extracted into chloroform ( 2 x 4 ml). The 
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combined organic extracts were washed with 1 TV hydrochloric acid ( 2 x 4 ml) and deionised 
water ( 2 x 4 ml), dried over magnesium sulphate and filtered. The solvent was evaporated 
under vacuum affording the crude Fmoc-protected amino acid. Samples were purified using 
semi-preparative HPLC (§4.2.2). 
Fmoc-5-fluoro-L-tryptophan (3a) 
Using the general method above (§4.4.1 J), the title compound was synthesised as a white 
crystalline powder. 
'H NMR (300 MHz, MeOH - dU): 5 3.11 (dd, J = 2.7, 14.7 Hz, //p, 1H), 4.12-4.33 (m, 
Fmoc//, FmocC// 2, 3H), 4.47 (dd, J= 6.9, 14.1 Hz, Ha, 1H), 6.85 (dt, J = 2.4, 9.3 Hz, mdH, 
1H), 7.14 (s, mdH, 1H), 7.21-7.30 (m, 2 x mdH, Fmoc//, 4H), 7.36 (t, J = 7.5, Fmoc//, 2H), 
7.56 (d, J = 7.5, Fmoc//, 2H), 7.76 (d, J = 7.5, Fmoc//, 2H); 1 3 C NMR (75MHz, MeOH -
d*): 5 28.84 (Cp), 56.12 (C a ) , 56.41 (FmocQ, 67.81 (FmocC), 108.6 (indC2), 111.86 (indC), 
112.24 (indC), 113.55 ( indQ, 121.74 (indC2), 125.34 (FmocQ, 128.37 (indC3a), 128.78 
(FmocQ, 128.91 (FmocC), 131.73 (indC7a), 141.16 (FmocQ, 143.61 (FmocQ, 156.72 
(indC5), 161.14 (FmocCO), 174.56 (COOH); MS (ES+): m/e 445.4 (100%) [m+Na] + ; Mp.: 
139-143 °C; [a]„ 2 5 : (MeOH, c= 1.0) -16.8°; C H N analysis (calcd % ) C, 70.26; H, 4.76; N , 
6.30; (found %) C, 70.25; H, 4.78; N , 6.29 
Fmoc-5-methoxy-L-tryptophan (31) 
Using the general method above (§4.4.1 . j) , the title compound was synthesised as a white 
crystalline powder. 
'H NMR (400 MHz, MeOH - d*): 6 3.08-3.13 (m, //p, 1H), 4.15 (m, Fmoc//, FmocC// 2, 
3H), 4.68 (m, Ha, 1H), 6.72 (dd, J= 2.2 Hz, 4.8 Hz, mdH, 1H), 7.05 (s, ind//, 1H), 7.20-7.30 
(m, Fmoc//, 2x mdH, 3H), 7.34 (m, Fmoc//, 2H), 7.55 (d, J= 1.6 Hz, Fmoc//, 2H), 7.57 (d, J 
= 1.9Hz, Fmoc//, 2H); 1 3 C NMR (100MHz, MeOH - d,): 5 28.71 (Cp), 54.73, 56.22, 56.36, 
68.04 (FmocQ, 101.18 ( indQ, 112.66 ( indQ, 112.94 ( indQ, 120.87 ( indQ, 125.21 ( indQ, 
126.27 ( indQ, 126.36 (FmocC), 128.17 (FmocQ, 128.74 (FmocQ, 142.52 (FmocQ, 145.25 
(FmocQ, 156.21 (indC5), 160.10 (FmocCO), 174.35 (COOH); MS (ES+): m/e 465.2 (100%) 
[m+Na] + ; Mp.: 82-85 °C; [ a ] d 2 5 : (MeOH, c= 1.0) +-24.5°; C H N analysis (calcd %) C, 
71.04; H, 5.30; N , 6.14; (found %) C, 71.01; H, 5.38; N , 6.13 
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4.4.2 Peptide Synthesis 
4.4.2.a Manual Coupling of Leucine to a Wang-resin 
In the manual peptide synthesis, the Fmoc-protected amino acids were activated with 
diisopropylcarbodiimide (DIC). Apart from this, the deprotection and coupling protocols 
were identical to the one used in the automated peptide synthesis (§4.4.2.b): Wang resin 
(400 mg, 0.3 mmol/g free sites = 0.12 mmol) was suspended in a mixture of dichloromethane 
(DCM) (5.4 ml) and dimethylformamide (DMF) (0.6 ml) under a nitrogen atmosphere. A 
solution of Fmoc-L-leucine (85 mg, 0.24 mmol, 2 eq) and 1-hydroxybenzotriazole hydrate 
(HOBt) (37 mg, 0.24 mmol, 2 eq.) was added. Di-isopropylcarbodiimide (DIC) (38 ul, 
0.24 mmol) and a solution o f dimethyl-aminopyridine (DMAP) (1.6 mg, 1.2 umol) in DMF 
(0.3 ml) were added and the reaction mixture stirred under a nitrogen atmosphere at room 
temperature for 2 to 3 hours. Excess reagents were filtered o f f under reduced pressure. The 
resin was then treated with acetic anhydride (22.4 ul, 0.24 mmol) and pyridine 
(20 ul, 0.24 mmol) and mixed for another 30 minutes. Filtration and washing with DCM (3 x 
5 ml), and DMF ( 3 x 5 ml) and subsequent drying through suction afforded the 432 mg of 
Fmoc-Leu-Wang resin (75% yield). Resin loading was determined using the procedure 
described in §4.3.1 .f. 
4.4.2. b Synthesis of AcWL WLL using a Solid Phase Peptide Synthesiser 
An Advanced Chemtech peptide synthesiser 348Q was used for the automated peptide 
synthesis with a 40-well Teflon reaction block. Superfluous reagents and waste fluids were 
removed by filtration under positive nitrogen pressure at 5 bar, applied for 2 min. The 
syringe used for injections was cleaned with methanol (0.3 ml) between individual additions. 
Peptides were prepared in parallel using two or more reaction wells (total capacity 5 ml) and 
no more than 100 mg Wang resin in each well. 
Wang resin (50 mg), pre-loaded with L-leucine (0.75 mmol g"1, 37.5 umol) was swollen and 
agitated in DMF (2 ml). Standard Fmoc-coupling procedures were employed using 
commercially available Fmoc-Leu-OH (0.188 mmol, 5 eq) and Fmoc-Trp(Boc)-OH 
(0.188 mmol, 5 eq) in solutions o f anhydrous yV-hydroxybenzotriazole (HOBt) (0.5 M) in 
DMF (375 \A each). The substituted Fmoc-protected tryptophan derivatives were used 
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without Boc protection on the indole nitrogen. The coupling procedure consisted of cycles of 
deprotection, washing, coupling, washing, second coupling, and final wash. 
Deprotection was achieved by addition of piperidine in DMF (20% v/v) (1 ml) and agitation 
for 5 min. The well was then emptied by positive nitrogen pressure for 2 min. The 
deprotection procedure was then repeated, agitating the suspension of resin in 
piperidine/DMF solution (1 ml) for 10 min this time. The removal o f the solvents was 
followed by a wash step. First, the resin was re-suspended in DMF (3 ml) and agitated for 
1 min. Then, waste solvents were removed by applying positive nitrogen pressure for 2 min. 
The washing protocol was repeated 4 more times. 
Coupling was achieved by addition of the next Fmoc-protected residue in HOBt solution 
(375 ul). The protected amino acids were coupled using Af-N-diisopropylethylamine (DIPEA) 
(0.375 mmol, 5 eq) and (benzotriazol-l-yloxy)tripyrrolidinophosphonium hexafluoro-
phosphate (PyBOP) (0.375 mmol, 5 eq) both dissolved in DMF (375 |^ 1 each). The resin was 
agitated for 60 min and solvents removed under positive pressure for 2 min. The coupling 
procedure was repeated after another washing cycle. After the attachment of the last residue 
and its deprotection, the /V-terminus of peptide was capped with an acetyl group by reaction 
with acetylimidazol (0.188 mmol, 5 eq) in DMF (375 ul) for 30 min. The resin was then 
washed thoroughly with DMF (2.5 ml) and then washed with DMF ( 3 x 3 ml), methanol 
( 4 x 3 ml) and dichloromethane ( 5 x 3 ml). 
4.4.2.C Cleavage of AcWLWLL from the Wang-Resin 
Wang-resin (59 mg with a loading of 0.3 mmol/g) was mixed with trifluoracetic acid (TFA) 
(1.4 ml), HPLC grade water (0.08 ml), phenol (0.08 ml) and triisopropylsilane (0.04 ml) and 
shaken for 2 hours. The solvents were removed and collected by suction filtration. The resin 
was washed with TFA (2 x 1.5 ml) and the washings combined with the filtrate. The solution 
was concentrated to a third of its volume in vacuo and a 10-fold excess of ice-cold diethyl 
ether (15 ml) was added drop wise. The solution was stored at 4 °C for 12 hours. Following 
centrifugation at 3000 rpm for 15 min, the supernatant was removed, concentrated under 
vacuum and any further precipitate collected by centrifugation. The collected peptide was 
washed with ether ( 2 x 5 ml) and centrifuged. The white pellet was dried under vacuum to 
afford 12 mg of peptide (88% yield). 
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4.4.2.d Ninhydrin Test 
Ninhydrin (1,2,3-triketo-hydrindene hydrate) was .dissolved in ethanol (0.2% w/v, 100mJ) 
and acidified slightly with cone, sulphuric acid (2 drops) to produce a staining dip. TLC 
plates were stained, dried with a heat gun for 30 seconds and analysed by visual inspection. 
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Chapter 5: Computational Chapter 
This chapter describes the parameters, forces and equations that were used in the molecular 
dynamics simulations and free energy calculations detailed in §2.5 - §2.7. 
5.7 Interaction Functions and Force Fields 
5.1.1 Molecular Dynamics Simulations 
Molecular dynamics (MD) simulations solve Newton's equations of motions for a molecular 
system using force fields, such as the one detailed in this chapter to describe intra- and 
intermolecular interactions. These are split into non-bonded interactions (§5.1.1.a) between 
an atom pair within a certain pre-defined cut-off radius and bonded interactions (§5.1.1 .b) 
between pairs of atoms sharing a chemical bond. Terms needed for free energy calculations 
are given in §5.1.1 .d. It follows a description of the solvent (§5.1.3) and structural 
representations of the analytes (§5.1.4). The computational procedures are detailed in §5.2. 
5.1.1.a Non-bonded Interactions 
Non-bonded terms include van der Waals interactions (modelled by a Lennard-Jones type 
potential) and electrostatic, Coulomb interactions. These interactions were computed based 
on a neighbour list, which was updated during the course o f the simulation at pre-defined 
intervals. The list contains all non-bonded atoms within a certain defined radius. 
Lennard-Jones Interaction 
The Lennard-Jones interaction, Vu, between two atoms / and j can be described as 
c ( l 2 > C « ) 
•J !/ 
12 6 
(4.1) 
where / and j are separated by a distance r,y and C/ / l 2 ) and Q ( 6 ) are the so-called Lennard-
Jones parameters. The force of this potential is obtained by differentiation o f Equation 4.1 
and can be written as 
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where F , is the force on atom /' arising from the interactions of atoms / and j, r,y is the 
separation vector between / and j. The Lennard-Jones parameters for different atoms were 
defined in the force field and are given in §7.6. 
Lennard-Jones type interactions between water oxygen (OW) and the lipid acyl chain 
(i.e. the OW-CH2 and OW-CH3 interactions) influence the interface region strongly. A 
variety of Lennard-Jones parameters for these interactions have been used so far.' The 
original GROMOS parameter resulted in a solubility of decane in water that was far too high. 
Therefore, the values were adjusted (according to the adjustments introduced made by Berger 
et al.2) to e= 0.529 and 5 = 0.637 (OW-CH 2 and OW-CH 3 respectively) with cr = 0.310 for 
both and implemented as such in the simulations containing lipid-water interactions (i.e. in 
the bilayer simulations §5.2.2 and in the simulation of water-lipid-tryptophan adduct 
formation §5.2.1 .b). 
Coulomb Interactions 
The Coulomb interaction between two charged particles / and j is given by 
V c ( r 9 ) = f ^ > (4-3) 
where q, and qj are the partial charges on atom /' and j respectively, sr is the relative dielectric 
constant of the medium in which the atoms are dispersed, and/ i s the Faraday constant. The 
Faraday constant corresponds to 
/ = — — = 138.935485 kJ mof 1 nm e"2, (4.4) 
47T£0 
where £0 is the dielectric constant in a vacuum (permittivity of free space); and e is the 
charge on an electron. 
201 
Coulombic Interactions Treated by Ewald Summation 
The total electrostatic energy of TV particles and the periodic images are given by 
i j n, »;,. n.' 'ij.n 
where (nx,ny,n:) = n is the box index vector, the star indicates that terms with i —j should be 
omitted when (nx,nv,n:) = (0, 0, 0), and r,y,„ is the real distance between the charges and <jy 
and not the minimum image. The force can be evaluated faster when it is split into a sum of 
its direct V D I R and reciprocal sums VREC as well as a constant term Vq\ 
V = V l l i r + V r e c + V , . (4.6) 
The individual parts can be expressed by: 
ij nx »,. n.' f j j .n 
^ ^ E M , i n 4 ( m , # : a , n ( , ' - r J 
l K V i j ' »,, my mz' m 
Here, Vdir is the direct sum, Vrec is the reciprocal sum, F 0 is a constant term for the evaluation 
of the total electrostatic energy of /V particles being a distance r,y apart from each other, where 
/ i s the Faraday constant, /?is a parameter that determines the relative weight of the direct and 
reciprocal sums and (mx,my,mz) = m is the highest magnitude of wave vectors in each 
direction. 
In the particle-mesh Ewald (PME) summation method, charges are assigned to a grid 
using cardinal B-spline interpolation. The grid is subsequently Fourier transformed with a 3D 
FFT algorithm and the reciprocal energy term obtained by a single sum over the grid in k-
space. Equation 4.3 needs to be adjusted for the evaluation of the short-range coulomb 
potential in the Ewald summation to 
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V,.:(r) = f 
e r f c ^ - , . ) ^ , (4.8) 
which gives the short-range electrostatic potential, VE, between two particles i and j a 
distance r,y apart from each other, where and qj are the partial charges on atom / and j 
respectively, /? is the relative weight between space sum and the reciprocal space sum for 
PME summation, erfc(A-) is the complementary error function, and/is the Faraday constant. 
PME has the disadvantage of enhancing artefacts caused by periodic boundary 
conditions. Alper et al? suggested that a simple cut-off treatment for systems of lipids with 
neutral total charge could be used. This also produces artefacts especially when ions are 
present, but works well for PC lipids. Anezo et al.A reviewed the effects of long-range 
electrostatic treatments of the molecular dynamics simulations of DPPC bilayers and found 
PME to outperform both a reaction field treatment and a simple cut-off approach. 
5.1.1.b Bonded Interactions 
Bonded interactions are defined as bond-stretching, angle bending as well as improper and 
proper dihedral forces. These interactions are generally approximated by harmonic potentials 
as described in detail in the following. Bonded interactions are defined during the set-up of a 
simulation and are fixed thereafter. 
Bond-Stretching Potential 
The bond-stretching potential, Vb, can be described by a harmonic oscillator with a spring 
constant, k j f , the distance r,y between two particles / and j and their ideal bonding distance 6,y: 
The corresponding force acting on particle i can then be written as the derivative of the 
potential 
(4.9) 
r 
(4.10) 
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Angle Potential 
The angle potential Va of three sequentially, covalently bound atoms and k (with j being 
in the middle) can also be described by a harmonic approximation: 
Va(0j={ki(Ou>-0iJ> ( 4 - n ) 
where k^6 is a spring constant, 0^ the angle between the three atoms /', j, and k, and 0^° is 
their ideal bond angle. The angle-bending forces acting on the three atoms are given by: 
F = 
dr 
F ^ - ^ M , (4 ,2 ) 
d r k 
Fj = -F,-Fk. 
The angle can be written in terms of the distances between the atoms as: 
0..k = arccos^'iJ' * (4.13) 
For the three atoms and k, where r,y and are the distances between the atoms i and j 
and the distance between atoms k and j respectively; r,y and rkj are the vectors between the 
atoms. 
Improper Dihedrals 
Improper dihedrals impose a force on a group of atoms k, and /, which keeps them planar, 
or prevents the 4 atoms from flipping to their mirror images. Improper dihedrals were treated 
by an harmonic potential: 
^ f c W ) = ^ ^ f e , / - ^ y , (4-14) 
where k.= is a spring constant, g^i is the improper dihedral and £,o is the ideal improper 
dihedral. 
204 
Proper Dihedrals 
Proper dihedral angles are defined according to the IUPAC/IUB convention, where <f>ijki is the 
angle between the ijk and jkl planes of the atoms i,j, k, and /, with zero corresponding to the 
cis configuration (/ and / on the same side). The proper dihedral potential was described by 
the Ryckaert-Bellemans function 
with coefficients C„. 
Restraints 
Several parameters in a simulation can be restrained to fixed values based on experimental 
data (e.g. N M R or x-ray crystallographic distance restraints) or to simplify a simulation {e.g. 
restraining of solvent bond-stretching and angle-bending forces). Typically, restraints can be 
imposed on positions, angles, distances, orientation, and dihedrals. Restraints are defined 
during the set-up of a run and are not altered during the simulation. 
5.1.1.C Free Energy Simulations - Theory 
Free energy calculations were performed using the so-called slow growth method in a 
thermodynamic cycle, which was employed as illustrated in Scheme 2.12. 
^> y J=2X(cos(y/ ) ) n 
n=0 
(4.15) 
y/ = ^ - 1 8 0 Q , 
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System 1 
AG, 
rp*> 
System 2 
1 AG2 
•.; 'f 
Scheme 5.1: General scheme for the calculation of a free energy of interest by using the thermodynamic 
integration method. A detailed description can be found in Scheme 2.12. 
It is difficult to calculate solvation and binding free energies directly using molecular 
dynamics simulations. However, with the use of a thermodynamic cycle, a molecule can be 
transferred into a non-interacting particle, a so-called dummy molecule (indicated in Scheme 
2.12 by a superscript'). Such a transition can be achieved by a gradual, linear decrease of 
non-bonding interaction potentials of the studied particle during the course of a series of 
molecular dynamics simulations. The generated free energy differences can be computed 
more easily and using a thermodynamic cycle one can determine the binding free energy of 
the system of interest indirectly by applying Equation 4.16: 
AG, - AG 2 = AG 3 - AG 4 . (4.16) 
Here, the partial free energies (AGi to AG4) are associated with an equilibrium between the 
two states. By gradually changing from one state to the other, the free energies associated 
with this change can be calculated. This is achieved by perturbing the Hamiltonian of the 
starting model state A gradually into the Hamiltonian of the target system B, Z/6. The change 
has to be small and reversible so that the system can be assumed to remain in equilibrium 
during the process. This means that the reverse calculation of changing the system from state 
B as a starting point into state A will yield the same results. A coupling parameter X is 
introduced, so that the Hamiltonian H is now a function depending on the coordinates, p, the 
charged interactions q, and X 
H = H(p,q;A). 
206 
(4.17) 
System A is now described by X = 0 while system B is described when X = 1 
H(p,q;0) = H'\p,q) ; H{p,q;\) = HB(p,g). (4.18) 
In GROMACS, the functional form of the X-dependence is different for the various force-
field contributions (see also §5.1.1 .d). 
The knowledge of the partition function A of an NpT ensemble allows the calculation 
of the Gibbs free energy of the process: 
G(A) = -kBT\n A (4.19) 
A = c j" J j e x p [ - f3H{p,q;A)}lqdpdV (4.20) 
where /? - (k BT)"', and c = (N\h1N)~]. These integrals over phase space cannot be 
evaluated from a simulation directly, but it is possible to evaluate the derivative with respect 
to X as an ensemble average 
\\\(^)exp[-{JH(p,q-,A)-/JPV]dqdp 
dX JJJ exp[-/3H(p,qU)-PpV]dqdp \M Lptu 
The difference in free energy between state A and B can be found by integrating the 
derivative of / /wi th respect to X 
>SH\ 
NpT:. 
Therefore several calculations at different X values can be used to determine the free energy 
GB(p,T)-GA(p,T)=\{—j dZ. (4.22) 
0 > ' NpT;A. 
change between the two states A and B using the (^—) at a number of well-chosen 
\dA/ 
intermediate values of X. It has been found that approximately 16 to 20 steps are necessary 
for an accurate and reversible free energy calculation. A proper error estimate can be made 
for each value of from the fluctuation of . 
dl SA 
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5. J. l.d Free Energy Simulations - Description of Forces 
Harmonic bond potentials were used to model bond, angles and improper dihedrals. These 
were interpolated linearly from state A to state B using the generic potential function 
V,=\ ((1 - M + J*? \ x - { \ - 4*o - J • (4-23) 
Vx describes a harmonic potential that changes with a coupling parameter, A, from a fully 
interacting state A to a fully non-interacting state B, where k A and kxB are the spring constants 
at state A and B, x the harmonic parameter, and XQA and x0B the ideal values for the harmonic 
parameter in state A and B respectively. The force is then given by the derivative of the 
potential function and can be exemplified by the bond-stretching force 
° £ = I (*« - kt%b - (i - a » b0B J + (b$ - b0°\b-(\- w - u») 
OA n 
(4.24) 
where Vb is given with respect to the coupling parameter A, b the bond distance, and boA and 
bo the ideal values bond lengths in state A and B respectively. 
Proper Dihedrals 
Proper dihedrals were interpolated using the potential function and its derivative: 
vd=(o - x)kAd + Ak» \\+cos(v - o - w + m ) ) 
^ = fa - KI+cos(v - [0 - M + ^ 5 -
((1 - A)k;l + k» If? - £ )sin(v - [(l - - Afs J ], (4.25) 
where k/ and kf are the spring constants at state A and B, <f> the dihedral angle, and <j>sA and 
<j)sB the ideal values dihedral angles in state A and B respectively, and n$ the multiplicity of 
the dihedral. 
Coulomb Interaction 
The Coulomb interaction between two particles i and j whose charge varies with A was 
represented by 
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v c = J - [((i - x ) q : + v )• ((i - w + ^ ; ) ] , 
with 
£ r f r i j 
= hB - qAj XO - % 4 + gf) + fcf - ^ XO - + ^ ) ] , (4-26) BA erfr. 
where qf and qf and qf and 9 / are the partial charges of particles / and j in state A and B 
respectively. 
Lennard-Jones Interaction 
The Lennard-Jones potential between two particles of which the atom type varies with A can 
be written as: 
_ ( ( 1 - A)C?2+AC;{ ) ( ( 1 - A)CA + *ct) V -
U 12 6 r r. U V 
with 
QV CA -CB CA -C -^.S ^ / l 
12 " 6 
r 6 
(4.27) 
where Cif and C / / and Cf and C / are the Lennard-Jones parameter of the interaction in 
state A and B respectively. 
Kinetic Energy 
When the mass of a particle is perturbed during the course of a free energy calculation, there 
is also a change in the contribution of the kinetic energy to the free energy that needs to be 
modelled: 
s ' - U - ( 4 - 2 8 ) 
Here, is the change in the kinetic energy with respect to the coupling parameter A, p is the 
momentum of the particle, and mA and mB its mass in state A and B respectively. The 
derivative gives then the overall contribution: 
BE, 1 p2(mB -mA) 1 , / B A \ . . . . . —*- = —, H v ^r = v-[m-mA), (4.29) 
dA 2{(\-A)mA+Am») 2 X 1 
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where p is the momentum of the particle, v its velocity, and rri4 and mH its mass in state A and 
B respectively. However, the free energy calculations in this study did not involve any 
changes in the mass of perturbed atoms. Consequently the kinetic energy in eqn. (4.28) 
BE 
collapses to the usual expression for kinetic energy and — - = 0 in eqn. (4.29). 
dA 
Constraints 
As constraints are formally part of the Hamiltonian, they contribute to the free energy of a 
system. Therefore, they need to be adjusted during the course of a free energy simulation. 
Soft-Core Interactions 
Due to the linear interpolation of the Lennard-Jones and Coulomb potentials, the free energy 
calculations for values of the coupling parameter A close to 0 or 1 are problematic as the 
simulations can approach singularities. Soft-core potentials Vsc were introduced to 
circumvent these problems and smooth the Lennard-Jones and Coulomb potentials when they 
are close to state A (A = 0) and state B (A = 1), 
Vsc{r) = (\-l)VA{rA)+AV»{rH). (4.30) 
This gives the soft-core potential, Vsc, as a function of distance /-, where A is the coupling 
parameter, V4 and V8 the normal "hard core" Lennard-Jones or Coulomb potentials in state A 
and B respectively, and r& and r# are the distances in state A and B respectively. The 
distances rA and rB in state A and B are given by: 
rA={aaAA"+rbj, 
rR={aa\{\-A)" + r 6 j , (4.31) 
where a is the soft-core parameter, p is the soft-core A power, and cr is the radius of the 
interaction, which is (C\2/C(,)Ub or a predefined value i f C(, or C\i is zero. 
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5.1.2 Simulation of Lipid Bilayers 
A triclinic box containing a DMPC lipid bilayer in the central plane was filled with 3655 
SPC water molecules. This resulted in 16853 atomistic sites in total. The system was energy-
minimized and equilibrated for 10 ns. One computed nanosecond took four 3.73 GHz Xeon 
Intel Processors 11.43 hours to compute using the GROMACS (Version 3.3.1) code.5'6 
A system size of 128 lipid molecules (64 per leaflet) was chosen as a compromise 
between feasible computational cost and reduction of artefacts arising through periodicity. 
Additionally, the conformational space of a single lipid molecule, with two flexible acyl 
chains, is very large. A bigger system will sample these different conformations more 
accurately. 
5.1.2. a Degree of Solvation 
The amount of water present in the system has a strong influence on the bilayer properties. It 
has been noted that the ratio of about 26 water molecules per lipid is the minimum required 
to allow for a fully solvated bilayer structure.7 In this study the bilayer structures were 
initially equilibrated with a solvation ratio of 57 to 2 as the insertion of peptides reduced this 
value somewhat. 
5.1.2.b Pressure Coupling 
The type of the pressure-coupling appears to have no significant effect on the equilibrium 
properties of bilayers.8 Although the Parinello-Rahman method is to be preferred on 
theoretical grounds as it generates a well defined ensemble in comparison to the Berendsen 
method, the latter scheme is more practical because it damps large oscillations in box 
dimensions that might occur. This is especially important during the equilibration time. The 
treatment of the pressure-coupling is not very computationally demanding in either of the 
methods. To improve the accuracy of the simulations the Parinello-Rahman method was 
chosen for the free energy calculations of the amino acid derivatives in chloroform. The 
Berendsen model was chosen for the bigger lipid bilayer systems. To account for the 
anisotropic nature of the bilayer, our simulations were performed in a way that an isotropic 
constant pressure (1 atm) was applied both in the bilayer plane and in the direction of the 
bilayer normal. The pressure was coupled independently with a 1.0 ps time constant using a 
Berendsen barostat. 
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5.1.2.C Temperature 
The temperature must be chosen carefully as not to coincide, or to be close to, the lipid 
transition temperature of DMPC. At the transition temperature the lipid changes its phase, 
structure and over all ordering. AFM studies of DMPC bilayer microstructure suggested a 
transition temperature of 301 ±0.1 K. 9 However, other researchers report the transition from 
the liquid-crystalline La phase which the lipid adopts at a temperature above 302.6 K. 1 0 The 
gel-phase Pp- is adopted at a temperature below 295.2 K. Enders et al)1 determined the main 
transition temperature of DMPC using temperature-controlled AFM to be at 296.5 ± 0.1 K. 
The temperature in the bilayer simulations was adjusted to be 303 K. Weak 
temperature coupling using the Berendsen algorithm with a coupling constant of 0.1 ps was 
used independently on all differing components of the simulated system. I.e. the temperature 
was coupled independently to the lipid bilayer, the solvent, and the solvated molecules. 
5.1.3 Solvent Models 
5.1.3. a Chloroform Simulation Boxes 
Chloroform molecules were represented by the model of Jorgensen et al.n (Figure 5.1), 
which includes a united CH unit. 
Figure 5.1: Representation of a united atom chloroform molecule of the model used. 
Since the electron density for the hydrogen atom is shifted well along the bond toward the 
carbon atom, this provides a reasonable approximation. The potential successfully reproduces 
the experimentally determined heat of vaporisation12 as well as the density and diffusion 
constant13 for chloroform. Configuration and partial charge distribution were adapted from 
literature values (Table 5.1).14 
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Chloroform Lennard-Jones C-Cl Cl-Cl Charges 
Model Parameter Dist. Dist. 
Parameter <7C| £c sa h rj Qi 
Units nm kcal mol"' nm e 
Value 0.380 0.340 0.3347 0.1252 0.1758 0.2903 
T ~ I 
-0.14 +0.42 
Table 5.1: Table presenting the values used in the chloroform representation. 
Two cubic simulation boxes were generated: one with 512 chloroform molecules (3.9 nm per 
side) the other with 4096 (8.2 nm per side). Both were equilibrated for 10 ns before used in 
the set-up of further simulations. 
5.1.3.b Choice of Water Model for Lipid- Water Simulations 
The single-point charge (SPC)15 model (Figure 5.2) was used in this study as it provides a 
computationally more economical representation of water model than the related extended 
single-point charge (SPC/E)16 or transferable intermolecular potential functions TIP 1 7 
representations. Although the differences in the charges and geometry for a single molecule 
are small, they accumulate to give noticeable effects on the total system. SPC/E was 
originally developed because previous models did not take into account the self-energy due 
to polarization.16 It was found that it gives a better density, radial distribution function, self-
I Q 
diffusion constant and dielectric constant than SPC. However, this comes at a 
computational expense that is prevalent specifically in larger systems such as common 
bilayer simulations. Additionally, SPC tends to produce larger area per lipid values and a 
broader lipid-water interface.19 This is favourable as experimentally determined area per lipid 
values and width of the interface are larger than the ones found in simulations. 
Figure 5.2: Representation of a water molecule using the SPC model. 
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The SPC water model employs the parameters listed in Table 5.2: 
SPC Lennard-Jones O-H Angle Charges 
Model Parameter distance 
Parameter a s r e q\ 
Units nm kJmol"1 nm o e e 
Value 0.317 0.650 0.1 109.47 +0.41 -0.82 
Table 5.2: Table presenting the values used in the SPC representation of water molecules. 3 
5.1.4 Representation of Analytes 
5.1.4. a Generation of Tryptophan Derivatives 
Structures for A^-acetyl-L-tryptophan ethyl amide derivatives were generated using the 
Maestro" software package from Schrodinger Inc. The geometry was optimized by ab-initio 
Jaguar21 calculations. Partial charges were computed with a 6-31G** basis set and assigned 
initially by using restricted Hartree-Fock (rHF) ab-initio Jaguar calculations (Set A). The 
electrostatic potential was fitted to the atom centres of the molecules using a quadrupole 
moment constraint and a spherical grip representation of the electrostatic potential. In a 
second set (Set B), partial charges were evaluated for 3-ethyl-indole derivatives using 
second-order perturbation theory (MP2) calculations in the GAUSSIAN 2 2 software package. 
Partial charges were fitted to atoms using the CHelpG (CHarges from ELectrostatic 
Potentials using a Grid based method)23 derivate of the electron density so that they gave the 
best representation of the latter. The derived partial charges of the substituted indole ring 
were used to represent the heterocycle of the equivalent tryptophan derivative. The partial 
charges for the backbone of the A^-acetyl-Z-tryptophan ethyl amide derivatives were adopted 
from the optimized parameters for liquid systems (OPLS_AA) 2 4 force field. Applied on the 
molecule, this lead to deviations from a net charge of zero for the entire compound 
(±0.011 e"). To regain an uncharged molecule, the charge difference was split and 
redistributed over the heavy atoms of the indole ring by adding the obtained fraction to the 
MP2 derived partial charges. Structures were subsequently transferred into the format of the 
Groningen machine for chemical simulation package GROMACS, 3.3.1. 2 5 , 6 
The charge groups used for the representation of the tryptophan derivatives are shown 
in Figure 5.3. 
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Figure 5.3: Representation of charge groups of the tryptophan derivatives (6a-g, 6n). 
5.1.4.b l,2-dimyristoyl-sn-glycerol-3-phosphocholine (DMPC) Representation 
Following an adapted model of Anezo et al.4, the DMPC molecule was represented in a 
united-atom fashion combining the hydrogen atoms with the heavy atom they are bound to 
(Figure 5.4). 
C M ( I I ( I I C H C M C H ( I I ( I I 
.vnl ( I I ( I I H 
O ( I I C H C H CH () 
( I I C H ( I I C H ( I I ( I I C H 
I I snl N 
C H C H ( I I C H ( I I 
Figure 5.4: United atom representation of a DMPC molecule. 
This representation is commonly employed and has been used in several other studies. ' 
Partial charges, bonded and non-bonded parameters of the lipid were adapted from those that 
have been established by Berger et a/.28 The authors showed that the volume per lipid agreed 
within 1% of the experimentally obtained value of 1.232 nm3. Similarly, the lipid order 
parameter, total volume of the lipid and certain distances between lipid molecules were 
represented within a 3% error of the experimentally determined values.28 
The charge groups used for the DMPC representation in all simulations are displayed 
in Figure 5.5. 
215 
Figure 5.5: Charge groups used in for the representation of DMPC molecules. 
A single DMPC molecule was inserted into a solvent box containing 512 chloroform 
molecules. Solvent molecules that lay within the van der Waals radius of the lipid molecule 
were removed using a self-written FORTRAN 95 program. Typically, this left around 496 
solvent molecules in a cubic box with a length of 3.9 nm per side. The energy of the system 
was minimized and subsequently the set-up equilibrated for 10 ns. This resulted in the 
starting structure for all the molecular dynamics simulations of the lipid in chloroform. 
5.1.4.C AcWLWLL Representation 
The structure of the pentapeptide AcWLWLL was generated using the Maestro software 
package.20 The geometry was minimized and partial charges computed and assigned using 
Jaguar ab-initio calculations (6-31G** basis set). The peptide was transferred into 
GROMACS format and inserted into a pre-equilibrated solvent box (5.6 nm per side) 
containing 5832 SPC water molecules, of which 119 were removed due to their overlapping 
with the peptide. Representative conformations of AcWLWLL at 300 K were sampled by 
two methods: A conformational search was run in Maestro using explicit solvent. 10000 
conformations of the peptide were sampled using MCMM tensional sampling. The energy 
window for the saving of structures was set to 50 kJ moF1 and the maximum distance 
between atoms in equal structures to 0.025 nm. Secondly, a 10 ns GROMACS molecular 
dynamics calculation was run, with subsequent cluster analysis to sample conformers. As 
detailed in §2.7.2.b, both revealed two statistically significant conformations: one in which 
the pentapeptide adopts a more helical form, and the other in which it is more stretched and 
W-shaped. 
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5.1.4.d Representations of Ac WL WLL Derivatives 
Derivatives of the parent AcWLWLL peptide were generated by substituting the hydrogen on 
the 5-position on the Wi indole ring by one of the halogen atoms, F, CI, Br, or I , where W! 
stands for the first tryptophan residue. The structures were the energy-minimised using the 
GROMACS software. 
The charge groups used for the representation of the pentapeptides are shown in 
Figure 5.6. 
CD 
H H H N N 
N N O H H 
Y N H N H 
Figure 5.6: Charge groups used in the representation of AcWLWLL peptides. 
5.2 Run Parameters 
5.2.1 Molecular Dynamics Simulations - Amino Acid 
The force field used in the simulations was based on OPLS AA . Simulations were 
performed in the constant NpT ensemble with the temperature controlled at 295 K using the 
weak coupling algorithm of a Berendsen thermostat30 with a coupling constant of 0.1 ps. The 
pressure was set to 1 bar and coupled every 1.0 ps using a Berendsen barostat31. DMPC, 
tryptophan derivative and the solvent were treated and coupled independently. The smooth 
particle mesh Ewald (PME) summation (Equations A.6-A.lf2^ was used to evaluate the 
electrostatic interactions with a real space cut-off of 1.2 nm, fourth-order spline interpolation, 
and a grid spacing of 0.12 nm. Van der Waals interactions were calculated using a Lennard-
Jones potential (equation 4.1) with a truncation at 1.9 nm. The electrostatic interactions were 
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calculated using PME. All cut-offs are given as atom based distances. Bond lengths of all 
molecules were constrained using the LINCS algorithm34. Using such constraints allowed a 
time step of 2 fs to be used. Coordinates and velocities of all atoms were recorded every 
10 ps. 
5.2. La Simulation of Amino Acid - Lipid interactions at a ratio of 1:1 
Various starting configurations were chosen to reduce the importance of the initial 
arrangement: one A^-acetyl-L-tryptophan ethyl amide derivative was placed on one of 6 
different positions on a sphere with 2 nm radius around the centre of a DMPC molecule. 
Overlapping solvent molecules were removed (typically leaving 450 chloroform molecules) 
and the starting configurations equilibrated for 10 ns before data was recorded. Both, the 
partial charge distributions of Set A and Set B were used in independent simulations. 
Production runs with the parameters were performed over 100 ns. A typical run would 
require about 2.14 hours per ns of simulation on four 3.73 GHz Xeon Intel Processors. 
5.2. Lb Simulation of Amino Acid- Lipid - Water interactions at a ratio of 1:1:1 
A set-up for the simulation of amino acid - lipid interactions at a ratio of 1:1 was used as the 
starting configuration (§5.2.1.a). An additional water molecule, represented with the SPC 
model, was inserted within 0.5 nm of the lipid head group. Overlapping solvent molecules 
were removed, leaving 434 chloroform molecules and the system pre-equilibrated for 10 ns. 
A production run with the parameters as described above was then performed over 100 ns 
requiring about 2.29 hours per ns of simulation on four 3.73 GHz Xeon Intel Processors. 
5.2. l.c Simulation of Amino Acid - Lipid interaction at a ratio of 2:1 
Two molecules of A^-acetyl-S-fluoro-Z-tryptophan ethyl amide (6n) were placed opposite to 
each other 2 nm away from the centre of a central DMPC molecule. Set B was used for the 
treatment of partial charges. The three molecules of interest were placed in the centre of a 
simulation box containing 4024 chloroform molecules. Overlapping solvent molecules were 
removed and the system pre-equilibrated for 10 ns. Several production runs with the 
parameters as described above were then performed over 10 ns each for a total of 50 ns. A 
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typical run would require about 25.1 hours per ns of simulation on four 3.73 GHz Xeon Intel 
Processors. 
5.2. l.d Simulation of Amino Acid - Amino Acid interactions at a ratio of 1:1 
Analogous to the simulation of amino acid - lipid interactions at a ratio of 2:1 (5.2.1 .c), two 
A^-acetyl-S-fluoro-L-tryptophan ethyl amide molecules (6n) were placed 2 run away from 
each other into a simulation box containing 4024 chloroform molecules. Overlapping solvent 
molecules were removed and the system pre-equilibrated for 10 ns. Set B was used for the 
treatment of partial charges. Several production runs, with the parameters as described above, 
were then performed over 10 ns each for a total of 50 ns. A typical run would require about 
21.93 hours per ns of simulation on four 3.73 GHz Xeon Intel Processors. 
5.2. l.e Cluster Analysis Adducts 
The trajectory from the molecular dynamics runs obtained through the protocols above 
(§5.2.1.a) were analysed for frames, when the distance between the centres of mass of the 
two molecules to be analysed (e.g. tryptophan derivative and the DMPC lipid) were 
<0.5nm. These frames were combined into a new trajectory using GROMACS internal 
software (trjcat). The extracted structures were then subjected to a cluster analysis tool 
(g cluster), which assigned them to a cluster when the root mean square difference in their 
coordinates was <0.1 nm (measured by comparing atom,i-atom,2 distances, where 1 and 2 
stand for structures 1 and 2, and / is an atom descriptor.) 
5.2.2 Molecular Dynamics Simulations - Peptides 
One of the two statistically significant conformations of the AcWLWLL pentapeptide was 
placed 1.5 nm away from a DMPC lipid bilayer face. Overlapping solvent molecules were 
removed, typically leaving 3640 SPC molecules, and the system pre-equilibrated for 1 ns, 
followed by a production run over 50 ns. An OPLS_AA force field with incorporated 
Ryckaert-Bellemans parameters for the treatment of the lipid was used. The simulations were 
performed in the constant NpT ensemble. The pressure was coupled semi-isotropically at 
1 bar with a coupling constant of 1.0 ps both, in the plane of the lipid bilayer and to its 
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normal using a Berendsen barostat, which applied two pressure couplings with independent 
coupling constants to the bilayer normal and the bilayer plane respectively. The temperature 
was set to 300 K and coupled to the lipid molecules, the solvent and any inserted peptides 
independently every 0.1 ps through a Berendsen thermostat. The electrostatic interactions 
were modelled by PME summation with a real-space cut-off at 1.2 nm, fourth-order spline 
interpolation, and a grid spacing of 0.12 nm. Every 10th step, the truncation for the PME 
summation was set to 1.5 nm. A Lennard-Jones potential with a cut-off at 1.5 nm was used to 
calculate van der Waals interactions. Water representations were restricted using the 
SETTLE algorithm35; bond lengths of the other molecules were constrained using the LINCS 
algorithm34. The simulations were run with a time step of 2 fs. Coordinates and velocities of 
all atoms were recorded every 10 ps. A typical run would require about 11.77 hours per ns of 
simulation on four 3.73 GHz Xeon Intel Processors. The other conformer and peptides 
analysed were treated in an analogous fashion. 
5.2.3 Molecular Dynamics Simulations - Free Energy 
5.2.3.a Free Energies of Solvation - ht-Acetyl-L-Tiyptophan Ethyl Amide Derivatives 
in Chloroform 
Free energy calculations of A^-acetyl-I-tryptophan ethyl amide derivatives were performed 
both in vacuo and when the molecules were dissolved in chloroform. The 1,4-interactions 
with neighbouring molecules of the tryptophan analogue were gradually turned off over 21 
linear steps. After a short pre-equilibration period at each step (100 ps), the free energy of the 
system was then calculated in a 400 ps production run. The OPLS_AA force field was used. 
Temperature and pressure were set constant at 295 K and 1 bar, both being coupled 
independently to the different molecule types via Berendsen algorithms with coupling 
constants of 0.1 ps and 2.0 ps respectively. All bonds were restrained using the LINCS 
algorithm. Electrostatic interactions were computed by the PME summation33 using a cut-off 
at 1.9 nm, fourth-order spline interpolation, and a grid spacing of 0.12 nm. Van der Waals 
interactions were modelled via a Lennard-Jones potential with a truncation at 1.9 nm, 
updating the neighbour list every 5 steps. Energies were recorded every 0.2 ps. Non-bonded 
interactions were interpolated linearly with the coupling parameter A. When going from the 
fully interacting state A (A = 0) to the fully non-interacting state B (A=\), all bonded 
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interactions were interpolated by linear interpolation of the interaction parameters. The soft-
core parameters were: a- 1.51, soft core power p- 1, and a radius of interaction cr=0.3nm. 
5.2.3.b Free Energies of Binding between N^-Acetyl-L-Tryptophan Ethyl Amide 
Derivatives and DMPC in Chloroform 
Simulations for the calculation of binding free energies used the same parameters as 
described in §5.2.3.a. The starting configuration for System 1 were obtained from the initial 
configuration used in the 1:1 association simulations for the tryptophan derivatives and 
DMPC (as detailed in §5.2.1.a). The starting configuration of the Trp:lipid 1:1 adducts for 
System 2 were chosen by evaluating the trajectory of the unperturbed molecular dynamics 
simulations of the 1:1 set-up (§2.5.2). States in which the two molecules could be considered 
as being bound (rAB < 0.5 nm) were extracted and a cluster analysis performed according to 
the procedure described in §5.2.I.e. The average structures of the most populated obtained 
cluster were used as starting configuration to evaluate free energies of association. 
5.3 References 
1 a) Lagiie, P., Pastor, R. W., Brooks, B. R., J. Phys. Chem. B., 2004, 705(1), 363-368 
b) van Buuren, A. R., Man-ink, S. J., Berendsen, H. J. C.,J. Phys. Chem., 1993, 97, 9206-9212 
2 Berger, O., Edholm, O., Jahnig, F., Biophys. J., 1997, 72(5), 2002-2013 
3 Alper, H., Bassolino, D., Stouch, T., J. Chem. Phys., 1993, 98, 9788 
4 Anezo, C, de Vries, A. H., Holtje, H.-D., Tieleman, D. P., Marrink, S.-J., J. Phys. Chem. B, 2003, 107, 9424-
9433 
5 Berendsen, H. J. C, van der Spoel, D., van Drunen, R., Comput. Phys.Commun., 1995, 91, 43-56. 
6 Lindahl, E., Hess, B., van der Spoel, D.,J. Mol. Model!.. 2001, 7, 306-317. 
7 Nagle, J.F., Tristram-Nagle, S., Biochim. Biophys. Acta, 2000, 1469(3), 159-195 
8 Anezo, C, de Vries, A. H., Holtje, H.-D.. Tieleman, D. P., Marrink, S.-J., J. Phys. Chem. B, 2003, 107, 9424-
9433 
9 Schuy, S., Janshoff, A , Chem. Phys. Chem., 2006, 7(6), 1211-1214 
1 0 Koynova, r., Caffrey, M., Biochim. Biophys. Acta, 1998, 1376, 91-145 
" Enders, O., Ngezahayo, A., Wiechmann, M., Leisten, F., Kolb, H.A., Biophys. J., 2004, 87, 2522-2531 
1 2 Jorgensen, W. L., Briggs, J. M., Contreras, M. L.,J. Phys. Chem., 1990, 94(4), 1683-1686 
1 3 Tironi, I . L., van Gunsteren, W. F., Mol. Physics, 1994, 83(2), 381-403 
1 4 Jorgensen, W. L., Madura, J. D., Swenson, C. J., J. Am. Chem. Soc, 1984, 106, 6638-6646 
1 5 Berendsen, H. J. C, Postma, J. P. M., van Gunsteren, W. F., Hermans, J., in Intennolecular Forces; 
Pullman, B., Ed., Reidel: Dordrecht, 1981, pp. 331-342 
1 6 Berendsen, H. J. R., Grigera, J., Straatsma, T., J. Phys. Chem., 1987, 91, 6299 
1 7 Jorgensen, W. L., J. Am. Chem. Soc, 1981, 103, 355 
1 8 Guissani, Y„ Gut, B., J. Chem. Phys., 1993, 98, 8221 
1 9 Tieleman, D. P., Berendsen, H. J., R.,J. Chem. Phys., 1996, 705(1 1), 4871-4880 
2 0 Maestro, Schroedinger Inc., www.schrodinger.com 
2 1 Schrodinger, Inc.: Portland, OR, 1991-2000 
221 
2 2 Gaussian 03, Revision 1, Frisch, M. J . ; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E . ; Robb, M. A.; 
Cheeseman, J. R.; Montgomery, Jr., J. A.; Vreven, T.; Kudin, K. N.; Burant, J . C . ; Millam, J. M.; Iyengar, S. 
S.; Tomasi, J . ; Barone, V.; Mennucci, B.; Cossi, M.; Scalmani, G.; Rega, N.; Petersson, G. A.; Nakatsuji, H.; 
Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J . ; Ishida, M.; Nakajima, T.; Honda, Y . ; Kitao, O.; 
Nakai, H.; Klene, M.; L i , X.; Knox, J. E . ; Hratchian, H. P.; Cross, J. B.; Bakken, V.; Adamo, C ; Jaramillo, J.; 
Gomperts, R.; Stratmann, R. E . ; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C ; Ochterski, J. W.; Ayala, 
P. Y . ; Morokuma, K ; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Raghavachari, K.; Foresman, J. B.; Ortiz, 
J. V.; Cui, Q.; Baboul, A. G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.; Liu, G. ; Liashenko, A.; Piskorz, P.; 
Komaromi, I.; Martin, R. L . ; Fox, D. J . ; Keith, T.; Al-Laham, M. A.; Peng, C . Y . ; Nanayakkara, A.; 
Challacombe, M.; Gill , P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Gonzalez, C ; and Pople, J. A.; 
Gaussian, Inc., Wallingford C T , 2004 
2 3 Breneman, C. M., Wiberg, K. B., J. Comp. Chem., 1990, / / (3) , 361-373 
2 4 Jorgensen, W., Tirado-Rives, J . , J. Am. Chem. Soc, 1988, 110, 1657-1666 
2 5 Berendsen, H. J. C , van der Spoel, D., van Drunen, R., Comput. Phys.Commun., 1995, 91, 43-56. 
2 6 Tieleman, D.P., MacCallum, J .L . , Ash, W.L. , Kandt, C , Xu, Z., Monticelli, L.,J. Phys.: Condens. 
Matter., 2006, 18, SI221-S1234 
2 7 Tieleman, D.P., MacCallum, J . L . . J. Comput. Chem., 2003 , 24, 1930-1935 
2 8 Berger, O., Edholm, O., Jahnig, F , Biophys. J., 1997, 72(5), 2002-2013 
2 9 Jorgensen, W. L . , Maxwell, D. S., TiradoRives, ).,J. Am. Chem. Soc, 1996, 118, 11225-11236 
3 0 Berendsen, H. J. C , Postma, J. P. M., DiNola, A., Haak, J. R.,J. Chem.Phys. 1984, 52, 1695-1697 
3 1 Berendsen, H. J. C , Postma, J. P. M., van Gunsteren, W. F., DiNola, A., Haak, J . R., J. Chem. Phys., 
1984, 5/(8), 3684-3690 
3 2 Darden, T.; York, D.; Pedersen, L.J. Chem. Phys. 1993, 98, 10089-10092. 
3 3 Essmann, U., Perera, L . , Berkowitz, M. L . , Darden, T., Lee, H., Pedersen, L . G.,J. Chem. Phys., 1995, 
103, 8577-8592 
3 4 Hess, B., Bekker, H., Berendsen, H. J. C , Fraaje, J. G. E. M.,J. Comp. Chem., 1997, /<S, 1463-1472 
3 5 Miyamoto, S., Kollman, P.A., J. Comp. Chem., 1992, 13, 952-962 
222 
Chapter 6: Conclusions 
It was shown that single-molecule binding interactions between lipid and tryptophan 
derivatives in the non-competitive solvent chloroform can be studied successfully using a 
variety of techniques such as NMR host-guest and isothermal calorimetry titrations (ITC) and 
molecular dynamics (MD) simulations. This enabled the importance of electrostatic 
interactions to be assessed in a model system where the number of secondary or multiple 
interaction pathways could be either avoided or accounted for. The specific interactions 
between DMPC lipid and derivatised tryptophan compounds were analysed, the latter having 
been produced in good to excellent yields using an improved synthesis of Snyder et al} The 
prepared free amino acid derivatives could be converted to 5-monosubstituted A^-acetyl-Z-
tryptophan ethyl amides, which mimic the non-terminal tryptophan residue in proteins and 
peptides. The implemented binding model accounted for lipid micellisation, water-lipid and 
water-lipid-tryptophan equilibria extremely well. With it, the critical micelle concentration of 
DMPC in chloroform (19.71 ±3.28 mM at 21 °C) could be determined via NMR dilution 
titrations of hydrated DMPC into chloroform, which also revealed the water content of the 
lipid as purchased (2 molecules of water per lipid) and highlighted water as an association 
partner of DMPC in chloroform. These observations were supported through ITC 
experiments, where an observed heat of 6 cal mol'1 could be attributed to the release of water 
from the lipid and the CMC for DMPC at 21 °C estimated to lie above 15 mM in agreement 
with available literature data.2 
The fitting of observed chemical shift changes of the water proton signals to a binding 
isotherm could be achieved with excellent accuracy (error between calculated and observed 
values <3%). The importance of water associations was also seen in the NMR host-guest 
titrations with the tryptophan derivatives (6a-g, 6n) as host and DMPC as guest. Here, water 
was found to associate with the lipid in a competitive manner with respect to the amino acid 
analogue. Binding interactions between water and lipid and Trp:DMPC complexes could be 
determined with a high accuracy as indicated by the small observed errors (<5%) in the 
calculated binding constants of repeat runs. 
The binding of the unsubstituted tryptophan analogue (6n) to DMPC was found to be 
the least favoured (AG| = -6.05 ± 0.35 k j mol'1) while both, the association free energies for 
the formation of a 1:1 Trp:DMPC adduct with 5-MeO (6f) and 5-N02-substituted (6g) 
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compounds were determined to be approximately twice that energy (AGi = -10.20 ±0.16 and 
A d =-11.10 ±0.53 kJ mol"1 respectively). AG\ values derived from MD simulations gave 
highly consistent results for all models analysed. The two sets of partial charges used to 
represent charges on the indole ring resulted in slight deviations from the n-shaped pattern 
indicating that it is sensitive to the differences in the partial charges (±0.2 e). However, the 
absolute values obtained for the association free energies were still within 1.9 ± 0.9 kJ mol"1 
to the experimentally obtained values. The truncation of long-range interactions in the system 
under investigation from 1.9 to 1.2 nm only had a minor effect on the obtained free energies 
of association. The treatment using the larger truncation was found to approximate 
experimentally obtained free energies of association the best with an average deviation of 
1.14 ± 0.79 kJ moi"1. Therefore, this model and partial charge set was used for all subsequent 
simulations of the tryptophan derivatives. 
The calculation of binding constants and associated free energies for complex 
formation using the ratios of bound and unbound tryptophan derivatives approximated 
experimentally obtained values extremely well, slightly overestimating the free energies of 
compounds with moderate electron density on the indole ring (6a-b, 6n). The free energies of 
association were underestimated to some extend (2.81 ±0.98 kJ mol"') when calculated by 
the survival function of the Trp:lipid complex. The calculated free energy can be represented 
schematically using: 
AG, r H F < A G , N M R < A G , M P 2 a ~ A G , M P 2 b < A G , M P 2 b 2 , 
where the superscripts indicate the methods used to determine the value. 
An n-shaped pattern was observed when the free energies of association of tryptophan 
derivatives and DMPC were plotted against the Hammett parameter. The pattern obtained on 
a microscopic level was widely conserved on the macroscopic level, which could be 
approximated by summation of the individual contributions of the free energies of 1:1 and 
2:1 Trp:DMPC adduct formation. In the analysis of the observed heats associated with the 
binding of the tryptophan derivatives to DMPC, ITC experiments also exhibited a similar 
pattern, which suggests that there is no first-order relationship between the electron density 
on the indole moiety of tryptophan compounds and their binding strength to DMPC 
molecules, but instead a more complex interplay of forces and second-order electrostatic 
interactions. The observed break in the trends either side of tryptophan (R = H) is consistent 
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with as least two factors influencing the observed binding. For higher order complexes these 
factors are likely to include hydrogen bonding and cation-Tt electron interactions between 
amino acid analogues. However, no significant direct influence of the electronic density on 
the strength and preferred interaction range of cation-7t interactions between the lipid choline 
head group and the indole side chain of the tryptophan derivatives was observed in both the 
1:1 and the 2:1 Trp:DMPC binding interactions. This was also reflected in the poor clustering 
of binding conformations between the lipid and the amino acid analogue in the 1:1 
Trp:DMPC complex. The latter was shown not to be supported by hydrogen bonding 
interactions between the two molecules in agreement with observations made in the 
literature.3'4 However, as seen in both deuterium exchange NMR titrations and molecular 
dynamics simulations of a Trp:DMPC 2:1 complex, hydrogen bonding becomes more 
importance in higher order complexes. The D 2 0 titrations illustrated a relationship for the 
strength and accessibility of hydrogen bonds that followed indNH < AcNH « EtNH with 
the indole amine proton (indNH) being the most easily removed and the most accessible one 
in relation to the acetyl amide and ethyl amide protons (AcNH and EtNH respectively). The 
MD simulations suggested that hydrogen bonding interactions are a major driving force in 
the formation and stabilisation of a 1:1 Trp:Trp complex, whose formation appeared to be 
enhanced and possibly fostered by DMPC molecules present in solution, as simulations of 
two tryptophan derivatives in the absence of lipid did not show any significant association 
between the two amino acid analogues in the time span analysed. 
Isothermal titration calorimetry showed that the binding of tryptophan analogues to 
DMPC molecules can be studied in the solvent chloroform, which is a non-standard solvent 
for ITC experiments. The data analysis of the binding isotherms was complicated through the 
underlying signal of the heat of dilution of micellar DMPC solutions. However, the 
concentration of lipid solutions employed was necessary not only to increase the signal to 
noise level (which is high for measurements in chloroform), but also to approximate the 
conditions used in the NMR host-guest titrations. The non-sigmoidal response of the 
observed heat of reaction between the analogues (6a-g & 6n) and the level of detail required, 
rendered the data analysis tools that the provided analysis software (MicroCal) offered 
unfeasible. Instead the data was analysed in more qualitative terms by observation of the heat 
flow curves and associated enthalpograms. However, the qualitative evaluation of the ITC 
experiments provided data that was in good qualitative agreement with the data obtained 
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from NMR titrations and simulations. I.e. the same trend as seen in the binding free energies 
of the compounds studied interacting with DMPC in chloroform could be obtained for the 
heat signals of corresponding ITC experiments. 
Free energy calculations for the solvation of the tryptophan derivatives in chloroform 
and for 1:1 Trp:DMPC adduct formation were performed. The obtained solvation free 
energies reflected the empirically observed poor solubility of the derivatives in chloroform. 
The free energy calculations of adduct formations had too high an error associated with them 
to be sensibly compared to the data obtained experimentally. 
Finally, peptide-lipid interactions between peptides of the AcWLWLL family to a 
fully hydrated DMPC bilayer were investigated via molecular dynamics simulations. The 
conformational sampling of the peptide revealed two statistically significant conformations 
that were analysed independently in subsequent simulations. Associative interactions of 
model peptides of the AcW*LWLL family with a DMPC lipid bilayer were observed. Here, 
W* stands for a tryptophan residue that carries a monosubstitution of F, CI, Br, or I on the 5-
position of its indole ring. The peptides quickly (<5 ns) dock at the bilayer interface, remain a 
preferred mean distance from it (averaged over all: ~1.76±0.19nm from the centre of the 
bilayer), and generally adopt a preferred, extremely stable conformation (occurrence >90%). 
These conformations show some degree of freedom around the central backbone segments of 
the peptide and relatively flexible Leu4 and Leu5 residues. An altered electron density of the 
indole moiety of the tryptophan residue Trp1 was not seen to affect the association profile of 
the peptide with the lipid significantly and no trends can be seen within experimental error. 
The subtle change was not found to be sufficient to influence either the formation of binding 
conformations or the strength of the peptide-lipid interactions significantly. 
In summary, this research shows that the association of tryptophan analogues with 
DMPC lipids in chloroform appears to be an interplay of many factors, including cation-7i 
interactions, hydrogen bonding (for higher order complexes), and secondary factors (such as 
water-binding). Binding free energies might be predicted for tryptophan compounds whose 
electron density is similar to the compounds analysed in this study. The simulation of binding 
events and the computation of their associated free energies appear to be very promising, as 
the general trend of experimental values was reproducible and free energies of binding could 
be determined with a high accuracy given a reasonably long time of sampling (>50 ns). 
Binding of compounds could be analysed on a nanosecond timescale with atom resolution 
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allowing the evaluation of preferred binding conformations, hydrogen bonding as well as 
self-association of the tryptophan compounds and interactions with water. 
The obtained results reflect the observations made for tryptophan residues and 
derivatives in bilayer and membrane research suggesting their transferability. They gave 
further insight and support to the observation that hydrogen bonding interactions between 
tryptophan analogues and lipid molecules are negligible. The individual interactions between 
the tryptophan derivatives and lipid molecules seemed also not to be governed or 
significantly influenced by the permanent dipole of the amino acid analogues. The cation-7i 
interaction of the indole ring to the charged lipid head group was also seen in this research. 
Although it may not be linearly influenced by the electron density of the aromatic ring, 
binding affinities of tryptophan compounds can still be altered and adjusted using 
substituents on the indole ring. Such alterations might be of predictable strength for 
compounds with Hammett parameters with the range analysed in this study. 
6.1 Suggestions for Further Work 
The scope of the improved synthesis for tryptophan derivatives, as demonstrated in this 
thesis, should allow the production of a variety of derivatives carrying multiple substitutions 
and the synthesis of 4- and 7-monosubstituted tryptophan derivatives. These could then be 
used to study additive effects of such alterations on the indole ring and their effect on binding 
to DMPC (and other lipids), The significance of inductive and mesomeric effects (if any) in 
tryptophan derivatives for lipid-peptide binding could then be investigated. The synthesis of 
a variety of such tryptophan derivatives is currently in progress in the Sanderson lab. 
The effect of multiple substitutions and the importance of the location of an altered 
tryptophan residue in model peptides of the type AcWLWLL could also be assessed with 
minor alterations to the simulation set-ups that were used in this study. The validity and 
quality of such computations could be assessed further by experimental analysis of the 
designed peptides (e.g. via 1TC). The starting materials for the synthesis of these peptides 
and the proof of concept that such a synthesis is feasible were provided in the preparation for 
this thesis. 
The use of monosubstituted tryptophan analogues as fluorescent probes and the 
intrinsic change in their emission spectrum upon binding to DMPC could provide an 
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interesting tool for the multiple, simultaneous structure determination of proteins and 
peptides and their adopted conformations upon binding to lipid bilayers. (Substituted 
tryptophan compounds have been shown to exhibit different absorption/emission profiles, 
which could be used to distinguish between individual tryptophan residues in a protein 
sequence). 
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Chapter 7: Appendix 
7.1 Solving a Cubic Equation 
A cubic equation ax3 + bx2 + cx + d = 0 can be solved by substituting x with x = y . This 
results in the depression of the cubic equation to the quadratic expression: 
ay + 
( L2 \ 
3a y + 
( J 2b} be 
d + r 
27a" 3a 
= 0. 
3a 
(7.1) 
Let q = 
9abc-21a2d-2bi 
54a3 
( 3ac-b2 ^ 
9a2 + q- . 
5 = \jq + r , and 
The solutions for x are then: 
x. - s +1 - -3a 
1/ n b V3 / v 
2 3a 2 
1/ n b V3 / v 
2 3a 2 
Applied to equation 2.1.4, the factors a, b, c, and d can be expressed as: 
a = Km{Km-KJ), 
b = (2Kd-2Km-Km2Lr), 
c = (\ + 2 K X r \ 
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d = -L"' 
7.2 Calculations of the Concentrations of Species 
7.2.1 NMR Titrations of hydrated DMPC into Chloroform 
7.2.1.a Concentration of Water:Lipid Adducts 
The concentrations of watenlipid adducts and free, unbound species were calculated 
iteratively by solving the following equations: 
[W] = [W\-[WL\-2[W2L\ 
W l ] = x - V * 2 - 4 K J ' Z 2 ( [ W ] 0 - 2 [ W 2 L M L ] 0 - [ M ) 
where x = \ + 2K]W1Z([L]0 - 3[W2 L] + [w]0) and 
Z = \ + [L]2Km2-2[L]Km 
where x = 1 + 2K2wl (2[w]0 - [w] - [WL]) 
^ _ 1 + X - V ( 1 + X ) 2 -{2Kmxf 
where x = 2Km {[L]0 - [WL] - [\V2 L\) 
[LI=[L\-[L)-[WL]-{W2L]-2[L\2 
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7.2.1.b Fitting of the Observed Chemical Shift for DMPC blank titrations 
The observed complexation-induced chemical shift for the water protons 80bs,w could then be 
fitted to 
obs.W 
K , „ , [ £ ] ( £ „ „ - 5 f ) + 2K2wl[WL](5boumi2w - S , j 
+ S, 
\ + KuJL] + 2K2wl[WL] 
where Ki„,/ and K.2W/ are the binding constants for the formation of WL and W->_L 
complexes respectively with their associated limiting chemical shifts Stou„d\w and Sbmmdiw, 
8f refers to the chemical shift of the free, unbound water species W. 
The observed complexation-induced chemical shift for the lipid protons S0bu could then be 
fitted to 
+ 5 f , 
where K|„,/ and K.2,w are the binding constants for the formation of WL and W2L 
complexes respectively with their associated limiting chemical shifts Sbound\w a n d Sboimd2^ 
Sf refers to the chemical shift of the free, unbound water species L. 
7.2.2 NMR Host-Guest Titrations of Tryptophan Derivatives with DMPC 
7.2.2.a Concentration of Trp: Lipid and Water .Lipid Adducts 
The concentrations of 1:1 and 2:1 Trprlipid adducts and water:lipid adducts were calculated 
iteratively by solving the following equations: 
[ L T ] = A- - jx2 - 4K? ( [ 4 - [WLT]- [WL] - [W2L] - [LT2 - 2[LT2 ]- l[LTwl 
where x = 1 + K, <[L\ - 2[WLT] - [WL] - [W2 L] - 3[LT2 ] + [T)0 ) 
[LT2} = 
V A - 2 - 8 i C 2 2 ( [ 4 - [ L ] - [ W L T ] - [ W L } - [ W 2 L M T l - [ L T ] - [ L T W ] ) 
4a:, 
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where x = 1 + K2{[T]0 - [LT]-3[WLT] + 2 ( [ 4 - [L]-[WL\-[W2L]}) 
\ w l t ] _ * - V * 2 - 4 K ' < d4 - M - M - ^ l - K ^ l , - [ L T \ - 2 [ L T ^ 
L J 2K\ 
where * = 1 + K\ ( [ 4 - 2[LT]- 3[LT2] + [L]0 - [L]-[W2L]) 
. 1 = x - V x 2 - ^ ( W - 2 [ ^ z ] - [ ^ r M 4 - [ i r ] - [ p f i r ] - [ ^ 4 i r 2 ] ) 
where x = I + I w , ( [ ^ ] 0 - 3 [ W 2 £ ] - 2 [ f W T ] - [LT2]+ [ 4 - [ z r ] ) 
\w L\-X~^XZ " 8 ^ ( t 4 - M - [ W L ] - [ W L T ] - [ L T M W \ -[WL]-[WLTI 
where x = \ + K2WL <[w\ - [WL\-3[WLT]+ 2 ( ' [ 4 - [ l ] - [ Z T ] - [LT2]j) 
[ 4 = [ 4 - [ L 7 ] - [ i r 2 ] - [ ^ r ] - [ ^ ] - [ ^ z ] 
7.2.2.b Concentration of Free, Unbound Species 
The concentrations of free tryptophan, lipid and water were calculated according to the 
concentration differences: 
[T]=[T]0-[LT]-2[LT2]-[WLT] 
[L] = [ 4 - [LT] - [LT2} - [WLT] - [WL] - [W2 L] - [L„ ] 
[W] = [W\ - [WLT]-[fVL]-2[W2L] 
7.2.2.C Fitting of the Observed Chemical Shifts 
The observed chemical shift S0bs could then be fitted to 
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+3, obi (, „ r,i „ r, ™ri ^ e e 
where Sfree, Sboundu 3bm,n<n, and Sboundv are the chemical shifts of the tryptophan 
analogue as free species, in the h i and 2:1 Trp:lipid adduct and the 1:1:1 Trp:water:lipid 
adducts respectively with Ki , K.2, and K\ describing the corresponding binding constants at 
these states. 
7,3 NMR Chemical Shift Data 
7.3.1 NMR Titration of Hydrated DMPC into Chloroform 
• I H 2 0 
1.468 3.402 4.294 4.501 5.256 ppm 
3.326 3.430 2,450 3.619 5.151 ppm 
5 l w l 5.759 3.270 3.934 4.272 5.202 ppm 
sm - 3,399 4.504 4.616 5.180 ppm 
A3M 1.858 0.028 -1.844 -0,882 -0.105 ppm 
A52wl 4.291 -0.132 -0.359 -0.229 -0.054 ppm 
A3m - -0.003 0.210 0.115 -0.076 ppm 
K l H , 31.73 31.73 32,05 31.73 31.73 A/"' 
122.09 122.09 117,99 122.09 122.10 M* 
143.78 143.78 146,16 143.79 143.73 
Table 7,1: Chemical shift data for the titration of hydrated DMPC into chloroform. Sftef&cs to the chemical 
shift of the signal of the free unbound species; Siw!, 8iWi and Sm are the limiting chemical shifts for the 1:1 and 
2:1 watenlipid adducts and micellar lipid respectively with their associated binding constants K J f K2, and K„. 
Aftwi, &&wi and A<5u stand for the chemical shift change of the adducts with respect to Sfi.ee. 
7.3.2 NMR Host-Guest Titrations with A -^acetyl-i-tryptophan derivatives (6a-g, 6n) 
The chemical shift data of the free, uncomplexed tryptophan derivative, 3^, the limiting 
chemical shifts A w i and Sbouma for the 1:1 and 2:1 Trp:lipid adduct formation with the 
respective binding constants Ki and K2 are given in this section. The calculated values for the 
limiting chemical shift for the association of a tryptophan derivative to a 1:1 DMPC:water 
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adduct, Shoundr. and the associated binding constant for this process, Ki' are presented along 
with K]W\ the association constant for the binding of water to a 1:1 Trp:lipid complex. 
Relative chemical shift changes of the limiting chemical shifts of adducts with respect to Sfree 
are shown as A< ,^ and Aft respectively. 
iV "-Acetyl-!, -tryptophan ethyl amide (6n) 
Sfree 8.166 7.761 7,394 5.460 2.004 6.361 0.885 
Abound 1 6.880 8.546 8.289 6.946 1.846 2.706 0.873 
Sbound 2 9.360 7,532 6.806 4.967 2.012 3.291 0.858 
Abound 1' 13.821 7.353 7.460 9.392 1.889 8.959 1.121 
-1.286 0.786 0.895 1.487 -0.158 -3.655 -0.0! 1 
AS2 1.194 -0.228 -0.588 -0.493 0.008 -3.071 -0.026 
ASi 5.655 -0.407 0.066 3.933 -0.1 i 5 2.598 0.237 
K x 1 1.5 11,4 11,2 11.7 11.3 11,7 11.7 11,57 ± 0.20 
K 2 I 14.3 114,5 115.1 113.5 115.1 1 12.6 1 12.9 113,40 ± 1,11 \r 
K S * 163.4 165.0 158.7 167.8 165.2 167.5 167.1 165.68 3.33 I f * 
Kiw" 452,7 459,1 450,2 456.5 464.1 453.8 452.8 454.36 ± 4.95 M
4 
Na- Acetyl-5-fluoro-X -tryptophan ethyl amide (6a) 
8,097 7.112 6.279 5,483 2,005 6.952 0.909 
Abound 1 7.384 8.461 5.168 5.472 2,011 8.009 0.985 
Sbound 2 11.209 6.970 6.673 7.789 1.882 6.628 1.032 
3bound I' 15.607 7,514 9,285 10,781 1.834 6,595 1.165 
ASt -0.713 1.350 -1,111 -0.0!! 0.006 1.057 0.076 
AS2 3.112 •0,142 0.394 2.306 -0,123 -0,324 0.123 
AS!' 7.510 0.402 3,005 5,298 -0,171 -0,358 0.255 
K i 17,7 19,4 16,7 18,6 17,4 17,6 18.3 18.04 ± 0,84 M'
x 
K 2 274.9 269.7 293.9 278.8 277.8 273.6 271.0 277.24 9.01 M
A 
K , ' 158.5 158.4 158.4 158.4 158.4 158.4 163,1 158.50 ± 1.91 M'1 
K i w ' 283,5 258.6 301,2 270,4 289,2 285,2 282,9 282.17 ± 14.51 M4 
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7Ya-AcetyI-5-chloro-l -tryptophan ethyl amide (6b) 
Sfree 8.142 7.681 2.009 0.923 
&bound X 8.229 7.327 1.899 6.858 
8 bound 2 13.255 7.504 1.958 0.064 
Abound %{ 13.782 7.428 i .873 0.625 
0.087 -0.354 -0.109 5.935 
AS2 5.114 -0.177 -0.051 -0.859 
ASt' 5.640 .0.253 -0.1.36 -0.297 
Kx 24.3 23.9 24.2 23,8 24.00 ± 0.33 AT 1 
K 2 237.3 232.4 236.7 215.X 237.13 ± 4.78 M
A 
K»" 255.6 261.4 254.4 255.6 255.89 ± 5.51 M"
1 
Kiw" 333.6 346.8 333.9 340.6 334,16 ± 12.63 A T
1 
A^a-Acetyl-5-bromo-Z, -tryptophan ethyl amide (6c) 
Sfree 8.161 7.072 6.258 5.517 2.006 7.814 0.923 
&bound 1 8.947 7.722 4.704 4.865 1.953 8.676 1.066 
& bound 2 12.298 6.959 7.724 8.579 1,967 7.523 1.120 
3 bound 1' 14.144 7.452 8.901 9.214 1.885 7.527 1.108 
0.786 0.650 -1.554 -0.652 .0.052 0.862 0,143 
AS2 4,137 -0.113 1,466 3.062 .0,039 .0.291 0.198 
ASi 5.983 0.379 2.642 3.698 -0.120 -0.287 0.185 
K i 24.4 26.7 26.3 30.2 29.2 28.4 28,1 27.10 ± 1.68 A T 1 
K 2 231.7 193.2 175.3 199,5 204.9 196.3 212.0 211.02 18.92 A/"
1 
Kt' 249.0 258.0 218.7 298.1 304.7 304.0 286.4 261.09 ± 35.46 A T
1 
325.5 306.1 264.1 313.4 331.4 339.4 573 9 311.99 ± 26.89 A T ' 
7Va-Acetyl-5-methyl-£ -tryptophan ethyl amide (6e) 
8 free 7.992 2,014 7.062 7.025 7.520 2.469 5.331 7.020 
0 boundi 8.283 2.091 8.567 5.738 7.905 5.194 7.531 7.569 
8 bound 2 10.849 1.901 6.065 7.672 7.246 2.018 1.718 6.689 
& bound X' (3.707 1.886 6.591 7.564 7.176 2.215 4.663 6.710 
AS i 0.291 0.077 1.505 .1.287 0.385 0.724 2.200 0.549 
AS2 2.857 -0,113 -0.997 0.646 -0.274 -0.452 -3.613 -0.53 i 
ASi 5.805 -0.128 -0.470 0.539 -0.344 -0,254 -0.668 -0.310 
Kx 31.8 35.1 31.8 36.! 35.1 39.9 36.1 35.1 35.36 ± 2.16 A T
1 
K 2 150.4 151.9 157.5 156.7 151.8 159.7 166.7 151.8 161.36 ± 5.05 M
A 
191,8 249,9 238.4 255.1 249.9 249.9 258.9 249.9 212.31 ± 26.95 M A 
191.6 225.6 238.1 224.2 225.7 198.7 227.7 2257 203.31 19.88 A/"
1 
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Ara-Acetyl-5-methoxy-£ -tryptopl hyl amide (61) 
8 free 7,967 2.024 5,365 6,388 6,855 7.036 3,893 0.896 
&bound 1 8.640 1.75 I 6.125 6.372 6.851 7.398 3.673 0.797 
Abound 2 8.799 2.031 5.952 6.446 6.816 7.001 3.895 0.954 
Abound 1' (4995 1,928 10,656 9,274 6.556 7,398 3.814 1.233 
0.673 -0.273 0.760 -0,016 -0 004 0.362 -0.22 i -0.100 
A82 0.832 0.006 0,587 0.058 -0.039 -0.035 0 002 0.058 
ASt' 7.028 -0.096 5.291 2,886 -0.299 0.362 -0.079 0.336 
Ki 60.7 59.4 61,0 60,9 60.8 62.3 61.3 6 1.0 60.94 ± 0,68 M
A 
K 2 2%. 7 298.6 294.6 304,6 296,7 297,4 295.9 296.5 296.22 ± 3.61 M'
1 
K i ' 168.4 162.9 164.7 166.1 168.5 170.6 167.8 168.9 166.85 4 2.65 MA 
88,1 87.0 85,7 86,6 87.9 87.0 86.9 87,9 87.01 ± 0.84 MA 
Na-Ace* ^1-5-nitro-Z, -tryptophan ethi ?\ amide (6g) 
<5free 8417 8,630 8,143 2.013 0,963 7.375 6.224 
8 bound 1 12.596 8,261 7.429 1.514 1,834 8.3 75 9.676 
^bound2 12.095 8.539 8.019 1.885 0.963 7.382 6,779 
8bound V 14.421 8.540 8,051 1.874 0.881 7.427 7.879 
ASt 4.180 -0,369 -0,714 -0.499 0.871 1,000 3,452 
AS2 3.678 -0.091 -0,124 -0,129 0,000 0.007 0.555 
ASS 6.505 •0.090 -0.092 -0.139 -0.082 0,053 1.655 
K t 89.7 89.1 89.2 83.6 91.4 89.0 86.2 88.40 ± 2.44 AT' 
K 2 488.0 489,0 496,7 492.7 477,1 493.1 482.9 487.82 ± 10.10 
Kx' 379.9 380.2 384.9 369.1 397.3 378.7 390,0 381.56 ± 13.31 M'1 
134.4 135.4 137,0 140,0 137.9 135.1 143.5 136.06 ± 4.81 M-1 
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7.4 Physical Constants of Tryptophan Analogues Plotted against Observed 
Free Energies of Association 
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Figure 7,l! Physical constants of tryptophan analogues plotted against observed free energies of association, 
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7,5 <g(r)>, of Trpl and Trp2 to DMPC 
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Figure 7,2; <g(/)>, of intermoleeuJar 
distances between Trpl and Trp2 hydrogen 
bond donors (acetyl amide (AcNH). ethyl 
amide (FlNH) and indole amide proton*. 
(indNH) respectively) to hydrogen bond 
acceptors in the DMPC molecule (the lipid 
carbonyl oxygens (DMPCJTQ1 and 
DMPC C02) and non-bridging phosphate 
oxygen atoms (DMPC_PO] and 
DMPC_P02) respectively, 
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7,6 Parameter Sets: 
a) 
Jt _ 
ns i l i s l | « 10 10 10 
Is 
mil r i u i 1.0 I . I) \ } ) 1.2 
toulomb-typc* 
1 i ! i I 
r /,.,„/, i 1.2 i 1.2 i \F> 1.2 n m 
vilVV=fypo 
nm 1 ,y i ,y 1.9 1,5 
Iburiei^paciriM 0,12 0,12 0.12 0.12 nm 
I 'MI tinier 4 4 4 4 
bvvald rmi \ir UT
S ur i t r 
Ewald geometry 3D 
/"cotipliiig licrcllilsen 
T 205 205 205 300 K 
Pr 0.1 0.1 0.1 0.1 ps 
p coupling Berendsen 
p coupling type isotropic isotropic j isotropic semi-isotropic 
— — — 
P IX) i.O 1.0 i.O bar 
r„ 5.0 5.0 2.0 1.0 ps 
compressibility 4.5 x 10- 4.5 x W* i 4.5 x 10- 4.5 x 10" 
constraints all-bonds 
constraints algorithm U N C S 
LINCS order 4 4 4 4 
LJNCS iteration 6 6 6 6 
LINCS warn angle 30 30 30 30 
T«ble 7.2s Table containing the parameter used in the MD simulations, "Parameters are defined in the text 
below, 
(ft refers to the time step used in the calculation; nstlist gives the number o f timesteps after 
which the neighbour list w i l l be updated; rm> r c i m u > m h and rvJW give the cut-off radii for the 
truncation o f the neighbouring list, calculation o f coulombic interactions and van der Wals 
interactions respectively; Coulomb type refers to the treatment o f long-range electrostatic 
interactions used; T and p coupling refer to the coupling of the temperature T and the 
pressure p with respective coupling constants TT and vP and the pressure coupling type, p 
coupling; cr refers to the relative dielectric constant; fourierspacing refers to the maximum 
grid spacing for the Fourier function transformation grid tor PME, which uses PME order 
with a tolerance defined by Ewald rmi. 
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